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Abstract 
Background: Descriptions of data, metadata, provide researchers with the 
contextual information they need to achieve research goals. Metadata enable data 
discovery, sharing and reuse, and are fundamental to managing data across the 
research data lifecycle. However, challenges associated with data discoverability 
negatively impact on the extent to which these data are known by the wider 
research community. This, when combined with a lack of quality assessment 
frameworks and limited awareness of the implications associated with poor quality 
metadata, are hampering the way in which epidemiological and public health 
research data are documented and repurposed. Furthermore, the absence of 
enduring metadata management models to capture consent for record linkage 
metadata in longitudinal studies can hinder researchers from establishing 
standardised descriptions of consent.  
Aim: To examine how metadata management models can be applied to 
ameliorate the use of research data within the context of epidemiological and public 
health research.  
Methods: A combination of systematic literature reviews, online surveys and 
qualitative data analyses were used to investigate the current state of the art, 
identify current perceived challenges and inform creation and evaluation of the 
models.  
Results: There are three components to this thesis: a) enhancing data 
discoverability; b) improving metadata quality assessment; and c) improving the 
capture of consent for record linkage metadata. First, three models were examined 
to enhance research data discoverability: data publications, linked data on the 
World Wide Web and development of an online public health portal. Second, a 
novel framework to assess epidemiological and public health metadata quality 
framework was created and evaluated. Third, a novel metadata management model 
to improve capture of consent for record linkage metadata was created and 
evaluated.  
Conclusions: Findings from these studies have contributed to a set of 
recommendations for change in research data management policy and practice to 
enhance stakeholders’ research environment.     
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Chapter 1 Introduction    
1.1 Epidemiological and public health research studies 
Epidemiological and public health data hold considerable research 
potential. These data provide a richness and longevity that can be harnessed 
to investigate disease and inform health policy and practice. Bringing 
together these data to enable these applications require increased 
standardisation and improved documentation.      
Electronic health records (EHRs) - longitudinal records of health and 
administration of care for an individual, potentially spanning several 
healthcare-related organisations (BS EN ISO 2012) - contain a set of rich 
data which can be utilised for secondary purposes such as research. By 
generating clinically phenotyped cohorts based on information sourced from 
EHRs, researchers are able to investigate disease across large populations 
at a relatively low cost (Rubbo, Fitzpatrick et al. 2015). Clinical information 
stored in EHRs has become a valuable resource and their strategic 
secondary use is helping to maximise their research benefits (Martin 2003; 
Coveney 2005; Chute, Ullman-Cullere et al. 2013). There are a variety of 
different data types, Table 1-1. 
Table 1-1 Types of data 
Type of data Description  
Clinical/General 
These records contain general clinical information about the 
administration of healthcare. These records can be produced 
and maintained at GP surgeries as part of primary care or 
hospitals as part of the administration of secondary care.  
Genetic 
Following genetic screening and diagnostic tests in 
secondary care, genetic information is collated and stored in 
the clinical records of patients. 
Imaging 
Images produced from MRI, PET or ultrasound scans are 
often produced in secondary care settings such as hospitals. 
Audiological  
These records assist with the treatment and/or managing of 
audiological conditions including the enabling of certain 
physiological and psychological interventions.  
Introduction 
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National resources such as the UK Biobank have to date recruited 
500,000 participants aged 40-69 from 2006 to 2010 (2016p). Consent was 
requested from the participants to gather anthropometric measurements and 
obtain biological samples. Resources such as these provide researchers with 
a comprehensive set of data which may be investigated; findings from 
analyses can help to inform recommendations for change in health policy 
and practice.     
1.1.1 Record sharing and record linkage 
In the UK and other countries such as the USA, Sweden, and 
Australia, it is possible to share and link records together. Record sharing 
involves giving a researcher or research group access to particular records. 
Record linkage involves combining records together from disparate sources 
to create enriched datasets. The research potential of these datasets can be 
harnessed as part of more complex investigations into the origins of disease. 
There are two types of record linkage: a) deterministic record linkage 
involves integrating records using unique common identifiers such as the 
NHS number (a unique series of ten digits from zero to nine assigned at birth 
or at first interaction with the healthcare system which uniquely identifies a 
patient) from multiple disparate health datasets; and b) probabilistic record 
linkage involving stakeholders calculating the probability that the records 
related to the same individual. It is also possible to link health records to 
other types of administrative records such as education.  
To perform record linkage in the UK, consent from research 
participants can be requested or permission to suspend the need for consent 
may be obtained from the National Information Governance Board. (Knies, 
Burton et al. 2012) The consent form itself must be written using accessible 
terms and encourage conversations between the participant and researcher. 
(Gori, Greco et al. 2012) Furthermore, the participant must be given the 
opportunity to ask questions and gain further clarification before confirmation 
of understanding and informed consent can be obtained.  
 
Introduction 
20 
 
1.1.2 Reusing existing datasets for epidemiological and public 
health research purposes 
Epidemiological and public health research studies draw on the wealth 
of clinical data available from sources such as the Clinical Practice Research 
Datalink (CPRD) (2016f). These disparate data sources are linked and their 
research opportunities harnessed by research platforms such as CALIBER 
(Denaxas, George et al. 2012). CALIBER combines linked electronic health 
records from various sources including CPRD.  
Sharing epidemiological and public health data facilitates collaboration 
between multiple institutions helping to achieve common research goals, 
reduce redundant efforts, and promote transparency (Thiru, Hassey et al. 
2003; Tenopir, Allard et al. 2011; Borgman 2012). For example, research into 
Autism spectrum disorder (ASD) demands large quantities of genotypic and 
phenotypic data; therefore, cross-organisational collaborations are vital if 
results are to be replicated and the causes of disease better understood 
(Johnson, Whitney et al. 2010). In the case of muscular dystrophy, families 
often altruistically share their clinical data with researchers, knowing that the 
findings of such studies may not necessarily be of direct benefit to 
themselves (Kush and Goldman 2014). Alzheimer’s research has also 
benefited from data sharing on a global scale. The Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) (2016a) provides researchers with MRI and 
PET images along with genetic, cognitive test and biomarkers to enable 
research into this area of mental health disease.  Another example of where 
the sharing of data has enabled epidemiological and public health research 
is the Emerging Risk Factors Collaboration (ERFC) (2016h). This is a central 
database which brings together over 125 studies with over 2 million 
participants to facilitate cardiovascular research.  
Further, sharing research data can potentially lead to an increase in 
citation rates. According to a study by Piwowar, Day et al. (2007) looking at 
the association between cancer microarray data sharing practices in clinical 
trials and increased citation rate, the authors found researchers who shared 
their data were cited approximately 70% more than those who did not.  
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On 10 January 2011, a Joint Statement of Purpose was launched to 
address issues relating to the availability of public health and realise visions 
of increased data sharing and efficiency of use (Walport and Brest 2011). 
Pisani, Whitworth et al. (2009) suggested that barriers to data sharing can be 
categorised into the following: a) ethical, b) technical, and c) professional. 
The authors also suggested that improved data management is vital 
particularly in certain developing countries where it is virtually non-existent.    
Furthermore, limited academic and career incentives can discourage 
researchers from publishing datasets. Consequently, the potential for data 
sharing and recognition to be awarded to those involved in research data 
management is reduced (Pisani, Whitworth et al. 2009). Other challenges 
associated with data sharing as identified through a systematic literature 
review include: financial costs, concerns over effective data governance and 
insufficient technology to meet the demands of data sharing whilst maintain 
patient privacy and confidentiality (Hopf, Bond et al. 2014).  
According to a study by Tenopir, Allard et al. (2011), limited data 
documentation (metadata) can also negatively impact the extent to which 
research data are shared. An inability to fully understand the data can 
potentially reduce scope for data reuse. There are also issues relating to the 
long-term archiving of such data and the undervaluing of the effort taken by 
those responsible for preparing the dataset for submission to a repository 
(Pisani and AbouZahr 2010; Kolker and Stewart 2014).  
Furthermore, inconsistencies between steps taken to manage and 
curate research data can potentially reduce the extent to which these data 
may be combined and used as part of more complex queries (Kush and 
Goldman 2014). This then gives rise to other potential problems such as 
reduced accuracy in meta-analyses as researchers are unable to analyse 
certain datasets for potential inclusion in their study (Ioannidis 2012).  
In epidemiological and public health research studies, the use of 
linked longitudinal data from multiple disparate clinical data sources must be 
matched with metadata management frameworks to facilitate meaningful use 
of these data (Mougin, Burgun et al. 2006; Safran, Bloomrosen et al. 2007).  
Such frameworks include those designed to support research data storage, 
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Figure 1-1 Stages of the research data lifecycle 
interoperability and longer-term archiving of data and metadata (Meredith, 
Crouch et al. 2010).  
1.1.3 A data lifecycle-based approach to epidemiological and 
public health research studies 
The inherent complexity and heterogeneity of clinical data can lead to 
difficulties when trying to process these data for epidemiological and public 
health research. A motivation to promote a cyclical approach to research 
data management, involving increased data reuse and repurposing, has 
begun to catalyse a shift in research culture. Stakeholders are increasingly 
being encouraged to work even more closely to maximise the potential 
benefits associated with this cyclical approach to research data 
management.  
The research data lifecycle (RDL) maps the different stages 
associated with a research study, Figure 1-1.  
 
 
 
 
 
 
 
 
 
 
 
Once a study has finished, findings have been published, and the data 
archived, there could be potential to repurpose the data and reuse it. 
Therefore, the life of that research data continues and a new cycle begins. 
The RDL successfully conveys the associated potential longevity of 
epidemiological and public health research data. It is through this process of 
data discovery, repurposing and reuse that the life of research data 
continues. Nevertheless, the extent of use is in accordance with consent 
given by the participants, stipulations from funding agencies, embargos, 
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applicable law(s) and any other factors which could potentially affect use. It is 
also possible for data to be destroyed, known as data destruction, should this 
be necessary.    
1.2 Drivers for change in epidemiological and public health research 
data management policy and practice 
1.2.1 Changes in research culture 
The agreeing of the FAIR principles for managing and stewarding 
scientific data signify a collective acknowledgement of the importance of 
enhanced research data management. The principles, Findability, 
Accessibility, Interoperability, and Reusability serve to guide researchers and 
other stakeholders on how to maximise potential research benefits 
associated with publications, tools and other such scholarly artefacts. Having 
FAIR research artefacts can help to address issues relating to the research 
data management such as, having sufficient metadata to describe a resource 
for discoverability and interoperability purposes (Wilkinson, Dumontier et al. 
2016). 
These changes in research culture also extend to the way in which 
scholarly publications are managed. As from April 2016, for a publication to 
be eligible for inclusion in the next Research Excellence Framework, (2016o) 
the author accepted manuscript must be made openly accessible within 90 
days of acceptance. Also, the Policy on Open Access (RCUK 2013) 
stipulates that all publicly funded research papers must be openly 
accessible. These policies are also in keeping with recommendations made 
by the European Commission (2012) and World Health Organization (2013b) 
to enhance the research environment.  
These changes in the way in which publications are managed 
encourages researchers to adapt the way in which they handle their research 
data in both the short and longer term. Often journals, such as PLOS 
(2016n), request the underlying research data be made accessible to the 
reviewer and sometimes request researchers deposit their data into 
repositories. Currently, there is a need for improved approaches to managing 
epidemiological and public health research data particularly given their 
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increasing complexity and the potential for future re-use (Anderson, Lee et 
al. 2007).  
1.2.2 Funder policies and increased investment 
Funder policies have been a driving factor in the shift towards 
enhanced research data management practice; whilst safeguarding the 
privacy and confidentiality of research study participants. In 2015, the RCUK 
revised the Common Principles on Data Policy (RCUK 2015b) and provided 
guidance on best practice in the management of research data (RCUK 
2015a).  In 2016, the RCUK also published the Concordat on Open 
Research Data which sought to ensure research data are made openly 
available within the limits of any applicable legal, ethical and regulatory 
frameworks (RCUK 2016).  
Certain funding agencies are requesting that researchers include data 
access statements in their journal article with funding councils such as the 
EPSRC stating that making data available solely upon request via email is 
insufficient. By researchers describing how the underlying research data can 
be accessed, the potential for data to be discovered, repurposed and reused 
potentially increases as does the scope for replicating and verifying research 
findings. There is also the potential to assign a globally unique, persistent 
identifier such as a DOI (digital object identifier) to the journal article and data 
and for these both to be citable. 
Furthermore, in January 2013, it was concluded by fifty delegates 
from eight countries that to meet the requirements of the clinical, research 
and patient communities, a global alliance, and technology platforms with 
open standards are needed to support data sharing (2013a). Another such 
example is the agreement of the UK government to investigate secure 
methods of data sharing in support of research (Economic & Social 
Research Council 2013) based on the findings of a report published by the 
Administrative Data Taskforce (2012).  
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1.3 Metadata 
1.3.1 Definition  
A fundamental component to the cyclical use of research data is the 
provision of, and access to, data documentation – metadata.  
Metadata are data about data and the process through which they were 
collected. 
Research artefacts such as data dictionaries (an example of 
metadata), are indispensable to researchers and support secondary use of 
clinical data for research. 
1.3.2 Stakeholders: creating and using metadata 
Metadata can be created and used by stakeholders in epidemiological 
and public health research settings across the research data lifecycle. For 
example, researchers and other users of data can create metadata during 
the data collection phase of projects. Information about which data were 
collected, when and why, can form research artefacts such as data 
dictionaries which are an example of metadata. They can also create 
metadata when analysing these data in the form of notes contained within 
analysis plans. Researchers can also create metadata detailing how 
research data should be stored and accessed (e.g. access to data safe 
havens are needed to enact data access protocols) in the form of data 
management plans. Subsequently, data managers, librarians, archivists and 
other stakeholders involved in managing research data can utilise these 
metadata in the form of data management plans to store these data on both 
a short and longer term basis.  
Other stakeholders in epidemiological and public health research, 
such as funders, can create and share metadata of the research studies to 
which they are affiliated. These metadata could be contained within online 
catalogues which can be utilised by other stakeholders; an example of this is 
the MRC Gateway. Collections of metadata records can help members of the 
research community to learn of existing research studies and which data 
were collected. Having access to this kind of information is particularly 
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important when wanting to discover and reuse existing data to maximise their 
research potential.  
1.4 Metadata and its importance to epidemiological and public health 
research   
Epidemiological and public health data have many potential research 
benefits. For these benefits to be realised, and research opportunities 
maximised, the users of these data need access to good quality metadata. 
Good quality metadata are key to opening up epidemiological and public 
health data for potential repurposing and reuse. Metadata provide the much 
needed context to enable stakeholders to investigate these data further and 
determine where additional research benefits may be realised (Liolios, 
Schrimi et al. 2012).    
1.4.1 The role of metadata in honouring consent and other ethical 
issues 
Honouring the limits of consent in a research study is a key aspect of 
epidemiological and public health research. Metadata are important to 
helping to protect the rights of study participants and assisting stakeholders 
in observing the limits of consent and addressing other ethical issues. For 
example, having access to good quality metadata can help stakeholders to 
determine where the Data Protection Act 1998 applies; for example, the act 
would apply if the study involves living participants. Having access to this 
kind of metadata is important to helping stakeholders fulfil legal and ethical 
obligations when using these research data.  
Access to good quality metadata can also help stakeholders to 
determine under which circumstances ethical approval was given to the 
primary researchers/data users. Having access to this kind of metadata is 
particularly important when wanting to share and reuse data ethically. In a 
study by de Vries, William et al. (2014), a concern shared by some of the 
interviewees around data sharing was that ethical approval was awarded to 
collect and use the data in a particular way. However, secondary users of the 
data could potentially use these data differently to the primary research 
team. Consequently, secondary users of the data must ensure the data are 
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used in accordance with the participants’ wishes and that legal and ethical 
obligations have been met. Hence, having access to good quality metadata 
detailing the scope of ethical approval is important to helping secondary 
users of data meet ethical obligations.   
Furthermore, having access to good quality metadata can also enable 
stakeholders to begin charactering research data without having direct 
access. For example, having detailed metadata about variables could help 
data users to gain a better understanding of which data were collected and 
how they may be utilised. Withholding direct access to the research data until 
such time it can be made available, could help to protect the privacy and 
confidentiality of participants, particularly in studies where the data collected 
is of a highly sensitive, personally identifiable nature. It is in these situations 
where good quality metadata is pertinent to enabling the research process. 
1.4.2 Challenges I: poor quality metadata 
Harnessing the benefits associated with metadata is challenging given the 
current inconsistencies in the availability and quality of these metadata. For 
example, in genomics research, stakeholders wanting to contextualise 
genomic research data, are in some instances unable to do so due to a lack 
of available metadata (de Vries, Williams et al. 2014). There are also 
instances whereby metadata contain missing fields and inaccuracies 
(Panahiazar, Dumontier al. 2017; Dumontier, Gray et al. 2016; Marc, Beattie 
et al. 2016). Consequently, stakeholders wanting to discover and 
characterise data, with a view to repurposing and reusing them for research, 
are hindered from doing so. It is these challenges which give raise to the 
need for improved quality of metadata and the subsequent enhanced 
discoverability of research data.  
Further, metadata are often not subject to the same level of the 
scrutiny as the research data to which they are associated. However, 
application of standards only affects the way in which the metadata elements 
are structured and does not necessarily influence the way in which the 
corresponding fields are completed by stakeholders. Therefore, the quality of 
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metadata instances is variable; a potential outcome is standardised, poor 
quality metadata Figure 1-2. 
 
Figure 1-2 High level metadata quality vs standardisation categories 
 
 
 
 
 
 
 
 
 
 
Acknowledgement is given the varying degrees of compliance to standards and the quality 
of metadata and Figure 1-2 is designed to present a very high level view of how instances of 
metadata could potentially be categorised according to these two factors. 
1.4.3 Challenges II: lifecycle-based metadata  
According to a literature review by Ochoa and Duval (2009) two 
methods of metadata evaluation were identified: a) manual, which involves 
individually reviewing metadata and evaluating quality, and b) statistical - 
using computational techniques for defining metrics to evaluate metadata 
quality. Nonetheless, metadata are domain-specific and require fit-for-
purpose metrics be created and evaluated to assess quality. Given that 
metadata are critical to the research process, much is needed in the way of 
developing and integrating metadata quality assessment into stakeholders’ 
workflows in public health and epidemiological research and across the 
stages of the research data lifecycle.   
At the data discovery and access stages, the provision of high quality 
metadata has the potential to help characterise the data and support 
researchers in deciding whether or not to request access (Taylor, Field et al. 
2008; Pickett, Liu et al. 2013). According to a study by Rans, Day et al. 
(2013) evaluating current mechanisms for public health data citation of which 
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metadata plays a key role, assigning unique and enduring identifiers to 
datasets, coupled with landing pages with high level metadata are needed to 
facilitate data discovery and access. The use of high quality metadata in 
these situations will help stakeholders to better cite datasets and indicate 
through which means they were accessed. 
Furthermore, data sharing practices vary amongst researchers and 
access to good quality metadata inclusive of data models can help 
researchers to better understand the data (Li, Wen et al. 2012; Van den 
Eynden 2012). According to a study by Wang, Vergara-Niedermayr et al. 
(2014) looking at metadata-based management and sharing of distributed 
biomedical data, three mechanisms for sharing data exist: a) centralised 
location using a single schema; b) federated architecture; and c) distributed 
architecture. Metadata quality plays a fundamental role in enabling data 
sharing and reuse as they provide the contextual information needed to 
better researchers’ understanding of how the data were collected, when, and 
how variables were managed. Another example of where the potential for 
data sharing and reuse can be hampered through the provision of poor 
quality metadata is that of managing repositories. According to a study by 
Neu, Crawford et al. (2012) looking at how heterogeneous neuroimaging 
metadata are managed by global repositories, the need to share usable 
metadata combined with the heterogeneity of research data are challenging 
aspects of research data management.  
At the data integration and harmonisation stages of the RDL, 
harmonising phenotypic data can benefit from good quality, and where 
possible, standardised metadata. These processes are further supported 
through access to contextual information in the form of metadata. The 
metadata can signal the commonalities between disparate datasets and 
support the performance of meta-analyses (Vardaki, Papageorgiou et al. 
2009; Davies, Gibbons et al. 2014). Nevertheless, the lack in uptake of 
standards coupled with inconsistent quality of metadata can render analyses 
of epidemiological and public health research data problematic (MRC 2014). 
Having a robust and standardised approach to metadata markup can help 
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better support the documenting of research studies (Kolker, Ozdemir et al. 
2014). 
1.5 Research aim and objectives 
1.5.1 Research aim  
The overarching aim of my research was to create and evaluate a 
series of metadata management models to improve the reuse of 
epidemiological and public health data within research settings.  The 
metadata management models support researchers and other stakeholders 
in harmonising data from disparate sources by providing standards-based 
mechanisms to help manage metadata across the research data lifecycle. 
These metadata management models build on existing standards and 
practices and consider how these can be reused and adapted to enhance 
the way in which researchers and other stakeholders manage their 
metadata.  
1.5.2 Research question 
How can information standards be applied at various points of the 
research data lifecycle to create information metamodels to facilitate the 
reuse and repurposing of research data within epidemiological and public 
health research? 
1.5.3 PhD research objectives  
I. To systematically review and evaluate methods for enhancing the 
discoverability of public health and epidemiological research data  
II. To create and evaluate a novel quality assessment framework for 
epidemiological and public health metadata 
III. To create and evaluate a novel metadata management model to 
support improved recording of consent for record linkage metadata in 
bespoke investigator-led cohort studies 
To make a series of recommendations for improving the 
management of epidemiological and public health research data  
 
 
 
Introduction 
31 
 
The following case study illustrates the challenges this Ph.D. addresses and 
demonstrates the novelty of my research: 
 
 
 
 
 
Case study: Millennium Cohort Study 
The Millennium Cohort Study is a UK-based study which follows the lives of 
approximately 19000 children born between 2000 and 20011. Birth cohort 
studies, in addition to other like studies, are an invaluable resource to 
researchers and other stakeholders wanting to investigate life course influences 
and origins of disease. The ability to reuse and repurpose research data from 
these studies is imperative to maximising resources and further investigating 
health conditions. Researchers are able to access the data from the Millennium 
Cohort Study through the UK Data Archive. Here, standardised metadata 
accompanies the data to facilitate its use.  
Nevertheless, with heightened discoverability, and greater availability of 
standardised metadata, the potential for reuse could be further enhanced. The 
aim of this Ph.D. project will be to address these current challenges facing the 
research community by applying information standards to create information 
metamodels to facilitate the reuse and repurposing of research data within 
public health and epidemiological research settings.  
The outcomes of the discoverability study (research case study I) will 
help to improve the current discoverability of this study and where associated 
research data may be found and potentially accessed. The outcomes of the 
metadata quality assessment study (research case study II) will help 
stakeholders to assess the quality of the metadata associated with this and 
other studies. The outcomes of the third study – recording consent to record 
linkage metadata (research case study III) will help to standardise and hence 
improve the way in which the associated consent forms are recorded.  
1. http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=851&sitesectionti
tle=Welcome+to+the+Millennium+Cohort+Study  
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1.5.4 Outline of research studies 
The first component of this thesis examines how metadata-based 
mechanisms can enhance the discoverability of epidemiological and public 
health research data. I then build on this examination by investigating how 
metadata management models can improve the approach to assessing 
metadata quality within these research settings. The third component of this 
thesis explores how consent for record linkage metadata can be recorded 
using a series of novel metadata management models. The third component 
also demonstrates how the recording of such metadata can be standardised 
and critically appraises the current prevailing standard for application to 
epidemiological and public health research settings. The issue of 
discoverability was firstly addressed as awareness of existing research 
datasets is a key aspect to the reuse and repurposing of research data. 
Having established that an existing research dataset may lend itself to a 
future study, the next step is to characterise the data; this gave rise to the 
metadata quality study. Having good quality metadata is vitally important to 
gaining an understanding of the data and its potential research opportunities. 
Finally, when using the data from multiple research studies, it is important to 
understand which the limits of consent are. Having standardised metadata 
describing the consent process, is critical to helping to facilitate the reuse of 
research data whilst respecting the wishes and rights of the participants. 
1.6 Researcher involvement 
The following outlines my role and responsibilities for each research 
case study presented in this thesis: 
1.6.1 Data discoverability study  
I was responsible for: 
 all aspects of the review, and designing and developing the survey,  
 all quantitative and qualitative analyses performed and drawing of the 
graphs, 
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 identifying the  need for a registration process for observational studies 
which could be enacted through a public health portal similar to that of 
ClinicalTrials.gov. It was through my systematic literature review I identified 
the potential to use data publications as another way of enhancing data 
discoverability. It was my research in this thesis, I identified the potential to 
use semantic web technologies as mechanisms to further enhance data 
discoverability.  
 All aspects of the evaluation and the recommendations made in this thesis.  
 
I was the project manager for this study and was also responsible for: 
 defining and describing the project work packages descriptions and 
deliverables,  
 writing the ‘Six criteria for assessing data discoverability’ and ‘Key findings 
from qualitative analysis of free-text responses’ information boxes for both 
the reports 
 writing the following appendices for the final report: a) data documentation 
and access: characterising current practice, and b) profiles – documenting 
cohorts and data resources.  
 helping to raise awareness of the study and presented the project at the 
Public Health Research Data Forum meeting at the Wellcome Trust in 
January 2014.  
 providing feedback, and suggestions for change and improvement to the 
final report. Drafting of the final report involved the entire project team.   
1.6.2 Metadata quality study 
I was responsible for all aspects of this study.  
1.6.3 Consent for record linkage metadata study  
I was responsible for all aspects of this study. 
1.7 Ph.D. project funding  
The Ph.D. project was funded by a 4-year Medical Research Council 
CASE award with AIMES Grid Services CIC and partially by the UCL 
Institute of Health Informatics. The enhancing data discoverability study was 
competitively commissioned by the Wellcome Trust on behalf of the Public 
Health Research Data Forum. 
 
 
Introduction 
34 
 
1.8 Ph.D. project timeline 
The following outlines when each research case study began and 
finished: 
 The consent for record linkage metadata study began in January 
2012 and was completed in September 2015.  
 The data discoverability study began in January 2014 and chapter in 
this thesis in September 2015.  
 The metadata quality study began in July 2014 and finished in 
September 2015.  
 
1.9 Chapter summaries   
Chapter 2 examines the application of information standards in 
epidemiological and public health research There are four components to 
this examination: a) health information standards including encoding and 
exchange standards; b) linked data on the World Wide Web and the role of 
Semantic Web technologies in epidemiological and public health research; c) 
clinical conceptual modelling; and d) application of metadata standards 
within epidemiological and public health research settings. 
Chapter 3 presents research case study 1: enhancing the 
discoverability of epidemiological and public health research data. This work 
has four components: a) a systematic review of existing approaches to data 
discovery and a survey aimed at stakeholders in public health and 
epidemiology research to identify current data discoverability practices and 
their subsequent implications; b) qualitative analysis of data in terms of the 
awareness of the challenges associated with data discovery and identify 
information; c) presentation of models to enhance research data 
discoverability; and d) evaluation of the models.  
Chapter 4 presents research study 2: improving metadata quality 
assessment in public health and epidemiological research. This study has 
four components: a) a systematic literature review of existing approaches to 
metadata quality evaluation and a survey aimed at stakeholders in public 
health and epidemiology research in order to identify current practice and 
challenges associated with creating metadata; b) identification of metadata 
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quality dimensions; c) creation of novel models and framework for assessing 
metadata quality in epidemiological and public health research settings; and 
d) evaluation of the novel framework.  
Chapter 5 presents research case study 3: improving the recording of 
consent to record linkage metadata in longitudinal studies. There are four 
components to this study: a) a systematic literature review of developing 
models to capture consent for record linkage in longitudinal studies; b) 
qualitative assessment of consent forms; c) critical evaluation of DDI 3.2; and 
d) creation and evaluation of the model through iterative application to three 
test cases.  
Chapter 6 presents a summary of my findings and recommendations 
for change in epidemiological and public health research data management 
policy and practice. This chapter then presents the overall Ph.D. project 
strengths and weaknesses followed by a discussion of future direction.      
Appendix - there are four appendices to this thesis: a) supplementary 
tables and a copy of the data discoverability survey; b) a copy of the 
metadata quality survey and supplementary tables; c) supplementary tables 
and supplementary code for the consent for record linkage metadata study; 
and d) a grant proposal for the development of a global metadata registry for 
epidemiological and public health datasets derived from observational 
studies. 
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Chapter 2 Information standards in 
epidemiological and public health research  
2.1 Introduction  
In the previous chapter, I introduced the thesis. In this chapter, I 
examine application of health information standards in epidemiological and 
public health research focusing on the use of encoding and exchange 
standards. I then look at the use of linked data on the World Wide Web, 
clinical conceptual modelling and metadata standards within epidemiological 
and public health research. 
2.2 Standardisation  
Standardisation in the public health and epidemiology research 
domains plays a key role in helping to form platforms or benchmarks from 
which quality and other such outcomes may be measured and compared 
(Swensen, Meyer et al. 2010). Impetus to develop and implement health 
information standards stems from the need to address problems associated 
with accelerating translation of research findings to policy recommendations, 
ensuring quality of care and clinical information(Singh, Singh et al. 2013) and 
implementing a robust information infrastructure to support clinical research 
(Richesson and Krischer 2007). The use of standards and standardised tools 
was identified as a key priority in a report by the World Health Organization 
(2007) and recognised as fundamental to the provision of interoperable 
health information by the European Commission (2013). 
2.3 Challenges associated with using information standards in 
epidemiological and public health research 
Within the UK and internationally, barriers to the adoption of 
information standards in epidemiological and public health research include: 
a) ensuring changes to the working environment are appropriately managed 
on both a technical and staff level (Timimi, Falzon et al. 2012; Singh, Singh 
et al. 2013); b) having the necessary resources to resolve issues relating to 
the security and privacy of exchangeable health information; c) having 
sufficient funding and contingency plans to address any potential financial 
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Approach 
 
Technical issues relating to the security and 
privacy of exchangeable health information 
Limited documentation of research datasets and 
associated processes 
Need for improved training and skills development 
programmes for researchers and clinicians 
Limited usability of user interfaces potentially 
impacting data access and querying 
Insufficient infrastructure to support cross-
organisational data sharing  
Semantic Web 
technologies  
+ 
Conceptual 
modelling  
+ 
Health 
information and 
metadata 
standards 
Limited formal structure of clinical documents and 
support for use of EHRs for identifying cohorts 
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Examples 
 
Limited mechanisms for automated data 
validation and quality assurance  
constraints; d) provision of adequate training and guidance; e) access to the 
required resources for data documentation and data sharing; and f) limited 
usability of user interfaces(Heidorn 2008; Rahmouni, Solomonides et al. 
2010; Blumenthal 2011; Simborg, Detmer et al. 2013). Figure 2-1 provides a 
synopsis of the challenges associated with the use of information standards 
in epidemiological and public health research.  
 
 
Exemplar challenges associated with use of standards in research and potential approaches 
to address these. 
 
 
Figure 2-1 Challenges associated with use of information standards in 
epidemiological and public health research 
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2.4 Health information standards 
There are two broad categories of health information standards: a) 
encoding – standardises free text found in clinical documents using 
controlled clinical terminologies which are a type of controlled vocabulary 
utilised to systematically organise information and support knowledge 
management); and b) exchange - provide the semantics needed to exchange 
clinical information/messages (Martin 2003; Tenenbaum, Sansone et al. 
2013). Figure 2-2 provides examples of exchange and encoding standards:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.1 Encoding standards  
Controlled clinical terminologies such as the Systematized 
Nomenclature of Medicine Clinical Terms (SNOMED CT) are a type of 
encoding standard. SNOMED CT is primarily used in clinical care to encode 
clinical information in EHRs. SNOMED CT has a hierarchical structure 
containing over 311000 concepts. In using a controlled clinical terminology 
such as SNOMED CT, the way in which clinical information is encoded in 
EHRs is standardised. Within the research context, this is advantageous as 
encoded, structured text can be entered into databases, queried and 
Figure 2-2 Exchange and encoding standards 
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analysed. Additionally, if researchers are presented with free text, by 
encoding the information using a controlled clinical terminology like 
SNOMED CT, the now encoded text can become an additional source of 
information.  
Medical Subject Headings (MeSH) is a controlled vocabulary system 
used to categorise biomedical concepts to support the indexing of biomedical 
literature from 5400 journals. MeSH has 16 descriptor categories 
alphabetically organised in a hierarchy.  
However, managing controlled clinical terminologies can be 
problematic. Issues relating to consistency (World Health Organization 
2014b) and adequate provision can negatively affect the quality of the 
encoded clinical information. Another problem associated with the use of 
clinical terminologies is achieving a consensus with regards to their content. 
Recent revisions made to DSM 5 included removal of the bereavement 
exclusion; consequently, a patient suffering with depression, in accordance 
with the structure and definitions of DSM 5, could be coded as having Major 
Depression – something certain stakeholders in mental health research and 
clinical practice stated was not necessarily appropriate (Nemeroff, 
Weinberger et al. 2013).     
Another example of encoding standards are statistical classification 
systems such as the International Classification of Disease (ICD).  ICD is 
used to capture and classify diseases for clinical epidemiological and 
management reasons as part of health records and death certificates and 
billing. The diseases are classified alphabetically and have a hierarchical 
structure. The Hospital Episode Statistics dataset, which can be used to 
investigate patterns in disease and the delivery of care in NHS hospitals in 
England, uses ICD-10 to classify diseases and OPCS-4 ontology to classify 
procedure codes. The provision of encoded clinical information on a national 
scale enables researchers to perform in-depth analyses using a rich set of 
data which have been structured through the controlled formation and 
expression of clinical information. For example, Raine, Wong et al. (2010) 
were able to investigate the extent to which hospital admission and surgical 
procedures varied by factor such as socioeconomic circumstances, age and 
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type of cancer. The authors found that social factors strongly impacted the 
accessing of care even though the NHS Cancer Plan had been implemented. 
Classification systems are complex and subject to change and yet to 
make meaningful comparisons requires consistent encoding. For example, 
Cimino (2011) uses the example of septic shock being encoded as 785.52 in 
ICD-9-CM after 2003; whilst, before 2003 this condition was encoded as 
785.59 - other shock without mention of trauma. Individuals wanting to 
identify cases of shock would need to ensure all possible codes from each of 
the revisions are included in the queries to help capture all cases. In 
circumstances such as these, semantic metadata play a key role in helping 
to integrate heterogeneous data. Integrating multiple datasets with disparate 
use of these terminologies is commonplace in public health and 
epidemiological research necessitating the provision and use of crosswalks 
and other such semantic mappings to enable this process. 
A systematic literature review by Stanfill, Williams et al. (2010) on 
automated clinical coding and classification systems found that the context 
and complexity of the coding are important factors when evaluating these 
systems. Of the 113 studies selected for review, examples of clinical 
terminologies identified included, MeSH terms. The four most commonly 
identified systems formed 91% of the named systems (46 systems named, 
21 not named) with Pneumonia being the most common use case. Studies 
such as these highlight the importance of encoding standards in clinical 
practice and research and how their active development and management 
play a key role in attaining widely accepted, clinically valuable resources.   
Table 2-1 presents a comparison of five encoding standards. These 
are: International Classification of Diseases (World Health Organization 
2013a), Systematized Nomenclature of Medicine Clinical Terms(International 
Health Terminology Standards Development Organisation 2013), Medical 
Subject Headings(United States National Library of Medicine 2013a), Logical 
Observation Identifiers Names and Codes(LOINC 2013), and Diagnostic and 
Statistical Manual of Mental Disorders 5(American Psychiatric Association 
2014). 
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Table 2-1 Comparison of encoding standards 
Characteristic ICD SNOMED CT MeSH LOINC DSM 
Responsible 
organisation 
World Health 
Organization 
SNOMED CT is owned and 
maintained by the 
International Health 
Terminology Standards 
Development Organisation 
(IHTSDO)  
 
United States 
National Library of 
Medicine (NLM) 
Regenstrief Institute 
(1994)   
American 
Psychiatric 
Association 
Use  Capture and classify 
diseases for clinical, 
epidemiological and 
management 
reasons as part of 
health records and 
death certificates 
and billing   
 
Capture clinical information 
in a standardised way to 
support healthcare 
provision 
Catalogue 
literature from 5400 
biomedical journals 
as part of the 
MEDLINE/ 
PubMED database 
(U. S. National 
Library of Medicine 
2015) 
 
Capture clinical and 
laboratory 
observations as used 
by >27000 users in 
158 countries (2013b)  
Capture and 
classify mental 
health 
conditions 
Versioning*  Current version - 10 
Yearly updates 
made with version 
11  currently 
underway(2015c). 
Other classifications 
include ICD-9-CM 
Current version - January 
2014  
Updates for the 
International Release are 
available in January and 
July every year(2014g) 
 
Current version – 
2014 
The MeSH browser 
is updated every 
Sunday(2014e) 
 
Current version - 2.46  
New versions are 
released in June and 
December each 
year(2014d)  
 
Current version 
– 5 
The previous 
version (DSM-
IV) was 
released in 
1994(2014c) 
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Characteristic ICD SNOMED CT MeSH LOINC DSM 
Size 14,199* codes 
(inclusive of Chapter 
XX (World Health 
Organization 2014a) 
 
 
>311,000* concepts 
(International Health 
Terminology Standards 
Development Organisation) 
 
27,149* descriptors 
(U. S. National 
Library of Medicine 
2015) 
73,115* terms 
(Vreeman 2013) 
20 disorder 
chapters  
Structure Classified by 
disease/alphabetical 
and hierarchical  
Hierarchical structure with 
underlying concept model  
(International Health 
Terminology Standards 
Development Organisation 
2014) 
16 descriptor 
categories, 
alphabetical and 
hierarchical (United 
States National 
Library of Medicine 
2013b; U. S. 
National Library of 
Medicine 2015)  
 
Each code has 3-7 
characters. LOINC 
names have 6 parts: 
Component, Property, 
Time, System, Scale 
and Method 
 
 
Each DSM 
code has a  
corresponding 
ICD code 
Example  I21.2 Acute 
transmural 
myocardial infarction 
of inferior wall  
174041007 laparoscopic 
emergency appendectomy 
Endocarditis, Non-
Infective  
Tree number: 
C14.280.282.703 
67293-1 Other MRI 
scan [PhenX] 
Component: Other 
MRI scan 
Property: Type 
Time: Pt 
System: ^Patient 
Scale: Nom 
Method: PhenX 
Language 
disorder 
315.32 (F80.2) 
   * Correct March 2014.  
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2.4.1.1 Exemplar applications of encoding standards in epidemiological and 
public health research 
Clinical cohort phenotyping: A recent review looking at approaches 
to identifying patient cohorts by Shivade, Raghavan et al. (2013) found that 
whilst use of standardised clinical terminologies were promoted in the 
identified studies, only a few had used them. The authors also identified a 
lack of metadata describing how certain concepts and terminologies had 
been mapped together. Subsequently, researchers wanting to identify these 
descriptions would need to conduct further investigation. This could 
potentially be a challenging process as due to the lack of metadata, 
researchers may not have to hand the necessary information to conduct 
these further investigations and subsequently make efficient and effective 
use of the data. Having access to good quality semantic metadata could 
enhance clinicians’ and researcher’ understanding of the methods used to 
link the concepts and terminologies and potentially provide them with 
contextual information which could impact use of the mapped resources as 
part of epidemiological and public health research studies.  
Genomics: Initiatives such as the eMERGE (Electronic Medical 
Records and Genomics) network promote use of EHRs (Pathak, Wang et al. 
2011; Pathak, Kiefer et al. 2012b) and examines the mapping of data 
elements to standardised metadata repositories and clinical terminologies. 
However, automated processing of clinical information is not without 
difficulty. Abbreviations, ambiguity and misspellings limit the extent to which 
aggregate information may be produced, and subsequently used in clinical 
practice and research such as identifying clinical phenotyped cohorts. This is 
because having any abbreviations, ambiguous descriptions or misspelling 
can cause researchers to inadvertently exclude the records of participants 
which could potentially be included in the cohort. The result of this is an 
under-identified cohort of participants with a reduced set of clinical data that 
could be repurposed and used as part of a research study.  Furthermore, 
having incomplete and erroneous datasets can impact the extent to which 
metadata standards may be utilised to create metadata.  
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Epidemiology:  The CALIBER (Denaxas, George et al. 2012) 
resource comprises of linked bespoke studies and electronic health records 
providing researchers with an in-depth source of information to investigate 
disease in UK populations. CALIBER contains clinical information from 
CPRD (2016f), the Myocardial Ischemia National Audit Project (MINAP) 
(Herrett, Smeeth et al. 2010), Hospital Episode Statistics (HES) (2016i), and 
the Office for National Statistics (ONS) mortality and social deprivation data. 
By combining these disparate datasets, researchers are better able to 
maximise the research benefits associated with record linkage to investigate 
cardiovascular disease. However, potential inconsistencies in the way in 
which clinical information was encoded in the primary sources (CPRD, 
MINAP, HES and ONS) could cause a decrease in data quality. Using data 
of less than optimal quality can lessen the extent to which research findings 
can inform cardiovascular policy and clinical practice. Furthermore, as the 
data is gathered from disparate sources, creating metadata becomes a 
challenging process. This is because the data originates from different 
systems in different locations where approaches to data management vary.  
2.4.2 Health information exchange standards 
A number of organisations focus on developing and maintaining 
standards in support of exchanging clinical information (Table 2-1). Health 
Level 7(2015b) is responsible for the development and maintenance of 
standards in support of the exchange of clinical data. Accredited by the 
American National Standards Institute, HL7 version 2 is characterised by the 
use of ASCII code to separate lines of text and is designed to capture patient 
information. Its uptake on an international level has been very successful 
(Kalra 2006; Al-Enazi and El-Masri 2013). However, a lack of interoperability 
and implementation of version 2 led to the development and implementation 
of version 3 (Kalra 2006).  
Messages conforming to version 3 are marked up using XML (Al-
Enazi and El-Masri 2013). All developmental work using version 3 is built on 
or around the BS ISO/HL7 27931:2006 Health Informatics HL7 version 3 -
Reference Information Model (RIM) (British Standards Institution 2007). The 
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RIM is an object oriented abstract model used to derive suitable models to 
represent healthcare information (Al-Enazi and El-Masri 2013).  The 
conceptual model forms the basis of all version 3.0 derived models and any 
subsequent development work. The RIM is a platform independent, logical 
representation of the health information domain facilitating exchange and 
management. Its structure is static and promotes interoperability between 
systems built on or around the model (British Standards Institution 2007; 
Smith, Ashburner et al. 2007; Health Level Seven International 2013). 
However, whilst HL7 promotes interoperability in clinical settings, the inability 
to fully characterise diseases or proteins, as discussed by Al-Enazi and El-
Masri (2013), Smith, Ashburner et al. (2007) and Smith and Ceusters (2006) 
limit its application. This is because there is the potential for the minutia 
needed to perform detailed, complex investigations using messages marked 
up in version 3 to be missing. This then potentially limits the scope for these 
messages to be used as additional clinical data sources for epidemiological 
and public health research studies.  
Other models managed by HL7 include the Clinical Document 
Architecture (CDA) (HL7 2014) and Fast Health Interoperable Resources 
(FHIR) (HL7 2013). The CDA(HL7 2014) is a mechanism for exchanging 
healthcare information. By utilising Sematic Web technologies, version 3 RIM 
and clinical coding schemes, exchangeable documentation has the 
semantics for machine-readability and clarity for researchers and clinicians. 
The FHIR framework furthers the progress made as part of the development 
and maintenance of versions 2, 3 and the CDA to provide a modular 
approach to building health informatics products (HL7 2013). FHIR provides 
more flexibility in the way in which health informatics products are designed 
and built. Consequently, there is the potential for researchers to build 
products specifically designed to meet their needs.  
The Clinical Data Interchange Standards Consortium (CDISC) is 
responsible for developing and maintaining a collection of standards to 
support the exchange of clinical data (CDISC 2013b). The Operational Data 
Model (ODM) is a conceptual model acting as a mechanism for the 
Information standards in epidemiological and public health research 
46 
 
exchange and archival of data and metadata across disparate sources 
(CDISC 2013c).   
The Biomedical Research Integrated Domain Group (BRIDG) (BRIDG 
2012a) is responsible for harmonisation work between certain current health 
information standards facilitating the development of interoperable 
applications based on a harmonised conceptual model (Richesson and 
Krischer 2007; Kush, Helton et al. 2008; McCay, Evans et al. 2008). This 
work is a collaborative initiative involving stakeholders from CDISC, HL7 
Clinical Research Information Management Work Group, National Cancer 
Institute and United States Food and Drug Administration.(BRIDG 2012b) 
Drawn using Unified Modelling Language and informed through user 
feedback, it is a platform-independent model which can be implemented 
locally to meet specialised user requirements. Furthermore, the provision of 
a Web Ontology Language (OWL) representation of the model (CDISC 
2013a) usability and interoperability are potentially increased through the 
provision of a machine-readable format. Initiatives such as these bring 
together expertise across the life sciences domain to promote common 
understanding. Development of the BRIDG model influenced design of the 
Life Sciences Domain Analysis Model and the way in which this model 
captures information (BRIDG 2012c; Freimuth, Freund et al. 2012). 
2.4.2.1 Impact of exchange protocols in epidemiological and public health 
research 
The use of electronic systems provides opportunities for automated 
data validation as a quality assurance mechanism, improving the 
management of clinical documents and enhancing research (Timimi, Falzon 
et al. 2012; Ohno-Machado 2013). In 2012, the World Health Organization 
published a guideline on the (re)development and use of electronic recording 
and reporting systems for Tuberculosis (TB) care and control (World Health 
Organization 2012) and in a study by Timimi, Falzon et al. (2012), the 
potential differences in ways to implement systems and the comparability of 
clinical data are presented. The current disparate use of electronic systems 
emphasises the need for standards; yet, a number of challenges associated 
with their implementation remain (Simborg, Detmer et al. 2013). Tenenbaum, 
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Sansone et al. (2013) discuss the pre-assessment of standards and offer 
potential categories of criteria such as adoption and user community, in 
addition to potential resources such as quality assurance tools. 
Initiatives such as BioSharing(2014b) map certain life sciences 
standards together and monitor the management, implementation and 
reference to these within policies. This is in support of enhanced 
discoverability and fewer instances of redundant endeavours (2014b). 
BioSharing has three registries: a) policies; b) standards, from BioPortal, 
MIBBI and Equator Network; and c) databases in BioDBCore records 
(BioSharing 2014b; BioSharing 2014c; BioSharing 2014a). 
Standards which support communication include ISO 13606(BS EN 
ISO 2012) and BS EN ISO 13120:2013 (The British Standards Institution 
2013). ISO 13606 - Electronic health record communication(BS EN ISO 
2012) has been designed to support exchanges of clinical information using 
the HL7 version 3 standard. BS EN ISO 13120:2013 Syntax to represent the 
content of healthcare classification systems standard (The British Standards 
Institution 2013) focuses specifically on standardising the organisation of 
classification systems and their application to clinical coding schemes such 
as ICD.  
Good quality descriptions (metadata) of clinical terminologies, 
modelling, data collection methods and the mechanisms are needed to help 
ensure the security and privacy of participant/patient identifiable data.  The 
development and use of a domain specific metadata quality assurance 
framework inclusive of Semantic Web technologies, conceptual modelling 
and health information standards could help researchers and clinicians to 
create such descriptions.  
2.5 Linked data on the World Wide Web 
Clinical documents often contain a combination of structured and free-
text fields. Consequently, clinicians are able to record both standardised and 
unstandardised clinical information. To maximise the potential research 
opportunities associated with these clinical documents, clearly defined 
underlying structures are needed. Increasingly, Semantic Web technologies 
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are being utilised to help provide these structures to enable researchers to 
more easily use these as sources of data in epidemiological and public 
health research (Schweiger, Hoelzer et al. 2002).  
Sematic Web Technologies (SWTs) are a group of methods that 
support the formation of semantically meaningful associations and 
relationships. Initiatives such as the World Wide Web Consortium Semantic 
Web Health Care and Life Sciences Interest Group (HCLS IG) (W3C 2013) 
develop, maintain and promote use of SWTs in the life sciences, healthcare 
and research. The HCLS IG highlight the important role SWTs play in 
translational medicine and data linkage (Semantic Web Health Care and Life 
Sciences Interest Group 2011).  
Two examples of SWTs are the Resources Description 
Framework(2014f) (RDF)  and Web Ontology Language(W3C 2012) (OWL). 
The RDF was developed by the W3C and has been a recommended 
standard since 2004 for the representing and linking together of 
heterogeneous data (2014f). The RDF is based on a simple model and has 
formally constructed semantics. RDF triples may be connected together to 
form a network. This network can be extended and new information added 
without negatively impacting the pre-existing structure. The RDF is 
particularly suitable for metadata management in health as its scalability can 
be harnessed facilitating the integration of multiple disparate resources. 
Health data can be stored in databases and spreadsheets across multiple 
organisations; the application of RDF to create information networks about 
these data can better support users in discovering health data and exploring 
its reuse potential particularly for research (Wang, Gorlitsky et al. 2005; 
Pathak, Kiefer et al. 2012a; Pathak, Kiefer et al. 2012c).The OWL(W3C 
2012) is a declarable language enabling clinicians and researchers to 
develop domain-specific ontologies to assist the capture and structuring of 
clinical information (Fernandez-Breis, Maldonado et al. 2013).  
2.5.1 Role of Semantic Web technologies in epidemiological and 
public health research  
SWTs such as the RDF and OWL provide the mechanisms needed to 
build searchable, structured networks of information online. SWTs have 
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since been identified as fundamental to the development of scalable 
solutions to problems associated with the integration of pharmacogenomics, 
drugs and other such biomedical data (Samwald, Coulet et al. 2012). 
However, there has not yet been widespread uptake of SWTs in 
epidemiological and public health research. This outcome could possibly be 
attributed to the complexity of using SWTs in epidemiological and public 
health research and the need for additional resources such as time, finance 
and staff training in order for researchers to benefit from associated research 
opportunities.   
A  study by Pathak, Kiefer et al. (2012b) investigated the role of SWTs 
in the identification of phenotypic data to enable analysis of genetic 
associations. This work involved a combination of converting clinical 
information into RDF and using SPARQL to query the information. This 
initiative utilised the HCLS IG’s Translational Medicine Ontology (TMO) 
(Luciano, Andersson et al. 2011) and other such ontologies to identify 
patients diagnosed with Type 2 Diabetes Mellitus.  Here the authors were 
able to replicate the findings from a study by Warodomwichit, Arnett et al. 
(2009) and in this context, acts as a proof of concept that SWTs can assist 
the identification of cohorts.  
Application of SWTs in public health and epidemiological research 
remains a challenging process. Free-text found in clinical documents are key 
sources of information; however, providing consistent and high quality 
annotation is difficult if the information is unstandardised and manually 
processed. A potential solution is to provide semantic annotations. Tools 
such as Semantator provide the methods needed link the information to 
concepts in ontologies to enable processing (Tao, Song et al. 2013). Another 
tool is the Open Biomedical Annotator (Jonquet, Shah et al. 2009) which 
focuses on annotating metadata with ontological concepts which are 
subsequently displayed to users as annotations.  Tools such as these can 
provide a formalised manner in which annotations are generated and 
subsequently applied. Having automated methods such as these can 
potentially reduce the risk of human error and biased markup. Nevertheless, 
Information standards in epidemiological and public health research 
50 
 
use of these tools necessitates additional training and access to resources to 
support their continued implementation and use.  
Awareness of SWTs is increasing and use of these in the biomedical 
context is important if the potential benefits of standardisation and 
interoperability are to be realised across the research data lifecycle (Post, 
Roos et al. 2007; Sagotsky, Zhang et al. 2008; Semantic Web Health Care 
and Life Sciences Interest Group 2011; Machado, Rebholz-Schuhmann et al. 
2013).  
2.6 Clinical conceptual modelling  
Harmonising definitions of commonly used health-related terms can 
prove challenging; particularly if there is a lack of, or access to, contextual 
information (Freimuth, Freund et al. 2012). Having common terminologies 
and shared understanding can help stakeholders to maximise potential 
research opportunities in clinical settings through a standardised and 
simplified approach to mapping information workflows. One such way to map 
information workflows is to develop clinical conceptual models.  
Clinical conceptual models comprise of a series of components and 
the relationships between these. Application of formalised modelling 
techniques in epidemiological and public health research settings can help 
harmonisation and data linkage efforts by providing a simplified yet highly 
detailed description of clinical settings and the information flows within them. 
These promote a shared understanding through application of standards 
applicable across the research domains (Daniel, Sinaci et al. 2014). 
2.6.1 Case studies: conceptual modelling in epidemiological and 
public health research 
The following are examples of where conceptual modelling has played 
an intrinsic role in epidemiological and public health research. In a study by 
Vawdrey, Weng et al. (2014) conceptual modelling was used to illustrate how 
common data elements can integrate with existing documentation around 
EHRs.  
Second, the Clinical Research Informatics (CRI) conceptual model 
(Kahn and Weng 2012) is designed to provide an insight into developments 
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in clinical research informatics. The CRI conceptual model combines clinical 
and translational research workflows with informatics principles and 
methodologies to produce a framework. The model centres on workflows, 
data sources and platforms and informatics core methods and topics (Kahn 
and Weng 2012). The model also identifies key topics in CRI with secondary 
use of clinical data, record linkage and data integration being three such 
examples.  
Third, the Life Sciences Domain Analysis Model (LS DAM) (Freimuth, 
Freund et al. 2012) is designed to facilitate semantic interoperability between 
several of the Cancer BioInformatics Grid (caBIG) applications. The model 
can be decomposed into several key areas: Specimen, Molecular Biology, 
Experiment and Molecular Databases (Freimuth, Freund et al. 2012).  
2.6.2 Clinical information models 
Standardised modelling techniques can also be used to help develop 
clinical information models (CIMs). CIMs provide the structural and semantic 
details needed to facilitate the documenting of clinical concepts (Moreno-
Conde, Moner et al. 2015). Collaborations such as the Clinical Information 
Modeling Initiative (2015a) focus on supporting and improving semantic 
interoperability within healthcare systems by developing and using 
collaborative information models. CIMs can also form the basis of information 
standards such as Health Level 7 and metadata standards such as ISO/IEC 
11179.  
2.7 Metadata standards  
Metadata can be made available in a range of formats such as 
Portable Document Format (PDF) and eXtensible Markup Language (XML) 
and can have varying levels of granularity such as research study, single 
dataset or sweep of data and at variable level.  They can be produced in 
real-time, or retrospectively to reflect one (or more) iteration(s) of the 
research data lifecycle. Metadata can be classified as: a) administrative - 
assists with efficient research data management including storage, access 
and reuse; b) descriptive - describes resources primarily for archival and 
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reuse purposes; and c) semantic - outlines the relationships between 
metadata elements helping to define underlying structures (Pollock and 
Hodgson 2004; Zeng and Qin 2008; Miller 2011).  
Stakeholders in epidemiological and public health research can 
systematically describe different metadata elements and their structure using 
established metadata standards. There are three types of metadata 
standard: a) structural standards describe the syntactic and semantic 
requirements needed to ensure the metadata are machine readable; b) 
content standards support stakeholders in generating metadata by defining 
what should and should not be included in the description; and c) format 
standards describe to encode metadata in support of archival and curation 
efforts(Elings and Waibel 2007; Miller 2011). These standards can be used 
individually, or combined to form components of a single, much larger 
standard.  
Over the course of a research study, it is possible for metadata 
standards to change. The use of application profiles, customised versions of 
metadata schemas, enables stakeholders to implement localised versions of 
standards to fulfil the stakeholders’ needs. Though this is acceptable, and 
scope for systematic interoperability with external systems remains possible, 
unless these changes are approved by the standardisation body responsible 
for the original standard, the customised version (application profile) may be 
valid but not formally recognised (Chute, Ullman-Cullere et al. 2013). 
Therefore, scope for metadata exchange may be negatively impacted 
subsequently affecting the extent to which the associated research data may 
be understood by stakeholders and (re)used.   
2.7.1  ISO/IEC 11179 
The ISO/IEC 11179 (2004) standard supports data reuse and the 
provision of clearly defined data through a standardised approach to the data 
management process. The standard is comprised of six parts: 1) framework, 
2) classification, 3) registry metamodel and basic attributes, 4) formulation of 
data definitions, 5) Naming and identification principles, 6) Registration: 
outlines the registration process.  
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In applying the ISO/IEC 11179 standards, researchers can potentially 
benefit from the facilitated monitoring of data to identify similar or identical 
names and the ability to implement the standard in heterogeneous 
environments(ISO/IEC 2004). ISO/IEC 11179 was recently implemented as 
part of METeOR. METeOR is the Australian Institute of Health and Welfare’s 
online metadata registry and is the national repository for public health 
metadata standards (Australian Insitute of Health and Welfare 2014).  
However, in a study by Papatheodorou, Crichton et al. (2009) looking 
at clinical data management for translational genomics studies in breast 
cancer using a metadata approach; the researchers found that whilst data 
elements have associated data element concepts, the standard does not 
structure the data elements in a particular order. Subsequently, the authors 
needed to create additional rules to link multiple common data elements and 
determine which the inferred common data elements were.  
Generic metadata standards such as ISO/IEC 11179 do not possess 
the mechanisms needed to address the needs of epidemiological and public 
health metadata since they were not designed and developed for sole use in 
a sole domain. Extending the standard so as to meet these needs is a 
potential workaround solution but ideally, standards developed specially for 
biomedical research could potentially alleviate problems such as those 
mentioned above. 
2.7.2 Dublin Core 
The Dublin Core Metadata Initiative is responsible for maintaining the 
Dublin Core metadata standard. Simple Dublin Core (DC) consists of 15 
elements designed to provide a standardised basic description of a resource. 
Each element has attributes as described in the ISO/IEC 11179 standard 
(ISO/IEC 2012; DCMI 2015).  
In a study by Song, Park et al. (2014) looking at the development of a 
health information search engine based on metadata and an ontology, the 
authors used the simple DC elements as part of their metadata schema to 
document resources. There are three parts to their schema: General 
metadata, Content classification, and Relation. The authors extended the DC 
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schema by adding additional elements such as ‘target audience’. The use of 
the Dublin Core Metadata Initiative Type Vocabulary (a type of ontology) 
enables health information to be categorised according to type. The authors 
were then able to cross-walk the terms in the ontology vocabulary to the 
clinical terminology, SNOMED CT producing a list of 1300 potential terms to 
describe health information. The authors found that when compared to a pre-
existing search engine, the newly developed health information search 
engine returned fewer yet more accurate results. Here, the use DC metadata 
elements combined with an ontology-based vocabulary helped produce a 
more accurate method of searching for and retrieving health information 
published to the web.  
However, since DC is designed to produce simplistic, domain 
independent descriptions, it too fails to fully meet the demands of public 
health and epidemiological metadata. Additionally, simple DC, (this refers to 
use of the fifteen elements only) does not have scope to record meta-
metadata (Miller 2011). Having access to this kind of information can help 
individuals monitor changes made the metadata and potentially improve 
opportunities for data citation by helping stakeholders to better identify the 
correct instance of metadata and to whom credit should be attributed.  
Another potential disadvantage with the application of simple DC is 
the limited scope to record semantic details (2009). Semantic information is 
needed to facilitate interoperability and enable preservation of digital 
resources; however, simple DC is not designed to record this kind of 
information. Within biomedical research, qualified DC would be better suited 
to producing detailed descriptions. Qualified DC is an altered version of DC 
consisting of some or all of the original fifteen elements in addition to other 
more context specific elements. For example, a qualified DC schema could 
include all, or some, of the 15 simple elements plus extra, user-defined 
elements to enable the recording of, variable level information, and in which 
catalogues the metadata has been indexed. Using a schema with additional 
elements such as these can help stakeholders in public health and 
epidemiological research to create lower level metadata. Nevertheless, once 
the simple DC schema has been changed, the resulting schema is no longer 
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compliant with the standard. Consequently, opportunities for metadata 
exchange could potentially be reduced as stakeholders may experience a 
loss of metadata or for the metadata to become distorted due to this 
reduction in interoperability.   
2.7.3 Data Documentation Initiative (DDI) 
The DDI is an XML-based metadata standard and was designed and 
developed primarily to describe social sciences research data. The standard 
is schema based and currently there are two versions both incorporating DC 
elements: DDI-Codebook (DDI-2)(DDI Alliance 2015a) and DDI-Lifecycle 
(DDI-3)(DDI Alliance 2015b). DDI-2 is generally used to markup relatively 
short and focused studies retrospectively. DDI-3 encourages a more real-
time approach to marking up metadata for longer term studies and provides 
mechanisms for metadata comparison. An instance of DDI-3 can be 
decomposed into four sections:  
1) Study unit: Comprises of seven subcomponents; conceptual components, 
inclusive of universes, codes and categories; data collection - describes 
methodology, question scheme and question logic; logical product, which 
contains variable information and details of any NCubes (tabulation of 
variables which is not limited by its own construction); physical data product, 
physical instance, archive, and profile.(Gregory and Thomas 2012);  
2) Group: Holds the resource package and enables maintainable items to be 
stored collectively. Use of resource packages facilitates inheritance and 
encourages metadata re-use across different metadata instances;  
3) Local holding package: This is the local archive; and  
4) Resource Package: Can either be single or multiple published modules 
containing questions, variables and concepts of a study. For an instance of 
metadata to be considered valid and compliant, a minimum set of metadata 
elements must be reached; otherwise the underlying XML will be valid but 
non-compliant. 
The DDI is now commonly used to standardise metadata globally and 
is the selected standard for international metadata catalogues and archives 
such as the Consortium of European Social Statistical Data Archives(2016e), 
Cohort & Longitudinal Studies Enhancement Resources(2016g) and the 
International Household Survey Network(2016j). The UK Data Archive at the 
University of Essex also uses DDI to standardise their metadata catalogue 
records. Application of DDI in this context enabled the creators of these 
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metadata records to provide rich and structured resources. Use of this 
standard also provides opportunity for metadata harvesting through use of 
protocols such as the Open Archives Initiative Protocol for Metadata 
Harvesting (OAI-PMH).  
As standards such as the DDI had their origins in the social sciences, 
they lacked the mechanisms needed to describe epidemiological and public 
health research studies effectively thus needing modification (Pisani and 
AbouZahr 2010).  By using extensions and customised versions of these 
standards, this has helped to facilitate their application into epidemiological 
and public health research settings.  
Figure 2-3 shows how these three metadata standards link together.   
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Figure 2-3 Metadata standards 
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2.8 Discussion 
The repurposing of existing datasets can help to maximise their 
potential as additional sources of clinical data for use in epidemiological and 
public health research studies. However, clinical information systems 
currently lack complete semantic interoperability thus necessitating 
researchers harmonise disparate data sources before clinical data may be 
reused in research studies (Bloomrosen and Detmer 2010; Al-Shorbaji 2012; 
Simborg, Detmer et al. 2013). 
Data integration processes are highly complex and demand 
interoperability on a number of different levels (Anwar and Hunt 2009). One 
such initiative which addresses these issues, in addition to others such as 
budget management, is the Clinical Research Administration (CLARA) 
platform. Bian, Xie et al. (2014) developed the CLARA platform to assist the 
clinical research management process at the University of Arkansas for 
Medical Sciences (UAMS) (Bian, Xie et al. 2014).  Piloted at the Cancer 
Institute at UAMS, the CLARA platform now contains 1083 studies of which 
91.14% have been fully re-entered into the system.  
Further, an increased use of EHRs coupled with the use of incentives, 
enabled the development of the Query Health initiative (Klann, Buck et al. 
2014; Embi, Weir et al. 2013 ). Query Health aims to address issues relating 
to performing standardised clinical queries in a secure and environment, 
implementation and to assess effectiveness through piloting. The pilot 
studies involved collaborating with the Department of Health in New York 
City and Massachusetts and the Food and Drug Administration Mini-
Sentinel(Platt, Carnahan et al. 2012) program (Klann, Buck et al. 2014). The 
developers used HL7 and SWTs to allow users to query and the Query 
Health ontology to manage terms derived from the National Quality Forum’s 
Quality Data Model (Klann, Buck et al. 2014).  
In conclusion, the application of SWTs, conceptual modelling and 
metadata standards, in addition to health information standards has had an 
impact on epidemiological and public health research and continues to do so.  
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2.9 Chapter summary 
In this chapter I investigated the use of information standards in 
epidemiological and public health research. I firstly examined the health 
information standards and focused on the application of encoding and 
exchange standards with epidemiological ad public health research settings. 
I then focused on the use of linked data on the World Wide Web in 
epidemiological and public health research. I then explored the use of clinical 
conceptual modelling and the use of clinical information models. Following 
this, I examined the use of metadata standards, ISO/IEC 11179, Dublin Core 
and the Data Documentation Initiative in epidemiological and public health 
settings. In the next chapter, I will describe the enhancing research data 
discoverability study and present my findings. In this study I investigated 
ways to enhance the discoverability of epidemiological and public health 
research data by performing a systematic literature review, online 
stakeholder survey and identified and evaluated mechanisms to enhance 
discoverability.   
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Chapter 3 Research case study 1: Enhancing the 
discoverability of epidemiological and public 
health research data 
3.1 Introduction  
In the previous chapter I examined the role of information standards in 
epidemiological and public health research. A key theme which emerged 
from this examination was the reuse of research data and repurposing of 
clinical data for research purposes. By repurposing and reusing data, 
stakeholders have the opportunity to maximise the research benefits 
associated with a cyclical use of research data in epidemiological and public 
health research settings.    
However, current limitations associated with research data 
discoverability can negatively impact the extent to which certain data are 
known to the wider research community. Discoverability refers to the ease to 
which research data may be identified by potential users. Subsequently, 
users may explore and characterise the data before harnessing or exploiting 
it potential research opportunities. Consequently, the potential for these data 
to be utilised for additional research purposes and the potential benefits 
realised is reduced (MRC 2014).  
Case study: ELFE, Growing up in France 
 
The ELFE study focuses on the lives of children growing up in France. It 
began in April 2011, and has since followed the lives of more than 18000 
children over a course of 20 years1.  
Whilst a list of related publications is provided on the study website, 
detailed metadata could not be found. Furthermore, there are no tools 
available to search through the metadata and visualise the research data. 
Consequently, researchers and other stakeholders wanting to discover and 
explore potentially available research data are unable to do so. 
The aim of my research case study is to identify and evaluate 
mechanisms to enhance the discoverability of public health research data 
discoverability. These mechanisms may be applied to the studies such as 
ELFE to enhance their discoverability and the potential to reuse and 
repurpose research data. 
 
1. http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=326&sitesectiontitle=ELF
E+%28Growin%20g+up+in+France  
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Furthermore, identifying and characterising certain research datasets 
such as linked clinical data as potential additional data sources, remains a 
challenging aspect of public health and epidemiology research (Weber, 
Mandl et al. 2014).    
This chapter presents the data discoverability study in which the 
enhancement of public health and epidemiology data discoverability was 
examined.  
3.2 Study aim and objectives 
The aim of this study was to identify and evaluate within the context of 
public health and epidemiological research settings mechanisms through 
which research data discoverability may be enhanced. This study had four 
objectives: a) describe current approaches to making research data 
discoverable; b) identify current awareness of the data discoverability issue 
and the perceived challenges of using tools, technologies and catalogues; c) 
identify models to enhance data discoverability; and d) evaluate these.  
3.3 Methods 
3.3.1 Systematic literature review  
The systematic literature review sought to characterise existing data 
discoverability practices and to identify current challenges and uses of 
metadata technologies. I used PubMed, Web of Science, Google and 
forward citation tracking (Kuper, Nicholson et al. 2006) and the following 
search terms: ‘public health and epidemiology’, ‘research datasets’, ‘data 
discoverability’, ‘metadata’ and ‘data reuse’. These terms were selected 
following a discussion with project team members and background literature. 
The use of these terms in the survey responses gave a degree of 
reassurance they were the correct terms to use. Unique identifiers were 
assigned to each of the studies and organisations as they were identified.  A 
total of 49 (Supplementary Table 1) public health and epidemiological studies 
and organisations were identified of which 13 were randomly selected and 
reviewed. Thirteen was a sufficiently large enough number for a range of 
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different studies to be analysed in-depth within the time constraints of the 
project and to avoid any potential bias. The six point criteria I defined was:   
1. Provision of study protocols: To establish the extent to which these were 
made publically available and in which formats.  
2. Approach to data documentation: To determine if these were publically 
available, in which formats and whether these were available for download 
3. Provision of data access mechanisms: To determine how these were made 
known to the public, identify any access and/or use policies and guidelines, 
and identify, if any, datasets available for immediate download.  
4. Publicly available online data visualisation and/or analysis tools: Firstly to 
establish whether researchers or other members of the public were able to 
utilise the data to perform basic analyses. Secondly, the recording of this 
information could inform development of any subsequent tools to enable 
researchers to better their understanding of the data before application is 
made for access and use.  
5. Provision of links to or descriptions of, publications: To characterise current 
approaches to publicising journals papers and other such forms of media to 
promote data discovery and inform the wider community of research 
findings.   
6. Use of social media and/or other forms of communication: To determine the 
extent to which social media is used to help improve knowledge of studies 
and/or organisations and which ones, if any, in particular. This would also 
inform development of any tools as these act as additional mechanisms 
through which discoverability may be enhanced.  
These criteria were selected as they were most appropriate to the literature 
review objectives. The use of social media was included as platforms such 
as YouTube and Facebook are being harnessed (in addition to other 
mediums) to better communicate with members of the public and (potential) 
participants of studies. I wanted to investigate use of these as they can 
contribute to the heightened discoverability of studies thus increasing 
awareness. 
3.3.2 Online stakeholder survey 
I have chosen to structure my description according to the 
CHERRIES(Eysenbach 2004) statement as adopted by the Journal of 
Medical Internet Research for reporting the results of web-based research as 
it enabled us to systematically describe in detail the design and 
administration of the online survey. 
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3.3.2.1 Design  
The survey was composed of six sections informed by findings of the 
review such as use of metadata standards and data publications. The 
sections were: a) background information – participant demographics; b) 
data discoverability – areas of importance, repositories, clinical terminologies 
and classification systems; c) data repositories; d) controlled vocabularies 
and thesauri; e) data documentation; and f) data citation and data 
publications. The survey is self-selecting hence not representative.   
In the data discoverability section, the list of repositories given to 
respondents to select from was based on a list provided by the Nature 
Publishing Group on their website (Nature Publishing Group 2014). In the 
data citation and data publications section, the list of perceived benefits was 
adapted from a report by the Digital Curation Centre (Ball and Duke 2012). A 
copy of the survey questions can be found in appendix A.      
During the pre-testing I found that the Boolean logic needed altering to 
ensure that certain questions, e.g. ‘If other, please specify…’ appeared as 
expected. I also changed the size of the answer boxes to enable 
respondents to provide more detailed responses. Other aspects of the 
survey that were adapted following pre-testing included altering the list of 
forms of data to include forms of data not previously listed. It was assumed 
that the respondents knew of and understood the term ‘metadata’ and other 
related terminology such as ‘research data lifecycle’.  
3.3.2.2 Ethical approval and informed consent process 
Ethical approval was not required for the work undertaken as part of 
the Ph.D. project. Implied consent to partake in the study was assumed from 
the individual through their decision to submit data using the online survey. 
All data collected is anonymous and contact details were provided if 
(potential) participants wished to contact the project team for further 
information or clarification. 
3.3.2.3 Development and pre-testing 
The survey was designed and developed using REDCap version 
5.7.5.(Harris, Taylor et al. 2009) REDCap, a web-based data capture tool 
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enabling development of survey instruments and collection of data in a 
secure environment. 
3.3.2.4 Recruitment process and description of the sample having access to 
the questionnaire 
The following mailing lists were used to circulate the survey:  
 JISC Research data management  
 JISC Managing research data 
 JISC Public health mailing list 
 JISC UK health and medical library  
 
The survey ran from 31st March 2014 to 21st April 2014. The advantage of 
using mailing lists is that a large number of people can be contacted in a 
relatively short period of time. The weakness of this recruitment method is 
that it is unfeasible to calculate a response rate as the total number of people 
subscribed to these lists, and to what extent the invitational emails were 
forwarded was unknown.  
In addition to the mailing lists, representatives of the signatories and 
supporting organisations of the Public Health Research Data forum were 
also contacted and asked to circulate the surveys. The signatories were: 
Agency for Healthcare Research and Quality, Bill and Melina Gates 
Foundation, Canadian Institutes of Health Research, Centres for Disease 
Control and Prevention, Deutsche Forschungsgemeinschaft (DFG), Doris 
Duke Charitable foundation, ESRC (UK), Health Research Council of New 
Zealand, Health Resources and Services Administration (USA), Hewlett 
Foundation, INSERM, MRC (UK), National Health and Medical Research 
Council (Australia), National Institutes of Health (USA), South African 
Medical Research Council, Substance Abuse and Mental Health Services 
Administration (USA), USAID, Wellcome Trust, and The World Bank. The 
supporting organisations are: Chief Scientist Office (Scotland), Creative 
Commons, Emergency Nutrition Network, UNICEF, and World Health 
Organization.  
During an initial stakeholder analysis as part of the initial scoping of 
the study, four groups were identified: researchers and other data users, 
data producers, archivists and librarians, and funders. These groups are not 
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mutually exclusive. This analysis also provided us with an opportunity to 
raise awareness of the survey and to collate additional email addresses of 
potential survey participants. A total of 113 individuals with a total of 88 
different affiliations, were identified and invited to complete the data 
discoverability survey.  
3.3.2.5 Survey administration  
The invitational email, inclusive of a brief description of the study and 
a link to the survey, asked the participant to forward the invitation to their 
contacts in an attempt to reach as many potential participants as possible.  
The survey began with a short introductory paragraph to the study 
describing the aims and objectives of the survey and the length of time it 
should take to complete (10 minutes). To facilitate data capture, the survey 
consists of several pages (Schleyer and Forrest 2000). The questions were 
grouped according to theme and the participants were able to track how far 
into the survey they are in terms of pages. All questions were optional and 
where multiple selections were possible, this is indicated in the question. 
When completing the survey, the participants had the option of saving and 
returning to the survey as many times as they deem necessary.  
Certain questions invited respondents to provide additional 
suggestions and comments through use of ‘if yes/other, please specify…’ 
style questions; Boolean logic was incorporated to automatically customise 
the survey depending on previously submitted answers, this in turn removed 
or added any necessary subsequent questions. The inclusion of open-ended 
questions in the survey facilitated the capture of qualitative data. 
Furthermore, a Likert scale comprising of five points (‘not at all’, ‘slightly’, 
fairly’, ‘extremely’, and ‘essential’) was used to gauge stakeholders’ opinions 
and feedback. 
3.3.2.6 Analytical strategy 
All completed questionnaires were analysed. I analysed the 
quantitative data collected through the online survey with SPSS. To analyse 
the qualitative results, I adopted a Grounded theory approach and the 
themes were collated inductively and iteratively.  This approach enabled us 
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to use to the data collected to develop theories hermeneutically rather than 
approach the data with hypotheses already formulated. 
3.3.3 Mechanisms to enhance discoverability  
Based upon the literature review and online stakeholder survey, three 
models were identified (data publications, linked data and a public health 
portal) through which funders could enhance data discoverability. Each of 
these models arose from my research findings. Through my systematic 
literature review I identified the potential to use data publications as another 
way of enhancing data discoverability. In this thesis (chapter 3), I identified 
the potential to use SWTs as mechanisms to further enhance data 
discoverability. Through qualitative analysis of the survey results, I identified 
the need for a registration process for observational studies which could be 
enacted through a public health portal similar to that of ClinicalTrials.gov.  
3.3.4 Evaluation strategy 
I conducted a series of feasibility analyses (Dennis, Wixom et al. 2015) by 
way of evaluation. This approach originates from the computer science 
domain and is used as part of systems analysis and design. In adopting this 
approach, I was able to systematically and thoroughly analyse three key 
areas of feasibility to determine how valid each model was in enhancing data 
discovery. The three areas were: a) technical – factors affecting how the 
system is built; b) economic – this examines the associated costs/benefits; 
and c) organisational – factors which could affect how the system is used by 
stakeholders. In having a clear framework from which to work I was able to 
identify case studies where these models had been previously utilised in 
epidemiological and public health research. I also engaged with stakeholders 
in epidemiology and public health to critically appraise each model by way of 
evaluation. The mechanisms were presented to members of the Public 
Health Research Data Forum and The Wellcome Trust through 
teleconferences and face-to-face discussions.    
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3.4 Results 
3.4.1 Systematic literature review 
A total of 49 studies and organisations were identified, of which 13 
were randomly selected and their websites reviewed in greater detail. Most 
of the studies identified are observational, for which there is no known 
mandatory registration process. Table 3-1 describes the results of the review 
of the sample of epidemiological and public health studies and organisations.  
The review showed that of the sample, PDF was one of the most 
common formats to provide study protocols. It also showed that SAS, STATA 
and SPSS were the most commonly supported file formats for the data. 
Results also show all studies and organisations in the sample provide either 
a list and/or sometimes link to publications involving particular datasets.  
The review showed that five studies and organisations provided online 
data visualisation/analysis tools: the European Prospective Investigation into 
Cancer and Nutrition (EPIC), European Social Survey, INDEPTH Network, 
IPUMS International Project, Measure DHS and the Worldwide Antimalarial 
Resistance Network. These help prospective researchers and members of 
the public are able to use certain datasets and perform basic analyses. 
Results also show newsletters, RSS feeds, Facebook, Twitter, 
YouTube and blogs were among the alternative forms of communication 
employed by the studies and organisations. 
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Table 3-1 Review results and review according to the 6 point criteria developed 
Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
6 - Avon Longitudinal Study of 
Parents and Children  
 
UK 
 
Questionnaires 
available as 
PDFs 
Downloadable data 
dictionary 
Data access 
policy and 
guidance 
available 
online (PDF) 
No Yes Facebook, 
Google+, 
Soundcloud, 
MyYahoo, 
YouTube, 
Twitter and 
QR code 
 
12 - ELFE, Growing up in 
France  
 
France 
 
Online 
description of 
key stages  
 
Could not find this 
information on their 
website 
Could not find 
this 
information on 
their website 
No Yes Newsletter 
13 - European Prospective 
Investigation into Cancer and 
Nutrition (EPIC) 
 
Lyon, UK (London), Denmark, 
France, Germany, Greece, Italy, 
Norway, Spain, Sweden, The 
Netherlands 
 
Questionnaires 
and statistical 
methods 
Questionnaires and 
descriptions of the 
cohort/anthropomet
ric measurements 
available online. All 
measurements 
were standardised 
using EPIC-SOFT 
(available in 
multiple languages) 
to enable 
comparison. 
Could not find 
this 
information on 
their website 
No Yes RSS and 
LinkedIn 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
14 - European Social Survey 
 
Albania, Austria, Belgium, 
Bulgaria, Croatia, Cyprus, Czech 
Republic, Denmark, Estonia, 
Finland, France, Germany, 
Greece, Hungary, Iceland, Ireland, 
Israel, Italy, Kosovo, Latvia, 
Lithuania, Luxembourg, The 
Netherlands, Norway, Poland, 
Portugal, Romania, Russian 
federation, Slovakia, Slovenia, 
Spain, Sweden, Switzerland, 
Turkey, Ukraine, UK 
 
Online 
descriptions and 
PDFs 
 
Available online by 
year, country and 
theme 
Data is 
available for 
download 
online in SAS, 
SPSS and 
STATA 
Yes Yes Email 
18 - INDEPTH Network 
 
South Africa, Guinea Bissau, 
Senegal, Ethiopia, Ghana, 
Gambia, Tanzania, Uganda, 
Malawi, Burkina Faso, Kenya, 
Mozambique, Nigeria, Cote 
d'Ivoire, India, Bangladesh, 
Vietnam, Cambodia, Thailand, 
Indonesia, Papua New Guinea 
Study overviews 
available online 
Online data 
dictionaries 
available with 
variable names, 
labels and 
descriptions. DDI 
compliant metadata 
is available. 
Downloadable 
microdata (must 
register/login) 
Two types: 
'Public use 
files' and 
'Licensed files' 
and data can 
be filtered 
according to 
centre.  
Yes Yes Email 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
20 - IPUMS International 
Project 
 
Argentina, Armenia, Austria, 
Bangladesh, Belarus, Bolivia, 
Brazil, Burkina Faso, Cambodia, 
Cameroon, Canada, Chile, China, 
Colombia, Costa Rica, Ecuador, 
Egypt, El Salvador, Fiji, France, 
Germany, Ghana, Guinea, Greece, 
Haiti, Hungary, India, Indonesia, 
Iraq, Iran, Ireland, Israel, Italy, 
Jamaica, Jordan, Kenya, Kyrgyz 
Republic, Malawi, Malaysia, Mali, 
Mexico, Mongolia, Morocco, Nepal, 
Netherlands, Nicaragua, Pakistan, 
Palestine, Panama, Peru, 
Philippines, Portugal, Puerto Rico, 
Romania, Rwanda, Saint Lucia, 
Senegal, Sierra Leone, Slovenia, 
South Africa, South Sudan, Spain, 
Sudan, Switzerland, Tanzania, 
Thailand, Turkey, Uganda, United 
Kingdom, United States, Uruguay, 
Venezuela, and Vietnam 
 
Questionnaires 
available as 
PDFs and 
HTML  
When data are 
extracted, 
codebooks are 
generated. 
Online variable 
selection 
(integrated 
and 
harmonised 
variables 
options 
available). 
Users must be 
registered 
before data 
extracts may 
be 
downloaded. 
Extract system 
provides 
support for the 
import of 
generated 
ASCII files into 
SPSS, SAS 
and STATA. 
 
Yes Yes Newsletter 
22 - Measure DHS, 
Demographic Health Surveys 
 
Angola, Benin, Botswana, Burkina 
Questionnaires 
are available for 
download (PDF) 
Data are recoded 
(variable names, 
locations etc.) with 
all recording 
Must be a 
registered user 
of the website. 
Application for 
Yes -HIV/AIDS 
Survey 
Indicators 
Database & 
Yes Email, 
Facebook, 
Twitter, 
YouTube, 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
Faso, Burundi, Cameroon, Cape 
Verde, Central African Republic, 
Chad, Comoros, Congo 
(Brazzaville), Congo Democratic 
Republic, Cote d'Ivoire, Equatorial 
Guinea, Eritrea, Ethiopia, Gabon, 
Gambia, Ghana, Guinea, Kenya, 
Lesotho, Liberia, Madagascar, 
Malawi, Mali, Mauritania, 
Mozambique, Namibia, Niger, 
Nigeria, Nigeria (Ondo State), 
Rwanda, Sao Tome and Principe, 
Senegal, Sierra Leone, South 
Africa, Sudan, Swaziland, 
Tanzania, Togo, Uganda, Zambia, 
Zimbabwe, Albania, Armenia, 
Azerbaijan, Egypt, Jordan, 
Moldova, Morocco, Tunisia, 
Turkey, Ukraine, Yemen, Central 
Asia, Kazakhstan, Kyrgyz 
Republic, Tajikistan, Turkmenistan, 
Uzbekistan, Afghanistan, 
Bangladesh, Cambodia, India, 
Indonesia, Lao People's 
Democratic Republic, Maldives, 
Nepal, Pakistan, Philippines, Sri 
Lanka, Thailand, Timor-Leste, 
Vietnam, Samoa, Bolivia, Brazil, 
Colombia, Dominican Republic, 
Ecuador, El Salvador, Guatemala, 
Guyana, Haiti, Honduras, Mexico, 
manuals available 
for download 
online. Use the 
DHS Recode. 
data must 
include contact 
information, 
research 
project title 
and 
description of 
intended 
analysis. 
Certain data 
require users 
to sign 
additional 
agreements/te
rms of use. 
Files are 
distributed as 
compressed 
Zip files. List of 
potential data 
downloads is 
available 
online. Data 
are available 
in ASCII, 
STATA, 
SPSS, SAS 
STAT compiler LinkedIn, 
Pinterest, 
Blog and 
Mobile phone 
app 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
Nicaragua, Paraguay, Peru, 
Trinidad and Tobago 
and CSPro 
 
23 - MIDUS Midlife in the US 
 
United States of America 
Available in 
catalogue/ICPS
R website 
Categories, codes, 
variable grouping 
etc. available 
through Colectica 
catalogue. DDI 
Codebook/Lifecycle
, Dublin Core and 
MARC21 XML 
metadata 
 
Data is 
available for 
download 
online in SAS, 
SPSS, 
STATA, ASCII 
and Delimited 
from ICPSR 
website 
No  Yes LinkedIn, 
Facebook, 
Google or 
MyData 
26 - Norwegian Mother and 
Child Cohort Study 
 
Norway  
Online 
description and 
downloadable 
questionnaires 
 
Basic participant 
response figures 
available online for 
version VIII 
Applications 
must be 
submitted and 
approved 
before use of 
data and/or 
biological 
materials is 
enabled. 
Researcher(s) 
may need to 
sign a contract 
with the 
Norwegian 
Institute of 
No Yes Facebook, 
Twitter, 
YouTube, 
RSS feed 
and 
newsletter 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
Public Health 
 
33 - Scottish Longitudinal Study 
 
Scotland 
 
Online 
descriptions of 
creation/develop
ment available 
as individual 
'Technical 
Working Paper' 
 
Online data 
dictionary with 
searchable lists of 
tables and 
variables 
2 methods - 
'safe setting' in 
Edinburgh or 
remote access 
involving use 
of variable 
names and 
labels only for 
creation of 
syntaxes. 
These 
syntaxes are 
then returned 
to the Support 
Officer who 
will arrange for 
the analysis to 
be run and the 
results, once 
cleared 
returned. More 
details 
available 
online 
No Yes Twitter, 
email, blog 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
 
34 - Study of Environment on 
Aboriginal Resilience and Child 
Health 
 
Australia 
 
Study protocol 
available as an 
academic paper 
Could not find this 
information on their 
website 
Describes 
'SURE' 
Secure, 
Unified 
Research 
Environment' 
but does not 
make it clear if 
SEARCH data 
can be 
accessed 
No Yes Email, 
Facebook, 
RSS, 
LinkedIn and 
Twitter 
 
48 - WHO Study on Global 
AGEing and Adult Health 
(SAGE) 
 
South Africa, China, Ghana, India, 
Mexico, Russian Federation 
 
Summary of 
measures in 
questionnaires 
and the 
questionnaires 
themselves 
available in PDF 
Related materials, 
study description, 
data dictionary 
(variables include 
name, label and 
question) and 
related citations all 
available. DDI 
compliant metadata 
available in PDF. 
 
Through WHO 
Multi-Country 
Studies Data 
Archive.  
No Yes RSS, 
YouTube, 
twitter, 
Facebook 
and Google+ 
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Study ID, name and coverage  Study 
protocols 
Data 
documentation 
Data access  Online data 
visualisation/ 
analysis  
Publication 
links/ 
descriptions  
Social 
media / 
other forms 
of 
communicat
ion 
49 - Worldwide Antimalarial 
Resistance Network 
 
Thailand, Kenya, Brazil, Senegal 
Searchable 
procedures 
available for 
download 
When sharing data 
(clinical, 
pharmacology, In 
vitro) data 
dictionaries should 
be accompany data 
WWARN 
standardise 
data and then 
make these 
available 
including of 
audit trail and 
original 
dataset to the 
data 
contributor and 
nominated 
individuals. 
Researchers 
(under ‘Third 
party data 
access’) 
should contact 
the data 
owner(s) as 
they alone can 
grant access 
to the 
transformed 
data. 
Yes Yes Facebook 
and twitter 
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3.4.2 Online stakeholder survey1   
3.4.2.1 Participant demographics  
253 individuals completed the survey of which most were employed 
by a university, Figure 3-1.  The respondents were also asked to indicate 
their role in public health research data and were able to make multiple 
selections. The most common role was ‘Data user’ and the least common 
was ‘Observer’. The most common respondent was a Data User located in 
Europe. Just over a quarter of survey respondents carried out work in 
Europe (28.9%) followed by Oceania (13.1%) and Northern America (8.3%). 
The survey also requested respondents indicate if they were in receipt of 
funding from any of the specified funding agencies, Table 3-2. The most 
common funding agency from the pre-determined list was the Medical 
Research Council (UK) (15%) followed by the Wellcome Trust (11%. A total 
of 61 respondents indicated that they received funding from other non-
specified agencies with the French Ministry of Foreign Affairs, Rio de Janeiro 
State research Support Foundation (Brazil) and Australian Red Cross Blood 
Service being three such examples.  
                                            
 
1 N.B. Where quotations have been used, these have been copied verbatim; 
in places words have been added in parentheses to aid understanding. 
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Roles are defined as: a) data provider – provides research data; b) 
data user – someone who uses research data; c) archivist/librarian – anyone 
who is responsible for cataloguing, curating or storing research data on both 
a short to medium term and longer term basis; d) policy maker – those 
involving in policy making and or advising; e) observer – anyone indirectly 
involved in the research process; and f) other.  
 
Figure 3-1 Roles in public health 
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Figure 3-2 Location of work undertaken 
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Table 3-2 Funding agencies 
3.4.2.2 Data types and the research data lifecycle 
The most commonly used form of data by survey respondents was 
survey data, (27%), and the second most common were, healthcare records, 
21%. The least common was imaging data, 3%. Table 3-3 presents the 
results (in percent) the different forms of data as used by the respondents 
who provided data. These results vary however at an individual country level 
and also by role.  
 
  
 Responses 
Number Percent 
 Medical Research Council (UK) 44 15% 
 Wellcome Trust 31 11% 
 
National Health and Medical Research Council 
(Australia) 
28 10% 
 Bill and Melinda Gates Foundation 25 9% 
 NIHR (UK) 24 8% 
 National Institutes of Health (USA) 18 6% 
 Economic and Social Research Council (UK) 18 6% 
 Centres for Disease Control and Prevention 8 3% 
 
Agency for Healthcare Research and Quality (USA) 4 1% 
Canadian Institutes of Health Research 3 1% 
Deutsche Forschungsgemeinschaft (DFG) 2 1% 
Health Research Council of New Zealand 4 1% 
Health Resources and Services Administration (USA) 3 1% 
Hewlett Foundation 3 1% 
Institut national de la santé et de la recherche médicale 
(INSERM, France) 
2 1% 
Substance Abuse and Mental Health Services 
Administration (USA) 
2 1% 
The World Bank 4 1% 
Other(s) 61 21% 
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Table 3-3 Forms of data 
  
 Responses 
N Percent 
 
Survey 157 27% 
Healthcare records 125 21% 
Disease registries 76 13% 
Ethnographic 24 4% 
Geospatial 46 8% 
Environmental 31 5% 
Genomic/Proteomic/Metabolomic 30 5% 
Imaging 19 3% 
Physiological measurement 47 8% 
Other 37 6% 
 
The respondents were also asked to indicate in which areas of the 
research data lifecycle were they involved in. Table 3-4 shows the 
respondents’ roles in public health as categorised by location.   
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Table 3-4 Role in public health and location of work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Role in public health (number) 
Data provider Data user Archivist / Librarian Funding agency Policy maker Observer Other 
 
Southern Asia 14 14 1 1 1 0 2 
Eastern Asia 8 8 1 1 1 0 1 
Europe 64 83 10 2 6 1 6 
South-Eastern Asia 9 14 1 1 1 0 2 
South America 5 9 1 0 2 0 2 
Eastern Africa 22 21 2 3 3 0 2 
Northern America 14 16 9 0 1 1 5 
Western Africa 17 20 2 3 2 0 1 
Western Asia 3 4 1 0 1 0 1 
Northern Africa 5 4 1 0 1 0 2 
Central America 2 3 1 0 1 0 1 
Middle Africa 6 4 1 0 1 0 2 
Central Asia 3 2 2 0 1 0 1 
Southern Africa 21 19 3 1 1 0 4 
Caribbean 2 1 1 0 1 0 1 
Oceania 22 42 6 1 5 0  1 
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3.4.2.3 Search options, controlled vocabularies and thesauri 
Another issue explored in the survey was the use of controlled 
vocabularies and thesauri. This issue was explored because there are 
inconsistencies between the way in which researchers describe their 
research and the way in which other stakeholders search.  
In certain circumstances, such as describing manuscripts, authors can 
select MeSH terms as ‘key words’. MeSH terms are used to index medical 
literature in biomedical databases; however, it is possible for a ‘key word’ 
associated with a manuscript to not appear in the MeSH term listing. For 
example, ‘metadata’ does not have an entry in the MeSH term listing2. A 
potential work around here would be to use related subject terms which do 
appear in MeSH; in the case of ‘metadata’, this could become 
‘documentation (L01.453.245)’3. Whilst this would not seem problematic, the 
challenge for stakeholders arises when they want to form search strategies 
to source literature i.e. how do they know when to use a key word such as 
‘metadata’ or a subject term such as ‘documentation’. It is also possible in 
these circumstances for authors to include ‘concepts’ in an attempt to 
enhance the description of their paper. For example, a concept could be 
‘epidemiology’ and a related concept could be ‘public health’. This does 
however raise the question of determining when a ‘concept’ ceases to be just 
that and becomes a ‘related concept’. To the best of my knowledge, the 
distinction or limits between these has not yet been clearly defined and 
ratified by the wider scientific community for purposes of describing 
manuscripts. And yet, some authors need to use these to describe their work 
as the ‘key words’ needed do not have equivalent ‘subject terms’.  
Therefore, should stakeholders treat ‘subject terms’, ‘key words’, 
‘concepts’ and ‘related concepts’ as though they are mutually exclusive and 
develop four different search strategies; or, is it that a single search strategy 
containing a mix of these will suffice? This does however raise the question 
                                            
 
2 correct January 2016 using 2016 MeSH 
3 correct January 2016 using 2016 MeSH 
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of at which point should stakeholders sourcing literature draw the boundaries 
of their search strategy since to use every ‘key word’, ‘subject term’, 
‘concept’ and ‘related concept’ (mutually exclusively or otherwise) can 
become infeasible. Differences in the way authors describe their manuscripts 
given a lack of clear guidelines could negatively impact the potential for 
discovery as part of literature searches.  
Hence, understanding the thought process behind the way in which 
authors describe their manuscripts is important to informing 
recommendations aimed at authors for purposes of enhancing discoverability 
of their scientific outputs. It is also important to informing recommendations 
aimed stakeholders in searching for literature for purposes of potential reuse 
of existing datasets to test additional hypotheses. Respondents were thus 
asked to indicate which their preferred search options were. For purposes of 
this study ‘key word’ is defined as a word associated to the manuscript 
critical to describing its content; ‘subject terms’ are defined as words or 
phrases as part of controlled vocabularies; ‘concepts’ are defined as ideas 
directly relating to content; and ‘related concepts’ are defined as other ideas 
relating to concepts already selected. Searching by ‘key word’ was most 
popular with 181 votes (44%) followed by ‘subject terms’ (133, 32%), then 
‘concepts’ (66, 16%) with the least preferred option being ‘related concepts’ 
(33, 8%). Table 3-5. 
Table 3-5 Preferred search options 
 Responses 
Number Percent 
 
Keyword 181 44% 
Subject terms 133 32% 
Concepts 66 16% 
Related concepts 33 8% 
Total 413 100.0% 
Survey respondents were also asked to indicate which aspects of a 
research study should be easily searchable. Results show that the ‘research 
study question’ was the most popular answer with the respondents followed 
by ‘variables’ and then ‘research publications’ (Table 3-6). 
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Table 3-6 Searchable aspects of a research study as indicated by role 
 
Role 
Searchable aspects of a research study 
Research 
study 
question 
Variables 
Research 
publications 
Research 
study 
protocol 
Data collection 
instrument 
designs 
Code 
lists 
Research data 
management 
plan 
Funding 
details 
Concepts 
Consent 
form and 
associated 
information 
pack 
Data user 124 116 113 111 101 87 48 43 34 39 
Data 
provider 
91 89 80 80 75 69 36 30 28 36 
Archivist / 
Librarian 
17 17 17 12 15 17 3 5 15 4 
Policy 
maker 
11 10 10 11 8 10 4 5 3 6 
Other 12 8 9 11 10 6 6 7 8 5 
Funding 
agency 
5 5 5 5 5 4 2 4 2 3 
Observer 1 1 1 1 1 0 1 2 1 1 
Total 162 152 147 143 129 116 61 55 55 53 
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Finally, the respondents were asked to indicate which of the specified 
list of terminologies, classification systems, thesauri and metathesauri they 
were familiar with. The most familiar standard was the International 
Classification of Disease and the least familiar was the European Language 
Social Science Thesaurus, Table 3-7.  
Of the 9 who specified they used other tools, two examples of 
responses include, but are not limited to, the WHO Anatomical Therapeutic 
Chemical Classification System with Defined Daily Doses (ATC/DDD) codes 
and WHO Drug Dictionary. The respondents were also asked to provide 
details of any tools they used to assist the management of controlled 
vocabularies, responses include the WHO Global Health Observatory.  
Table 3-7 Classifications and thesauri 
  
 Responses 
Number Percent 
 
International Classification of Disease (ICD) 148 32% 
Medical Subject Headings (MeSH) 119 25% 
Diagnostic and Statistical Manual of Mental Disorders (DSM 5) 78 17% 
SNOMED CT 36 8% 
Read Codes 34 7% 
OPCS-4 17 4% 
Other 9 2% 
Humanities and Social Sciences Electronic Thesaurus (HASSET) 11 2% 
European Language Social Science Thesaurus (ELSST) 4 1% 
Unified Medical Language Service (UMLS) 5 1% 
 Logical Observation Identifiers Names and Codes (LOINC) 6 1% 
Total 467 100.0% 
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3.4.2.4 Data documentation and metadata standards 
The survey also aimed to identify current challenges in creating and/or using 
data documentation (a total of 50 people answered this question). The 
challenges fall into the following categories:  
1. Standardisation 
2. Resource availability 
a. General comments 
b. Time and costs 
c. Technology  
d. People/staffing   
A total of 16 people commented on standardisation with 9 focusing on 
data management and 7 commenting on research data. Of those which 
commented on standardisation in data management, a common concern 
was the current lack of data management standards with one person stating 
there was an,  
“…inappropriate data management  tools (and) Poor 
standardisation of data dictionary”.  
Two people commented on marking up variables and  
“ensuring sufficient documentation on derived variables”  
with a third noting  
“providing sufficient detail and access while retaining data 
confidentiality”  
is important. A common concern held by those who commented on 
standardising the data itself, was how the heterogeneity of the data impacts 
documentation. One respondent commented,  
“creating data is easy, documenting data is the rather more 
complex issue”  
whilst another commented on  
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“The complexity of data...collected using CAPI is a challenge”  
and representing,  
“an instrument that may have been experienced differently by 
different respondents to researchers in a straightforward way is 
difficult.”  
A total of 29 people commented on issues relating to the availability of 
resources to cover the time required, financial cost and availability of trained 
staff to document data. Generally, it was felt by respondents that more 
resources are needed to support data documentation. One respondent 
stated that,  
“skill, time, resources and the less tangible aspect of lack of 
recognition/appreciation for doing this work…one does not 
normally get grants, get REF brownie points or publication kudos 
out of producing this documentation.”  
In terms of time and costs, 9 people commented specifically on the 
lack of time and funding for data documentation with one respondent saying, 
“I would need funded time for data management staff” to complete this task. 
With regards to technology, a total of 4 people commented specifically on 
use of technology as a resource with a “lack of good quality tools” and 
standards being two such concerns. Lastly many of those who responded 
commented on the implications generating data documentation has on 
people and staffing. Further to time and costs, skills development; or rather, 
a lack of sufficiently skilled staff is a particular challenge. This subsequently 
raises issues over current skills development programmes and whether more 
can be done in the way of training.  
The most commonly indicated metadata standard were the Data 
Documentation Initiative 2/3 standards, particularly with data providers 
employed by universities, Supplementary Table 2. 
In terms of tool availability, this ranged from in-house options such as 
those developed by WWARN to commercial tools such as Colectica. Another 
commonly used tool was the Nesstar publisher. Other responses included 
Research case study 1: Enhancing the discoverability of epidemiological and public health research 
data 
 
88 
 
Microsoft Excel and Word with one respondent writing they used “NVivo, 
Zotero” to assist data documentation.   
3.4.2.5 Promoting data discoverability and use of data repositories 
The most popular repository was ClinicalTrials.gov (23%). Of the 
repositories respondents were intending to use, again ClinicalTrials.gov was 
the most popular (7%) and the least popular was social science (0%), Table 
3-8  
If the option ‘Other’ was selected, the respondents were then given 
the option of providing details of any other repositories not listed, exemplar 
answers included, the “INDEPTH Data Repository” and the “Spanish 
National Institute of Statistics”.  
The respondents were also asked to provide their opinion on areas of 
importance to data discoverability (Table 3-9). The numbers in bold signify 
where the median is. 
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Table 3-8 Current and intended use of repositories 
Repositories 
 Use of repositories  
Already used Intended to use 
Number of 
respondents 
% of survey 
respondents 
CI Number of 
respondents 
% of survey 
respondents 
CI 
ClinicalTrials.gov 58 23 22-36 18 7 4-17 
Social Science 47 19 18-30 1 0 0-67 
Other 20 8 6-15 6 2 3-15 
Genetic association & genome variation 17 7 5-13 5 2 2-14 
Environmental & geoscience 16 6 5-13 9 4 1-12 
Organism or disease specific resources 13 5 3-11 7 3 4-17 
Functional genomics 8 3 2-8 4 2 1-12 
DNA protein sequences 6 2 1-6 2 1 0-9 
Figshare 5 2 0-6 9 4 1-12 
Molecular interactions 4 2 1-5 2 1 0-9 
Molecular structure 3 1 0-4 2 1 0-9 
Taxonomy & species diversity 3 1 0-4 5 2 2-14 
Dryad 2 1 0-4 6 2 3-15 
Proteomics 1 0 0-3 5 2 2-14 
Total 203 80  81 32  
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Table 3-9 Aspects important to discoverable data 
Aspects of importance to discoverable data 
Opinion 
Essential Extremely Fairly Slightly Not at all (blank) 
Be on the web 
Number of survey respondents 83 69 31 7 9 54 
% of survey respondents 33% 27% 12% 3% 4% 21% 
Be provided in a machine-readable format 
Number of survey respondents 94 74 19 3 6 57 
% of survey respondents 37% 29% 8% 1% 2% 23% 
Be provided in a non-proprietary form 
Number of survey respondents 44 61 64 5 14 65 
% of survey respondents 17% 24% 25% 2% 6% 26% 
Conform with recognised data management standards 
Number of survey respondents 55 82 50 1 5 60 
% of survey respondents 22% 32% 20% 0% 2% 24% 
Be linked to an underlying conceptual framework or ontology 
Number of survey respondents 20 45 78 14 34 62 
% of survey respondents 8% 18% 31% 6% 13% 25% 
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3.4.2.6 Data publication and citation 
The survey showed that most common way of first hearing about data 
publications was through a colleague (35%). This was then followed by 
journal (29%), conference/workshop (23%), search engine (6%)  and the 
other option (7%), to which respondents offered “Involved in projects in this 
area”, “Blog posts” and, “I edit a journal where we promote publication of 
data resource papers” as three such alternative methods. 
The respondents were also asked to indicate which of the perceived 
benefits of citation (adapted from a report by Ball and Duke (2012) from the 
Digital Curation Centre) they consider to be of most importance. 
Respondents were able to make multiple selections. It was identified that the 
ability to ease the process for readers to locate the data and attributing credit 
to those who contributed the data was the two most important benefits of 
data citation, Table 3-10.  
 
Table 3-10 Benefits considered important to data citation 
 
Other benefits of data citation (provided under the ‘Other’ option) included 
“avoid duplication of effort e.g. for validation studies” and “Provides accurate 
and sufficient wording to use in reference lists”. A further two benefits were 
  
 Responses 
Number Percent 
 
Easier for readers to locate data 137 22% 
Proper credit given to data contributors 113 18% 
Links between datasets and associated methodology publication provide 
context for reader 
114 18% 
Links between datasets and publications describing their use can 
demonstrate impact 
77 12% 
Infrastructure can support long-term reference and reuse 69 11% 
Promotes professional recognition and rewards 64 10% 
Less danger of data plagiarism 40 6% 
Other 4 1% 
Total 618 100.0% 
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provided, the first discussing the potential for these to be “…assessed for its 
own value, provenance and potential…” and the second as a mechanism to 
help,   
“…secure funding from agencies such as the National Institutes of 
Health and the National science Foundation for new and 
continuing data integration and dissemination projects.  We must 
prove that the datasets are being used for science and policy and 
can only do so if users appropriately cite our datasets.”  
Continuing this focus on data citations, respondents were asked to indicate 
how granular data citations should be. Results showed that the most popular 
level of citations were at the data collection level followed by a single dataset 
(or sweep). For those that selected the ‘other’ option, an exemplar answer 
included, but is not limited to “subset of data used for analysis” (Table 3-11)  
Table 3-11 Granularity of data citations 
Levels of data citation Percent  
Dataset collections 36 
Single datasets (or 
sweep) 
33 
Files within datasets 16 
Individual items of data 13 
Other 2 
 
To help identify best practice in managing longitudinal and regularly 
changing datasets, the respondents were asked to indicate how these data 
should ideally be handled. The most common approach was to ‘Publish 
revisions at regular intervals’ followed by ‘All published versions should be 
published in instalments’, Table 3-12.   
Two suggestions were made for alternative approaches; the first was 
to include lists of, “…changes made from release to release…Also provide 
any crosswalks to enable linking between different releases/time periods.” 
The second was to make use of ‘timestamp’ to assist identification of 
changes.   
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Table 3-12 Managing longitudinal and regularly changing datasets 
Approach Percent 
New identifier assigned at each update 18.3 
Publish revisions at regular intervals 28.9 
Time series data should be published as complete 
'snapshots' 
16.3 
Time series data should be published in instalments 10.3 
All published versions of the datasets must be stored 25.1 
Other 1.1 
 
The survey identified a number of challenges currently associated with the 
adoption of data publications. These can be categorised into the following:  
 
a) limited significance: A number of respondents questioned the value of 
data publications with several stating that there is little incentive to publish, 
for example, the publications are not acknowledged in the REF. One 
respondent felt these articles were unnecessary:   
“In many fields, the information in a data publication is already 
available in documentation accompanying the data”  
b) Inadequate resource availability: Time and costs were the most 
commonly discussed with their efficient use being a concern. One 
respondent wrote these publications are “resource intensive…” and another 
described them as, “…likely to be lower priority than publishing actual 
research on the data”. Another wrote that there is, 
 “excessive linking of university fuinding and employment and 
tenure to outdated private journal models based on prestige and 
less accessible to non-established researchers and in developing 
countries”. 
c) Need for changes in research culture: six respondents each 
commented on research culture and current approaches to scientific 
research. One respondent commented,  
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“Culture change –specifically, that data be considered and 
acknowledged (by funding bodies and employing institutions) as a 
valuable scholarly output alongside publications”.  
It was also noted that researchers are “…over-stretched…” and there 
is “…a shortage of expertise in data management staff.” 
These findings highlight the limited perceived significance of data 
publications and the undervaluing of efforts to produce these particularly 
within the context of academic reviews where HEFCE block funding could be 
awarded. Additionally, the perceived lesser contribution these make to 
science in comparison to original research articles appears to discourage 
researchers from prioritising their creation. These results also suggest that 
funding agencies and institutions could do more in the way of promoting data 
publications and in particular provide greater support for researchers to 
produce these. Consequently, the use of data publications as a mechanism 
to enhance the discoverability of research data may be negatively affected.  
3.4.2.7 Areas of importance to data discovery  
Areas of importance to data discoverability are categorised as follows:  
Identification of commonalties and links between studies: The 
ability to identify common research questions and hypotheses will help 
reduce redundant research efforts and help streamline research processes. 
One respondent wrote that it was, “important to encourage data analysts to 
move out of the comfort zone of using a favourite study and to use several 
complimentary sources” However, the ability to make links between studies 
is determined in part by the extent to which they are published which is a 
“…major challenge (in) unpublished data, particularly for trials…” The 
process of obtaining data is another issue which needs to be addressed 
through, “…simple…” processes which are not subject “…to constant 
change”.  
Metadata markup and producing other associated 
documentation: Producing metadata and other study artefacts will help 
secondary researchers identify “…any local influences on 
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variables/interpretation” as written by one respondent and “…ensure 
transparency and reproducibility” as written by another.  
The request was also made for researchers to be able to search for 
particular instruments and, “…to discover subject characteristics, such as 
gender, age, socio-economic status”. Provision of a “detailed analysis plan” 
will also support data discoverability. Regarding use of schemas, the 
argument was made for “a clear and transparent schema…” for variable 
name annotations as this would be “most helpful” if these accompanied the 
questionnaires.  
Use of technology: The use of “…new, often complex…” databases 
were argued by three people as an important aspect of data discoverability 
as, 
“public health research depends on breaking data silos, 
which is not possible with conventional querying procedures on 
conventional databases.”  
In terms of data warehousing, one person suggested, “development of 
data warehousing standards and practices for medical data”. Additionally, the 
capacity for data linkage and/or harmonisation was raised by two 
respondents. One discussed the capability of linking data from, 
“…sources such as administrative data bases” whilst the 
other questions whether in terms of “harmonization – has the data 
set already been transformed into a simplified standard format?” 
Consent and other ethical issues: Three people raised the subject 
consent respecting the rights of the participants’. More specifically, 
“…meeting privacy/confidentiality requirements” using, 
“standards for releasing protected health and public health data…” 
and gaining “…public trust need to be of the highest priority”. 
 
These findings suggest that greater focus is needed on enhancing the 
infrastructure supporting epidemiological and public health studies and in 
particular, the way in which research data are managed. The results suggest 
that standards which encourage the uniform development of data 
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warehouses and mechanisms to enable data linkage and/or harmonisation 
are required to facilitate this enhanced management, particularly so that the 
boundaries of consent are respected. Greater focus on enhancing the 
infrastructure could also potentially encourage researchers to produce more 
detailed metadata to assist the management process. This is important to 
data discovery as the metadata can provide the details needed to understand 
the data, the circumstances under which data were collected/generated and 
the potential for data integration creating even richer datasets.  
3.4.2.8 Areas of improvement and immediate priority  
A total of 73 people answered the question focusing on areas of 
improvement and immediate priority. The following areas were suggested:  
a) registration of studies: a total of 11 people made the argument 
for some kind of public health portal/register whereby details of studies can 
be uploaded with two citing ClinicalTrials.gov as an initiative whose approach 
to recording studies should be taken into consideration.  Having a single 
point of discovery encourages development of standardised study 
documentation and could enable “cross collection searching…” Furthermore, 
this kind of approach to improving discoverability has the potential to enable 
researchers to define data access and sharing policies, caveats and 
conditions for use. There appeared to be no expectation by the respondents 
that the data itself be made available but certainly a record confirming the 
data’s existence was firmly encouraged.  
b) Standards: A number of people raised the issue of increased use 
of standards. One respondent discussed the, 
“need international standards (not just European vs. rest of world). 
Basic information about the type of information that is collected 
and surveys administered for each country needs to be made 
available, not just in native language.”  
Another respondent discussed the need for “greater harmonisation of 
indicators…and more standardised formats for storage and access”. Three 
respondents suggested international agreement of standards and 
approaches. Specifically, “a global framework of best practice”, “international 
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criteria developed for data sharing…” and a “…universal strategy…” were 
requested by the respondents.  
Another individual discussed use of the, 
“…ISO 13606 family of standards, the openEHR or the Multilevel 
Healthcare Information Modelling (MLHIM) specifications…”  
Having a standardised working environment promotes, 
“…semantic interoperability between distributed, independently 
developed databases, which solves all the technical aspects of 
data discoverability…”  
This particular individual then suggested use of Semantic Web 
technologies to assist implementation of these kinds of standards.  
Five people raised the issue of metadata standards and their 
increased application in the field. For example, one respondent discussed 
use of  
“…internationally recognised data documentation standards e.g. 
DDi lifecycle” and another suggested “Public health data should 
be curated to appropriate metadata standards…”  
Another respondent said there is a, 
“…lack of true assessment and straight reporting about how 
relevant studies are to the original populations and how 
generalizable findings might be”.    
c) Publications and citations: Improved data publications and 
citations were raised by several people. One respondent called for funders to 
link publications to the datasets they financially support whilst another called 
for “improved data citation practices…” The use of identifiers and in particular 
digital object identifiers was also raised in the context of publications.    
d) Consent and other ethical issues: ensuring the wishes of 
participants are respected and mechanisms are in place to protect 
participants’ identifies were suggested as areas of improvement. One 
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respondent also noted a “…lack of confidence by ethics committees and data 
custodians” and that this negatively impacted data access and linkage. 
These findings suggest that more is needed in the way of 
standardisation to address the current insufficiencies in the way in which 
research data are made discoverable. More specifically, increased use of 
standards have the potential to improve the quality of data and provide the 
basis from which standardised research data descriptions may be created. 
3.4.3 Mechanisms to enhance discoverability  
1. Data publications  
This is the provision of collections of data publications which provide 
detailed descriptions of datasets. The datasets themselves do not need to be 
publicly available but any unrestricted metadata or other associated artefacts 
should be made publically available. Where possible, these publications 
should provide links to where the data themselves may be accessed and 
include details of any caveats and data use/access policies so as to inform 
potential secondary users and help characterise the datasets. It was through 
the systematic literature review that I identified the potential to use these 
publications as a mechanism to enhance data discoverability. 
Currently, several journals already publish data papers; for example, 
the International Journal of Epidemiology publishes ‘Cohort Profiles’ each 
describing epidemiological studies. This particular journal also publishes 
‘Data Resource Profiles’. These two types of publications differ in that 
‘Cohort Profiles’ describe a particular study of the cohort of participants; 
whist, ‘Data Resource Profiles’ describe a platform/source of data. These are 
another type of data publication but are specifically for describing 
epidemiological data for purposes of testing hypotheses and performing 
analyses. Both types of data publication are concise (2500 to 3000 words) 
and are indexed by biomedical databases such as PubMed. Other journals 
include Scientific Data as published by the Nature Publishing Group. This 
multidisciplinary journal publishes ‘Data Descriptors’ which describe pre-
existing datasets for purposes of promoting data discovery and reuse.  
Ubiquity Press also publish a series of open data journals such as, Journal of 
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Open Health Data (2016k), publishes papers describing datasets with reuse 
potential and the Open Journal of Bioresources (2016m) which publishes 
papers describing bioresources (collections of biological data and samples) 
also with reuse potential. The advantage of publishing data or bioresource 
publications in journals such as these, the papers can be cited correctly and 
there is the potential to track the level of reuse.  
2. Sematic Web technologies   
This model utilises SWTs maintained by the World Wide Web 
Consortium (W3C 2014b), to link data and metadata together which can then 
be published on the Web. SWTs can be used to enhance data discoverability 
as standards such as the RDF can be utilised to build searchable networks 
of epidemiological and public health information online. The scalability of the 
RDF is such that these networks can build without the potential to negatively 
impact existing links. The use of OWL ontologies can help to structure this 
epidemiological and public health information in a way that is controlled and 
yet has the potential to grow larger as more information is added. It was 
through my research in this thesis (chapter 2) that I identified the potential to 
use SWTs to further enhance data discoverability. 
Organisations such as the Semantic Web Health Care and Life 
Sciences Interest Group are already looking at ways to embed SWTs into 
epidemiological and public health research to harness their potential benefits 
to the research process.  
3. Public health portal   
This involves the use of a public facing catalogue containing records 
of pre-existing public health and epidemiology studies. The centralised portal 
should be freely available online and where possible, provide links to where 
more information can be found relating to the individual studies. I identified 
the potential to use a public health portal to enhance data discoverability 
through findings from my qualitative analyses of the survey results. I also 
identified the need for a registration process for observational studies which 
could potentially be enacted through the use of a public facing portal.  
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There are portals such as these already publically available such as 
ClinicalTrials.gov. Another such example is the CALIBER portal (Denaxas, 
George et al. 2012). Researchers using CALIBER data are required to 
provide details of their study, with the ClinicalTrials.gov identifier, which is 
then made available through a public facing catalogue. Variable-level detail 
is also provided on the portal. Other examples include the CESSDA(2016e) 
portal and the UK Data Service(2014h).  
3.4.4 Evaluation of mechanisms to enhance discoverability  
I performed a series of feasibility analyses and engaged with stakeholders at 
the Public Health Research Data Forum to evaluate the mechanisms.   
3.4.4.1 Data publications  
Technical: Data publications are an established form of literature with 
journals such as Scientific Data (Nature Publishing Group) providing a 
mechanism through which papers describing scientific datasets may be 
published. To uniquely identify data publications globally, specialist technical 
support would be needed to mint DOIs; the DOI would resolve to a landing 
page for the publication. This too requires additional resources as for an 
organisation to mint and maintain DOIs, they must have the finance 
infrastructure available to maintain the DOIs and landing pages in the long 
term.   
Organisational: The submission process of these manuscripts 
utilises journal submission webpages and are likely to be subject to peer 
review. Stakeholders are likely to be familiar with the submission and 
publishing process as it very much mirrors that of research articles. 
Familiarity with this kind of publication, and their potential benefits is 
increasing, however formal academic recognition of their significance is 
limited. Review processes such as the REF do not acknowledge their value 
and consequently stakeholders are not incentivised to produce such 
publications. However, stakeholders are likely to need increased support 
when producing such publications. Guidance for authors is generally 
provided on journal websites but writing data publications concisely with the 
Research case study 1: Enhancing the discoverability of epidemiological and public health research 
data 
101 
 
appropriate level of detail can be time-consuming and potentially increase 
the workloads of stakeholders.       
Economic: data publications can have an associated processing 
charge or publication fee. Journals such as the International Journal of 
Epidemiology (Oxford University Press) offer different price models 
depending on the location of the author and the type of access ranging from 
£0 to £20004. Data publications are potentially costly but varying cost models 
can help researchers in publishing their manuscripts. Another factor to take 
into consideration are the changes taking place around the way in which 
publications are made openly accessible. As from April 2016, HEFCE 
mandate that the author accepted manuscript must be made openly 
accessible within 90 days of acceptance. There are two ways to do this: a) 
green route whereby the publication is embargoed; or b) gold whereby the 
publication is made immediately openly accessible but potentially at a cost. 
Furthermore, it is unlikely that additional software or tools are likely to be 
needed/purchased when producing data publications – commonly used word 
processing packages should suffice.  
3.4.4.2 Semantic Web technologies  
Technical: Harnessing the benefits of linked data and SWTs is 
advantageous as methods such as the RDF use uniform resource identifiers 
(URIs) to provide a rigorous method to differentiate between resources thus 
supporting data integration processes (Pathak, Kiefer et al. 2012b). 
However, any changes made to the URIs must be managed effectively 
otherwise the links could incorrectly resolve. Producing high quality and 
responsibly managed URIs remains a challenging yet intrinsic part of 
integration processes. Another potential issue with the implementation of 
RDF technology is meeting the need to develop and execute queries using 
disparate sources of data (Pathak, Kiefer et al. 2012b). The stability of 
SPARQL endpoints in addition to the current need for user-friendly, reliable 
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tools to write SPARQL queries could limit the extent to which these 
technologies are implemented and their potential benefits realised (Pathak, 
Kiefer et al. 2012b).  
A number of RDF conversion tools are available, a list of which can be 
found on the W3C’s website (W3C 2014a). One example is Bio2RDF as 
supported by the W3C’s HCLS IG. Tools such as these can help researchers 
and clinicians to mark-up up clinical data potentially increasing their 
interoperability.  
Another mechanism which could potentially be utilised as part of this 
model is ontologies. An example of a biomedical ontology is the TMO 
developed by the HCLS IG’s Translational Medicine task force (Luciano, 
Andersson et al. 2011). The TMO as part of the Translational Medicine 
Knowledge Base (TMKB) is an initiative which represents drug data using 
the RDF and maps to over 60 other ontologies (Luciano, Andersson et al. 
2011; Pathak, Kiefer et al. 2012b). Research into mental health disease has 
also benefited from application of SWTs. The HCLS IG’s Semantic Web 
Applications in Neuromedicine (SWAN) ontology was developed to help 
improve knowledge management of Alzheimer Disease and connect 
resources together (Ciccarese, Wu et al. 2008).  
Ontologies may be collected together and presented in public facing 
catalogues. The BioPortal (2014a) is an open repository which collates the 
ontologies written using OWL, RDF, OBO and Protégé and their associated 
metadata (Noy, Shah et al. 2009). A key feature of this tool is the provision of 
mappings and mapping annotations (metadata) between the ontologies to 
facilitate integration endeavours; it is possible to link records together using 
common ontological annotations (Noy, Shah et al. 2009; Whetzel 2013). The 
National Cancer Institute(National Cancer Institute 2014) use the BioPortal 
as a repository for their clinical ontologies (Noy, Shah et al. 2009). In having 
biomedical ontologies available in public facing catalogues, it is possible to 
see how other research groups have structured their clinical data and there 
is the potential to reuse the ontologies. In being able to use pre-existing 
ontologies, scope for collaboration increases and the possibility of duplicate 
efforts potentially reduced.  
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Organisational: familiarity with linked data on the World Wide Web 
and use of methods such as RDF and OWL is currently limited potentially 
causing a significant demand for training. Also, integrating use of such tools 
into daily work routines would require effective change management so as to 
minimise any potential disruption experienced by stakeholders.   
Furthermore, this model is potentially biased towards those with 
internet access based in higher income countries. This is a weakness of the 
model as those from lower and middle income countries, where internet 
access can be variable, may be at a disadvantage. Consequently, they may 
not fully benefit from the potential research opportunities associated with use 
of SWTs in epidemiological and public health research.  
Economic: A number of open-source software packages are currently 
available to the scientific community. For example, Bio2RDF is an open-
source tool designed to integrate data from over fifty sources such as NCBI’s 
Entrez Gene and OMIM with release 2 having a total of one billion triples 
using SWTs (Belleau, Nolin et al. 2008). Protégé, developed by researchers 
at Stanford University is a free open-source ontology development platform 
which can be utilised to create OWL ontologies(2015d). Nevertheless, use of 
any commercial RDF convertors or ontologies development platform could 
cause stakeholders to incur purchase and license fees.  
Additionally, given the need to maintain equity, financial costs could 
be incurred when implementing the necessary infrastructure in locations 
where this is currently insufficient. There is also the need for increased 
training and support, both of which may have an associated cost. Therefore, 
factors such as these could negatively impact how widespread adoption of 
this model is and its continued use. 
3.4.4.3 Public health portal 
Technical: To build and implement a public health portal, there are a 
number of stages each with their associated technical factors. The first step 
is to gather stakeholder requirements to inform design and development of 
the portal. This is potentially complex task given the diverse nature of 
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epidemiological and public health research the tool could potentially 
encompass.  
The second step is to build an underlying metadata model consisting 
of several layers to structure the metadata. The first layer would consist of 
general information potentially utilising the schema for Simple Dublin Core. 
This is a multidisciplinary metadata standard which enables generic 
metadata to be recorded. The second layer would depend on which sub-
domain of epidemiological and public health research a research study sits. 
This would firstly utilise some kind of ontology to structure this knowledge 
effectively and provide a mechanism through which changes to the different 
categories of research may be made. Engaging with stakeholders will help to 
define the ontology; although this is potentially problematic given the 
possibility of a research study to sit in multiple areas. Once the ontology has 
been developed, a standard such as DDI may be incorporated into the 
metadata model to record lower level detail. The advantage of using 
metadata standards such as these is that DDI has the Simple DC schema 
built into it (Figure 2-3) so the use of both these simultaneously is potentially 
straightforward. Another advantage is that linking to other portals such as the 
MRC Gateway and UK Data Archive is potentially enabled as their metadata 
is DDI compliant.   
The third step is to build a test portal to establish whether all user 
requirements have been addressed. It is at this stage that strengths and 
weaknesses of the model can be identified and corrective action taken if 
necessary. The fourth step is to build a pilot portal where stakeholders from 
across the research domains can be engaged to determine whether the 
portal is fit for purpose.  
Organisational: use of online portals such as ClinicalTrials.gov and 
CESSDA are an already established practice in epidemiological and public 
health research. Therefore, stakeholders are likely to be familiar with the use 
of online portals to support research efforts.  
Nevertheless, the challenge will be integrating the use of a novel 
public health portal for observational studies into stakeholders’ work routines. 
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A potential mechanism to ensure pre-existing and newly established studies 
register with the portal would be for it to become a funder requirement.   
Economic: Initially, resources are needed to perform requirements 
gathering and building of a test portal. Once strengths and weaknesses have 
been identified, and changes made, further funding is needed to support the 
development of a pilot portal containing test cases (which can be evaluated) 
before a finalised portal may be developed and become available for use. In 
the longer term, funding is likely to be required to maintain the portal and 
records, and to allow enhancements to be made where necessary. 
3.5 Discussion 
3.5.1 Systematic literature review 
From this review, the use of methods to enhance data discoverability 
is limited. For example, three studies (ID’s 3, 6, and 13) do not provide 
information around the accessing of data. The review also found 
inconsistencies in the way in which research data were documented as 
described below. Therefore, further investigation into the issue of data 
discoverability is needed with a view to identifying ways in which the 
discoverability of research data may be improved.  
This review identifies a range of approaches to providing data 
documentation; for example, three studies (study IDs: 18, 33 and 48) provide 
data dictionaries while another provides questionnaires (study ID: 13) and a 
third providing a manual (study ID: 22). The review also identified application 
of the metadata standard, DDI in three of the studies (study IDs: 18, 23 and 
48) all of which make use of some kind of catalogue to provide data 
documentation. Therefore, the use of metadata standards and the process of 
searching through catalogues to find metadata in addition to other 
approaches to identify research data e.g. data papers (such as those 
published by the International Journal of Epidemiology) were investigated 
further as part of the survey.  
The review was also successful in identifying that all the studies 
provided links/descriptions of related publications and 5 studies (study IDs: 
14, 18, 20, 22 and 49) provided tools online for data visualisation and 
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analysis; both of which can help potential secondary users characterise the 
data before requesting access. A total of 11 out of the 13 studies (study IDs: 
6, 14, 18, 20, 22, 23, 26, 33, 34, 48, 49) provided descriptions pertaining to 
data access. Therefore, issues relating to access and in particular, use of 
metadata repositories will be investigated further to help further characterise 
current practice.     
A potential weakness of the review is the way in which it is structured. 
If the review were to be repeated, the studies would be categorised 
according to the amount of funding they receive; for example >£10000, 
£10000-£20000 etc. This is because the differences in approaches to 
discoverability could be attributed to the level of resources a study has – 
stakeholders may want to use a range of mechanisms to facilitate 
discoverability but only have resources for one. By grouping the studies 
according to funding, this would potentially give a clearer overview of what 
can realistically be achieved using a finite amount of resources. This issue of 
available resources is an area in need of further exploration and could 
potentially have an impact on the models suggested – a study cannot be 
penalised for not having enough resources. 
3.5.2 Online stakeholder survey  
Data types: Most of the research studies identified through the 
systematic literature review were observational which could probably account 
for why the three most popular forms of data were ‘survey’ followed by 
‘healthcare records’ then ‘disease registries’.  
The research data lifecycle: The results of survey illustrate less 
activity towards the end of one iteration of the research data lifecycle. This 
can probably be attributed to the nature of the jobs held by those who 
completed the survey.  The most common role in public health research data 
was data user; this is reflected in the results relating to the area in which 
most of the respondents were actively involved in - analysis. The next most 
popular stage in the research data lifecycle is access, use and reuse; again 
these results correspond to the role in public health; the second most 
commonly cited role was data provider. The stage in which the fewest 
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number of people indicated they were actively involved was data destruction. 
With current drives to improve data reuse and enhance use of resources, the 
destruction of data does not seem in keeping with current data reuse and 
repurposing initiatives. However, again, job role could explain these results. 
For example, in the event of a participant requesting their data be destroyed, 
then this must occur to the best of the ability of the person(s) responsible. 
(Acknowledgement is given to the inability to destroy individual-specific data 
from anonymised aggregate datasets, especially if these data have been 
shared with third parties). Therefore, the respondents who indicated they 
were involved in data destruction could form a part of this particular group of 
stakeholders within the wider scientific community. Further investigation is 
needed to confirm this, and the ways in which data are destroyed, to 
establish how these individuals may be better supported. These particular 
stakeholders are fundamental to the process of respecting participants’ rights 
and the limits of their consent – consent and other ethical issues is a 
recurrent theme in the results of this study.    
Search options: When asked to indicate preferred search options, 
the most popular methods were ‘keyword’ followed by ‘subject terms’. Given 
key words can be sourced from classification systems such as Medical 
Subject Headings (MeSH) or the International Classification of Disease 
(ICD); it is possible that since the survey was aimed at the research 
community in particular, whereby use of classification systems such as these 
is commonplace, these proved most popular in the survey results. The 
search option results correspond with the results of the controlled vocabulary 
and thesauri question asking participants to indicate which controlled 
vocabularies and thesauri they are familiar with – ICD and MeSH were the 
two controlled vocabularies most familiar to the survey respondents. In terms 
of future work, the next step would be to investigate at a lower level the 
extent to which ‘key words’ were selected from controlled vocabularies and 
the possible implications of this practice. 
Controlled vocabularies: Datasets such as Hospital Episode 
Statistics (HES), which can be used as part of public health and 
epidemiology research, provide clinical information using ICD and OPCS. 
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Given that the survey was aimed at stakeholders from the public health and 
epidemiology research communities, this result could be a reflection of the 
daily work routines of those who completed the survey. If the survey had 
been aimed at clinicians, it is possible that SNOMED CT could have scored 
more highly.   
Thesauri: The controlled vocabulary respondents were least familiar 
with was the European Language Social Thesaurus (ELSST). This 
thesaurus’ English translation however, the Humanities and Social Sciences 
Electronic Thesaurus (HASSET), scored slightly higher with 11. This is likely 
to be because ELSST (and HASSET) are used primarily in the social 
sciences; whilst the survey was aimed at stakeholders within the public 
health and epidemiology domains. It is possible that had the survey been 
aimed at social scientists too, both these thesauri may have scored more 
highly. Further analysis and in particular a widening of the scope to include 
those in the social sciences and clinicians is needed to better understanding 
of the use of controlled vocabularies and thesauri in research to inform 
application in clinical environments.    
Data documentation and metadata standards: Following collection 
of results, the low level of response to the question asking which of the 
specified metadata standards respondents had knowingly used, could be 
attributed to the nature of the job roles of those who completed the study.  
The majority of respondents indicated their role in public health research 
data were as users. Therefore, since metadata markup may not necessarily 
form an everyday part of data users daily work routines, this could explain 
the low level of response. Had the results included more individuals from the 
archival and librarian communities, the number of respondents could 
potentially increase. All questions were optional so this too may have been a 
factor contributing to the low level of response.  
Nevertheless, with study artefacts such as protocols and data 
dictionaries often being provided in formats such as PDF (based on results 
from the review conducted earlier in the study) this could also attribute for the 
low response rate. The artefact could in fact be standardised but the 
researcher might not necessarily be aware of this unless they request a 
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machine-readable format of the documentation such as XML. Regarding tool 
availability, even though several examples were provided by the 
respondents, some in-house and some commercial, more work is needed to 
establish how mature these tools are and implications of their use; for 
example, are there any potential costs or specific training needed to enable 
use.   
With current motivation to increase use and standardisation of 
metadata these results show that more emphasis is needed on the 
importance of metadata as supported through increased training and support 
for researchers using the metadata (and data) and the data managers and 
other professionals who are responsible for the metadata and data. Further 
investigation will enable identification of the points in the metadata pathway 
from generation through to sharing which require further support and/or 
improvement.  
Data repositories: Use of specialised repositories is essential given 
the intricacies of biomedical data and the need to ensure they are correctly 
managed. The most commonly used repository, both already used and 
intended for use was ClinicalTrials.gov. Registration with this repository is 
compulsory for clinical trials so this could account for the high proportion of 
votes. The second most popular repository already used was Social Science. 
This could be because organisations such as the UK Data Archive are 
responsible for the management of a number of datasets which have the 
potential to be used as part of public health and epidemiology research. An 
emerging common theme was the use of metadata repositories, examples of 
which include the “MRC Research Data Gateway” and the “Australian 
Institute of Health and Welfare Meteor metadata repository.” Additional 
investigation could help determine the extent to which metadata repositories 
are used by in public health and epidemiology research and how those using 
and those maintaining them can be better supported. This too will help inform 
development of best practice guidelines and gold standards. 
Data publications: The most commonly indicated method of knowing 
about data publications is through a colleague followed by a journal. Based 
on the responses from the open-ended question focusing on challenges 
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associated with the widespread adoption of data publications, three key 
themes emerged: significance, resource availability and research culture. 
Further work focusing on the promotion of data publications, particularly as a 
method of charactering datasets as a mechanism to enhance discoverability 
and to alter perceptions relating to their significance is needed. 
Data citation: Regarding the benefits of citation, being ‘Easier for 
readers to locate data’ was most commonly indicated by the respondents; 
the least commonly cited were ‘Less danger of data plagiarism’ and then 
‘Other’. Based on these results, and suggestions provided by the 
respondents, it is clear that many researchers view data citation as being 
particularly important to the attribution of credit and supporting increased 
visibility of datasets.  
3.5.3 Evaluation: Mechanisms to enhance discoverability 
Data publications may be used by researchers to publicise their data 
to improve discoverability; whilst, retaining a sense of ownership of the data 
and respecting the participants’ rights (de Carvalho, Batilana et al. 2010). 
There are established models and academic journals for publishing this kind 
of manuscript and they are already being indexed in biomedical literature 
databases such as PubMed.  
Furthermore, there is opportunity to assign metrics to the publications 
for researchers to monitor the number of times their paper has been read, 
downloaded and/or cited. However, caution is needed so as to not turn data 
publications into a way of monitoring the publication success of researchers 
or as an alternative to data sharing. The purpose of data publications is to 
provide unambiguous descriptions of research data and the process through 
which they are/were managed.    
There are also potential problems associated with the enhanced 
promotion and adoption of this model. For example, stakeholders in public 
health and epidemiological research must be sufficiently trained and 
experienced to produce such publications. There also needs to be adequate 
resources available such as time and finance to support the writing and 
publishing processes. Additionally, stakeholders are discouraged to produce 
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data publications due to their perceived limited significance given the lack of 
formal academic recognition. 
Data publications can work in both the short and longer term. They 
offer stakeholders a mechanism to describe their data without infringing on 
any confidentiality or privacy laws/ governance frameworks if written well. Of 
the three models, this is the most organisationally demanding as changes 
are needed to current research culture. Much is still needed in the way of 
increasing their prominence in scientific publishing and improved academic 
recognition is sorely needed. 
The second model was use of linked data on the World Wide Web. 
The potential benefits of having a linked data approach through application of 
SWTs have already encouraged discussion within the clinical research 
community (Sinaci and Laleci Erturkmen 2013). Having metadata could 
potentially improve the efficiency of searches online and help to improve 
identification of resources (2009). 
Additionally, RDF networks could include links to social media sites 
and other such potential providers of metadata. The review identified 
examples of where the benefits associated with social media have been 
harnessed to enhance data discovery. Having links to metadata on websites 
such as these could enable creation of metadata tailored to a particular 
audience. For example, interviews with principal investigators may be 
uploaded to these sites describing the research study aimed specifically at 
the general public. Being able to facilitate public engagement is important to 
a research study and this model could lend itself well to enabling this. 
This approach does however pose several challenges. For example, 
inadequate provision of machine-readable formats of the data and metadata, 
such as RDF, limit the model’s application. Transforming the information and 
continued maintenance requires additional resources as does ensuring 
unique identifiers resolve to the correct resource (Belleau, Nolin et al. 2008; 
Katayama, Wilkinson et al. 2013). Furthermore, by applying SWTs to create 
RDF networks to provide linked data on the World Wide Web; there is the 
potential for URL links to resolve incorrectly, if at all. The ability for networks 
to be built up without some kind of control is an inherent weakness of the 
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linked data model. Nonetheless, use of linked data in life sciences research 
is increasing, and the potential benefits of applying formalised data 
management techniques such as ontologies from computer sciences in 
medicine are already being realised. In 2.5.1, detailed examples of where 
SWTs have been applied in life sciences research are provided. 
Widespread use of linked data on the World Wide Web and SWTs is 
very much a longer term goal of enhanced data discoverability. Of the three 
models identified, this model is the most technically demanding. 
Implementation of this model is inherently challenging given the high 
dependence on the technical expertise of stakeholders and ready access to 
the necessary infrastructure. Much has already been achieved using SWTs 
(as described in chapter two) yet more is needed in the way of championing 
the potential research benefits associated with this model to stakeholders. 
The third model was the public health portal. The potential for a single 
portal to contain records of public health and epidemiology studies would 
make a valuable research tool. This, joined with recent computational 
advances enabling more affordable analysis of big data(Chute, Ullman-
Cullere et al. 2013) and an increased capacity for data linkage, as supported 
by robust mechanisms to help protect participant privacy and 
confidentiality,(Lyons, Ford et al.) serves to enhance the research working 
environment.  
Currently there is no known mandatory registration process for 
observational studies which could be a contributing factor in the limited 
discoverability of certain research data. By having a standardised registration 
process for these studies in addition to having the metadata publically 
available, scope for data discovery and subsequent reuse is potentially 
increased. Furthermore, having this kind of registration process also 
facilitates application of standards to the metadata. There is the potential to 
use a metadata standard such as DDI to structure the underlying XML and 
opportunity to use encoding standards such as ICD to populate the metadata 
fields.  
Nevertheless, development of the portal raises concerns over its 
continued maintenance, study registration (additional analyses possibly 
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required to determine feasibility), and the sustainability of this model i.e. 
could the portal grow too big? Issues are also raised relating to stakeholders 
having the time to enter details of their research data and assigning the task 
of monitoring the records to a member(s) of the research team. There is also 
the challenge of addressing any language barriers which may arise. Given 
the portal would be international in scope; mechanisms must be in place for 
stakeholders to select in which language they would prefer to register their 
study in.  
Of the three models identified, this is the most economically 
demanding. Nevertheless, having pooled metadata records for observational 
studies accessible through a public facing and searchable catalogue is a 
novel contribution to epidemiological and public health research. Based on 
the qualitative results of the survey, having a public health portal specifically 
for observational studies appeared to be most favoured by participants. A 
grant proposal detailing how I will take this work forward and build the portal 
can be found in appendix D. 
3.6 Summary of major findings 
3.6.1 Review  
Most of the studies identified were observational for which there is 
currently no known mandatory registration process. Results showed that 
PDF was the most common format in which to provide study protocols and 
there was limited use of online data visualisation tools. All the studies 
incorporated social media/other forms of communication in their approach to 
facilitating data discovery. Therefore, increased investigation is needed into 
mechanisms to enhance the discoverability of research data in epidemiology 
and public health. 
3.6.2 Online stakeholder survey 
The most common form of data was ‘survey’ (27%); the least common 
was ‘imaging’ (3%). Results show that 82% of respondents thought that the 
‘research study question’ should be most easily searchable aspect of a 
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research study. Results also show the terminology most survey respondents 
were familiar with was the International Classification of Disease (32%).  
Most commonly used metadata standard was the Data 
Documentation Initiative. Survey results show that challenges associated 
with creating and/or using data documentation can be categorised into 2 
groups: a) standardisation; and b) resource availability.  
Most popular repository was ClinicalTrials.gov; the least popular was 
Dryad. The  following shows where the median was for aspects important to 
discoverable data include: a) be on the web – extremely; b) be provided in a 
machine readable format – extremely; c) be provided in a non-proprietary 
format – fairly; d) conform with recognised data management standards – 
extremely; and e) be linked to an underlying conceptual framework or 
ontology – fairly.  
The most common way to hear about data publications was through a 
colleague. Survey results also show that 22% of respondents who submitted 
data indicated that data citation was important as it made it easier for readers 
to locate data. The most popular level of granularity was ‘dataset collections’ 
- 36% of those who submitted data. Furthermore, 29% of those who 
submitted data indicated that revisions to longitudinal and regularly changing 
datasets should be published at regular intervals. Results of the survey also 
show the challenges associated with the adoption of data publications 
include: a) significance; b) resource availability (time and cost) and c) 
research culture.  
Areas of importance to data discovery include: a) identification of 
commonalities and links between studies; b) metadata markup and 
producing other associated documentation; c) use of technology; and d) 
consent and other ethical issues. Moreover, results showed that areas of 
improvement and immediate priority include: a) registration of studies; b) 
standards (use, metadata standards, quality assessment); c) publications 
and citations; and consent and other ethical issues 
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3.6.3 Mechanisms and evaluation  
Three mechanisms were identified to enhance research data discoverability: 
a) data publications; b) application of SWTs; and c) development of a public 
health portal containing the metadata records for observational studies 
globally. The public health portal proved most popular with stakeholders.  
3.7 Chapter summary   
The aim of this chapter was to present the data discoverability study 
which was composed of a review of a random sample of public health and 
epidemiology studies and organisations followed by a survey. In this chapter 
I examined existing approaches to data discovery, identified current 
challenges and areas of potential improvement, and proposed mechanisms 
through which funders could enhance the discoverability of their data. The 
three mechanisms evaluated were: a) data publications; b) linked data on the 
World Wide Web; and c) public health portal. Following the publishing of the 
report (Castillo, Gregory et al. 2014), the Wellcome Trust with the Public 
Health Research Data Forum has begun preparations to take this work 
forward.    
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Chapter 4 Research case study 2: Improving 
metadata quality assessment in public health and 
epidemiological research 
4.1 Introduction  
The increase in generation of, and access to, public health and 
epidemiology data necessitates robust mechanisms to produce metadata. 
The use of clinical data sourced from electronic health records can greatly 
benefit from access to metadata and other such documentation (Pathak, 
Bailey et al. 2013). Researchers can utilise metadata artefacts such as data 
dictionaries which describe the data to support them in maximising the 
research potential of the clinical data.  
However, in most cases, the extent and quality of available metadata 
is variable.  Some research studies used data publications as a means of 
providing additional metadata such as the Avon Longitudinal Study of 
Parents and Children and ELFE, Growing up in France. Whilst others, such 
as MIDUS Midlife in the US and the Scottish Longitudinal Study used data 
publications plus provided access to data dictionaries.  
Having access to good quality, wide-ranging metadata across the 
stages of the research data lifecycle is critical to enabling stakeholders to 
manage their research data more effectively and to investigate the causes of 
disease at a greater depth. Research artefacts such as data publications can 
Case study: SABE – Survey on Health, Well-being, and Aging in 
Latin America and the Caribbean 
Project SABE ran between 1999 and 2000 and focused on investigating health 
conditions in those aged 60 and over in Latin America and the Caribbean.1  
A wealth of information is available on this study from the National 
Archive of Computerized Data on Aging, but there is currently no mechanism to 
assess the quality of these metadata. Consequently, stakeholders wanting to 
assess the metadata available, and potentially compare the metadata to 
previous versions, are unable to do so. Furthermore, there appears to be no 
mechanism to monitor changes to the metadata from the user’s perspective.  
The aim of this research case study is to create and evaluate a novel 
metadata quality assessment framework. The novel framework will address the 
current lack of assessment criteria to evaluate metadata in public health and 
epidemiological research settings. 
 
1. http://www.icpsr.umich.edu/icpsrweb/NACDA/studies/3546  
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describe the study protocol and the data dictionary the variables; combined 
these can provide researchers with the contextual information needed to 
enable them to analyse the research data more effectively. 
This chapter presents the metadata quality study in which I suggest a 
novel, quality assessment framework for biomedical metadata. This 
framework will be a word processed document which can be used alongside 
your metadata management software and is not restricted to one particular 
operating system. This work addresses this gap in knowledge relating to 
metadata management within the context of epidemiological and public 
health research.  
4.2 Study aim and objectives 
The aim of this work was to create and evaluate a novel metadata 
quality assessment framework to support the administration of metadata and 
improve overall quality. 
This study had four objectives: a) describe the current state of the art 
in metadata quality assessment of biomedical research data through a 
systematic literature review; b) identify key metadata quality assessment 
dimensions of biomedical research data; c) create and evaluate a novel 
framework for assessing metadata quality for epidemiology/public health 
research data; and d) apply the framework to test cases and perform 
stakeholder interview by way of evaluation. 
4.3 Methods  
4.3.1 Literature review 
I performed the literature review using the PRISMA checklist(Moher, Liberati 
et al. 2009)  for guidance. This systematic literature review aimed to answer 
the following questions: 
1. What is the current state of art in metadata quality assessment? 
2. Which methods of metadata quality assessment are available? 
3. Are there any methods specifically designed for use in public health 
and epidemiological research settings? 
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4.3.1.1 Eligibility criteria 
To be included in the review, the publication had to be available in 
English and accessible through open access or using login credentials. The 
publication had to clearly define a method of quality assessment and ideally 
provide examples of where the method has been applied.  
4.3.1.2 Information sources and search terms 
The literature review was performed in July 2014 using cross-
disciplinary databases to identify literature for inclusion in the review. The 
databases were, ACM Digital Library, BioMed Central, CINAHL Plus, 
Cochrane Library, EMBASE, Lecture Notes in Computer Science, JSTOR, 
PubMed, SCOPUS and Web of Science. I included both biomedical and 
computer science databases to help me identify literature which may have 
been indexed under research domains such as librarianship or archive 
management. Additional sources included Google and Google Scholar, and 
forward citation tracking (Kuper, Nicholson et al. 2006) was used to help 
source any other potential methods of quality assessment. The searches 
included all forms of literature and were not restricted in terms of publication 
date or location, Supplementary Table 3.  
I used the following search terms: ‘epidemiology’, ‘metadata’, 
‘metadata quality assessment’, ‘metadata quality dimensions’, ‘metadata 
quality evaluation’, ‘public health’, ‘public health and epidemiology’, ‘quality 
assessment’, ‘quality evaluation’.  
4.3.1.3 Study selection 
Once the publications were identified, I firstly removed duplicates. I 
then screened each publication by reading the title and abstract. Based on 
these, I then removed publications if they were irrelevant, not available in 
English or if the full text was unavailable. The remaining publications were 
then fully reviewed and I removed an additional set of manuscripts due to 
their ineligibility.  
The publications included in the review had the following recorded: a) 
title; b) aim; c) conclusion; d) method of quality assessment – a brief 
description of the approach to quality evaluation; and e) identified metadata 
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quality dimensions – identified underlying principles of quality. As each 
approach is recorded, it was assigned a unique ID.  
4.3.2 Online stakeholder survey 
To describe the design and development of the online stakeholder 
survey in a systematic way, I have chosen to follow the 
CHERRIES(Eysenbach 2004) statement as adopted by the Journal of 
Medical Internet Research.  
4.3.2.1 Design 
The survey has five sections: demographics, metadata, tools and 
technologies, metadata usability, and quality assessment. I designed and 
developed my survey using REDCap (Research Electronic Data Capture) 
version 5.7.5.(Harris, Taylor et al. 2009) which is a secure, online data 
collection tool.  A copy of the survey can be found in the appendix B. 
In the metadata section, the types of metadata listed were identified 
through desk research (Pollock and Hodgson 2004; Zeng and Qin 2008; 
Miller 2011). In the tools and technologies section, the list of metadata 
standards was partially based on a list provided by the Digital Curation 
Centre on their website(Digital Curation Centre 2014) and the outcomes of 
the  discoverability study. In the usability of metadata section, aspects of 
potential importance are based on the exploration of metadata quality 
impacting the different stages of the research data lifecycle from chapter 
one, 1.4.2. The aspects are also based on the findings from chapter two. In 
the quality assessment section, the suggested quality dimensions are based 
on the outcomes of the data discoverability study(Castillo, Gregory et al. 
2014) and results of the review. 
4.3.2.2 Ethical approval and informed consent process 
Ethical approval was not required and implied consent to partake in 
the study was assumed from the individual through their decision to submit 
data using the surveys. All data collected was anonymous and contact 
details were provided should (potential) participants wish to contact me for 
further information or clarification. Given the anonymity of the survey 
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participants, participants were asked if they would like to potentially partake 
in any other aspects of the study. Therefore, participants were asked to 
provide contact details if they choose to reveal their identity and give consent 
to be contacted. Any identities and contact details provided are and will 
remain confidential.   
4.3.2.3 Recruitment process and description of the sample having access to 
the questionnaire 
The following mailing lists were used to circulate the survey:  
 UCL data management – public health: staff and students involved in public 
health data management at UCL  
 UCL Centre for Health Informatics and Multidisciplinary Education (CHIME) - 
staff and students affiliated with UCL CHIME  
 DDI users mailing list – all those interested in and/or using the DDI metadata 
standard 
 UCL Epidemiology and public health student mailing list 
 UCL Epidemiology and public health staff mailing list 
 JISC Research data management  - all research domains 
 JISC Managing research data – all research domains 
 JISC Public health mailing list  
Promotional material was circulated at the following conferences to 
raise awareness of the study: American Medical Informatics Association 
2014 Annual Symposium (Washington DC, USA), and EDDI 2014 – Annual 
European DDI User Conference (London, UK)  
In addition to these, representatives of the signatories and supporting 
organisations of the Public Health Research Data forum were also contacted 
and asked to circulate the surveys. I also sent an invitation to complete the 
survey to a colleague at the Nature Publishing Group and requested the 
invitation be shared with their colleagues too. Calculating response rates was 
unfeasible given the approach adopted to recruit participants to the survey. 
4.3.2.4 Survey administration 
The invitational email included a short description of the metadata 
quality, study, a link to the survey, mention and hyperlink to the data 
discoverability report(Castillo, Gregory et al. 2014)  and the request that 
participants forward the invitation to any parties they feel may be interested.  
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The metadata quality survey ran from November 2014 to February 
2015. A set of reminder emails were sent two weeks before the survey was 
due to close. The survey begins with a short introductory paragraph to the 
study describing the aims and objectives of the survey and the length of time 
it should take to complete (10 minutes).  
The survey questions (all optional) were collated according to theme 
and spread across different pages to ease the process of stakeholders 
submitting data (Schleyer and Forrest 2000). Boolean logic was incorporated 
to customise the survey based on previously submitted answers by 
automatically adding or removing subsequent questions (Wyatt 2000). In 
doing so redundant questions were removed from the survey and only those 
relevant to the respondent were presented on screen. I also included open 
ended questions to help facilitate the capture of qualitative data. (MacKenzie, 
Wyatt et al. 2012) I also included a Likert scale (5 points) to help the 
stakeholders convey their opinions. The options were as follows: ‘not at all’, 
‘slightly’, fairly’, ‘extremely’, and ‘essential’.  
4.3.3 Framework definition and evaluation 
I analysed the results using a Grounded Theory (Glaser and Strauss 1967) 
approach which enabled me to develop hypotheses based on the data 
helping to produce a truer reflection of current events. I used a hermeneutic 
approach when inductively and iteratively collating themes (Dahlberg 2010; 
Svanstrom, Andersson et al. 2016). I analysed the quantitative data using 
SPSS. The metadata quality assessment framework consisted of four 
sections: a) general information; b) tools and technologies; c) usability; and 
d) management and curation. I identified the four sections by initially 
grouping together the suggested headings according to the issues they 
addressed. Once all the suggested headings had been grouped, I assigned a 
single more generalised heading. For example, the ‘indexing in catalogues’, 
‘encoding and exchange standards’ headings are grouped under ‘Tools and 
technologies’.  The requirements of the framework were based on findings 
from the systematic literature review and the online stakeholder survey.  
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The evaluation of the framework is a two stage process. Part A 
involved iteratively applying and evaluating the framework to three test 
cases. After each application, the framework was improved. The first test 
case was the Millennium Cohort Study (Supplementary Table 4). The second 
and third test cases were: Midlife in the United States (MIDUS) 
(Supplementary Table 5) and the Danish National Birth Cohort (DNBC) 
(Supplementary Table 6). Part B involved engaging with stakeholders in 
public health and epidemiological research to further evaluate the framework 
and provide insights to facilitate implementation of the framework into 
research policy and practice. I engaged with stakeholders through a 
combination of face-to-face discussions and email conversations.   
4.4 Results 
4.4.1 Literature review 
4.4.1.1 Study selection 
A total of 11 publications were identified and included in the review. 
Figure 4-1 shows how the final set of publications was identified and Table 
4-1 shows results of the review.  
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Figure 4-1 Metadata quality literature PRISMA flow diagram 
Records identified 
through database 
searching 
N= 428 
Records screened 
N= 442 
Records excluded 
N= 123 
Records after duplicates removed 
N= 442 
Full-text articles assessed for 
eligibility 
N= 319 Full-text articles 
excluded as not 
relevant  
N= 308 
Manuscripts included  
N= 11 
Additional records 
identified through 
other sources 
N= 23 
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Table 4-1 Review of methods of metadata quality 
ID Title  Aim  Conclusion  
Method of 
quality 
assessment 
Identified 
metadata quality 
dimensions 
1 
Assessing metadata 
quality: findings and 
methodological 
considerations from 
an evaluation of the 
US Government 
Information Locator 
Service (GILS) 
Moen, Stewart et al. 
(1998) 
 
To investigate the use of 
qualitative and quantitative 
techniques to assess metadata 
quality. The objectives are:  
 establish how accurate 
the GILS records are 
 compare completeness of 
records 
 identify common 
characteristics of GILS 
records 
 assessment serviceability 
of records  
 
The identification of 4 dimensions 
of quality operationalized by the 
indicators successfully enabled 
the GILS records to be evaluated. 
It was also noted that 
development of the records needs 
participation of all those involved 
in GILS records. Findings will 
inform development of records 
and improvement of service.   
 
17 indicators 
divided 
between 4 
categories 
 
Completeness, 
Accuracy*, 
Accessibility  
 
2 
The continuum of 
metadata quality: 
Defining, expressing, 
exploiting Bruce and 
Hillmann (2004) 
 
To report on: 
 quality dimensions 
 levels of metadata quality  
 suggest potential 
indicators of quality  
 short and longer term 
quality  
 
A total of 7 dimensions of quality 
were suggested accompanied by 
criteria and indicators. The 
inability to exhaustively list quality 
indicators is acknowledged as is 
the need for further development.  
 
7 indicators  
Completeness, 
Provenance, 
Timeliness, 
Accuracy, 
Accessibility, 
Logical 
consistency and 
coherence, 
Conformance to 
expectations 
 
3 
Metadata quality 
evaluation: 
Experience from the 
To develop and implement a 
framework to assess metadata 
quality within the Open 
Successful development of a 
scalable method to evaluate 
metadata quality. 
7 metrics  
Accuracy, 
Completeness  
 
  
 
1
2
5
 
ID Title  Aim  Conclusion  
Method of 
quality 
assessment 
Identified 
metadata quality 
dimensions 
open language 
archives community 
Hughes (2005) 
 
Languages Archives Community 
(OLAC) as part of the Open 
Archives Initiative (OAI).  
Acknowledgement is given to the 
lack of support for qualitative 
assessment and the vision for the 
wider OLAC community to be 
assisted by the proposed 
framework.    
 
4 
An assessment of 
metadata quality: A 
case study of the 
National Science 
Digital Library 
Metadata Repository 
Bui and Park (2006) 
  
To report on: 
 Metadata quality of 
records in NSDL repository 
 Extraction of Dublin Core 
metadata  
 Present preliminary 
results 
 
A total of 1311169 metadata 
records were extracted using OAI-
PMH 2 protocol. The most 
important DC elements were 
(random order): descriptor, 
subject, title, identifier, type and 
creator.  
 
15 Dublin 
Core 
elements  +  
other local 
elements    
 
Accuracy, 
Completeness, 
Consistency, 
Frequency 
  
5 
Author-generated 
Dublin Core 
metadata for web 
resources: A 
baseline study in an 
organisation 
Greenberg, Pattuelli 
et al. (2006) 
  
 
To investigate the Dublin Core 
metadata standard may be used 
to produce quality metadata for 
resources on the national Institute 
of Environmental Health Sciences 
web site. More specifically, it is to 
evaluate manually-generated 
metadata.  
 
In using the Dublin core elements, 
the authors were able to 
determine users’ opinions on 
metadata and the user interface. 
Results show users were able to 
produce metadata in accordance 
with the NIEHS-Dublin Core 
schema. A limitation of the study 
is the sample size due to the 
nature of the study – more 
analysis is needed.  
 
15 Dublin 
Core 
elements 
Accuracy, 
Completeness, 
Timeliness, 
Interoperability, 
Accessibility  
  
  
 
1
2
6
 
ID Title  Aim  Conclusion  
Method of 
quality 
assessment 
Identified 
metadata quality 
dimensions 
6 
A framework for 
information quality 
assessment Stvilia, 
Gasser et al. (2007)   
 
To present a domain-independent 
quality framework. Such a 
framework can be used a basis 
for the development of more 
specialised methods of 
assessments.  
 
Development of quality taxonomy 
enables problems associated with 
quality to be studied in greater 
depth. The generality of the 
framework lends itself well to 
further development.  
 
22 dimensions 
categorised 
according to 
structure 
 
Totality, Accuracy, 
Accessibility, 
Interoperability 
  
7 
Toward releasing the 
metadata bottleneck 
A baseline evaluation 
of contributor-
supplied metadata 
Wilson (2007)  
 
To assess the contributions made 
by persons other than metadata 
experts to the assurance of 
quality. The study focuses on 
ascertaining completeness of 
records, establishing the types of 
errors and identifying additional 
metadata to the records.   
 
This study uses the abstracts 
from RILM (music literature) and 
serves as a basis for future work 
on metadata quality. The potential 
of contributors as a source of 
additional metadata needs to be 
further explored as do 
opportunities to develop systems 
to ingest this type of metadata to 
improve overall quality.  
12 – Record 
analysis 
8 – Abstract 
content 
analysis 
 
Totality**, 
Accuracy**, 
Completeness**  
8 
A Conceptual 
Framework for 
Metadata Quality 
Assessment 
Margaritopoulos, 
Margaritopoulos et 
al. (2008) 
 
To develop and present a 
conceptual framework (using a 
court of law analogy) for 
evaluating metadata quality using 
logic rules.  
 
Application of the framework took 
into consideration structural and 
semantic relationships to evaluate 
quality. Future work includes that 
of deriving metrics to quantify 
metadata quality.  
 
 
3 categories 
of logic rules: 
rules of 
inclusion, 
rules of 
imposition and 
rules of 
restriction 
 
 
Completeness, 
Correctness 
 
9 
Automatically 
characterizing 
resource quality for 
To report on: 
 previous and related 
research  
Presentation of 7 low level quality 
indicators accompanied by 
computational methods to 
12 (general 
descriptors) 
7 (low level 
Totality, 
Accessibility, 
Conformance, 
  
 
1
2
7
 
ID Title  Aim  Conclusion  
Method of 
quality 
assessment 
Identified 
metadata quality 
dimensions 
education digital 
libraries Bethard, 
Wetzer et al. (2009) 
 
 approaches to study 
 identify general areas of 
quality and then develop low 
level metrics 
 accuracy of machine 
learning techniques  
 
automatically assess quality as 
part of educational libraries. Using 
machine learning techniques, they 
were able to achieve over 80% 
accuracy.  
 
indicators) Interoperability   
 
 
10 
Automatic evaluation 
of digital libraries with 
5Squal Moreira, 
Gonçalves et al. 
(2009) 
Development and evaluation of 
the tool, 5Squal, to enable 
automatic quantitative evaluation. 
The tool is based on the model 
proposed by Gonçalves, Moreira 
et al. (2007)   
 
Following evaluation, the tool 
meets the need for a method of 
evaluation of digital libraries. 
Users liked the user interface and 
graphs.  Possible areas of future 
work include inclusion of 
additional dimensions/metrics and 
standards.  
 
8 (2 relate 
specifically to 
metadata) 
Timeliness, 
Completeness, 
Conformance, 
Accessibility  
 
11 
Automatic evaluation 
of metadata quality in 
digital repositories 
Ochoa and Duval 
(2009) 
To present previous work on 
approaches to quality evaluation 
using the framework developed 
by Bruce and Hillmann (2004), as 
a basis for metadata quality 
metrics specifically for information 
completely manually, 
automatically or both.     
The metrics were evaluated in 
three ways: 1) comparison of 
metrics and human reviews, 2) 
looking at metadata sets and 3) 
metrics as low-quality filters. 
Authors suggest the metrics be 
used as a baseline for 
comparison with other new 
metrics. 
7 – based on 
framework 
proposed by 
Bruce and 
Hillmann 
(2004) 
Completeness, 
Provenance, 
Timeliness, 
Accuracy, 
Accessibility, 
Logical consistency 
and coherence, 
Conformance to 
expectations 
Provenance 
*In terms of formatting only; ** Using record level dimensions only.  
See  Table 4-2  for metadata quality definitions.   
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4.4.1.2 Synthesis of results 
Results of the review showed that the greatest total number of metrics 
used as part of a single approach was 22 (Stvilia, Gasser et al. 2007).  I also 
identified that several methods group the metrics according to different 
criteria (Moen, Stewart et al. 1998; Stvilia, Gasser et al. 2007; Wilson 2007; 
Moreira, Gonçalves et al. 2009). This review also identified a method which 
uses a series of logic rules to divide the assessment. These were: a) rules of 
inclusion; b) rules of imposition; and c) rules of restriction (Margaritopoulos, 
Margaritopoulos et al. 2008).  
Collectively, the methods detailed in this manuscript presented a total 
of nine different dimensions of quality. These dimensions of quality were 
measured using the metrics identified in each method. Following the review, 
a number of common metadata qualities emerged. The amalgamated set of 
metadata quality dimensions with definitions can be found in Table 4-2.  
Table 4-2 Dimensions of metadata quality and associated studies 
Identified dimension of metadata quality  Study ID 
Accessibility - Extent to which the metadata can be accessed 
1, 2, 5, 6, 9, 10 
and 11 
Accuracy/correctness - Correctness of the metadata 1 - 8, 11  
Completeness/totality - Presence of all metadata  1-11 
Conformance - How well the metadata conforms to expected 
standards  2, 9 - 11  
Interoperability - Extent to which metadata can be exchanged 
and used without problems) 5, 6, 9, 
Consistency - Does the metadata form, content etc. change 
throughout the document or does they remain  2, 4, 11 
Frequency - How often a metadata element is used 4 
Timeliness - How current the metadata are 2, 5, 11 
Meta-metadata - Metadata about the metadata 2, 11 
 
The most commonly occurring dimension was completeness/totality 
with all the approaches incorporating this dimension; the least common 
dimension was frequency(Bui and Park 2006). Figure 4-2 shows a 
comparison of the quality dimensions across the 11 manuscripts included in 
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the review. Use of metadata standards were also identified as part of the 
review. Here, the simple Dublin Core elements had been incorporated into 
two methods (Bui and Park 2006; Greenberg, Pattuelli et al. 2006). 
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Figure 4-2 Metadata quality dimensions 
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4.4.2 Online stakeholder survey   
The following are the results of the online stakeholder survey. Where 
quotations have been used, these have been copied verbatim; in places 
words have been added in parentheses to aid understanding. 
4.4.2.1 Participant demographics 
Ninety-six individuals submitted data using the survey; most of whom 
indicating they were employed by a university and currently located in 
Europe Figure 4-3. The most commonly indicated role in public health and 
epidemiology (multiple selection enabled) was ‘Data user’. 
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4.4.2.2 Section one of the survey results: Metadata  
The participants were asked to indicate how often they used metadata. A 
total of 47 people answered this question with the majority indicating they 
had used metadata on a regular basis (Table 4-3).  
Table 4-3 Use of metadata  
 
 Frequency Percent 
 
Never 6 6% 
Sometimes 6 6% 
Regularly 15 16% 
Frequently 9 9% 
Very frequently 11 11% 
Total 47 49% 
  
The participants were also asked to indicate which types of metadata they 
used. The most commonly selected type of metadata was descriptive with a 
total of 37 votes followed by administrative with 30 (Table 4-4). Of those that 
indicated ‘other’, the issues of it not always being clear which type of 
metadata was being used, and developing metadata for future use was 
raised.  
Table 4-4 Types of metadata 
  
 Responses 
N Percent CI 
 
Administrative 30 31% 22-41 
Descriptive 37 39% 29-49 
Microdata 15 16% 9-24 
Semantic 12 13% 6-21 
Other 2 2% 0-7 
Total 96 100.0%  
 
Participants were asked to indicate in which of the specified formats the 
metadata they routinely handled had appeared. Results indicate, of those 
that answered this question the most commonly handled format of metadata 
was PDF(s) with 27; the least commonly indicated was RDF.(Table 4-5) Of 
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those which indicated other, additional responses included: SAS files, Stata 
syntax files, SQL and txt.  
 
Table 4-5 Formats of routinely used metadata 
  
 Responses 
Number Percent 
PDF(s) 27 23% 
Spreadsheet(s) 18 15% 
Word© document(s) 20 17% 
XML 25 21% 
RDF 6 5% 
HTML 17 14% 
Other 6 5% 
 
 
The respondents were asked to indicate in which stages of the research data 
lifecycle they handled metadata. Again, multiple selections were enabled. 
Results show the stage at which most respondents used metadata was the 
analysis stage; the stage which received the fewest votes was data 
destruction. (Table 4-6) 
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Table 4-6 Handling metadata across the research data lifecycle 
 
Handling metadata across the research data lifecycle 
 Stages of the research data lifecycle Total 
Conceptual
isation 
Creation 
or receipt 
Appraisal & 
Selection 
Analysis Preservation 
action 
Access, 
use and 
reuse 
Transforma
tion 
Data 
destruction 
Archive 
management 
Administration 
Role in 
public 
healtha 
Archivist / 
librarian 
4 4 3 1 3 4 2 0 4 3 6 
Clinician / 
clinical advisor 
3 4 3 6 1 5 3 0 3 2 8 
Data provider 8 11 7 10 10 12 8 2 4 5 17 
Data user 10 12 11 16 7 12 12 3 3 9 20 
Funding agency 0 1 0 0 0 1 0 0 1 0 1 
Policy maker 1 3 2 2 1 3 1 1 2 2 3 
Observer 1 1 1 1 1 1 1 1 1 1 1 
Other 4 2 2 4 2 4 3 1 3 2 7 
Total 18 21 17 23 16 24 18 3 13 14 39 
 
a. Dichotomy group tabulated at value 1. 
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The granularity of metadata was also addressed with participants 
being asked to indicate at which levels metadata should be made 
available. The most popular level was ‘Research study level’ (38 
votes) followed by ‘Variable level’ (37). Through the ‘if other, please 
specify’ option, one respondent noted that metadata should become 
available each time there is a, “Major transformation e.g. merging”. 
(Table 4-7) 
 
Table 4-7 Granularity of metadata 
  
 Responses 
Number Percent 
 
Research study level 38 28% 
Single dataset / sweep of data 35 26% 
Variable level 37 28% 
Each time a change is made to the data 23 17% 
Other 1 1% 
Total 134 100.0% 
 
The last question in this section requested participants describe the 
main barriers to creating and/or using metadata in biomedical 
research. The barriers can be categorised into the following Table 
4-8:  
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Table 4-8 Main barriers to creating and/or using metadata in public health 
and epidemiological research  
Main barriers to creating 
and/or using metadata in 
biomedical research 
Findings 
a) Lack of skills and 
experience 
 
This refers to the inadequate training and in particular, 
 “a lack of guidance on how to create 
metadata for normal data users…many 
internal initiatives that request te same 
information without in the end generating 
sustainable end product, thus wasting the 
time of metadata creators” 
Three respondents commented on the lack of awareness 
relating to metadata use. For example, one respondent 
said that,  
“…a lot of people in my team are not aware 
they are using metadata…it would be nice if 
the metadata were provided by the data 
providers theirselves (HSCIC, ONS etc.)” 
Whilst another commented on a, “lack of understanding of 
why metadata is important (until it’s too late!)” It was also 
noted by one respondent that a  
“…big problem is that the process of 
document the data starts to late. The 
research doesn’t have a structured plan 
from the beginning that includes 
documentation of metadata.” 
 
b) Inconsistencies  
 
Namely formatting of metadata and the approaches to 
“…developing and categorising models (and) usable 
interfaces for development”. One respondent in particular 
commented, “…sometimes I am sent data with no 
associated metadata and therefore don’t know the 
definitions of the variables…” 
 
c) Inadequate tool 
availability  
 
Three respondents commented on a lack of tools with one 
stating, for example, there being a “…lack of tools to 
create data dictionaries across sweeps…” Another 
commented on having the relevant support to use the 
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tools once these were available. Another related issue is 
being able to extract metadata from older, potentially 
inaccessible versions of software.  
 
d) Lack of standards  
 
Five respondents commented on a lack of standards with 
one respondent stating, “as far as I’m, aware there are no 
standards so quality can very”. Another commented on 
the, “agreement to adopt common standards”. 
 
e) Ethics  
 
Two respondents commented on restrictions put in place 
due to data protection and other issues related to ethics 
impacting the creation and/or use of metadata; one 
respondent in particular comments on “…trust, privacy 
and security…” 
 
f) Inadequate 
resources: cost and 
time  
 
Six respondents commented on a lack of resources to 
create and curate metadata effectively. 
 
 
My work can help to address these issues through a number 
of different ways. Firstly, the framework provides a robust method to 
assess metadata quality which also serves to help better educate 
users through the provision of guidance and definitions throughout 
the framework. Secondly, the framework serves as a tool to help 
users systematically assess metadata quality in a replicable way. 
This help to standardise the method of quality assessment. Thirdly, 
the availability of a framework reduces the time otherwise taken by 
users to create their own tool to assess metadata quality. 
This tool has already been shared with a data manager at another 
institution and is currently under review.   
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4.4.2.3 Section two of the survey results: Using tools and 
technologies 
Clinical terminologies and classification systems: This 
section of the survey focused on tools and technologies. The aim of 
the initial question was to determine how tools and technologies were 
selected. The most commonly selected answer was ‘Standard 
practice’ while the least commonly selected answer was ‘Funder 
requirement’. (Table 4-9). A total of 4 people indicated ‘other’ with 
additional suggestions including, “What I am used to”, “Highlighted 
via mailing list”, “based on requirements of the end user or data 
provider” and “Do my own research into tool”.  
 
Table 4-9 Selecting tools and technologies 
  
 Responses 
N Percent 
 
Funder requirement 9 14% 
Suggestion from colleagues 21 33% 
Standard practice 29 46% 
Other 4 6% 
Total 63 100.0% 
 
 
 
Survey respondents were then asked about their experiences with 
encoding standards. Of those which submitted data, the classification 
system most people had come across was International 
Classification of Diseases followed by Medical Subject Headings. 
Both Diagnostic and Statistical Manual of Mental Disorders and 
Logical Observation Identifiers Names and Codes each received 0 
votes (Table 4-10). Of those which provided additional answers, 
other clinical terminologies included “Multilex”. 
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Table 4-10 Clinical terminologies 
Clinical terminologies 
 Role  
Archivist / librarian Clinician / clinical 
advisor 
Data provider Data user Funding agency Policy maker Observer 
Other 
 
ICD 1 4 6 14 1 2 1 5 
MeSH 1 4 3 8 1 2 1 5 
OPCS 0 1 4 6 0 0 0 1 
Read Codes 0 3 2 11 0 1 1 3 
SNOMED CT 1 3 4 6 1 2 1 3 
Other 0 0 3 2 0 0 0 0 
Total 1 6 8 16 1 2 1 7 
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Respondents were also given the opportunity to describe any 
difficulties they faced when using clinical terminologies. Results can be 
categorised into the following:  
A lack of medical knowledge: respondents felt that due to a lack of 
medical knowledge, the time taken to understand the terminology, and hence 
utilise the clinical information, increased. These findings suggest greater 
explanatory information is needed to support the use of clinical data for 
research purposes.  
Lack of ease of use: one respondent commented on the, “sheer 
volume of terms” whilst two others commented on “translating from one 
coding system to another…” and “overlapping codes Inappropriate codes 
Missing codes”. A third commented on the appropriateness of using certain 
coding systems for research purposes, for example, “MeSH not adequate for 
public health research”. While another respondent commented on the 
“variable coding by clinicians” as being another problem associated with use 
of clinical terminologies. Another two respondents commented on the 
structure and complexity of the codes themselves. One wrote, “…codes used 
not the best for the situation, some confusion over code hierarchies”. While 
the other wrote,  
“the terminologies (and the codes) are complex and with many 
levels. Not a 100pct. uniq connection (ICD) between the codes 
and terminology over time” 
These findings suggest that the size, complexity and application of 
clinical terminologies and classification systems can negatively affect how 
easily they may be utilised in research. Consequently, researchers are 
experiencing difficulties in harnessing these controlled vocabularies to 
support the realising of the potential research benefits of clinical data.  
Variable access to classification system - one respondent 
commented that, “…the WHO classification is easily available online, but the 
HES classification is harder to obtain…”.  which negatively impacts the 
speed at which codes may be verified. These findings suggest that the 
inconsistent access to classification systems can negatively impact their 
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application in research. Consequently, the respondents reported having to 
spend in increased amount of time trying to verify encoded clinical 
information. 
Metadata standards: The most commonly used metadata standard 
by the respondents was the Data Documentation Initiative 2(Codebook) 
followed by Data Documentation Initiative 3 (Lifecycle). The least commonly 
used metadata standards with no votes each were, Minimum Information for 
Biological and Biomedical Investigations (MIBBI), Observ-OM and Open 
Microscopy Environment eXensible Markup Language (OME-XML). 
(Supplementary Table 2) Additional metadata standards include Metadata 
Object Description Schema (MODS), “EHR standards – openEHR, HL7 and 
EN13606”.  
A total of 11 people indicated that they used metadata catalogues to 
help improve the discoverability of their research. Of those which submitted 
data, challenges associated with catalogues to improve discoverability 
include the catalogue not being fit for use, and having researchers and other 
stakeholders use/contribute to the catalogue. For example, one respondent 
said there was an,  
“…impossibility to use existing tools as they don’t apply to 
longitudinal studies with several data sweeps.”  
This was echoed by other respondents who commented that a 
challenge was, “having people contribute their models!” and that they are 
“normally treated by researchers as add on, thus a cost with no benefit to 
their work”.  
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With regards to using catalogues to identify and characterise 
metadata, a total of 16 people indicated they had used a catalogue in this 
way with six stating they had experienced problems. Problems included not 
having the granularity required to assess the data, and the method of 
selecting variables being inconvenient,  
“Data were described sweep by sweep instead of giving an 
overview across sweeps. Using 'shopping baskets' to select 
variables is extremely inconvenient and it is very slow when 
hundreds of variables are needed” 
Other problems included limited knowledge of standards such as 
“DDI” and being able to maintain the catalogue itself. 
Survey participants were asked to indicate whether they had used 
SWTs when handling metadata. A total of five people indicated they had with 
two sharing their experiences. Challenges shared include, “insufficient 
resources” and there being a “small community” with a “higher barrier of 
knowledge”. 
The survey then asked the respondents to indicate whether they had 
used any kind of metamodel as part of their research. A total of five people 
said they had used some kind of metamodel with examples including, “HL-7”, 
“OpenEHR”, “EN ISO 13606”.  
4.4.2.4 Section three of the survey results: Metadata usability  
In order to identify areas of importance to metadata usability, respondents 
were asked to share their opinions of different aspects of usability. Results 
show that the majority view the metadata being available in an open access 
repository as being essential whilst 17 people view being standards-based 
as extremely important to usability. A total of two people thought that the 
inclusion of unique identifiers resolving to relevant landing pages as being 
not at all important to the usability of metadata (Figure 4-4).  
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Respondents were also given the option to share additional 
suggestions of aspects important to metadata usability. Additional responses 
include, the metadata being “…easy to create and edit by non-programmers, 
using user-friendly tools” and for there to be an “encouragement of common 
understanding between contributors and users”. These findings suggest that 
more is needed in the way of tools to support the creating and managing of 
usable metadata. These findings also suggest more is needed in the way of 
harmonised definitions of terms to enable multidisciplinary teams, including 
contributors and user, to work even more closely together. Problems 
associated with usability include having the training and documentation to 
use the metadata in particular having, “…a human readable as well as 
machine readable…” formats of the metadata. Other issues raised include 
using open source technologies, the process of “doi minting” and having 
access to, “…semantic mapping to relevant terms.”  
I fed these issues relating to usability into the framework in a number 
of different ways. For example, in the Tools and Technologies section, I 
suggested users consider whether the metadata have been included in 
catalogues and if any use had been made of encoding standards – controlled 
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vocabularies. Further to this, I also suggested users consider whether other 
standards used such as exchange standard and metadata standards. With 
regards to inclusion of unique identifiers, in the framework I suggested, in the 
General section, that users included location of the research artefacts and 
links resolving to studies, sweeps or publications.    
By having access to metadata in both machine and human readable 
formats, researchers can have an increased flexibility in terms of processing 
the metadata - this can either be done manually using the human-readable 
format or electronically using the machine-readable format.  
4.4.2.5 Section four of the survey results: Quality assessment 
To determine the dimensions of quality important to public health and 
epidemiological research metadata, the participants were asked to vote 
(multiple selection enabled) for dimensions from a pre-defined list (Table 
4-11). Results show of those who submitted data, accuracy was viewed as 
being most important to epidemiological and public health metadata. The 
second and third most important were, accessibility and discoverability 
respectively. The dimension participants viewed as being least important was 
meta-metadata. Of those which provided additional information, suggestions 
for dimensions were not provided; instead the following two comments, 
“before meta metadata let’s get metadata clear and well understood” and the 
second, stating that other research communities use metadata too, were 
made. 
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Table 4-11 Dimensions of metadata quality 
  
 Responses 
N Percent 
Dimensions of 
metadata qualitya 
Accessibility (extent to which the metadata can be accessed) 34 14.5% 
Accuracy (correctness of the metadata) 35 14.9% 
Appropriateness (extent to which the metadata are relevant) 24 10.2% 
Comprehensiveness (extent to which the metadata are complete) 24 10.2% 
Discoverability (how visible the metadata are - can it be easily found) 33 14.0% 
Extendibility (extent to which the metadata may be easily extended) 14 6.0% 
Interoperability (extent to which metadata can be exchanged and used without problems) 21 8.9% 
Meta-metadata (metadata about the metadata) 10 4.3% 
Timeliness (is the metadata current, inclusion of temporal information) 20 8.5% 
Versionability (extent to which a new version may be easily created) 18 7.7% 
Other 2 0.9% 
Total 235 100.0% 
a. Dichotomy group tabulated at value 1.  
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Results also showed that most of the respondents, who submitted 
data sometimes assessed its quality while eight people never assess quality 
(Table 4-12). 
The survey then asked participants if they used any kind of formal 
metadata assessment criteria. A total of 28 people answered this question of 
which only one said they used some kind of criteria. This was a, “built in 
diagnostics within metadata editor”. 
 
Table 4-12 Frequency of metadata quality assessment 
 
 
Challenges associated with assessing metadata quality in 
epidemiological and public health can be categorised into technical and 
cultural. For example, several participants commented on the lack of 
guidance to assist quality assessment with one respondent in particular 
commenting that one of the problems is identifying, “…the best way to 
determine quality” while another wrote, “I haven’t thought about this”. This 
lack of guidance and awareness of metadata quality assessment 
demonstrates the current unmet need of a formalised method of assessing 
metadata quality within the public health and epidemiological research 
context. Having access to a formalised method of metadata quality can 
potentially help researchers to improve the way in which metadata are 
managed. 
Another perceived challenge was a lack of domain-specific knowledge 
that negatively impacting how well respondents understood the metadata. 
 
 Frequency Percent 
Never 8 8% 
Sometimes 19 20% 
Regularly 6 6% 
Frequently 3 3% 
Very frequently 1 1% 
Total 37 39% 
System 59 61% 
Total 96 100% 
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For example, one respondent commented on a “lack of experience and 
knowledge of the area” whilst another commented on the “lack of knowledge 
of biomedical analysis”. This reported lack of domain-specific knowledge 
demonstrates the needed for increased support, possibly through improved 
training and access to formalised guidelines, to enable researchers to better 
understand and utilise metadata.    
Respondents also reported how the limited availability of tools and 
resources negatively impacted how well they were able to assess metadata 
quality. For example, respondents reported not knowing about software and 
other such tools and secondly not being able to access these. They also 
reported on how time-consuming a process like metadata quality 
assessment is and how finding this time was problematic. These findings 
demonstrate the need for a formalised method of assessing metadata quality 
which can be implemented relatively quickly and without disruption to daily 
work routines. These findings are also indicative of the lack of focus on the 
issue of metadata quality to date and demonstrates the need for greater 
emphasis on not only assuring metadata quality but also the potential 
negative impact of not doing so.  
4.4.3 Framework definition  
The following describes the sections of the framework: 
4.4.3.1 Novel metadata quality models  
In the ‘General information’ model, the completeness refers to how 
comprehensive the metadata are, and the granularity looks at the level at 
which the metadata available, e.g. research study level. The types of 
metadata, includes administrative, descriptive, microdata and semantic. The 
formats includes but are not limited to, PDF, Spreadsheet, Word processed 
document, XML, RDF and HTML. In having access to metadata in different 
formats, the discoverability and accessibility of research data can be 
potentially enhanced. Metadata provided in RDF for example, can be 
published on the World Wide Web whilst its characteristic scalability can be 
harnessed facilitating the integration of multiple disparate resources in 
support of clinical research (Pathak, Kiefer et al. 2012a; Pathak, Kiefer et al. 
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2012c). This also helps to improve accessibility as the metadata can be 
retrieved in a number of different ways; there is also scope for inclusion in 
catalogues through use of metadata harvesting tools – both of which 
contribute to the enhanced discoverability of research data. 
In the ‘Tools and technologies’ model, accuracy refers to the use of 
clinical terminologies and in particular the provision of any codes assigned to 
pre-determined answers and the categories these codes may fall into; more 
specifically, it suggests stakeholders look at the way in which clinical 
information were encoded using clinical terminologies. Structure refers to 
how the metadata are presented; for example, some studies provide tables 
containing sweep-level metadata with downloadable files inclusive of 
descriptions of any use of clinical terminologies. Provision of clearly 
structured and unambiguous metadata can help stakeholders to navigate 
through the metadata more easily. Accessibility can also be enhanced 
through inclusion of the metadata in a public facing, searchable catalogue 
such as the CALIBER portal (Denaxas, George et al. 2012). Use of portals or 
catalogues can also help to enhance the discoverability of research data by 
providing collections of metadata from a range of epidemiological and public 
health studies. The use of Semantic Web technologies such as biomedical 
OWL ontologies in epidemiological and public health research serve to 
potentially enhance the interoperability, extendibility and discoverability of 
research data. Inclusion of the Semantic Web technologies heading in the 
model also serves to encourage stakeholders into considering how well 
maintained, for example, links are – broken links could potentially be a sign 
of poor quality metadata. Additionally, by using mechanisms such eXtensible 
Markup Language (XML), there is the potential to create newer versions of 
the metadata whilst referencing previous versions; an example of where this 
is possible is using the DDI Lifecycle metadata standard.  
In the ‘Usability’ model, standards can refer to metadata standards 
such as MIBBI or exchange standards such as HL7 or CDISC. Cross walks 
could either refer to mappings between metadata standards such as DDI 2 to 
DDI 3; and/or between clinical terminologies such as Medical Subject 
Headings and International Classification of Diseases. In having cross walks 
Research case study 2: Improving metadata quality assessment in public health and epidemiological 
research 
 
149 
 
between metadata standards, the metadata’s interoperability could 
potentially be enhanced. In providing cross walks between clinical 
terminologies, researchers wanting to run queries using multiple 
terminologies from disparate datasets could potentially identify which clinical 
codes are equivalent in support of for example, clinical cohort phenotyping. 
The use of repositories acts as a mechanism to enhance discoverability and 
provide meta-metadata. Meta-metadata are metadata about the metadata; 
for example, date when metadata were created, the version number and by 
whom. 
In the ‘Management and curation’ model, inclusion of the ‘dates’ and 
‘versions’ headings encourage stakeholders to look at the meta-metadata 
and encourages them to assess how timely the metadata are. Provision of 
this meta-metadata also helps to support version control, and scope for 
extension. 
4.4.3.2 Novel quality assessment framework 
The quality assessment framework for epidemiological and public health 
metadata has four components, Table 4-13:  
Table 4-13 Framework component definitions 
Part Definition 
1. General information 
Assesses provision of, but not limited to, the types, 
formats and granularity of the metadata available 
2. Tools and 
technologies 
To assess the structure, application of clinical 
terminologies, indexing in catalogues, and use of 
SWTs 
3. Usability 
Assess presence in repositories, application of 
metadata standards, and provision of cross-walks or 
other semantic mappings 
4. Management and 
curation 
This refers to how the metadata were created and 
provision of and access to other metadata versions 
 
The boxes in pink denote the area of the framework and are based on the 
sections of the survey. The boxes in yellow are the associated quality 
dimensions and the boxes in green are the question topics. This model also 
aims to show how the different elements are linked together and that 
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question topics can have a basis in more than one quality dimension. In 
Figure 4-5, the model is broken down according to the different areas of the 
framework. Following development of these models and definitions, a 
metadata quality framework is proposed in Table 4-14.  
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Figure 4-5 Models of metadata quality by assessment section 
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Table 4-14 Metadata quality framework 
Area of 
metadata 
quality 
Underlying quality dimensions Justification Headings 
General 
information 
Accessibility To determine how accessible metadata are Types of metadata 
Formats of metadata 
 
Accessibility, 
comprehensiveness, 
appropriateness  
To facilitate comparison and ensure that metadata are 
available to meet a range of potential needs. 
Acknowledgement is given to the inability to provide 
an exhaustive list of different metadata levels. The 
levels reflect those identified as part of the review and 
survey.  
 
Granularity of metadata 
Completeness To identify where there are gaps in the metadata Missing or incomplete 
metadata 
    
Tools and 
technologies 
Accessibility Addresses how easily human readable versions of the 
metadata may be read and understood 
 
Structure of metadata E.g. 
continuous prose, 
sectioned,  
Accuracy, accessibility To determine extent of application of controlled 
terminologies. 
Presence of clinical 
terminologies  
Discoverability, accessibility To determine extent of catalogue use to address 
issues such as usability and access 
Indexing in catalogues  
Restrictions on access to 
metadata 
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Interoperability, extendibility, 
discoverability  
To determine how extensively Semantic Web 
technologies have been knowingly applied and how. 
Application of Semantic 
Web technologies 
Method of application and 
reason(s) for use  
    
Usability Accessibility, interoperability, 
discoverability, 
comprehensiveness,  
meta-metadata 
To determine how usable the metadata are and help 
identify areas of potential improvement 
Metadata repositories  
Metadata standards  
Cross-walks or other 
mappings 
    
Management 
and curation 
Versionability, Meta-metadata, 
Timeliness, Extendibility  
To help improve management and curation of the 
metadata 
Creation of metadata 
Provision of other versions  
N.B. the presence or absence of timeliness information about the data fall under the ‘Management and curation’ section and in part icular the 
two suggested headings, ‘Creation of metadata’ and ‘Provision of other versions’. Here, the user is able to record when the metadata were 
created – hence how current the metadata are - and if other, older versions are available.   
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Given the breadth of public health and epidemiology research, application of 
this framework would promote a more in-depth and focused assessment of 
the metadata.  Future steps will include evaluating the framework by applying 
it to a series of case studies. Recommendations for changes in research data 
management policy and practice will be made following the evaluation.  
4.4.4 Framework evaluation - Part A: Test cases 
General information: In the first test case, Millennium Cohort Study 
(MCS), links to the UK Data service were available as were links to the 
variable information in addition to other such information in the Nester 
publisher catalogue. Metadata were available at a number of different levels 
and the artefacts reviewed were all complete. By applying the framework to a 
real world test case, I identified several areas of potential improvement. 
These improvements could help users to perform a more in-depth review of 
metadata quality. For example, in the MCS there was opportunity to browse 
variables and tabulate these using the Nesstar catalogue. This is an 
additional way to characterize the research data and mechanisms to record 
this kind information are needed in the framework.  Also, by adding a section 
where additional information may be recorded, this will enable the reviewer to 
add findings which may not fall under a heading previously proposed in the 
framework. Furthermore, a section where links to other studies, sweeps and 
publications may be recorded is also required. For example, the MCS 
provided multiple links to this information but there was nowhere in the 
framework to record this. 
Additionally, the framework did not include a section to specify which 
artefacts were reviewed and where these can be found. To work around this, 
this information was placed under the ‘Missing or incomplete metadata’ 
section where the completeness of the metadata were reviewed. Though not 
ideal, this served to record the artefacts reviewed and specify simultaneously 
if there were any problems. In a more low level assessment, mechanisms to 
specify clearly which documents are being reviewed are needed. This does 
however, raise issues regarding the point at which someone reviewing the 
metadata decides when they have gathered enough documents to review. A 
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group of documents for each case study were randomly selected and it 
quickly became apparent that metadata are spread across documents and 
that it is through their collective review that quality may be effectively 
assessed. Reviewing one single document may not necessarily provide 
someone with enough detail to conduct the review properly. It is possible 
users may review multiple documents to gain a better understanding of the 
data. Hence, to adapt to this problem an area was be added to the general 
information section to record the names and locations of the research 
artefacts reviewed and where these can be found. By adding this section, 
recording this kind of information is potentially easier and clearer.   
Other changes made included adding sections for variable 
descriptions, online data visualisation tools, links to other studies, sweeps or 
publications, and other. By adding these headings, I was able to record in 
greater detail the outcomes of the quality assessment and list where these 
metadata can be found. For example, in the MIDUS study I was able to 
record links to publications at sweep and study level. In the DNBC study, I 
was able to record links to all four sweeps, NCI indexed publications and a 
list of theses using DNBC data. No additional information was recorded 
under the ‘other’ heading.  
When assessing the metadata for the DNBC study, locating the 
metadata was more challenging than MIDUS. At times there was an initial 
language barrier (although pages were easily translated) and links between 
the research artefacts were not as well established in comparison to the 
MIDUS study. This could be because the metadata for MIDUS were mostly 
found in the ICSPR catalogue which produces metadata compliant with 
multiple standards; while the DNBC study metadata were more sparsely 
located and the only metadata standard identified was DDI. The changes 
made enabled me to record more detailed findings from the assessment. 
Tools and technologies: The structure of the metadata in the MCS 
was a combination of: a) PDFs comprising of continuous prose broken down 
by numbered paragraphs; and b) a list consisting of headings and sub-
sections in the UK Data Service record, and a series of collapsible headings 
in the Nesstar catalogue. In the MCS, application of clinical terminologies 
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was not found in the artefacts reviewed. This could be due to the information 
sitting in another document inadvertently missed; however, listings of 
categories and codes were located. The metadata reviewed were indexed in 
the Nesstar catalogue and the UK Data Service and were unrestricted. 
Regarding use of Semantic Web technologies, and reasons for use, DDI 2.5 
compliant XML was found for the MCS through use of the UK Data Service 
catalogue. I could not find a justification from the organisation for using DDI 
compliant XML; although, given that the UK Data Service are mainly 
responsible for social sciences data, and DDI is a metadata standard aimed 
primarily at social sciences metadata, this could be a contributing factor in 
the decision to apply this standard.  
Regarding the further development of the tools and technologies 
section, mechanisms to record use of category and coding schemes were 
also needed. Codes and categories were utilized by the test case and it is 
useful to record where this information may be found if there are any access 
issues. Furthermore, what quickly became apparent through the evaluation 
was the inherent links between the different sections of the review and the 
suggested headings, and how best to record overlapping information. For 
example, clinical terminologies are only one way to categorize information 
and can involve use of ontologies. Recording this information using the 
framework involves use of, the ‘Presence of clinical terminologies’, 
‘Application of Semantic Web technologies’, and ‘Method of application and 
reason(s) for use’ headings. A potential solution here would be to treat the 
headings as guidelines rather than a ‘question and answer’ exercise to 
enable a thorough review of the metadata which can then be recorded.     
For the MIDUS and DNBC studies, two changes were made following 
the first application: a) addition of a separate codes and categories section; 
and b) merging of the indexing of catalogues and metadata repositories 
sections. By adding the codes and categories section, I was able to review 
and record details regarding controlled vocabularies employed by the 
research teams. This is useful as in the MIDUS study I was able to record 
variable coding conventions and in the DNBC study I recorded the locations 
of the codebooks for all four interviews. By merging the catalogues and 
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repositories sections together, I was able to reduce repetition in the 
framework and group together this kind of information. In the MIDUS study 
metadata were sourced from the ICPSR catalogue.  
For both the MCS study and the MIDUS and DNBC studies, I was 
unable to find the method of application and reason(s) for use of Semantic 
Web Technologies. This could be because it is not commonplace to provide 
this kind of information and so it was difficult to find. I decided to include this 
section in the framework as I wanted to see if the method of application is 
linked in some way to the quality of the metadata. I decided not to remove 
this section before circulating the framework with stakeholders as I wanted 
their views on this.  
Usability: In the MCS, metadata are available from both the Nesstar 
publisher and UK Data Service repositories both of which employ the DDI 
standard. Cross-walks and other such mapping could not be found in the 
metadata reviewed.  
Enhancements to the usability section included the addition of 
mechanisms to record web links relating to data access and use caveats 
which could impact use of catalogues or repositories. Having access to this 
kind of information could help stakeholders better navigate through the 
metadata. Also, having some kind of mechanism to record provision of the 
underlying metadata model would also be useful. Having access to this kind 
of information could potentially facilitate metadata exchange enhancing the 
interoperability of the metadata.  
Another potential enhancement was to include mechanisms to record 
in more detail cross-walks and other such mappings. Having access to this 
kind of metadata could also further support researchers’ and clinicians’ 
understanding of which variables have been mapped and the process 
through which this occurred. I will also remove the metadata repositories 
heading and combine this with the metadata catalogue heading in the 
previous section. This is because no new information was recorded here; 
rather, information was repeated from the catalogue heading.     
In the usability section, changes made following the first application 
included addition of mechanism to record metadata models, and enhanced 
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mechanisms to record cross-walks and other such mappings. In making 
these changes, it was easier to record findings which could potentially 
indicate the interoperability of the metadata. In the MIDUS study, four 
standards are used (DDI, DC, MARC21 and Datacite) whereas only DDI 
compliant metadata was found for the DNBC study. I could not find 
crosswalks and metadata models for either of the studies.     
Management and citation: In the MCS, locating the creation and 
versioning information was easier and quicker using the underlying XML 
syntax; this outcome could be attributed to purpose of the metadata. Whilst 
the catalogue record provided a detailed description of the study; I was 
searching for very specific elements of the meta-metadata. A link to the XML 
syntax is provided from the UK Data Service record so accessing this 
information is relatively straightforward. However, stakeholders would need 
to be familiar with DDI elements to identify the information they require 
efficiently. 
Enhancements to the management and curation section included 
splitting this section into two: a) the creation and version information of the 
metadata being reviewed; and b) the creation and version information of the 
review itself. In being able to record more efficiently the meta-metadata, 
stakeholders can quickly see how current the review is, and if another is 
needed. The creation and maintenance of metadata is an ongoing process 
and being able to conduct regular reviews will help to maintain a high level of 
quality. 
In the management and curation section, in the MIDUS study full 
version history was provided inclusive of a brief description of the changes. In 
the DNBC study, I could not find previous versions of metadata but dates of 
when metadata were created were provided. Other changes made to the 
management and curation section included the addition of mechanisms to 
record the date and version of the assessment and name of the person 
responsible for the assessment. By making these changes, I was able to 
improve recording of meta-metadata of the quality assessment itself and 
facilitate a tracking of the different versions of the assessments. The basic 
tracking system with versions and dates, help stakeholders monitor the 
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quality of the metadata across assessments and note any necessary 
corrective action taken and the subsequent impact. A potential weakness of 
this section is the lack of automation when producing the version numbers. 
Since this information is added manually, there is the potential for human 
error, version numbers could be missed or repeated as two such examples. 
4.4.5 Framework evaluation - Part B Stakeholder engagement 
The framework was then evaluated by 10 stakeholders (3x research 
data managers, 1x policy adviser and 1x metadata manager, 1x software 
developer, 3x post-doctoral researchers, 1x PhD student) in public health and 
epidemiological research. The following remarks were raised and are 
described below. 
Firstly, the framework itself does not have a column specifically for 
research findings; in the evaluation part A, an altered version of the table was 
used. The framework should be viewed as more of a reference document 
and the altered version inclusive of a ‘findings’ column should be used when 
assessing the metadata.  
The suggestion was also made to include potential answers for some 
of the headings; these were ‘granularity, ‘types of metadata’ and the ‘formats 
of metadata’. In the next version of the framework possible answers will be 
included to help better guide stakeholders when they are assessing 
metadata. These answers will be sourced from results of the review and 
survey. 
Another query raised was the definition of certain headings e.g. 
“…what does “continuous prose” mean…I don’t know exactly what Semantic 
Web technologies refers to…” Where the structures of the metadata were 
being assessed, the example of ‘continuous prose’ was included. I included 
this example to establish whether the metadata are structured in paragraphs, 
tables etc. to determine how clear the metadata are to read i.e. if there are no 
headings/signposts, then the extent to which other researchers can navigate 
through the metadata quickly and easily could be negatively impacted.  
Regarding inclusion of the Semantic Web technologies, this is looking 
at, for example, whether controlled clinical terminologies had been used as 
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part of the study. An exemplar answer is, “the ICD 10 ontology was used as 
part of the study and the metadata comply with the DDI-Lifecycle schema”. 
Completion of this section will also help determine how clearly this 
information is conveyed to the person conducting the assessment. Therefore, 
examples will be included in the framework to help stakeholders complete the 
assessment more easily by reducing ambiguities.  
The use of clinical terminologies in the framework was also queried; 
the data manager was unsure which terminologies the framework was 
referring to. The inclusion of the clinical terminologies heading in the 
framework is to deduce: a) if clinical terminologies have been used and which 
ones e.g. ICD 10; and b) how clinical data were encoded. This will help 
stakeholders to track the following: a) any version changes e.g. ICD 9 to 10 
and how these changes were managed; and b) any harmonisation work to 
help facilitate the transitional period, on-going and further work using these 
encoded data. Therefore, this section will need refining to make the intention 
for inclusion clearer to the person assessing the metadata, and to better 
guide them. 
Furthermore, a comment was made that finding metadata at a range 
of levels complete with links to publications is unrealistic and increased 
support for stakeholders is needed when assessing metadata. Whilst I 
acknowledge that the framework may provide a somewhat idealistic 
expectation of metadata, the framework was designed to provide a non-
exhaustive list of headings to guide stakeholders. Context needs to be taken 
into consideration when assessing metadata quality as the granularity of 
metadata available may differ across the epidemiological and public health 
research domains.  
From the evaluation, metadata standards such as DDI are commonly 
applied to metadata already indexed in repositories/catalogues. Though this 
is beneficial as the metadata elements are standardised, and there is scope 
to download the DDI compliant XML, this does emphasise the need for 
increased application of metadata standards across biomedical research and 
regardless of whether or not the metadata are indexed. Though this in itself 
presents challenges (access to the necessary resources, ongoing 
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maintenance etc.), if the metadata are standardised, there is potential for 
automatic metadata harvesting protocols to be enacted and the metadata be 
available for automatic inclusion in a repository. This will help to enhance 
research data discoverability in support of improved opportunities for data 
reuse and repurposing.  
Following the evaluation, Table 4-15 shows the finalised framework 
v1.0. 
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Table 4-15 Evaluated metadata quality assessment framework  
Area of 
metadata 
quality 
Underlying quality 
dimensions 
Justification Headings 
General 
information 
N/A To record which artefacts were reviewed and 
where these can be found 
Names and locations of research artefacts 
reviewed  
Accessibility To determine how accessible metadata Types of metadata  
 
(administrative, descriptive, microdata, semantic, 
other) 
Formats of metadata 
 
(PDF, Spreadsheet, Word processed document, 
XML, RDF, HTML, other) 
 
Accessibility, 
comprehensiveness, 
appropriateness  
To facilitate comparison and ensure that metadata 
are available to meet a range of potential needs.  
Acknowledgement is given to the inability to 
provide an exhaustive list of different metadata 
levels. The levels reflect those identified as part of 
the review and survey.  
 
Granularity of metadata  
 
(research study level, single dataset/sweep of 
data, variable level, each time a change is made 
to the data, other) 
Completeness To identify where there are gaps in the metadata Missing or incomplete metadata 
Discoverability To identify how extensively metadata can be used 
to characterize the research data 
Online data visualisation 
Provision of variable descriptions 
Comprehensiveness To identify how well linked the metadata are to 
other potentially useful resources 
Links to other studies, sweeps or publications 
Comprehensiveness To record any additional details which may not fit Other  
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under any of the suggested headings. (list of 
proposed headings in non-exhaustive)  
    
Tools and 
technologies 
Accessibility Addresses how easily human readable versions of 
the metadata may be read and understood 
 
Structure of metadata  
 
(headings, paragraphs, tables, other)  
Accuracy, 
accessibility 
To determine extent of application of controlled 
terminologies. 
Encoding and exchange standards 
 
(Encoding - ICD, SNOMED CT, DSM, LOINC, 
OPCS, Read Codes, other) 
 
(Exchange – HL7, CDISC, other) 
Presence of code(s) and category(ies) lists 
 
Discoverability, 
accessibility, 
comprehensiveness, 
meta-metadata 
To determine extent of catalogue use to address 
issues such as usability and access 
Indexing in catalogues/repositories  
(iSHARE2, IPUMS, CALIBER, CESSDA, MRC 
Gateway, other) 
 
Restrictions on access to metadata 
Interoperability, 
extendibility, 
discoverability  
To determine how extensively Semantic Web 
technologies have been knowingly applied and 
how. 
Semantic Web technologies 
 
(biomedical ontologies e.g. ICD 10 ontology and 
where these can be found e.g. The OBO 
Foundry, XML, RDF/SPARQL, other) 
 
Method of application and reason(s) for use  
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By structuring the framework according to the issues the suggested headings address (resulting in four sections), and not the underlying 
quality dimension, the dimensions repeat throughout the framework. The repeating quality dimensions demonstrate the possibility that one 
quality may underpin multiple suggested headings. Therefore, users should engage with the framework by working through the sections 
systematically using the suggested headings to guide their assessment.  
Usability Accessibility, 
interoperability, 
comprehensiveness, 
meta-metadata 
To determine how usable the metadata are and 
help identify areas of potential improvement 
Metadata standards  
 
(Dublin Core (or derived standard), Data 
Documentation Initiative  Code book/Lifecycle, 
ISO/IEC 11179, MIBBI, Observ-OM, OME-XML, 
Protocol Data Element Definitions, SDMX / 
SDMX-HD) 
Interoperability, meta-
metadata 
 
To determine how current the cross-walks and 
other mapping are and if any problems were 
experienced  
Cross-walks inclusive of method and when these 
were created 
 
(between metadata standards and/or clinical 
terminologies) 
Other mappings 
Interoperability To help improve opportunity for metadata 
exchange and better researchers’ and clinicians 
understanding of the structure of the metadata 
Provision of metadata model (metamodels) 
    
Management 
and curation 
Versionability, Meta-
metadata, 
Timeliness, 
Extendibility  
To manage the results of assessment and help 
track improvements made to the metadata 
Date and version of assessment 
Name of person assessing the metadata 
To help improve management and curation of the 
metadata 
Creation of metadata 
Provision of other versions  
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4.5 Discussion  
4.5.1 Literature review  
A total of 11 manuscripts were identified and reviewed. As part of the 
analysis, the method of quality assessment and quality dimensions were 
recorded. Following this review, no method of metadata quality assessment 
was identified for use in public health and epidemiological research. 
Therefore, an approach to quality assessment in public health and 
epidemiology is needed to address this gap in knowledge. Following the 
review, I was able to compare the identified dimensions of quality across all 
the methods of assessment (Figure 4-2).  
Following the identification of metadata standards in the review, the 
survey addressed the application of standards. The standards listed will take 
into account the outcomes of the discoverability study(Castillo, Gregory et al. 
2014) and include other metadata standards relevant to biomedical research 
not previously included in the discoverability survey. Additional areas of 
interest which will be incorporated into the survey are the role of metadata 
across the research data lifecycle and the availability of software and tools 
and technologies to support the management of metadata. This will help 
inform any subsequent developmental work.   
In using both biomedical and computer science databases, I identified 
a wide range of publications for potential inclusion in the review. This was 
advantageous as in areas such as e-libraries and archive management, a lot 
of work had been done on metadata quality assessment and so I was able to 
identify literature, though not included in the review, provided useful 
contextual information.   
However, as all methods identified were from research domains other 
than public health and epidemiology, the applicability of the methods of 
assessment identified to public health and epidemiological research is 
inherently limited. Nonetheless, the review did identify a range of quality 
dimensions, such as accuracy and accessibility, which are applicable in the 
public health and epidemiology research domains. The challenge will be 
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defining these taking into consideration the intricacies of public health and 
epidemiological research especially at a low level. 
This systematic literature review identified a lack of structured 
methods to assess metadata quality within the context of public health and 
epidemiological research settings. The next step was to conduct a 
stakeholder survey to better understand the current role of metadata in public 
health and epidemiological research and which are the perceived challenges 
associated with the management of metadata. 
4.5.2 Online stakeholder survey  
Metadata types and formats: Most of the respondents who 
submitted data indicated that they used descriptive metadata. This outcome 
could potentially be a reflection of the respondents’ roles in public health and 
epidemiology research and by extension their daily routines. Given that most 
of the respondents were data users employed by a university, and that 
metadata often accompanies public health research datasets, this could be 
why descriptive metadata was the most popular whilst semantic was the 
least popular. Further to these findings, the framework was developed in 
such a way that it could potentially be applied by a range of stakeholders 
including data and metadata producers, data managers, archivists etc. For 
example, data managers and archivists could use the framework as a guide 
to ensuring minimum metadata quality standards have been met. This is 
because the framework is adequately detailed to facilitate a robust and 
systematic assessment of metadata quality; yet, sufficiently abstract to 
enable applications in multiple scenarios.  
Results also show that PDF was the most commonly handled format 
of the metadata whilst RDF was the least most commonly handled. PDFs are 
easily produced and managed, particularly when compared to the marking 
up resources using the RDF. This ease of use combined with the speed at 
which such documents may be produced and disseminated could be 
contributing factors to the popularity of this type of metadata. Furthermore, 
organisations such as the Health & Social Care Information Centre provide 
the metadata for HES data as PDF documents. Given the proclivity of 
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researchers to use these clinical data for research purposes, familiarity with 
this type of metadata is ameliorated. Nonetheless, PDFs are not machine 
readable so this poses a problem when trying to automate the process of 
ingesting these documents and automating their processing. 
In terms of informing the development of the model and framework, 
these findings can inform the framework’s structure. The framework needs to 
take into consideration that metadata can be presented in multiple formats, 
and the framework needs to enable the recording of each different instance.  
Research data lifecycle: The most commonly indicated stage was 
‘Access, use and reuse’ followed by ‘Analysis’. Regarding the granularity of 
the metadata, the most popular level was ‘Research study level’ followed by 
‘Variable level’. It is possible that given most of the respondents were data 
users and data providers, this could account for this result. The use of clinical 
data for research purposes to better inform the development of clinical policy 
and practice is commonplace in public health and epidemiological research. 
Such endeavours demand multidisciplinary teams to work even more closely 
to achieve research aims. It is possible that this continued need for data 
users capable of investigating big biomedical data coupled with the need for 
increased visibility of research data could have caused these survey 
outcomes.     
In terms of informing the framework, mechanisms to record the 
granularity of the metadata are required. Having metadata available at 
different various levels could potentially help to address issues relating to 
comprehensibility, and presence of different levels of metadata should be 
recorded as part of the quality assessment. Having this kind of information 
recorded is helpful as stakeholders across public health and epidemiological 
research could more easily identify the metadata most appropriate to their 
needs. Potential secondary users may request variable level metadata; 
whereas, a member of the public may request research study level 
metadata. Additionally, in having a record of which metadata are available 
and at which levels has the potential to support metadata quality comparison 
work across different instances of metadata. The aim of this work would not 
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be to ‘name and shame’ but to inform the development of quality 
benchmarks by which other metadata may be compared. This type of work 
does however raise problems relating to defining which are the acceptable 
levels of quality and how are these are measured. Defining these levels is 
made difficult by the subjectivity of such work; automatic methods of quality 
assessment will help to reduce any potential bias in the results of the quality 
assessment but again the same issue of defining what is good quality 
metadata arises. Therefore, the quality assessment framework will present 
scope for the addition of quantifiable metrics of quality, but not necessarily 
define these.  
Creating and/or using metadata in biomedical research: Results 
showed that the barriers can be categorised into six categories. This 
outcome could potentially be explained through a previous lack of focus on 
the importance of biomedical metadata possibility contributing to the 
subsequent lack in training and support. Knowledge of the role of metadata 
in the research data lifecycle is increasing as is familiarity with metadata 
standards. Funding agencies are increasingly calling for high quality 
metadata to accompany research datasets and, in certain circumstances, 
request metadata be available in standardised, public facing catalogues. 
Therefore, the framework needs to have some kind of mechanism which 
records the overall completeness as a preliminary measure of quality; if the 
metadata are incomplete, the first task stakeholders must address is to 
record the missing metadata before the rest of the metrics may be applied.   
Tools and technologies: In identifying how respondents chose a tool 
and/or technology provided a clearer understanding of which factors 
influence decisions made. Results show the most commonly indicated way of 
selecting a tool and/or technology was standard practice. This result is most 
likely due to stakeholders’ tendency to refer to best practice guidelines to 
inform the undertaking of research subsequently causing recommendations 
to gradually become standard practice. This is important to the development 
but more so the implementation of the model and framework as integrating 
Research case study 2: Improving metadata quality assessment in public health and epidemiological 
research 
 
169 
 
quality assessments of metadata in best practice guidelines and 
assessments becoming standard practice is a future goal of this work.  
Clinical terminologies and classification systems: Of those who 
provided data, the terminology most respondents had come across was ICD 
followed by MeSH. ICD was developed to be used as part of clinical coding 
for death certificates whilst clinical terminologies such as Read Codes and 
SNOMED CT were designed to encode information for clinical care. Both 
sources of data are routinely harnessed in public health and epidemiology for 
secondary use but the current proclivity to encode clinical information using 
ICD, could be a contributing factor to the results of the survey. Familiarity 
with MeSH could possibly be attributed to stakeholders’ use of databases 
such as PubMed which use MeSH terms for indexing purposes.  
Encoding standards, which standardise free text found in clinical 
documents using controlled clinical terminologies to systematically organise 
information and support knowledge management are used in clinical practice 
to primarily encode clinical information; and yet their use in clinical research 
is often to facilitate querying and clinical phenotyping using ontologies. Using 
SWTs in clinical research can potentially increase interoperability and 
extendibility of metadata in addition to enhancing research opportunities for 
the research data. In terms of informing development of the framework, 
scope must be included to record presence of encoding standards, how 
these were implemented and for which purpose(s). 
The participants were then asked to share any difficulties experienced 
with these clinical terminologies. Challenges included a lack of medical 
knowledge and the lack of ease of use. Given that medical knowledge is 
needed to better understand the encoding process, when querying for data 
using clinical codes, this can become difficult if there is a lack of medical 
knowledge. Often researchers work in multidisciplinary teams which include 
data users and clinicians to determine which codes are needed. And given 
that mostly data users responded, this could have caused this outcome. 
Furthermore, use of clinical terminologies is not mandatory in clinical 
research as it is in clinical practice, therefore, availability of clinical 
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terminologies will inevitably vary. This could also have been a contributing 
factor to the results of these survey questions.  
With regards to informing the framework, there needs to be 
mechanisms to firstly record any use of clinical terminologies; secondly – any 
issues such as lack of definitions which could impact subsequent use; and 
thirdly, a note describing which version of a clinical terminology was used. 
This is to help bring any (potential) secondary users to a greater 
understanding of how any clinical information was encoded.    
Catalogues: The issues associated with the use of metadata 
catalogues could possibly be attributed to the lack of academic incentives to 
use this kind of catalogue coupled with limited publicity of the existence of 
such platforms. Metadata catalogues serve as mechanism to enhance the 
discoverability of data and given recent motivation to adopt a cyclical 
approach to the use of data, being able to identify and characterise data 
without accessing the research data directly is potentially beneficial. 
However, catalogues are not extensively used in this way and in certain 
circumstances researchers continue to contact data managers to ascertain 
variable level information.  
In terms of informing development of the framework (Table 4-14), 
mechanisms to enhance discoverability need to be identified, and where 
possible, record the details of any metadata catalogues used for indexing.  
SWTs: These findings could be a reflection of the lack of awareness 
of the use of SWTs in public health and epidemiology research and the need 
for a greater understanding of the supporting technologies which help enable 
public health and epidemiology research.  
Metamodels: With regards to use of metamodels, 5 people said they 
used some kind of metamodel examples of which include HL7 and 
OpenEHR. Again, limited publication of metamodels could be attributed to a 
lack of awareness of mechanisms such as these and the critical role they 
play in enabling clinical research and practice.  
In terms of informing development of the framework, there needs to 
be a mechanism to record use of these technologies and the purpose. For 
Research case study 2: Improving metadata quality assessment in public health and epidemiological 
research 
 
171 
 
example HL7 is an exchange standard used primarily to facilitate the sending 
of encoded messages in secondary care. Recording use of HL7 or the 
underlying reference information model could enhance provision of 
contextual information and better support any subsequent analysis work. 
Recording the use of XML, to provide a machine-readable format of the 
metadata, could help to support stakeholders in identifying how interoperable 
the metadata are and identify any areas of potential improvement.      
Metadata usability: Given that metadata needs to be accessible to 
potential secondary users to enable them to characterise the research data, 
these results serve to emphasise the importance of the provision of properly 
indexed, usable metadata. For example, only listing variables is not entirely 
useful, information round how these variables were collected, when, why etc. 
is needed to provide the context around these variables and to enable these 
metadata to be useful; without these additional metadata the variable 
metadata is not as usable as it could be.  
However, there remains a tension between having enough metadata 
to characterise the dataset and the amount of resource required to generate 
the metadata (Ellul et al., 2013). Of those who submitted additional aspects 
of importance to metadata usability, suggestions included, but not limited to, 
multiple formats of the metadata and semantic mappings. As metadata 
standards such as DDI are being continuously developed, semantic 
mappings between the different schemas are needed to support 
interoperability.  
Therefore, the framework needs to enable the person assessing 
metadata quality to record use of metadata repositories, metadata standards, 
provision of human and machine readable versions of the metadata, and use 
of any crosswalks. Recording information such as this will help evaluate 
quality aspects such as accessibility, interoperability, meta-metadata and 
discoverability.          
Metadata quality assessment: A challenging aspect of quality 
assessment is being able to define the dimensions of quality at a low level. 
The definitions presented in the survey are generic and potentially applicable 
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across all aspects of public health and epidemiology research. However, the 
difficulty remains in being able to deliver pragmatic dimensions for the sub-
domains of research. For example, accuracy of metadata associated with 
EHRs may not necessarily be the same as for metadata associated with 
cohort studies; nor is the approach to quantifying accuracy and the 
mechanism through which it may be tested. In trying to provide low level 
definitions of the quality dimensions, context must be taken into 
consideration to help improve implementation of the quality framework.  
Therefore, the initial framework should serve a preliminary evaluation of 
quality and the catalyst for more in-depth analysis of the metadata handled. 
In terms of informing development of the framework and its subsequent 
evaluation, low level definitions will be suggested for case studies to evaluate 
how well the framework lends itself to expansion within different contexts.   
Based on the outcomes of the review, the framework needs to specify 
which aspects of quality are being assessed and have a way of recording the 
outcomes, and if necessary, steps to be taken if problems with the metadata 
are identified. This will also help to encourage the recording of meta-
metadata and improved management of the different versions of the 
metadata. Furthermore, when developing the framework for public health 
and epidemiology, some kind of mechanism enabling researchers to 
decompose the assessment into a series of smaller assessments is needed. 
The subsections could potentially be based on the different areas of 
metadata quality identified and used to structure the survey. In having a 
standardised approach to metadata quality assessment, this could potentially 
help improve stakeholders’ ability to compare across metadata instances 
through the standardised recording of the assessment outcomes.  
4.5.3 Framework 
The framework is based on all 10 identified quality dimensions in 
biomedical research but focus was placed on basing the questions on the top 
5 scoring quality dimensions as voted for in the survey. The top 5 were: 
accuracy, accessibility, discoverability, appropriateness and 
comprehensiveness. The following describes how these may be assessed: 
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Accuracy: stakeholders could establish how timely the metadata are 
and when the metadata were updated. It is also possible to look at any 
application of clinical terminologies, in particular looking at how these were 
applied and if any code listings have been provided.  
Stakeholders could determine if sufficient metadata have been 
provided or whether more is needed to better understanding of the research 
data and its context. Nevertheless, determining the level of sufficiency is 
challenging as this could vary depending on a person’s point of view – what 
is sufficient to one, may not be sufficient to another. In this case, the 
framework itself would not judge sufficiency, this would be determined by the 
user.  
Accessibility and discoverability: stakeholders could determine 
how well structured the metadata are and if they are available through a 
catalogue. Stakeholders are advised to establish whether encoding 
standards such as ICD, SNOMED CT etc. and/or exchange standards such 
as HL7, CDISC etc. have been utilised. It is also possible to assess how well 
knowledge has been managed through effective application of biomedical 
ontologies and whether these can be viewed possibly through an online 
portal such as The OBO Foundry, The Open Biological and Biomedical 
Ontologies. 
Appropriateness: stakeholders could determine whether necessary 
details have been provided to enable other stakeholders to understand and 
potentially reuse the research data. These details (under appropriateness) 
differ from sufficient (under accuracy) as the details provided could be 
accurate but inappropriate in the sense that they do not provide the 
information needed by the user – the metadata is accurate, but does not 
answer the user’s question.  
More specially, stakeholders are advised to determine how 
comprehensible the metadata are at different levels; for example, 
stakeholders could assess whether sufficient descriptions have been 
provided of variables to enable potential secondary researchers to 
characterize the dataset.  
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Comprehensiveness: this could be determined by establishing how 
encompassing the metadata are and if the metadata contain gaps. For 
example, stakeholders could assess whether details of changes made to a 
sweep of data have been communicated effectively.  
However, the difficulty remains in being able to deliver pragmatic 
dimensions for the sub-domains of epidemiological and public health 
research. For example, accuracy of metadata associated with electronic 
health records may not necessarily be defined in the same way as for 
metadata associated with cohort studies; nor is the approach to quantifying 
accuracy and the mechanism through which it may be tested. In trying to 
provide low level definitions of the quality dimensions, context must be taken 
into consideration to help improve implementation of the quality framework. 
4.5.4 Framework evaluation  
Metadata standards such as DDI are commonly applied to metadata 
indexed in repositories/catalogues. Though this is beneficial as the metadata 
elements are standardised, and there is scope to download the DDI 
compliant XML, this does emphasize the need for increased application of 
metadata standards across epidemiological and public health research 
regardless of whether metadata are indexed. However, this in itself presents 
challenges such as having access to the necessary resources and assigning 
responsibility for ongoing maintenance.  
Furthermore, for each test case, I was unable to find the method of 
application and reason(s) for use of Semantic Web Technologies; potentially 
as it does not seem commonplace to provide this kind of information. I had 
decided to include this section in the framework as I wanted to see if the 
method of application is linked in some way to the quality of the metadata. As 
stakeholders are able to customize the framework to suit local needs, I 
decided to keep this section as it is not a mandatory field in the assessment.  
A potential weakness of the framework is that given multiple research 
artefacts may need to be sourced before quality can be assessed, the 
question of how much metadata is needed is raised. Another potential 
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weakness of the framework is the lack of quantitative analysis; all 
assessments are manual/qualitative which are inherently subjective.  
4.6 Conclusions  
The use of epidemiological and public health data for research 
purposes to better inform the development of clinical policy and practice is 
critical in public health and epidemiological research. One of the main 
challenges in assessing quality in epidemiological and public health research 
is a lack of awareness of the issue of poor quality metadata and the potential 
implications this can have on research data discoverability. Improved 
awareness of the issue of metadata quality is needed, as are mechanisms to 
integrate metadata quality assessments into daily routines of stakeholders in 
epidemiological and public health research.  
A novel framework was created and evaluated as a platform-
independent method of assessing metadata quality, with the goal of 
improving metadata in epidemiological and public health research settings 
and enhancing the potential for data discovery and reuse in the context of 
epidemiological and public health research studies. 
My next steps include engaging with stakeholders to establish a set of 
requirements for a series of computational metrics. The short term goal is to 
identify a set of quantitative measures of quality to compliment the 
framework. The longer term goal is to use these metrics to increase 
objectivity and automate/quicken the overall assessment process. 
4.7 Summary of major findings 
4.7.1 Literature review 
A total of 11 publications were eligible for full review; none of which are 
aimed specifically for use in epidemiological and public health research 
settings. A total of nine different quality dimensions were also identified. The 
literature review highlighted the need to create a framework for 
epidemiological and public health metadata. 
 
Research case study 2: Improving metadata quality assessment in public health and epidemiological 
research 
 
176 
 
4.7.2 Online stakeholder survey 
Results showed that the most common type was administrative (31%) 
and the most popular format was PDF (23%). The least popular format was 
RDF with only 5%. Survey results show that most respondents used 
metadata during the ‘analysis’ stage of the RDL. The most popular level of 
metadata as indicated by the respondents was ‘research study level’ with 
28%.  
I identified the main barriers to creating and/or using metadata in 
biomedical research include: a) lack of skills/experience in generating/using 
metadata; b) inconsistencies (namely formatting metadata); c) inadequate 
tool availability; d) standards; e) ethics; and f) inadequate resources (time 
and cost).  
Results also showed the most common response indicated 
suggestions from colleagues determined how they selected tools and 
technologies. Survey results also show that ICD was the most popular 
statistical classification system followed by MeSH. Challenges associated 
with use of clinical terminologies can be categorised into: a) lack of medical 
knowledge impacting meaningful use; b) ease of use; and c) inconsistent 
availability. The results showed that ‘Accuracy’ was the most important 
quality of biomedical metadata. The least important was ‘meta-metadata’. 
Results show that 19 respondents sometimes assess the quality of metadata 
whilst eight respondents never do so.  
Furthermore, of the 28 respondents who submitted data, only one 
respondent indicated they used a quality assessment criterion. Moreover, 
challenges associated with assessing metadata quality in biomedical 
research include: a) lack of guidance and awareness of the metadata quality 
issue; b) lack of domain-specific knowledge negatively impacting on how well 
the metadata are understood; c) limited tools availability (supportive software 
and being able to access these); and d) limited resources (time). 
4.7.3 Model/framework and evaluation 
These models are: a) general information; b) tools and technologies; 
c) usability; and d) management and curation. These models underpin the 
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novel metadata quality assessment framework for use in epidemiological and 
public health research settings. The framework was validated and evaluated 
through iterative application to the metadata for a series of test cases and 
areas for improvement were identified; corrective action was taken to 
address these.  
4.8 Chapter summary 
This chapter focused on reviewing existing methods of metadata 
quality assessment, investigating the current state of the art in 
epidemiological and public health assessment role of metadata quality in 
public health and epidemiology research, and creating and evaluating a 
framework to assess metadata in public health and epidemiological research 
settings.  
This study involved a literature review which identified of 11 studies 
and nine dimensions of quality; none of which were aimed specifically at 
biomedical metadata. The online survey identified use of metadata across 
the research data lifecycle but quality assessment was conducted by most 
people only sometimes. The online survey also confirmed the lack of 
metadata quality assessment frameworks for use in public health and 
epidemiology and confirmed the need address the gap in metadata 
management.  
Based on the results of the literature review and online survey, a 
model of epidemiological and public health metadata was created. These 
were then validated and evaluated using a series of test cases and engaging 
with stakeholders. The framework can assist stakeholders in assessing 
epidemiological and public health metadata quality in a systematic and 
robust manner.   
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Chapter 5 Research case study 3: Improving the 
recording of consent for record linkage metadata 
in longitudinal studies 
5.1 Introduction  
In the previous two chapters I presented the data discoverability and 
metadata quality studies. Findings from both these studies have shown that 
having access to metadata is vital in enabling stakeholders to undertake 
record linkage research. Researchers are increasingly linking combinations 
of longitudinal cohort studies, genomic, and administrative datasets together 
to produce enriched datasets through their inherent complexity.  
The longevity of these data is such that it must be matched with 
consent models equally as enduring. However, developing these models is a 
challenging process hindered by a lack in standardised methods of recording 
them. There is guidance on the format and wording of consent but this 
guidance changes frequently and there is a lack of standardised methods to 
record this process(Friedlander, Loeben et al. 2011; National Research 
Ethics Service 2011). According to a study by Rothwell, Wong et al. (2014) 
there are currently no standardised formats to present the different elements 
of consent and there are additional problems such as a lack of recorded 
comprehension associated with the consenting process.  
Case study: Life Study 
Life Study was a birth cohort study based in the UK and aimed to follow 
80000 babies through to adulthood1. 
The Life Study website provides a list of downloadable resources 
for stakeholders to explore and use. The difficulty in using these however 
lies in their format – the resources are in PDF and there is currently no 
standardised method of recording these. Consequently, resources such as 
the consent form to access personal records remains in an unstandardised 
format. 
The aim of this research case study is to address this current lack 
of standardised methods of recording consent for record linkage by 
creating and evaluating a novel metadata management model. This model 
can be applied to consent forms from studies such as Life Study to record 
the elements of consent in a standardised way. 
1. http://www.lifestudy.ac.uk/  
Research case study 3: Improving the recording of consent for record linkage metadata in 
longitudinal studies 
 
179 
 
In this chapter I present the recording consent for record linkage 
study. In this study I created and evaluated a novel metadata management 
model to support improved recording of consent for record linkage in 
consented longitudinal studies. Please see 1.6.3 for a detailed description of 
my role, responsibilities and contributions to this study and the published 
report. 
5.2 Informed consent in epidemiological and public health research 
studies 
Informed consent is a fundamental aspect of the clinical research 
process and to enabling record sharing and linkage. Consent is required for 
data from different sources to be linked by researchers for epidemiological 
studies. When obtaining consent, an individual can consent or on behalf of 
another; for example, a legal guardian/parent consenting on behalf of an 
infant in a longitudinal study. In such studies, the extent to which a legal 
guardian/parent consents on behalf of a child lessens as the child matures 
and their autonomy increases (the extent of assent and dissent taken into 
consideration) (Hens, Van El et al. 2013). Researchers based in the UK, can 
request permission from the National Information Governance Board to 
suspend the requirement of consent(Knies, Burton et al. 2012). Section 251 
allows researchers to access data without consent under certain 
circumstances; for example, it being impractical to gain consent from 
potential research participants (NIGB 2013).  
The consent process can be modular in design enabling participants 
to partake in a study but opt-out of certain tests and/or analyses such as 
whole genome analysis (Buckow, Quade et al. 2014). Consent may be 
withdrawn at any point during a study and can occur on different levels such 
as: a) complete removal of consent – all data must be destroyed and its use 
discontinued; b) removal of consent for future contact  - allows continued use 
of pre-existing data and record linkage; and c) removal of consent for future 
contact and record linkage – allows continued use of pre-existing data only 
(Ries, LeGrandeur et al. 2010).  
Research case study 3: Improving the recording of consent for record linkage metadata in 
longitudinal studies 
 
180 
 
Consent for record sharing and record linkage is a multileveled 
process and all decisions made by potential participants must be well 
informed if stakeholders in research are to be entrusted with the participants’ 
records. Though use of linked health records enables researchers to yield a 
greater insight into life course influences, concerns over the security of these 
data and with whom the data is being shared, are raised. If potential 
participants fear their data will not be handled with diligence and respect, 
whilst acknowledging there is no such thing as guaranteed complete 
security, they may be discouraged from sharing their records for research 
use.  
5.2.1 Challenges associated with recording consent for record 
linkage  
When collecting research data as part of epidemiological and public 
health studies, researchers each have a unique way of managing the 
consent process. When linking different sources of data together, these 
different consent models must be harmonised before researchers can use 
these linked datasets. Harmonising the different approaches to consent, in 
addition to methods for archiving and preserving data, can help to stream 
line research processes at a national level (Singleton and Wadsworth 2006). 
By simplifying and standardising these approaches, there is the potential for 
researchers to better understand the extent to which consent has been given 
by participants and under which conditions.  
The provision of metadata can assist consent model harmonisation 
and the need for enhanced application of extended metadata standards is 
increasing (Pisani and AbouZahr 2010). Access to standardised, and where 
possible, automatically generated metadata can support stakeholders in 
characterising datasets and identifying the infrastructure needed to enable 
effective use of the research data. Examples of consent details include, 
information around which records could potentially be linked together e.g. 
health and education, the format of the consent form itself e.g. the contents 
of the form i.e. the questions, instructions and confirmatory statements, the 
logic, and how the consent may be obtained e.g. through face-to-face 
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interview or electronically through an online form.  Therefore, an increased 
investigation into the adoption of health information standards to facilitate 
enhanced use of big biomedical data for research purposes is needed and  
builds on recommendations which actively encourage the use of standards 
(Boulton, Campbell et al. 2012; MRC 2014). 
Currently, there is a gap in knowledge around the recording of 
consent for record linkage in longitudinal studies using information 
standards. There is guidance on the format and wording of consent but there 
is a lack of standardised methods to record this process (Friedlander, 
Loeben et al. 2011; National Research Ethics Service 2011). By having a 
standardised method of recording consent, stakeholders will potentially be 
better placed to compare across the different consent models and will also 
help to reduce ambiguities when trying to establish the extent to which 
consent has been given (Administrative Data Taskforce 2012).  
5.3 Study aim and objectives 
The aim of this work was to create and evaluate a novel method of 
recording consent for record linkage metadata applicable to longitudinal 
studies. This study had four objectives: a) systematically identify and review 
current methodologies for recording consent for record linkage using 
metadata elements in the context of bespoke investigator-led consented 
longitudinal studies; b) systematically identify and extract the key elements of 
consent for record linkage in longitudinal consented studies; c) critically 
evaluate DDI 3.2; and d) create and evaluate the metadata management 
model by iteratively applying it to a series of test cases. 
5.4 Ethics  
Ethical approval was not required.  
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5.5 Methods  
5.5.1 Literature review 
To perform the literature review in a methodical and thorough manner, I used 
the PRISMA checklist(Moher, Liberati et al. 2009) for guidance. This 
systematic literature review sought to answer the following questions: 
1. What developmental work has been undertaken on models to record 
consent forms for record linkage in longitudinal studies?  
2. What methods were used to develop the model? 
3. What evidence is available regarding the successes or failures of different 
approaches?  
4. Are there any best practices or guidelines available to assist with 
development?  
These questions were relevant to this research case study as the results 
informed the direction in which I took this work. By knowing what 
developmental work had already been undertaken, and the methods used, I 
was able to establish what had already been achieved and identified 
potential gaps in knowledge. Further, by gathering the evidence for the 
success and failures of the approaches and establishing best practices or 
guidelines, this information informed the methods used in designing and 
developing the metadata management model. 
5.5.1.1 Eligibility criteria 
To be included in the review, the literature had to be available in English and 
the full text available through open access sources or using institutional 
login. All forms of media were accepted and the latest date of publication 
was limited to January 2015.  
5.5.1.2 Information sources and search terms 
The review was conducted in January 2015. I used the following databases, 
PubMed, Ovid, Scopus, The Cochrane Library, JSTOR, ACM Digital Library, 
Lecture Notes in Computer Science, Web of Science, Inspec, Google, 
Google Scholar, Intute, and forward citation tracking(Kuper, Nicholson et al. 
2006). I used the following search terms: ‘consent forms’, ‘longitudinal 
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studies’, ‘record linkage’, ‘informed consent’ and ‘consent models’ with the 
Boolean logic ‘and’; ‘or’. 
5.5.1.3 Study selection 
When publications were identified, the citation information was downloaded 
into the reference management software EndNote. Using this software, 
duplicates were identified and removed.  
5.5.2 Qualitative analysis of consent forms: Metadata 
management model design and development 
I designed and developed the metadata management model in two 
steps. Firstly, I used 30 consent forms from nine longitudinal studies to 
inform the design and development of the model. (Table 5-1). The elements 
were grouped according to theme; these themes were collated inductively 
and iteratively. The four resulting themes were: a) people; b) consent form; c) 
personal records; and d) information document. I then combined the 
elements for each section and removed repeating elements to reduce 
redundancies in the model. I created the model using Unified Modelling 
Language. The Unified Modelling Language (UML) is an open modelling 
standard which helps users to model a domain and identify key processes 
and people (Brazma, Krestyaninova et al. 2006). UML is often used to 
develop object oriented models to support object oriented systems design 
and analysis. Object orientation is a technique used to decompose 
information, processes, attributes and behaviours into manageable subunits. 
These subunits are referred to as objects and each object has a unique 
name and can have variables (the attributes) and methods (the behaviours). 
When creating the metadata management models, I used the object oriented 
principle of inheritance. This involves a class, known as child or sub-class, 
obtaining variables and methods from another class, known as the parent or 
super-class. Inheritance of such methods and variables potentially increases 
efficiency as the risk of repetition is reduced.   
The studies selected to inform design and development of the model 
had to be investigator-led, longitudinal and consented, be population 
focused, and have a record linkage component. The studies were identified 
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through a combination of desk research and engaging with stakeholders. 
The studies were: Avon Longitudinal Study of Parents And Children 
(ALSPAC) (2016b), Born in Bradford (2016c), British Household Panel 
Surveys (2016d), Health Survey for England (Mindell, Biddulph et al. 2012), 
Life Study (2016l), Millennium Cohort Study (Connelly and Platt 2014), 
Scottish Health Surveys (Gray, Batty et al. 2010), UK Biobank (2016p)  and 
Understanding Society (2016q).  
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Table 5-1 Longitudinal, consented studies 
 
Study Years Coverage Participants Consent forms reviewed Record linkage 
ALSPAC 
Supplementary Figure 1 
 
1991-
on-
going 
Bristol 
and 
nearby 
areas 
14,062 
children, 
14,541 
mothers 
 
1. Project to Enhance ALSPAC through Record 
Linkage 
 Health 
 Education  
 Benefits and 
earnings 
 Police 
Born in Bradford 
Supplementary Figure 2 
2006-
2011 
Bradford 
13, 857 
children, 
12,453 
mothers 
1. Father’s consent form 
2. Mother’s consent form 
3. Born in Bradford Allergy and Infection Study – 
Mother’s consent form 
4. Mechanisms of the Development of Allergy – 
Mother’s consent form 
 
 Health 
British Household Panel 
Survey 
Supplementary Figure 3 
1991-
2009 
Britain 
10,300 
individuals 
1. Form B (all households with children aged 0 to 
15 years) - Adding information from 
administrative health records 
2. Form C (all adults aged 16-24) - Adding 
information from other sources 
3. Form D (all adults) - Adding information from 
mother sources 
4. Form E (all households with a child aged 3 to 
15 years) - Adding information from other 
sources 
 
 Health 
 Education 
 National Insurance 
contributions 
 Benefits and tax 
records 
 Saving and pensions 
Health Survey for 
England 
Supplementary Figure  4 
1991-
on-
going 
England 
4,000 
children, 
16,000 adults 
1. NHS Central Register and Cancer Register – 
(Adults 16+) 
2. Hospital Episode Statistics – (Adults 16+) 
 Health 
  
 
1
8
6
 
Study Years Coverage Participants Consent forms reviewed Record linkage 
Life Study 
Supplementary Figure  5 
2014-
2015  
UK 
Expected to 
have 80,000 
babies born 
between 
2014 and 
2018 
1. Consent form for partner at 28 week visit (MC) 
2. Consent form for pregnant mother at 28 week 
(MC) 
3. Consent form for record linkage at 4 months 
(child) 
4. Consent form for child at 4 month visit (NC) 
5. Consent form for child at 4 month visit (MC) 
6. Consent form for partner at 4 month visit (NC) 
7. Consent form for mother at 4 month visit (NC) 
8. Consent form for record linkage at first 
visit/contact (father/partner) 
9. Consent form for record linkage at first 
visit/contact (mother) 
 Health 
 Education 
 Mobile phones (to 
establish how often 
calls are made) 
 Economic 
 Fertility (only if 
consent is 
specifically given) 
 Potentially records 
held by the 
Department for Work 
and Pensions 
Millennium Cohort Study 
Supplementary Figure  6 
2000-
on-
going 
UK 
19,519 
children, 
19,244 
families 
1. Age 7 Survey – Information from other 
sources 
 Health 
 Education 
Scottish Health Surveys 
Supplementary Figure  7 
1995, 
1998, 
2003, 
2008-
2015 
Scotland 
Approximatel
y 2,000 
children, 
6,5000 adults 
from 4,500 
households 
1. Scottish Health Records – (Adults 16+) 
2. Scottish Health Records – (Children 0-15) 
3. Scottish Government Follow-up Research – 
(Adults 16+) 
4. Scottish Government Follow-up Research – 
(Children 0-15) 
 Health 
UK Biobank 
Supplementary Figure  8 
2006-
2010 
UK 503,316 
1. Consent Form: UK Biobank  Health 
Understanding Society 
Supplementary Figure  9 
2009 UK 
40,000 
households 
1. Form A: Adding information from 
administrative health records – adults (16+) 
2. Form B: Adding information from 
administrative health records – children (0-
15yrs) 
 Health 
 Education 
 Economic 
circumstances 
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Study Years Coverage Participants Consent forms reviewed Record linkage 
3. Form C: Adding information from 
administrative education records – adults (16-
24) 
4. Form D: Adding information from 
administrative education records – children (4-
15yrs) 
 Transport 
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5.5.3 DDI3.2 critical evaluation 
Secondly, I critically evaluated the Data Documentation Initiative 3.2 
(DDI 3.2) – the prevailing existing metadata standard - to determine its 
applicability to epidemiological and public health research settings. More 
specifically, I investigated the extent to which consent for record linkage in 
longitudinal study elements can be recorded using DDI 3.2.  
I critically evaluated DDI3.2 by systematically mapping manually, the 
elements in DDI 3.2 to the consent elements previously identified. By 
creating these mappings, I was able to determine whether a direct link could 
be made between consent elements and DDI3.2 elements; or, if a related 
element in DDI3.2 could be used, potentially in conjunction with the ‘Note’ 
element, to record the consent element. This critical appraisal also enabled 
me to determine which consent elements could not be recorded using DDI 
3.2 thus identifying insufficiencies in the metadata standard and where 
potential extensions are needed to create low level descriptions.  
5.5.4 Metadata management model evaluation  
I evaluated the metadata management model by iteratively applying it 
to the metadata from three consent forms as test cases making any 
necessary changes for improvement after each application. The first test 
case was, the English Longitudinal Study of Ageing (ELSA) (Steptoe, Breeze 
et al. 2013). The consent form was taken from wave six and is entitled, ‘HES 
and DWP consent form’. The second was the Canadian Longitudinal Study 
of Aging, Étude longitudinale canadienne sur le vieillissement (CLSA) study. 
The consent form the CLSA study is the ‘Consent form – Home Interview & 
data Collection Site Visit’. The consent form requests consent to access and 
link to health data. The third test case was, Growing Up in Australia: The 
Longitudinal Study of Australian Children (LSAC). The consent form selected 
from LSAC is the ‘Adolescent study participant form’ taken from wave seven. 
This consent form requests access to health records and pharmaceutical 
benefits information. In adopting this approach to model evaluation, I was 
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able to determine how fit for purpose the model was and which are its 
strengths and weaknesses. 
5.6 Results 
5.6.1 Literature review 
5.6.1.1 Study selection  
A total of 61 manuscripts were identified and reviewed, Figure 5-1.  
 
 
 
 
 
 
 
  
Figure 5-1 PRISMA flow diagram 
Records identified 
through database 
searching 
N= 769 
Records screened 
N= 704 
Records excluded 
N= 68 
Records after duplicates removed 
N= 117 
Full-text assessed for eligibility 
N= 636 
Full-text articles 
excluded as not 
relevant 
N= 575 
Studies included in qualitative 
synthesis 
N= 61 
Additional records identified 
through other sources 
N= 52 
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5.6.1.2 Synthesis of results 
I synthesised the results by identifying the primary theme of the manuscript 
and categorised it accordingly. Seven themes were collected inductively and 
iteratively: a) analysis - to either improve or establish knowledge; b) 
comparison of models – comparison of different types of consent; c) consent 
aspects of secondary uses of data: discussion of consent in the research 
context; d) development of tools to assist consent process - development of 
methods to assist with management; e) discussion of a single model - 
discussion of a single method of requesting consent; f) establishing and/or 
improving participant understanding - development and/or discussion of 
methods/tools to better patients’ understanding; g) development of a new 
model/form and h) other. 
Table 5-2 Manuscripts fully read and categorised according to theme 
Theme Percentage 
Analysis 20% 
Comparison of models 25% 
Consent aspects of secondary uses of data 3% 
Development of a new model of consent/form 8% 
Development of tools to assist consent process 3% 
Discussion of a single model 7% 
Establishing and/or improving participant understanding 14% 
Other  20% 
5.6.2 Metadata management model design and development 
Having reviewed the literature, I then qualitatively analysed the consent 
forms, Table 5-1. Results of these analyses identified four main groups of 
metadata elements:  
a) people – those involved in the consent process 
b) consent form – the composition of the consent form  
c) personal records – potential sources of personal data e.g. health, 
education etc.  
d) information document – additional informational documents 
accompanying the consent forms.  
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The following tables present the metadata elements for each of the nine 
longitudinal studies Supplementary Table 15 – 22. The following sections 
describe the four main groups of metadata elements: 
5.6.2.1 People  
The first section refers to all those involved in the consent process. 
Following the analyses, common demographic details included: full name, 
dates and signatures of those consenting, statement of whether consent was 
on behalf of a child, confirmation of understanding and details of how to 
withdraw consent. The persons most commonly involved in the consent 
process is the person consenting (interviewee), and in certain situations, the 
person for whom consent is given if this is different from the interviewee. 
Others included the interviewer or staff member, as referred to in UK 
Biobank, teacher in the MCS, and GP in Life Study.  
For the ALSPAC and UK Biobank studies, consent could not be given 
on behalf of another. Whereas, in certain consent forms for, BHPS, MCS, 
Scottish Health Survey, Understanding Society, Born in Bradford, and Life 
Study, a parent/guardian could consent on behalf of a child or children. It 
was also noted that the consent form completed by (potential) participants 
sometimes depended on age and/or relationship to the person for whom 
consent is given. This was reflected in the consent forms available for the 
BHPS, Health Survey for England, Scottish Health Survey, MCS and 
Understanding Society - the consent form completed depended on age. For 
Life Study, the consent form completed depended on relationship and stage 
of pregnancy/number of months post birth. A combined set of elements can 
be found in Table 5-3. 
. 
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Table 5-3 Combined elements for persons identified 
People 
Persons Demographics 
 Person giving consent 
o Individual consenting for 
themselves 
o Parent/guardian on behalf of a 
child 
 Details 
o Date 
o Location 
 Interviewer 
o Name 
 Forename  
 Surname  
 Witnesses  
o Name 
 Forename 
 Surname 
 Identifiers 
o NHS number 
o Passport number 
o Other    
 
 Name 
o Forename 
o Surname 
 Birth details 
o Date  
o Location  
 Address 
 Ethnicity 
 Nationality  
 Disability  
 Contact details 
 Next of kin  
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5.6.2.2 Consent form 
The second section, consent form, focuses on recording the composition of 
the consent form. Following the analyses, the consent forms all followed a 
similar basic pattern in terms of structure. Each had the consent 
questions/statements and then confirmation of consent through the signing, 
dating and printing of name on the form. Each of the consent forms followed 
a particular logic and specified to which organisations they were associated. 
Furthermore, studies such as Understanding Society and BHPS provided full 
contact details; whilst Life Study specified data holders e.g. the English 
Department for Children, Schools and Families. The consent form for UK 
Biobank however, does not specify from where the health records could be 
obtained. Other studies provided details of which data may be accessed e.g. 
health records (Born in Bradford/Scottish Health Survey/Health Survey for 
England), health and education (Understanding Society/MCS/ALSPAC) and 
economic, education and health (BHPS). The combined elements can be 
found in Table 5-4. 
Table 5-4 Combined consent form elements 
Consent form 
General Consent statements/questions 
 Description/aims 
 Undertakings 
o Declaration 
o Rights of 
participants 
 Organisations/ Data 
providers 
o Funding agencies 
o Universities 
o Government 
departments 
o Archive 
 Confirmatory information 
o Confirmation of 
understanding 
o Signature 
o Date 
o Full name 
 Method of collection 
o Computer assisted personal 
interviews (CAPI) 
o Computer assisted self-
interviewing (CASI) 
 Questions/consent statements 
o Logic 
o Purpose 
o Potential Reponses 
o Codes and categories 
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5.6.2.3 Personal records 
The third section, personal records, refers to the records of individuals 
consent may be given for sharing and/or linkage purposes. I found that the 
most common type of record to link to was health where consent was 
requested across the three sectors of care; the least common type was 
mobile phone record. It was also noted that the only study to request police 
records was ALSPAC. Regarding the education records, the combined 
elements included all three education sectors and their associated data 
providers such as the Department of Education. The organisation most 
commonly cited as a potential provider of data was the NHS.  
Studies which requested access and use of educational records 
included: ALSPAC, BHPS, MCS, Understanding Society and Life Study. 
Access and use of economic records was only requested in the Life Study, 
BHPS and ALSPAC studies. Request was made to access data on, for 
example, National Insurance contributions and participation in any benefits 
programmes. The combined elements can be found in Table 5-5 
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Table 5-5 Combined elements for personal records 
Personal records 
Health Education Economic Criminal Mobile 
 Organisation 
o National Health Service 
 The NHS 
Information Centre 
 NHS Central 
Registrar  
o Department of Health 
o General Registration 
Office 
o Office for National 
Statistics 
 Healthcare professional 
o Primary care 
 GP 
o Secondary care 
o Tertiary care  
 Clinical Terminologies  
o ICD-10 
o ICD for Oncology  
o SNOMED-CT 
o Read Codes 
o DSM 
o OPCS  
 Type 
o School records 
o Further education 
o Higher education  
 Organisations/Data providers 
o Department of Education 
o The Data Service 
o Department for Business, 
Innovation and Skills  
o Universities and Colleges 
Admission Service 
(UCAS) 
o Higher Education 
Statistics Agency 
o Department for Children, 
Schools and families 
o Department for Children, 
Education, Lifelong 
Learning, and Skills 
o Government Education 
Directorate 
o Department of 
Education/Education and 
 Organisations 
o Department 
for Work and 
Pensions 
o HM Revenue 
and Customs 
 Records    
o Salary 
o National 
insurance 
contributions 
o Tax  
o Savings 
o Benefits 
o Pensions  
 
 Organisations 
o Ministry of 
Justice 
 Records  
o Official 
cautions 
o Convictions  
 
 Past 
 Current 
 Future 
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Personal records 
Health Education Economic Criminal Mobile 
 Treatments and management 
of conditions 
o Current 
 Health treatment 
 Use of health services  
o Previous  
 Health treatment 
 Use of health services  
 Samples provided 
o Method 
 Invasive 
 Non-invasive  
o Type  
 Blood 
 Urine 
 Hair  
 Saliva  
o Storage of samples  
 Rights  
 Benefits and 
compensation  
o Tests and assessments 
 Rights to results  
 Length of test 
Skills Authority 
o Educators  
 Name 
 Associated 
school/college/u
niversity  
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Personal records 
Health Education Economic Criminal Mobile 
 Location  
 Follow-up on health 
registration 
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5.6.2.4 Information document 
The final part of the model, information document, refers to the 
additional informational material which may accompany the consent 
form. Results of the analyses show that topics discussed included 
more information on the study and details regarding the withdrawal of 
consent. In the ALSPAC study for example, the accompanying 
information describes how data linkage works and how enduring the 
consent given is until withdrawn. The ALSPAC study is the only study 
to provide case studies of where record linkage has been used in the 
past e.g. I4C – researching childhood cancer. Results of the 
analyses also showed that in the ALSPAC and Life Study 
informational booklets, the benefits of participating in the study are 
outlined.  
Furthermore, results of the analyses showed that in the BHPS, 
Scottish Health Survey, UK Biobank, Understanding Society and Life 
Study booklets, a description is provided of who may use your data. 
It was in the Life Study, Understanding Society, Born in Bradford and 
BHPS that data security/confidentiality are discussed.  
Additionally, results of the analyses showed that there were 
different types of material available e.g. booklets, leaflets etc.; 
following the analysis, leaflets were identified for MCS and 
Understanding Society only. In the MCS, the first informational leaflet 
describes where data may be obtained whereas the second 
describes the study itself and the role of the child. In the 
Understanding Society study, one leaflet provided information on 
adding administrative health records and the other adding education 
records. The combined elements can be found in Table 5-6. 
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Table 5-6 Combined accompanying information booklet elements 
Information document 
General information Participation Record linkage 
 Study 
o Aims 
o Objectives 
o Funding bodies 
o Reviewers 
o Contact details 
 Confidentiality and security 
o Safeguards in place to 
protect participant 
confidentiality and data 
security 
 
 Invitation process 
 Benefits and risks 
o Immediate  
o Future  
 Consent process 
o Coverage  
o Length of time 
o Withdrawal 
 Levels of withdrawal 
 Visits 
o Prior 
 Preparation  
o During 
 Biological samples 
 Specify which ones 
 How will these be taken 
 Who will the samples be 
taken from 
 Questionnaires to complete 
o Post 
 Obtaining certain results  
 Other people 
o GP 
o School teachers 
 Expenses  
o travel 
 Definition 
 How is it achieved 
 Case studies/examples 
 
 Data 
o Which 
records/registries will 
be linked to 
o How will the data be 
accessed 
 
 Subsequent research 
o Who will have access to the 
data 
o Getting to know results 
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5.6.2.5 Metadata management models 
Having analysed each group of metadata elements, Table 5-7 shows 
these combined together. Based on this table, I then created five metadata 
management models using the information I had abstracted during the 
qualitative analyses. The models were created using a combination of 
conceptual modelling and object oriented techniques.  
Figure 5-2 to Figure 5-5 Proposed person metadata management 
model present the four components of the metadata management model; the 
fifth - In Figure 5-6 I present a HTML report displaying a series of consent 
classes based on the elements from Table 5-7. 
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Table 5-7 Combined metadata elements of consent for record linkage in longitudinal studies 
Personal records People Consent form  Information document 
Health 
 Organisation 
o National Health Service 
 The NHS Information Centre 
 NHS Central Registrar  
o Department of Health 
o General Registration Office 
o Office for National Statistics 
 Healthcare professional 
o Primary care 
 GP 
o Secondary care 
o Tertiary care  
 Clinical  
o Terminologies  
 ICD-10 
 ICD for Oncology  
 SNOMED-CT 
 Read Codes 
 DSM 
 OPCS  
 Treatments and management of 
conditions 
o Current 
 Health treatment 
 Use of health services  
o Previous  
 Health treatment 
 Identifiers 
o NHS number 
o Passport number 
o other   
 Interviewee  
o Name  
 Forename 
 Surname 
o Address 
o Birth details 
 Date  
 Location  
o Ethnicity 
o Nationality  
o Disability  
o Contact details 
o Next of kin  
o Family 
 Partner  
 Dependents  
 Participant 
o Individual consenting for 
themselves 
o Parent/guardian on 
behalf of a child 
 Persons present 
o Date 
o Location 
 Description/aims 
 Method of collection 
o CAPI 
o CASI 
 Undertakings 
o Declaration 
o Rights of 
participants 
 Organisations 
o Funding 
agencies 
o Universities 
o Governments 
o Archive 
 Questions/consent 
statements 
o Logic 
o Purpose 
o Potential 
Reponses 
o Codes and 
categories 
 Confirmatory 
information 
o Confirmation of 
understanding 
o Signature 
o Date 
 Study 
o Aims 
o Objectives 
o Funding bodies 
o Reviewers 
o Contact details 
 Participation 
o Invitation process 
o Benefits and risks 
 Immediate  
 Future  
o Consent process 
 Coverage  
 Length of time 
 Withdrawal 
 Levels of 
withdrawal 
o Visits 
 Prior 
 Preparation  
 During 
 Biological samples 
o Specify which 
ones 
o How will these 
be taken 
o Who will the 
samples be 
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Personal records People Consent form  Information document 
 Use of health services  
o Samples provided 
 Method 
 Invasive 
 Non-invasive  
 Type  
 Blood 
 Urine 
 Hair  
 Saliva  
 Storage of samples  
 Rights  
 Benefits and compensation  
o Tests and assessments 
 Rights to results  
 Length of test 
 Location  
 Follow-up on health registration 
 
Education  
 Type 
o School records 
o Further education 
o Higher education  
 Provider  
o Organisation 
 Department of Education 
 The Data Service 
 Department for Business, 
 Interviewer 
o Name 
 Forename  
 Surname  
 Witnesses  
o Name 
 Forename 
 Surname 
 
o Full name 
 
taken from 
 Questionnaires to 
complete 
 Post 
 Obtaining certain 
results  
o Other people 
 GP 
 School teachers 
o Expenses  
 travel 
 Record linkage 
o Definition 
o How is it achieved 
o Case studies/examples 
o Data 
 Which 
records/registries will 
be linked to 
 How will the data be 
accessed 
 Subsequent research 
o Who will have access to the 
data 
o Getting to know results 
 Confidentiality and security 
o What safeguards are in 
place to protect participant 
confidentiality and data 
security 
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Personal records People Consent form  Information document 
Innovation and Skills  
 Universities and Colleges 
Admission Service (UCAS) 
 Higher Education Statistics 
Agency 
 Department for Children, 
Schools and families 
 Department for Children, 
Education, Lifelong Learning, 
and Skills 
 Government Education 
Directorate 
 Department of 
Education/Education and 
Skills Authority 
 Location  
o Educators  
 Name 
 Associated 
school/college/university  
Criminal  
 Organisations 
o Ministry of Justice 
 Records  
o Official cautions 
o Convictions  
Work and employment 
 Organisations 
o Department for Work and Pensions 
o HM Revenue and Customs 
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Personal records People Consent form  Information document 
 Records    
o Salary 
o National insurance contributions 
o Tax  
o Savings 
o Benefits 
o Pensions  
 
Mobile 
 Past 
 Current 
 Future  
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  Figure 5-2 Proposed information document metadata management model 
Physical
+Name of activities
Computer-based
+Log in ID
Activities
+Description of activies
During
Samples
+Healthcare professional
+Method
+Type
Questionnaires
+Questionaire ID
Visits to assessment centres
+Name of centre
+Location
Post
Prior
Reimbursement
+Total
+Receipiant
Participant information document
Consent process
+Type of consent
Extent of consent
+Consent statement
Research
+Accessing data
+Knowing results
Study
+Aims
+Contact details
+Funding bodies
+Objectives
+Reviewers
Confidentiality and security
+Security risks
+Confidentiality statement
General
+Accessibility
+Type of information document
Participation process
+Description
Risks and benefits
Immediate
+Risks
Future
+Future risks
Invitation process
+Date of invitation
Record linkages
+Definition
+List of potential records
+Process
  
 
2
0
6
 
  Figure 5-3 Proposed consent form metadata management model 
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Figure 5-4 Proposed records metadata management model 
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Figure 5-5 Proposed person metadata management model 
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Figure 5-6 HTML report based on combined metadata management model 
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5.6.3 DDI 3.2 critical evaluation  
I mapped the consent metadata elements to the Data Documentation 
Initiative 3.2 (DDI 3.2) elements to determine the extent to which consent for 
record linkage in longitudinal studies may be recorded using the prevailing 
existing metadata standard. The evaluation had four components: a) 
personal records; b) people; c) consent form; and d) information document. 
The cross-walks test how well consent metadata elements identified in Table 
5-7 can be mapped directly to elements in DDI 3.2.  
5.6.3.1 People 
Results of the first mapping analysis (Supplementary Table 24) 
showed that general metadata elements such as full name, location and 
nationality can be mapped directly to DDI 3.2 using the ‘FullName’, 
‘LocationName’ and ‘Country’ elements respectively. It was also possible to 
map to DDI 3.2 directly for other elements such as contact details 
(‘TelephoneNumber’ and ‘Email’) and date (‘Date’). By using these elements 
in DDI 3.2, in addition to others, descriptions of the people involved in the 
consenting process can be created relatively quickly.  
However, a fundamental aspect of consenting process associated 
with longitudinal studies is the possibility for the interviewee to consent on 
behalf of another person; for example, a mother consenting on behalf of her 
infant. Recording this information in DDI 3.2 is a more complex process; I 
was unable to locate an element designated to recording this information. 
DDI 3.2 does not contain an element to record this kind of information.  
Currently, stakeholders could use the ‘Note’ element along with another 
object to record this information. Though this solution works in the short term, 
as the infant matures, and they become more able to assent/dissent, DDI 3.2 
lacks the necessary mechanisms to record this metadata. Therefore, 
additional elements (e.g.for whom consent is given) are needed in DDI to 
enable the recording of these critical pieces of metadata.  
5.6.3.2 Consent form 
Results of the second mapping analysis (Supplementary Table 25) 
focused on identifying and mapping to DDI 3.2 elements to record the 
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consent form’s composition. This process was fairly straightforward and the 
majority of elements could be mapped directly. This is because DDI 3.2 is 
designed to capture survey instruments and this is what a consent form 
essentially is. In places, text can be recorded using ‘ResponseText’; or 
stakeholders could select a response from a predetermined, named list and 
use a combination of, 'CodeList', 'CodeListName' and 'CodeListReference' 
DDI elements.  
Nevertheless, DDI 3.2 again lacks the elements needed to record 
details specific to consent to record linkage in longitudinal studies. For 
example, 'Undertakings' and 'Confirmatory information' could not be mapped 
directly to a DDI 3.2 element. Instead, stakeholders may use ‘Note’ element 
to hold the necessary information which can then be attached to another 
maintainable object. It is in these areas in particular that the standard fails to 
provide the necessary mechanisms to record consent for record linkage 
using metadata elements effectively. Therefore, extensions are needed to 
the DDI 3.2 standard to enable to the recording of the different aspects of 
consent forms for record linkage. 
5.6.3.3 Personal records 
Results of the third mapping analysis (Supplementary Table 26) 
indicated that a number of different elements associated with personal 
records can be recorded using DDI 3.2. For example, I could group together 
organizations and assign a group name. Here, the element ‘CodeListGroup’ 
can be used to specify the name of the group; while ‘CodeList’ will enable 
stakeholders to record the possible codes such as ICD-10. The DDI has 
built-in mechanisms to successfully record code lists and categories so the 
process of providing links between these elements was relatively 
straightforward. Other areas in which the DDI provided the necessary 
mechanisms to map directly included location - ‘LocationName’.  
However, results of this cross-walk analysis demonstrated that a 
direct link from elements associated with, ‘Treatments and management of 
conditions’ and 'Tests and assessments' to DDI 3.2 was not possible. Having 
access to this kind of metadata in a standardised and simplified format is key 
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to supporting stakeholders in determining use of health services (part of 
current treatment and management of conditions) and rights to results (part 
of tests and assessments). This lack of opportunity for mapping between the 
two could be because this level of functionality has not been previously 
needed in DDI and so does not contain mechanisms to record this metadata.  
5.6.3.4 Informational document  
Results of the last mapping analysis (Supplementary Table 27) 
indicated that DDI 3.2 can successfully record the study and its objectives 
can be mapped directly using the ‘Citation’ element. Other elements such as 
funding bodies can also be mapped directly using the, ‘FundingInformation’ 
element. Another advantage of using DDI 3.2 is that lifecycle events, such as 
a participant withdrawing their consent can be recorded, and mapped with 
relative ease. Here, a combination of ‘EventType’ and ‘LifecycleEvent’ would 
enable stakeholders to record this information in a clear and standardised 
manner. This is very important as the boundaries of consent have a direct 
impact on researchers wanting to use certain research data. DDI 3.2 also 
enables stakeholders to create multiple lifecycle events. This can be used to 
the stakeholders’ advantage as they can record any additional relevant 
events in a systematic and robust manner.  
Although, stakeholders are again restricted in recording details 
specific to consent for record linkage. For example, there are no elements in 
DDI 3.2 which can be mapped directly enabling the recording and use of 
biological samples and how these will be taken. Being able to record, and 
have access to, this kind of metadata is important to informing potential 
secondary users of which biological samples could be used as part of their 
further analyses of the research data. Furthermore, having access to this 
kind of metadata can also help other stakeholders, such as potential 
participants understand what could be requested of them should they 
partake in the study. This metadata is critical to informing these and other 
stakeholders and ensuring potential participants are even more informed 
prior to engaging with the study. 
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5.6.4 Evaluation of consent for record linkage metadata management 
model  
5.6.4.1 Person 
I applied the model to the first test case, ELSA, and found that the 
model provided the metadata elements needed to record information about 
the interviewee and the interviewer. However, the model lacks elements to 
record when the consent form was completed; this indicated that the model 
needed revising to enable recording of this information. In terms of recording 
confirmation of understanding, I was able to use the ‘Confirmation of 
understanding’ attribute as part of the ‘Person’ element. This is a key aspect 
of the model as the need for a standardized approach to recording this kind 
of information is needed and this section of the model address this current 
unmet need. I then applied the model to the second test case, CLSA. I found 
that the metadata relating to the people involved could be recorded using the 
‘Person’ element and the child elements, ‘Non-professional’ and 
‘Professional’. In having two separate child elements, I was able to reduce 
the number of repeating attributes in the model through use of inheritance; 
whilst, enabling ourselves to distinguish between the different types of 
people involved in the consenting process – ‘professional’ e.g. principal 
investigator and ‘non-professional’ e.g. interviewee. Following application of 
the model to the second test case, I decided to create a new element, ‘date 
of completion’, and that this should be moved, and joined to, the ‘consent 
form’ element. In doing so, I was able to group together all the elements 
relating to the consent form itself to help users better navigate through the 
model. The final test case used to evaluate the model was the LSAC study. 
Having iteratively applied the model to the previous test cases and made 
changes, I was able to record information such as ‘confirmation of 
understanding’ successfully. 
5.6.4.2 Consent form 
I firstly applied the model to ELSA to evaluate how well our model 
could record information relating to the consent form’s composition. I found 
that use of elements such as ‘Academic institution’ enabled us to record 
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detailed information, particularly since this element inherits the ‘Ethics 
approval reference’ and ‘Organization name’ attributes from the 
‘Organization’ element. In using object-oriented modelling techniques, I was 
able to harness the advantages using a typically computer science technique 
can bring to life sciences research. Following this initial test, I identified areas 
for improvement. For example, the ELSA consent form contains a set of 
instructions detailing what to do with the completed form - one copy is 
retained by the participant and the other is returned to the office. The model 
does not contain an element to record this information and so an additional 
element was needed. I altered our model accordingly, by adding ‘Instructions 
for next steps’, and applied the revised version to the second test case. 
Results of the second test, using the CLSA consent form, showed us that by 
adding the new element, I was then able to record more detailed information 
about this aspect of the consent process. Results of the second test also 
demonstrated that by harnessing the element such as ‘Questions’, as 
composed of ‘Logic’, ‘Responses’, ‘Purpose’, forming a part of the ‘Data 
collection’, I was able to record the questions and question logic of the 
consent form in detail. This is important as being able to identify and record 
the minutia around this aspect of the consent process can potentially give 
stakeholders greater support in determining the scope of consent. The model 
was then reapplied to the final test case, LSAC. Here I was able to test how 
well the model could, for example, record introductory information. Recording 
this information involved use of the ‘Aim’ and ‘Undertakings’ elements which 
are a part of the ‘General’ elements. The next step was to test the records 
component of the model. 
5.6.4.3 Personal records 
The model contains six different types of personal record: ‘Economic’, 
‘Education’, ‘Legal’, ‘Family’, ‘Mobile phone Usage’, and ‘Health’. I applied 
the model to the first test case, ELSA, and found I was able to record 
previous hospital visits and treatments through the ‘Health’ element and one 
of its child elements, ‘Past’. In having a child element ‘Past’, in addition to 
two others, ‘Present’ and ‘Future’ I was able distinguish between these 
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different events. In terms of recording economic information for example, I 
used the ‘Economic’ elements with attributes: ‘Benefits claims’, ‘NI 
contributions’ and ‘Tax’. However, to enhance the model further, I converted 
these attributes into separate elements which, when combined, create the 
‘Economic’ element. I made this change to simplify the recording of this kind 
of information; in terms of cardinality, there would be no restrictions on the 
number of times elements can be used. I then applied the model to the 
second test case and were able to record health related information using 
the existing ‘Health’ element’. For the third test case, the LSAC study, I again 
used the ‘Health’ element but also used the ‘Persons’ element in addition to 
sufficiently record this information.  Results of these tests demonstrate that 
the model can record information about consent to use of personal records in 
longitudinal studies. 
5.6.4.4 Informational document 
The last section of the model I evaluated was information document. 
Results of the application to the ELSA study consent form demonstrated that 
to record different kinds of informational documents, the parent element, 
‘Participant Information document’ and the child element ‘General’ needed to 
be combined to form a new element, ‘Informational document’ with 
‘accessibility’, ‘audience’, and ‘type as attributes’. This enabled the recording 
of, and differentiation between, the different types of informational document. 
However, I was not able to locate additional informational material online for 
ELSA; I also experienced this problem for the CLSA study. Therefore, I 
decided to proceed to the third test case, LSAC, to continue testing this 
aspect of the model. During the final test, I was able to use the newly 
created, ‘Informational document’ to specify the document type – in this case 
it was the corresponding information sheet. In making this change to the 
model, I reduced the total number of elements whilst increasing scope to 
record metadata relating to the different kinds of informational document. 
This is an advantage of using a formalized modelling technique as changes 
were made quickly without impacting the rest of the model. I then recorded 
Research case study 3: Improving the recording of consent for record linkage metadata in 
longitudinal studies 
216 
 
the description of the study using  the ‘Study’ element with attributes, ‘Aims’, 
‘Contact details’, ‘Funding bodies’, ‘Objectives’ and ‘Reviewers’.  
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Figure 5-7 Evaluated metadata management model for records  
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Figure 5-8 Evaluated metadata management model for person  
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Figure 5-9 Evaluated metadata management model for consent form  
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Figure 5-10 Evaluated metadata management model for information document 
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5.7 Discussion 
5.7.1 Literature review 
A total of 61 manuscripts were identified and reviewed but none were 
identified focusing on the development of models to record consent for 
record linkage in longitudinal studies. The literature review suggested that 
research into the development of these models is limited.   
Following the review I was able to begin gathering requirements for 
the metadata management models. The literature I identified provided the 
contextual information needed to better my understanding of the overall 
consent process. Findings from the literature review demonstrated the need 
for the development of metadata management models to facilitate the 
standardised capture of consent metadata elements.  
The strength of the literature review lies in the way it was 
systematically conducted using the PRISMA checklist. Both computer 
science and biomedical databases were used to increase the potential for 
sourcing literature for review. A potential weakness in the literature review 
however lies in the combination of search terms. The terms used were 
specific to public health and epidemiological research and not readily used in 
other domains such as computer science. Therefore, possible differences in 
use of controlled vocabularies may have resulted in literature being missed.  
The next step was to create and evaluate a novel model that uses 
metadata elements to record this kind of information. 
5.7.2 Metadata model design and development 
Following analysis of the consent forms, a combined list of elements 
for each component of the model was established. These components were: 
a) personal records; b) people; c) consent form; and d) information 
document. Findings from each of the individual analyses were combined into 
a single table which presents all the metadata elements for consent for 
record linkage.  
People:  it was identified that for the ALSPAC and UK Biobank 
studies, consent could only be given from the participant themselves. As the 
consent forms reviewed are not necessarily the only forms associated with 
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these studies, it is possible that other forms are age/relationship restricted 
and that in this instance that differentiation was not evident. Therefore, in 
terms of informing the development of the model, a mechanism is needed 
through which this distinction may be made.  
Furthermore, developing a simplistic yet highly detailed model 
required the use of inheritance to create a parent class, ‘Person’, in which 
commonly identified elements such as full name appearing as attributes. This 
parent class also contains attributes such as, ‘Confirmation of 
understanding’, ‘Forename’, ‘Surname’ and ‘Unique identifier’ which are 
inherited by the child classes, ‘Professional’ and ‘Non-professional’. By 
having these two child classes, stakeholders can differentiate between those 
working for the study – professionals, and those who are (potentially) a part 
of the study – non-professionals. The use of inheritance here also serves to 
further define the different types of professionals e.g. ‘healthcare-related’ 
such as GPs, ‘research-related’ such as principle investigators and 
‘education-related’ such as teachers. This principle will also be applied to the 
non-professionals where elements such as, ‘interviewee’ and ‘witness’ will be 
included. 
Moreover, the model needs to differentiate between the interviewee 
and person for whom consent is being given. This is because a participant 
may be consenting for themselves, as in the UK Biobank study, or be 
consenting on behalf of another, e.g. in the Life Study. Being able to record 
clearly for whom consent is given is key as a parent/guardian may be 
consenting on behalf of a child; a situation which may change as the child 
matures, autonomy increases and becomes more able to assent/dissent. 
Therefore, there are two separate elements in the model, ‘Interviewee’ and 
‘Person for who consent is given’. By adding an associated element, 
‘Withdrawal of consent’ with an attribute, ‘Withdrawal of consent’, this will 
facilitate the recording of metadata such as date of notification, extent of 
withdrawal and confirmation of understanding. This is important as there are 
instances whereby if data have been anonymised, aggregated and shared 
with other parties’, destroying this information is not always feasible. By 
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having this attribute, the interviewee can confirm whether this, along with 
their right to withdraw consent has been understood. 
Consent form:  I noticed that all the consent forms followed a similar 
structure – introduction, consent questions/statements and confirmation of 
understanding including dates and signature(s). In terms of model 
development, principles such as composition enabled me to build parts of the 
model individually, to then demonstrate how different elements can then 
combine to form something else. For example, the responses, logic and 
purpose combine to form questions; these questions can then be combined 
with other elements to form the consent form. By adopting a modular 
approach to model development, this helped me to build the model 
systematically and identify where aggregation may also be applicable 
improve the model’s design.  
Additionally, the studies (except for UK Biobank) stated on the 
consent form from where data may be obtained. Given the potential for 
information to be sourced from multiple, different data holders, a mechanism 
was needed in the model to record where data have been received and the 
scope/reason for the data/data linkage. Therefore, I used inheritance to 
define the relationship between the parent and more generalised class, 
‘Organisation’ and the more specialised, child classes such as ‘academic 
institutions’, ‘governments’ and ‘regulatory bodies’. These child classes can 
inherit common attributes contained in the parent class, such as organisation 
name, and use these. Consequently, stakeholders will potentially be better 
able to distinguish between the different types of organisations and from 
where records were sourced.  
Personal records, I noticed that age plays a role in deciding which 
consent form to complete. For example, in the Understanding Society study 
for example, the distinction is made between children aged 0-15years and 
those aged 16-24 years; consequently, two separate forms are used. This is 
so the parent/guardian can consent on behalf of a child aged 0-15 whilst 
those aged 16-24 may consent for individually. Being able to record this 
distinction in the model is important as it reflects the increasing autonomy 
children have throughout the course of a longitudinal study and their rights to 
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assent and/ dissent. Therefore, the element ‘Records’ had to have an 
attribute ‘Declaration’ where this information can be specified. 
Furthermore, I decided to use a combination of aggregation and 
inheritance to ensure the model is built as efficiently as possible, enabling 
stakeholders to record the different types of records. By using aggregation, 
stakeholders can select which elements they need e.g. ‘Education’, ‘Health’, 
Economic’ etc. whilst still being able to indicate that these elements combine 
to form the ‘Records’ element. Inheritance will be used to indicate how 
certain elements are connected. For example, the element ‘Parents/Legal 
Guardians’ will inherit attributes and methods from the ‘Immediate’ element 
which in turn will inherit attributes and methods from the ‘Family’ element. I 
will use aggregation to connect the ‘Family’ element to the ‘Records’ 
element.  
Results of the analysis also showed that elements such as ‘Education’ 
and ‘Health’ are composed of other elements. For example, education 
records may be sourced from all three sectors of education. Therefore, the 
model will have the elements, ‘Primary’, ‘Secondary’ and ‘Tertiary’ which will 
aggregate together to form the ‘Education’ element. The ‘Health’ element will 
be aggregated of, ‘Past’, ‘Present’ and ‘Future’. This enables stakeholders to 
record the different types of health data available to them. This is important 
to the (on-going) development of the model as in studies such as the Health 
Survey for England and Scottish Health Survey request to follow up is made.  
Additionally, results of the analysis showed that consent to access 
and use economic records was requested from the, Life Study, BHPS, and 
ALSPAC. To maintain simplicity in the model and yet allow stakeholders to 
record more low level metadata, the ‘Economic’ element has attributes such 
as ‘National insurance contributions’, ‘Benefit claims’ and ‘Tax’. By giving the 
‘Economic’ element these attributes, detailed descriptions may be recorded 
in a standardised manner.         
Informational documents: In this component of the analysis, the 
elements identified could be categorised into three groups: a) general 
information; b) participation; and c) record linkage. In terms of informing 
development of the model, I used composition to show that the ‘Participant 
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information document’ element is made up of several other elements. For 
example, the ‘Study’ element will have attributes such ‘Aims’ and ‘Research 
objectives’; whilst, the ‘Participation process’ element will be associated with 
a ‘Risks and benefits’ element – another common theme in the information 
documents.  
Furthermore, several of the studies (Life Study, Understanding 
Society, Born in Bradford and BHPS) provided a description relating to data 
security/confidentiality. In terms of informing development of the model, an 
element was needed to enable the recording of this metadata and specify (if 
necessary) from where this metadata was sourced. Additionally, for studies 
such as the MCS and Understanding Society, several informational leaflets 
were identified and reviewed. In terms of informing development and use of 
the model, stakeholders must be able to record multiple items; hence, any 
associated cardinality/multiplicity is reflective of this. Table 5-7 shows the 
finalised complete set of elements for consent to record linkage metadata in 
longitudinal studies.  
By adopting an object oriented approach to the design of the model, 
use of inheritance in particular, enabled multiple elements to share attributes. 
By using inheritance I was able to reduce repeating elements in the model, 
potentially increasing its efficiency.  For example, in the consent form section 
using the third test case, in having a generalized parent element of 
‘Organization’, attributes such as ‘Organization name’ are inherited by every 
child element helping to produce a simplified model capable of recording low 
level detail. The sharing of attributes can potentially decrease the number of 
repeating, thus redundant, elements. 
The statements on the consent forms were recorded using the 
‘Questions’ element. The use of aggregation enabled us to specify the 
elements needed to compose metadata relating to the questions, or in this 
case, the three statements. This is an advantage of using object oriented 
modelling techniques to design and develop the model. As part of section D, 
an example is provided describing potential information that may be 
accessed. This may be captured using the ‘Research’ element as part of the 
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‘Informational document’ element. Use of aggregation here enabled a 
detailed and structured description to be constructed. 
5.7.3 DDI 3.2 critical evaluation   
Results of the evaluation indicated that whilst many DDI 3.2 elements 
may be harnessed to create standardised descriptions of consent for record 
linkage in longitudinal studies, the standard lacks the mechanisms needed to 
record low level metadata specific to epidemiological and public health 
research. For example, it was challenging to identify and select which 
elements could be used individually or together to record the interviewee’s 
decisions and the reason(s) why. It is having access to these details which 
could potentially better support researchers in undertaking analyses using 
record linkage.   
Nevertheless, the strength of DDI sits very much in the opportunity for 
stakeholders to package together standardised instances of metadata in an 
interoperable format (XML) which can then be published as a ‘StudyUnit’. 
These instances may be entered into inter/national catalogues where they 
can be actively maintained. Subsequently, stakeholders such as potential 
secondary users, members of the public, and in addition to others, may view 
these metadata records to better inform themselves of past and current 
longitudinal studies. Consequently, stakeholders can potentially have a 
greater understanding of what could be achieved if access to the data and/or 
biological samples was granted.  
This evaluation served as additional confirmation for the need to 
develop a novel model to record consent for record linkage using metadata 
elements. It also demonstrated the areas in which greater focus in needed to 
improve the recording of low level metadata relating to longitudinal studies in 
epidemiological and public research settings. 
5.7.4 Metadata model evaluation 
Currently, identifying metadata elements involves a qualitative 
analysis of the consent form and there is the potential for bias given the 
potential subjectivity of the process. This is a potential weakness of the 
model. Further, there is a limit to which these analyses may be conducted 
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manually particularly when on a much greater scale. Consequently, this 
impacts the extent to which it is ready for use in real world applications. 
Ideally, the entire process would be automated and identification of concepts 
would be through use of a predefined concept list, possibly structured using 
some kind of ontology, from which concepts may be selected and assigned. 
In having a fully automated process, this could potentially reduce human 
error and scope for bias. Furthermore, information documents could not be 
found online for ELSA and CLSA studies. This is a weakness in our 
approach to evaluating the model as this section of the model was not tested 
to the same extent as the other three sections. 
To enhance the model further, the ‘type of test’ and storage of sample’ 
attributes of the ‘health’ elements should be removed and placed in a new 
element entitled ‘biological samples’. This is because having a separate 
element for this information widens the scope for further extension and 
enables additional, element-specific attributes to be added such as name 
and site of labs. This could also potentially improve the extent to which 
dynamic consent may be captured as changes in the model would facilitate 
the recording of more low level detail. In the records section, extending the 
health element to include a separate element for biological samples would 
also enhance the model further. 
5.8 Conclusions  
Longitudinal studies are critical to investigating the aetiology of 
disease and its impact across the life course. Performing recording linkage 
using personal records accessed through longitudinal studies can create 
datasets with even greater complexities which lend themselves well to 
thorough analyses. Hence, recording consent for record linkage in 
longitudinal studies in a standardized and robust manner is vital to 
supporting the record linkage process.  
I created and evaluated a novel metadata model to record consent for 
record linkage in longitudinal studies using metadata elements. This 
addresses the current unmet need for architectures to support the systematic 
recording of such information. 
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Next steps include engaging with stakeholders to further evaluate the 
model and discuss how the model may form a part of stakeholders’ work 
routines. The longer term goal is to integrate this model into a tool which will 
help to quicken the recording process through automated or semi-automated 
processes.  
5.9 Summary of major findings 
5.9.1 Literature review 
A total of 61 publications were fully reviewed of which none described the 
development of models to record consent to record linkage metadata. This 
underlines the unmet need for approaches to support the systematic 
recording of such information. 
5.9.2 Metadata model design and development 
A total of 30 consent forms from nine longitudinal studies were qualitatively 
analysed. The analysis involved identifying the metadata elements belonging 
to four categories: a) people involved in the consent process; b) composition 
of the consent form; c) personal records; and d) additional informational 
document. Individual analyses were conducted before these were combined 
and repeating elements were removed.  
5.9.3 DDI 3.2 critical analysis 
I mapped the metadata management models to test how well the consent 
metadata elements could be mapped directly to elements in DDI 3.2. Results 
of the analyses showed that generalised metadata elements can be mapped 
directly whilst others may be linked using a combination of elements 
including ‘Note’. The results demonstrated that DDI 3.2 lacks the 
mechanisms needed to produce detailed descriptions of the consenting 
process indicating the need for a novel model to do so. 
5.9.4 Model evaluation 
A total of five consent metadata management models were created with a 
corresponding XML schema. The models were built using object oriented 
modelling techniques. By way of evaluation, the metadata management 
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models iteratively applied to the consent to record linkage metadata for the 
ELSA (wave 6), CLSA study and LSAC. Following each application, changes 
for improvement were identified and corrective action taken. 
5.10 Chapter summary 
This chapter focused on exploring the current state of art in capturing 
metadata for record linkage metadata in longitudinal studies, identifying the 
key elements of consent metadata, creating a novel metadata model to 
capture these and evaluating the model. 
I performed a systematic literature and conducted a qualitative 
analysis of 30 consent forms sourced from nine different longitudinal studies. 
The literature review did not identify any literature focusing on the 
development of consent models for record linkage metadata within the 
context of longitudinal studies. Results of literature review signal the lack in 
formalised methods to record this type of metadata and the need to develop 
a model to address this gap in knowledge.  
Results of the consent form analysis show metadata elements for 
consent to record linkage can be categorised into four components: a) 
personal records; b) people; c) consent form; and d) information document. 
The elements of these components were then cross-walked with the 
elements in DDI 3.2. 
Once the qualitative analyses and DDI 3.2 critical analysis were 
completed, a novel metadata management model was created to capture the 
metadata elements associated with consent to record linkage. I evaluated 
this model by applying it to a series of test cases and identifying the 
strengths and weaknesses. Changes were made to the model iteratively until 
it had been fully evaluated. The metadata management model can now be 
used to assist the capture of consent for record linkage metadata in 
longitudinal studies. It can also form the basis of development work on 
creating a tool to help automate this process. 
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Chapter 6 Findings, recommendations and future 
work 
6.1 Introduction  
In this final chapter I firstly present summaries of my principal findings and 
novel contributions to knowledge. I then make recommendations for change 
in epidemiological and public health research data management policy and 
practice. Following these, I discuss the overall strengths and weaknesses of 
the Ph.D. project and explore potential future research directions. 
6.2 Summary of Ph.D. findings  
6.2.1 Research case study I: Enhancing data discoverability 
Background: An increase in the linking together, and utilising of, 
disparate datasets is helping to maximise opportunities to investigate the 
origins of disease and influences on the life course. However, the limited 
discoverability of epidemiological and public health research data renders it 
challenging for researchers to identify these datasets as potential additional 
sources of data. This combined with an inability to sufficiently characterise 
these datasets due to limited provision of and access to metadata limits the 
extent to which these data be used.  
Aim: To identify and evaluate mechanisms to enhance the 
discoverability of epidemiological and public health research data. The 
objectives were to: a) investigate current approaches to data discoverability; 
b) examine current stakeholders’ awareness of issues relating to data 
discoverability and identify perceived challenges; and c) propose and 
evaluate methods to enhance data discoverability. 
Methods: I used a combination of investigative techniques: a 
systematic literature review of current approaches to data discovery; an 
online stakeholder survey; and feasibility analyses of the mechanisms 
identified. I also used grounded theory to analyse the qualitative data to 
develop theories hermeneutically. 
Results: A total of 49 public health and epidemiological studies and 
organisations were identified, 13 of which were reviewed. I identified varying 
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approaches to facilitating data discovery; the most common format to present 
research protocols was Portable Document Format.  
A total of 253 individuals completed the survey of which most 
undertake research in Europe. The survey identified the following perceived 
challenges with creating and/or using metadata: a) differing standards of 
research data management; and b) limited availability of resources. The 
survey also identified challenges associated with data publications such as 
limited academic incentives to produce these and a need for changes in 
research culture.   
Based on findings from the literature review and survey, three models 
to enhance data discoverability were identified: a) data publications; b) 
semantic web technologies; and c) a public health portal. These were 
evaluated through the performance of feasibility studies and by engaging 
with stakeholders. The development of a portal proved most popular with 
stakeholders.  
Conclusions: Data discovery is a fundamental step in the research 
data lifecycle and by implementing one or a combination of these 
mechanisms, researchers are more able to facilitate the discovery of their 
research data. The mechanism which proved most popular was the public 
health portal. Currently, there is no mandatory registration process for 
observational studies, this would be the first of its kind. The Wellcome Trust 
has begun preparations to take this work forward.  
Furthermore, parts of the review, and online survey results and 
recommendations were published through the full and summary reports, 
(Castillo, Gregory et al. 2014). Elements of this work form part of a 
manuscript under review (McMahon, Denaxas et al. 2016). This work was 
also presented at the DDI conference NADDI in 2015. 
6.2.2 Research objective II: Improving epidemiological and public 
health metadata quality assessment 
Background: Making robust inferences from epidemiological and 
public health research data necessitates access to good quality and data 
lifecycle-based metadata. The provision of metadata can help researchers to 
better understand data and facilitate analyses; examples of metadata 
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artefacts already being used by researchers in the epidemiological and 
public health domains include data dictionaries. However, in many instances, 
metadata are not subject to the same level of scrutiny as the research data 
they are associated with. Subsequently, metadata are of a variable quality 
and researchers cannot sufficiently characterise certain research datasets.   
Aim: To create and evaluate a novel quality framework to assess 
metadata quality within epidemiological and public health research settings. 
The objectives were to: a) describe current practices in metadata quality 
assessment; b) identify metadata quality dimensions; c) create a novel 
quality assessment framework; and d) evaluate the framework through 
iterative application to test cases.     
Methods: I used a combination of analytical techniques: a systematic 
literature review using cross-disciplinary databases to source literature on 
metadata quality assessment and an online stakeholder survey. The quality 
assessment framework was evaluated by applying it to three cohort studies 
as test cases and engaging with stakeholders.   
Results: The performance of a systematic literature review combined 
with a comprehensive online stakeholder survey provided the evidentiary 
basis for the development of the novel metadata quality framework. The 
review identified 11 studies and nine dimensions of quality. The review did 
not identify a method of quality assessment designed for use in the 
epidemiology and public health domains.  
A total of 96 individuals completed the survey globally most of whom 
were located in Europe. The survey identified challenges such as a lack of 
guidance to assist quality assessments associated with assessing metadata 
quality in epidemiology and public health. The survey also identified that 
‘accuracy’ was deemed by respondents as the most important metadata 
quality dimension.    
Results of both the systematic literature review and comprehensive 
online survey have shown that there is currently no framework designed 
specially to assess epidemiological and public health metadata quality. To 
address the challenges identified, I created a novel epidemiological and 
public health metadata quality assessment framework. The framework 
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consists of four components: a) general information; b) tools and 
technologies; c) usability; and d) management and curation. The framework 
was evaluated by being applied iteratively to three test cases and engaging 
with stakeholders. The framework was evaluated by applying it iteratively to 
three test cases and by engaging with stakeholders.  
Conclusions: Having access to good quality metadata can support 
researchers when sourcing additional datasets to investigate disease 
aetiology at scale. However, the literature review and survey demonstrated 
that metadata quality is variable and that there is currently no framework to 
assess metadata quality in the epidemiology and public health domains. By 
using the novel framework, researchers are now able to qualitatively assess 
epidemiological and public health metadata quality using a framework 
designed specifically for use in these domains. The framework has a unique 
basis in metadata quality dimensions such as discoverability and extendibility 
– dimensions not identified in any of the pre-existing frameworks. The 
framework also contains headings such as encoding and exchange 
standards (types of health information standard) again not identified in any of 
the existing frameworks. Use of this framework can also help to address 
issues relating to a lack of guidance through the explanations provided and 
can help researchers follow a formalised method of quality assessment.  
Findings from this study were published in (McMahon, Castillo et al. 
2015) and parts were also presented as a poster at a conference, 
(McMahon, Denaxas et al. 2015). Results of the online stakeholder survey 
and recommendations can be found in (McMahon and Denaxas 2016).  
6.2.3 Research objective III: Improving recording of consent for record 
linkage metadata 
Background: Researchers are increasingly linking disparate sources 
of data to produce datasets with an enhanced complexity and depth. These 
datasets may be harnessed to further investigate the longitudinal nature of 
disease; as such, they must be matched with consent models equally as 
enduring. Nevertheless, before these data may be linked together and 
utilised, researchers must harmonise these differing consent models. 
However, there is a lack of standardised methods to capture consent to 
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record linkage metadata in longitudinal studies. By having standardised 
descriptions of this process, researchers can better understand the extent to 
which consent is given and under which conditions.   
Aim: To create and evaluate a novel metadata management model to 
capture consent for record linkage metadata in longitudinal studies. The 
objectives were to: a) systematically identify and review methods for 
recording consent; b) comprehensively review consent elements from nine 
longitudinal studies; c) critically appraise DDI 3.2; and d) create and evaluate 
a novel metadata management model to record consent for record linkage 
metadata.  
Methods: I performed a cross-disciplinary literature review to firstly 
source literature in this area. I then qualitatively analysed 30 consent forms 
from nine longitudinal studies to identify key consent elements. These 
elements were grouped together and a series of metadata management 
models were created using an object oriented modelling approach. I then 
critically appraised DDI 3.2 by mapping the key consent elements previously 
identified to those within DDI 3.2.  These models were evaluated by being 
iteratively applied to three test cases.  
Results: A total of 61 manuscripts were identified and reviewed all of 
which were categorised into themes inductively and iteratively. The literature 
review did not identify any manuscripts which described the development of 
metadata management models.  
Following the analysis of the consent forms, the key consent elements 
identified were categorised into four groups: a) people; b) consent form; c) 
personal records; and d) information document. I created a corresponding 
metadata management model for each consent element group; all of which 
were applied to the test cases. The models were revised following each 
application.  
Results of the critical appraisal of DDI 3.2 showed that whilst 
generalised metadata elements can be mapped directly, DDI 3.2 lacks the 
more specialist metadata elements needed to create detailed metadata 
descriptions of consent for record linkage. 
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I evaluated the model through its iterative application to a series of 
test cases. With each application, the model was tested and changes for 
improvement were made. 
Conclusions: The novel metadata management model can now be 
used to assist stakeholders in documenting consent for record linkage given 
as part of a longitudinal study. This model also provides elements to assist 
researchers in creating standardised descriptions not found in the current 
prevailing standard, DDI 3.2.  
Parts of this work were presented as posters at conferences, 
(McMahon, Dezateux et al. 2013a) and (McMahon, Dezateux et al. 2013b) 
and a publication is currently in press, (McMahon and Denaxas 2017). 
6.3 Summary of novel contributions 
This thesis makes multiple novel contributions to the field: 
I. Research case study I: Enhancing the discoverability of 
epidemiological and public health research data 
I.1. Performance of a systematic literature review and a large scale online 
stakeholder survey focusing on data discoverability; these 
investigations had not previously been undertaken in epidemiological 
and public health research settings.  
I.2. Identified multiple areas of importance to data discovery, (3.4.2.7) 
such as identifying the commonalities between studies and being 
mindful of consent and other ethical issues pertaining specifically to 
the reuse of epidemiological and public health study data to maximise 
potential research opportunities.   
I.3. Utilised a combination of techniques to identify and appraise three 
options, not currently applied to their fullest extent in epidemiological 
and public health research settings, to determine their strengths and 
weaknesses and make recommendations to better their application in 
these fields to enhance data discoverability. 
 
II. Research case study II: Improving metadata quality assessment in 
epidemiological and public health research 
II.1. Performance of a comprehensive literature review demonstrating that 
there had been no previous work undertaken on the metadata quality 
issue in epidemiological and public health research settings. The 
literature review took into consideration the wider implications of the 
metadata quality issue by evaluating metadata quality assessment 
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criteria from other research areas and identifying metadata quality 
dimensions considered important by the wider research community. 
II.2. Performance of an online stakeholder survey focusing on metadata 
and metadata quality assessment; an investigation not previously 
undertaken in epidemiological and public health research settings. 
The results of which informed the design and development of the 
novel metadata quality assessment framework. 
II.3. Creation and evaluation of a novel metadata quality assessment 
framework for use in epidemiological and public health research 
settings. The framework addresses the gap in knowledge on 
assessing metadata quality in epidemiological and public health 
research settings. 
 
III. Research case study III: Improving the recording of consent for 
record linkage metadata in longitudinal studies  
III.1. Performance of a rigorous literature review demonstrating no work 
had previously been undertaken to address the challenges 
associated with recording consent for record linkage metadata in 
epidemiological and public health studies in a standardised manner 
by developing a standards-based model.   
III.2. Critical appraisal of DDI3.2 evaluating the applicability and in 
particular the challenges of the current prevailing standard to record 
consent for record linkage metadata specifically. I fed the results of 
this appraisal into the design and development of the novel metadata 
management model by way of addressing the challenges associated 
with the recording of consent for record linkage metadata.  
III.3. Creation and evaluation of a novel metadata management model 
which addresses the gap in knowledge on recording consent for 
record linkage metadata in a standardised and robust manner.  
6.4 Recommendations 
The findings from each research case study have informed a series of 
recommendations for change in epidemiological and public health research 
data management policy and practice. These have been categorised 
according to the stakeholder group at which they are aimed. The stakeholder 
groups are: a) all stakeholders; b) researchers, data users and data 
producers; c) archivists, data curators and librarians; and d) agencies – 
funding, governance, and formal academic review.  
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6.4.1 All stakeholders  
I. Recommendation: Create a harmonised research data lifecycle 
model to support improved documentation of data and metadata work 
flows and to enhance stakeholders’ understanding of the potential 
research benefits associated with a cyclical approach to research data 
management inclusive of lifecycle-based metadata 
Background and problem: Researchers are increasingly recognising 
the potential research benefits associated with a cyclical approach to 
research data management. The current shift in research culture to adopt a 
cyclical approach to research data management must be matched with a 
cyclical approach to the way metadata are managed. Having a lifecycle-
based approach to metadata markup will help to support research data reuse 
and repurposing across the stages of the research data lifecycle. However, 
given the heterogeneity of RDL models available and a lack of guidance as 
to when to use which one, systematic metadata markup is potentially 
hampered.  
Basis in PhD research findings: My work specifically addresses this 
current lack of emphasis on a modular approach to the research data 
lifecycle and issues relating to metadata management within these individual 
modules. My discussion in 1.1.3 on a data lifecycle-based approach to 
epidemiological and public health studies provides the basis for the 
recommendation to create a harmonised set of RDL stages. This work builds 
on existing work focusing on the research data lifecycle; the novelty of my 
work lies in the particular focus placed on organising the different stages of 
the RDL into modules which can be addressed either individually, as 
demonstrated through my work in chapter 6 where I created and evaluated a 
novel metadata management model to standardise the recording of consent 
to record linkage in longitudinal studies, or a combination of stages as 
demonstrated by my work in chapter 5.    
Recommendation: A harmonised set of RDL stages with definitions 
is needed so that metadata markup may become more modular in design 
and stakeholders are potentially more able to effectively compare metadata 
across the different stages. However, determining how granular definitions of 
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each RDL stage could prove challenging. This is because data curation 
processes may differ according to the type of study being documented.   
The development of a harmonised RDL model is recommended and 
stakeholders should identify at which stage their research study sits and 
begin generating metadata inclusive of data flows and any steps taken to 
manage the data.  In having a clearly defined metadata pathway, this could 
help to ease the process of creating and maintaining metadata and help 
researchers to identify opportunities to produce data publications.  
II. Recommendation: Improve awareness of the implications 
associated with poor quality metadata in public health and 
epidemiological research 
Background and problem: High quality metadata is needed in 
epidemiological and public health research to not only describe research 
study results (Musen, Bean et al. 2015). In an article by Phimister (2015), the 
author discusses how missing metadata in genetic databases coupled with 
constraints over the sharing of metadata put in place due to the way in which 
consent was given, have resulted in incomplete descriptions of her family 
history and potentially incomplete descriptions of her genetic data possibility 
reducing scope for reuse. However, results of the survey (chapter 4.4.2.5) 
show one of the main challenges in assessing quality in public health and 
epidemiological research is a lack of awareness of the issue of poor quality 
metadata and the potential implications this can have on research and 
research data management.  
Basis in PhD research findings: It is this problem of a limited 
awareness of poor quality metadata in public health and epidemiological 
research that my work on a novel metadata quality assessment framework 
addresses. Findings from chapter 4 and in particular sections, 4.4.2.2, 
4.4.2.4, 4.4.2.5 provide evidentiary basis for this recommendation. For 
example, results of the survey chapter 4.4.2.2 showed that of those who 
submitted data, most regularly use metadata; yet, awareness of the 
metadata quality issue is limited (McMahon, Denaxas et al. 2016).   
Recommendation: A change is needed in research culture to widen 
the focus to include the quality of metadata and to increase attention to the 
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different dimensions of metadata such as completeness and accuracy. 
Researchers are dependent on research artefacts such as data dictionaries 
and so mechanisms are needed to better educate researchers on the 
potential negative outcomes of producing and/or using poor quality metadata 
in their research. Potential incentives to encourage researchers to adopt 
better metadata management practices include enhanced opportunities for 
their research data to be discovered and reused resulting in increased 
collaboration. A potential challenge with this is determining the how to 
quantifiably measure how effectively these mechanisms are working and 
their effect on the research environment.   
III. Recommendation: Integrate metadata quality assessments into 
stakeholders’ work routines as supported by increased provision of 
training and guidance 
Background and problem: The provision of research data coupled 
with good quality metadata can enable stakeholders to glean even greater 
insights from datasets of varying sizes (Thornton 2015). For example, access 
to variable level metadata enabled Williams, Bunch et al. (2013) to develop a 
protocol maximising “…the sensitivity and specificity of the data linkage…” in 
their study looking at the risk of cancer in children following assisted 
conception. However, results of the survey show that currently, quality 
assessments are only performed sometimes (Table 4-12 and chapter 
4.4.2.5) and in certain circumstances not at all.  
Basis in PhD research findings: My work addresses the challenge 
of integrating quality assessment into stakeholders work routines by 
providing a tool – the novel framework – to help users assess metadata 
quality. The framework (chapter 4.3.3) created and evaluated can be 
adopted by stakeholders from across the epidemiological and public health 
research domains (McMahon, Denaxas et al. 2016).  
Recommendation: The novel framework serves as a formalised 
approach to assist metadata quality assessment in the epidemiological and 
public health research domains. Inclusion of domain-specific detail not before 
seen in other pre-existing frameworks such as, ‘use of clinical terminologies’ 
and ‘provision of links to other studies, sweeps or publications’ are just two 
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examples of how the framework has been tailored to meet the needs of 
epidemiological and public health metadata. There is scope to develop the 
framework further to include a set of quantitative metrics which complement 
the underlying metadata quality dimensions. By having a set of quantitative 
metrics, changes to the metadata may become easier to monitor and 
benchmark against other standardised metadata instances.  
IV. Recommendation: Investigate mechanisms to further integrate 
health information standards into epidemiological and public health 
research 
Background and problem: In chapter 2.3, I explored the realised 
research benefits of applying health information standards in epidemiological 
and public health research where they are not currently widely adopted. For 
example, stakeholders can use ontologies to map between ontological 
concepts for purposes of data discovery and data reuse (Subramanian, 
Kitchen et al. 2015). Furthermore, according to Dugan, Emrich et al. (2014), 
the provision of interoperable databases was enabled through use of a 
semantic framework which was ontology-based. This helped to maximise 
benefits associated with use of semantic frameworks and reduce potential 
information loss during transmission or conversion.  
Basis in PhD research findings: My work in chapter 2 addressed 
this challenge by my investigating and discussing potential ways of utilising 
these standards so that the potential research benefits of integrating health 
information standards (encoding and exchange) may be harnessed. Results 
of the evaluation of the mechanisms in chapter 3.4.4 of the models have 
demonstrated that there are many potential research benefits associated 
with the application of information standards. Increased use of standards 
was also identified as an area of improvement and immediate priority in 
chapter 3.4.2.8. Other such benefits are discussed in Chapter 2. 
Recommendation: By further investigating mechanisms to better 
integrate SWTs, potential benefits may be realised and stakeholders better 
supported in maximising the research potential of data. Nevertheless, the 
challenge here is providing adequate training and support to researchers 
instructing them how to effectively integrate these into their research 
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practices. More resources are potentially needed here. This work builds on 
and furthers existing work on the improved application of standards in life 
sciences research. The novelty of my work lies in the focus on the 
application of health information standards, namely encoding and exchange 
standards, into epidemiological and public health research settings in support 
of a cyclical approach to research data management.  
6.4.2 Researchers, data users, and data producers 
V. Recommendation: Make better use data management plans 
as an approach for characterising research data to enhance the 
potential for data reuse and repurposing 
Background and problem: Data management plans (DMPs) 
describe how research data will be managed over the course of a study. 
Good quality descriptions of research data are vital in helping stakeholders 
determine whether studies are feasible using a particular dataset without 
accessing the dataset(s) directly (Lee, Black et al. 2015). DMPs, if written 
well, can do just this. For example, DMPs can contain details relating to 
(potential) application of clinical terminologies; details of which are vital to 
developing cross-institutional solutions to problems associated with 
phenotyping (Shivade, Raghavan et al. 2014). DMPs are most commonly 
used when researchers are submitting grant applications to funding 
agencies. Nevertheless, use of DMPs to characterise research data beyond 
that which is expected of them during a grant review process is not 
commonplace and the plans themselves can be of variable quality; 
consequently limiting the extent of their potential use as a mechanism to 
enhance the characterisation of data.  
Basis in PhD research findings: My work in chapter 5 on improving 
the way in which consent for record linkage metadata are recorded 
demonstrates how increased standardisation could improve its associated 
quality. If the way in which DMPs are produced were to be standardised, and 
these processes became a part of regular work routines, this could help to 
address the associated issue of variable quality.    
Recommendation: It is recommended more emphasis is placed on 
improving the quality of DMPS and their integration into daily work routines of 
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stakeholders. Stakeholders should be encouraged to consider the research 
data lifecycle and its impact on performing and documenting life sciences 
research. Development and management of DMPs should become an 
iterative process with each new version reflecting any changes made to the 
management strategy; organisations such as the Digital Curation Centre 
provide an online tool to help generate DMPs (DCC 2014).  
This recommendation adds to current guidelines focusing on the use 
of DMPs by encouraging users to make greater use of existing resources i.e. 
a study’s DMP. The novelty of my recommendation lies in the extension 
made tot eh scope of a DMP’s various uses – now DMPs should be looked 
at as another potential tool which may be harnessed to characterise research 
data for reuse/repurposing.  
VI. Recommendation: Increase identification of commonalities 
and links between studies through improved provision of openly 
available metadata and other associated research artefacts 
Background and problem: Realising the benefits of collaborative 
working across institutions globally necessitates some form of data sharing. 
Data sharing within this context can be seen as a step towards making 
effective use of resources by helping to reduce duplicated efforts (Thiru, 
Hassey et al. 2003; Tenopir, Allard et al. 2011; Borgman 2012). However, 
certain research studies have involved researchers creating their own data 
elements list (Dugas, Jockel et al. 2015). Consequently, this is not always an 
effective use of resources when other, pre-existing lists may be repurposed 
and reused.  
Basis in PhD research findings: My work addressees the current 
lack of focus on the impact a lack of openly available metadata could 
potentially have on the extent to which commonalities may be identified 
between studies. Survey results in chapter 3.4.2 provide the basis for the 
recommendation to increase the identification of commonalities and links 
between studies.  
Recommendation: Researchers are advised to identify 
commonalities between studies as early on in the lifecycle as possible to 
help inform design and development of their own study protocols and to 
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identify best practice (Castillo, Gregory et al. 2014). The development of a 
public health portal as discussed in chapter 3 would help to facilitate this as 
the portal would hold a collection of metadata records created through some 
kind of registration process. These records would ideally contain variable-
level detail which can be used to help identify areas of potential overlap and 
reuse. Researchers should aim to record, and make openly available, 
metadata throughout the course of a study and to standardise where 
possible. However, much is still needed in the way of incentivising 
researchers to create detailed high quality metadata records which can then 
be shared. Researchers should also be more encouraged, again through 
incentives such as potential increase in citations through creation of data 
publications (as discussed as an area of improvement and priority in chapter 
3.4.2.8), to publicise their research data to help maximise its reuse potential.  
The recommendation adds to the research priorities as discussed by  
Moher, Glasziou et al. (2016) focusing on making, “publicly available the full 
protocols, analysis plans or sequence of analytical choices, and raw data for 
all designed and undertaken biomedical research.” The novelty of my 
recommendation lies in users being encouraged to then utilise these openly 
available artefacts to then identify commonalities between studies with a 
view to repurposing research data to maximise their reuse opportunities.  
6.4.3 Archivists and librarians 
VII. Recommendation: Adopt better documented metadata 
pathways which map from where metadata have been sourced, how 
they have been used and where they have been shared inclusive of 
any additional research artefacts such as consent forms 
Background and problem: Documenting research data without use 
of adequate and standardised methods to do so can hinder the extent to 
which these data are managed effectively (Parekh, Armananzas et al. 2015). 
Current unstandardised approaches to metadata markup can reduce the 
potential for data discovery and reuse (Toga, Foster et al. 2015).  
Basis in PhD research findings: My work addresses the problems 
associated with a lack of standards-based approaches to manage metadata. 
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The basis for this recommendation can be found in chapter 5 and in 
particular sections, 5.1 and 5.2.1. 
Recommendation: Mapping metadata pathways will help 
stakeholders to determine which tools/technologies work well, which need 
further development, and to facilitate the development of best practice 
guidelines within the context of metadata markup in epidemiological and 
public health research. More specifically, mapping the metadata pathway 
serves two purposes: a) helps to determine at which stages of the research 
data lifecycle the metadata, (plus its type and format) have been handled 
and which, if any, changes were made; and b) supports efforts to formalise 
an approach to integrating metadata quality assessments along the research 
data lifecycle. This recommendation adds to other recommendations made 
such as providing this kind of metadata will help improve stakeholders’ 
understanding of the circumstances under which the metadata were created 
(Musen, Bean et al. 2015). Also, access to study documentation will also 
help to improve scope for data sharing without compromising participant 
confidentiality (Dugas 2013).   
As CIMs define the structural and semantic details needed to produce 
a detailed description (Moreno-Conde, Moner et al. 2015), these could help 
the mapping process. Furthermore, lists of tools and technologies should be 
collated together to identify what has been used, for which purpose, and why 
these tools/technologies were selected. Tools and technologies can include 
use of clinical terminologies and other such controlled vocabularies, SWTs, 
and metamodels. In terms of sharing the metadata this includes 
stakeholders’ manually sending metadata e.g. PDF through emails, and 
uploading and/or creating metadata records into public facing catalogues. It 
can also include use of any metadata harvesting protocols to expedite this 
process potentially reducing the risk of human error.  Retrospective metadata 
markup is an alternative approach to markup in real time, but there is the 
potential increase in the risk of recall bias. Appropriate use of metadata 
markup tools could assist the process; survey results show in certain 
circumstances this is already happening.  
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6.4.4 Agencies - Funding, governance, and formal academic 
review  
VIII. Recommendation: Improve recognition of the significance of 
data publications and other such published5 articles in formal 
academic reviews 
Background and problem: Data publications describe not only the 
research data but the ways in which the data were collected and managed. 
These papers could also include descriptions of study protocols and 
investigative/analytical methods. Currently, data publications are under-
valued by the wider research community particularly within the context of 
formal academic reviews. And yet, these publications are critical to the 
enhanced discoverability of research data and support increased scope of 
data reuse and repurposing.  
Basis in PhD research findings: My work in chapter 3 addresses the 
need to improve the perceived significance of data publications and other 
such articles by discussing their advantages to enhancing data discovery. 
The survey results, as detailed in chapter 3.4.2.6 demonstrate the need for 
increased academic rewards as incentives for the publishing of data 
publications and other such manuscripts. 
Recommendation: More support is needed to move their position 
higher in the perceived hierarchy of academic literature. Increased focus is 
also needed on reducing the potential association stakeholders may make 
between the scientific value of a paper and its place of publication. This 
recommendation complements and adds to a recent recommendation calling 
for increased rewards including funding and recognition of stakeholders 
commitments to “…reproducible research and an efficient culture for 
replication of research” (Moher, Glasziou et al. 2016). A potential challenge 
here is determining how to encourage researchers to include data 
                                            
 
5 Published is defined here as available online and/or in print either through open access or through 
use of login credentials. The article must have a persistent unique identifier such as a DOI and be 
citable. 
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publications in submissions to formal academic review panels/bodies in 
addition to original research articles.  
IX. Recommendation: Develop a public health portal to enable 
researchers to register observational studies for purposes of 
enhanced data discovery, repurposing and reuse  
Background and problem: Greater opportunities are needed for the 
wider research community to make their research data and/or protocols more 
discoverable. However, to the best of my knowledge, there is no such 
registration process for observational studies. There are registration 
processes for other types of study such as clinical trials through 
ClinicalTrials.gov.    
Basis in PhD research findings: My work addresses the current lack 
of some kind of formalised registration process for observational studies. A 
registration process such as this could help users to identify existing 
research studies by providing a centralised portal of metadata records. The 
basis for this recommendation can be found in the survey results (chapter 
3.5.3) which demonstrate the need for a portal to enable stakeholders in 
public health and epidemiological research to register observational studies.   
Recommendation: A potential way to incentivise stakeholders to do 
so is to increase use of metadata harvesting tools to automate this process. 
If there was some kind of pre-requisite or data use caveat that insisted on 
use of metadata catalogues to enhance the discoverability of the research 
data, this could potentially have a positive impact on knowledge of these 
catalogues and how they are used. The provision of meta-metadata will help 
support the management of metadata held within the catalogues. A 
challenge here is implementing the necessary infrastructure to enable these 
processes. Additional resources such as funding will also need to be 
arranged to facilitate this process. Furthermore, plans must be put in place to 
then maintain the public health portal and ensure longer term sustainability.   
This portal will serve as a cross-funder initiative to enhance 
discoverability(Castillo, Gregory et al. 2014) and furthers a recent  
recommendation from Moher, Glasziou et al. (2016) stating “funders, 
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sponsors, regulators… should endorse and enforce study registration 
policies”. It is this registration process that my work addresses. 
6.5 Ph.D. thesis strengths and weaknesses  
6.5.1 Literature reviews 
Strengths: The strength of the literature reviews lie in how the 
literature was systematically sourced using both biomedical and computer 
science databases, sources of gray literature such as search engines and 
forward citation tracking (Kuper, Nicholson et al. 2006). For research case 
study 1, the use of the six point agreed criteria enabled me to thoroughly 
investigate current approaches to discoverability and better my 
understanding of the current challenges associated with data discovery. For 
the second and third research case studies, use of the PRISMA checklist 
(Moher, Liberati et al. 2009) enabled me to identify and review manuscripts 
in a systematic manner. Additionally, by inductively and iteratively identifying 
the themes, this helped to ensure a thorough and comprehensive analysis of 
the literature review findings.  
Weaknesses: The weakness of the literature reviews lie in the 
restrictions put in place by the inclusion criteria such as needing to be 
available in English. Literature was also excluded if the publication was not 
openly accessible or available by logging into the journal using institutional 
login details. This could have excluded potentially useful literature for 
inclusion in the review. Other limitations include, using search terms specific 
to public health and epidemiology whilst the databases utilised were not 
limited to these two domains – they included other domains such as 
computer science, librarianship and archiving. Therefore, possible 
differences in use of controlled vocabularies may have resulted in literature 
being missed. Nevertheless, in adopting a systematic approach to the review 
process, the reviews were conducted in robust manner using an 
internationally recognised methodology.  
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6.5.2 Online data collection – stakeholder surveys 
Strengths: The strength of the method of data collection for the first 
and second research case studies lie in my being able to request 
participation from stakeholders both within the UK and internationally in a 
relatively short period of time. The use of mailing lists enabled me to contact 
stakeholders in public health and epidemiological research quickly, and the 
request to forward the invitational email served to potentially increase the 
number of potential participant reached. Furthermore, in having web-based 
data collection, the potential risk of participants being unable to submit data 
in person due to their distance from London is reduced.(Schleyer and Forrest 
2000; Whitehead 2011) Consequently, I received 96 responses to the 
metadata quality survey and 253 responses to the data discoverability 
survey. Additionally, in using a web-based survey, built-in mechanisms for 
data validation helped to reduce the potential risk of nonsensical information 
being recorded. The use of self-administered surveys helped me to maintain 
a standardised approach to data capture as use of interviewers, each with 
potentially varying interviewing techniques was removed (Coggon, Rose et 
al. 2014). Having in place mechanisms to involve international stakeholders 
adds to the potential applicability of my findings on a global scale as my 
results and recommendations are based on both a national and international 
perspective.  
Additionally including open-ended questions in the surveys helped me 
to capture qualitative data (MacKenzie, Wyatt et al. 2012). According to a 
study by Keusch (2014) on the design of self-administered, web-based 
questionnaires, the length of the input field of an open-ended question can 
impact how detailed the response provided is. Hence, to guide the 
participants when submitting their data through the surveys, one of the five 
potential ways to structure input fields to open-ended questions in web 
surveys as suggested by Couper, Kennedy et al. (2011) are included. The 
style of question most suitable to the surveys was a narrative response with 
no length or formatting constraints. This is so the participants have the 
freedom to provide additional answers, describe their experiences, and share 
their opinions without restriction.  
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Weaknesses: Having used an online data collection method, a 
potential weakness here is the possibility that my data is biased towards 
those with online access. The use of telephone assisted or postal 
submissions may have led to different outcomes. Furthermore, by using 
mailing lists, I was dependent on those managing the lists to have current 
and working emails addresses for all those that subscribe, and that those 
subscribed to these lists read their email messages. Also, by requesting 
those that receive the email to forward it to other potentially interested 
parties, determining a response rate is unfeasible.   
In addition, there is also the possibility for one individual to have 
submitted multiple answer sets as the only unique identifier assigned to a set 
of answers is a record ID once the responses have been received by 
REDCap - the survey system does not monitor who has already submitted 
data. Though this is a potential weakness in my approach to data collection, 
in not recording any kind of identifiable information from the respondent, the 
risk of unintentionally identifying the respondent through the responses 
provided is potentially reduced.   
6.5.3 Qualitative data analyses – a Grounded Theory approach 
Strengths: When analysing the qualitative results for data 
discoverability and metadata quality studies collected through the online 
stakeholder surveys, I used a Grounded Theory approach (Glaser and 
Strauss 1967). The strength in using Grounded Theory to analyse qualitative 
results lies in being able to collect rich data (Glaser 1999) more reflective of 
reality. This theory focuses on studying the interactions of the respondents 
when exposed to a particular situation (Sbaraini, Carter et al. 2011). 
Grounded Theory enabled me to explore these data without having to adhere 
to pre-defined theories; rather, I was able to develop my own ideas (Callen, 
Braithwaite et al. 2008; Thomassen, Ahaus et al. 2014). The freedoms that 
came with applying a Grounded Theory approach enabled me to gather data, 
and then analyse these data without having to determine whether I am 
proving or disproving pre-formulated hypotheses.    
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Qualitative research in biomedicine is increasing(Kuper, Reeves et al. 
2008) and in using this approach I was able to perform my data analyses 
guided by an established approach applied regularly across healthcare 
research (Mays and Pope 2000; Foley and Timonen 2015). When analysing 
my data, I adopted a hermeneutic approach and identified and grouped 
themes inductively and iteratively. In adopting this approach, I was able to 
build theories in a systematic and robust manner and was able to identify 
subgroups within categories.   
In terms of how well the results may be replicated, the process of 
resurveying stakeholders online is fairly straightforward; a potential barrier is 
gathering respondents with the same characteristics and prior experience. 
Whilst I acknowledge that replicating results in qualitative research is a 
challenging process, in adopting a methodical approach to data collection, I 
was able to successfully gather data and develop theories. These theories in 
turn helped me to better my understanding of, for example, perceived 
barriers to enhancing data discoverability. It is this process of iteratively 
collecting ideas and themes which may be replicated by other researchers if 
the data are collected in the same way and of the same quality (Collingridge 
and Gantt 2008). 
Weaknesses: There are several limitations to applying a Grounded 
Theory approach.  As the basis of these qualitative analyses is interpretive, 
this could reduce the generalisability (Winkelman, Leonard et al. 2005) and 
applicability of research findings to the wider scientific community. Therefore, 
there is the possibility of potentially reduced external validity of my research 
findings. The generalisability of findings which are the result of using a 
Grounded Theory approach is improved through increased abstraction of 
findings (Corbin and Strauss 1990). It is possible, that my findings may need 
to become more abstract to increase their applicability to the wider scientific 
research community. Verifying research findings is a step towards reducing 
subjectivity and so more is potentially needed to increase objectivity in my 
findings (Corbin and Strauss 1990). Nevertheless, in following a robust 
method of data analysis, I was able to successfully derive theories from the 
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data collected and used these to inform my recommendations for change in 
policy and practice.  
6.5.4 Models/framework design and development 
Strengths: The strength in using a standards-based approach to 
designing and developing the models and framework lies in the ability to 
harness existing standards and their scalability to build formalised models 
and frameworks for application in epidemiological and public health research 
settings. These standards can be critically appraised, as demonstrated in 
chapter 5.6.3, and extended to better enable their application in 
epidemiological and public health research. For example, an object oriented 
approach was used to develop the metadata management models to record 
consent metadata. Consequently, simple yet detailed models were quickly 
created which can be further developed. Further, an adherence to object 
oriented principles such as inheritance enabled me to reduce the risk of the 
model including repeating or redundant elements. This is advantageous as 
the model created and evaluated is more efficient and the scope for it to be 
instantiated is potentially increased.  
Weaknesses: A potential weakness in the design and development of 
the quality assessment framework lies in the lack of quantitative quality 
analysis of the metadata. Currently, stakeholders are expected to perform 
qualitative analyses using the framework. Though this will work in the short 
term, the longer term goal is to produce a series of computable metrics to 
automate the assessment process. These algorithm-based mechanisms aim 
to quantify the assessment process helping to improve its objectivity by 
reducing any potential bias in the findings and quicken the overall 
assessment process. The metadata quality dimensions these metrics could 
prove potentially useful in assessing more effectively include completeness 
and accuracy. Furthermore, quantitative findings (as opposed to the current 
qualitative findings), can be better compared. By making these comparisons, 
areas of potential need of further support can be provided. Nevertheless, this 
current lack of quantitative metrics is demonstrative of the challenges 
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associated with providing low level definitions of metadata quality dimensions 
which would form the basis of quantitative analysis.  
6.5.5 Evaluation strategies 
Strengths: the strength of the evaluation strategy for the first research 
case study lies in performing a series of feasibility analyses following an 
established methodology. Feasibility analyses originate from the computer 
science domain and promote a systematic evaluation of the three key 
aspects of the mechanisms - technical, organisational, and economic 
feasibility within the context of enhancing the discoverability of observational 
studies. For the second and third research case studies, the metadata quality 
assessment framework and consent for record linkage metadata 
management model, were applied to a series of test cases and improved 
after each iteration. These real world applications enabled a thorough testing 
of the quality framework and metadata management model.    
Weaknesses: The weakness in conducting feasibility analyses for the 
first research case study lies in them not generally being applied in 
epidemiological and public health research settings. Feasibility analyses are 
generally associated with object oriented systems analysis and designs as a 
decision support tool when determining whether to buy and/or develop new 
tools. As this method was not specifically designed for use in epidemiological 
and public health research context, it is possible that aspects of each 
mechanism may not have been as fully explored as possible.  
The weakness in the evaluation strategy for the third research case 
study lies in the lack of stakeholder engagement. The models were iteratively 
applied to test cases only and improved after each application. Nevertheless, 
this approach to evaluation is demonstrative of the advantage of using real 
world applications of model as these can be shared with stakeholders to 
facilitate debate and discussion around the models and their application in 
epidemiological and public health research.   
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6.6 Future direction 
Research case study I: The next step is to begin planning the 
development of the public health portal. I will work with the community to 
determine the requirements of the portal and how stakeholders would ideally 
interact with this tool. Tasks I am likely to undertake include: a) creating and 
evaluating conceptual models of the system to circulate to stakeholders; b) 
creating and evaluating an underlying metadata model to which the metadata 
records will comply; c) identifying and critically apprising metadata standards 
to incorporate into the public health portal.  
In addition to building the portal, I will continue to investigate the 
application of semantic web technologies and data publications to 
epidemiological and public health research. This is so I can harness their 
advantages and feed them into the portal where possible. For example, I will 
link to any associated data publications for each study from their metadata 
record. I will also further investigate the challenges associated with using 
semantic web technologies and data publications so that I can continue to 
address these. I will then be able to provide a set of recommendations to 
facilitate their enhanced application in epidemiological and public health 
research settings.       
Research case study II: The next step for the metadata quality study 
is to investigate a set of quantitative measures of quality. These measures 
will help to increase objectivity by reducing the amount of assessment 
conducted manually. To implement these quantitative metrics, I will firstly 
determine if there are any pre-existing quantitative metadata metrics for use 
in epidemiological and public health research settings. If any are in 
existence, I will critically appraise these for use looking particularly at where 
extensions are needed before they may be applied to the framework. If no 
such metrics currently available, I will investigate computational techniques 
to determine how algorithm-based mechanisms may be harnessed to better 
determine metadata quality. In applying these mechanisms to the framework, 
I will also be able to quicken the overall assessment process to potentially 
increasing efficiency.  
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Once I have conducted the systematic literature review, critically 
appraised (if any) existing metrics, and developed novel metrics where 
needed, I will then extend the scope of the framework by applying it to 
metadata associated with cohorts identified using electronic healthcare 
records. It is possible that the metadata associated with data whose primary 
use is research, and data whose primary use is to assist clinical care, 
perform differently in terms of quality according to the framework. For 
example, when assessing use of encoding standards such as ICD 10, 
stakeholders are dependent on clinical information having been encoded 
accurately and in a timely manner. An example of where clinical information 
have been encoded using a standard is HES data. However, it is possible 
that potential differences in the approach taken to encode this information 
between that collected from existing clinical data and that from research 
studies could impact their associated metadata and its quality. A key element 
here is deciphering whether the metadata quality varies due to the process of 
metadata maintenance and curation, or whether, the metadata of repurposed 
clinical data (resulting from clinically phenotyped cohorts) cannot be 
assessed by the same framework. Further investigation is needed to 
determine the cause of these potential differences and any subsequent 
implications particularly on the use of quantitative metrics as these may need 
to be altered too.   
Research case study III: The next step for the consent for record 
linkage metadata study is to design a user interface to assist stakeholders in 
documenting their metadata. This will help stakeholders to interact with the 
model and ease its application into daily work routines. The first step would 
be to hold a series of focus groups to present the model and gain feedback 
particularly around areas in need of further development. The information 
and critiques gathered from these focus groups will also feed into the user 
requirements I will need to collect to ensure my user interface is fit for use.  
The tool would be built on the model and incorporate the 
corresponding XML schema. I will also investigate ways to tailor the user 
experience when using the tool. For example, if the user indicates that there 
will be no face-to-face interviews, any additional metadata elements relating 
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to face-to-face interviews will be hidden from view. In doing so, the user will 
only be presented with the metadata fields relevant to their study. 
Nevertheless, by ensuring that the metadata fits the underlying model, future 
versions of the metadata, where additional metadata elements are needed, 
can be included without previous versions being negatively impacted such as 
introduction of missing or distorted metadata.  
 
6.7 Closing remarks 
As a biomedical informatician, I am neither computer scientist nor clinician; I 
sit in the space between. My research focuses on creating solutions to 
informational workflow problems in epidemiological and public health 
research settings. In this body of work, I demonstrated how metadata 
management models may be applied to enhance the use and reuse of 
research data and made multiple novel contributions to knowledge. The 
recommendations made in this thesis aim to enhance the research 
environment by addressing current challenges in epidemiological and public 
health research data management policy and practice. 
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Glossary 
ABPI Association of the British Pharmaceutical Industry 
ALSPAC Avon Longitudinal Study of Parents and Children 
BRIDG Biomedical Research Integrated Domain Group 
caBIG Cancer BioInformatics Grid 
CDA Clinical Document Architecture 
CDISC Clinical Data Interchange Standards Consortium 
CHERRIES Checklist for Reporting Results of Internet E-Surveys 
CLSA 
 
CPRD 
Canadian Longitudinal Study of Aging, Étude longitudinale 
canadienne sur le vieillissement 
The Clinical Practice Research Datalink 
CRI Clinical Research Informatics 
DC  Dublin Core  
DCC Digital Curation Centre 
DCMI Dublin Core Metadata Initiative 
DDI Data Documentation Initiative 
DFG Deutsche Forschungsgemeinschaft  
DMP Data Management Plan 
DNBC 
DSM 
Danish National Birth Cohort study 
Diagnostic and Statistical Manual of Mental Disorders 
EA Enterprise Architect 
EHR(s) Electronic Health Record(s) 
ELSA 
ELSST 
English Longitudinal Study of Ageing 
European Language Social Science Thesaurus  
eMERGE Electronic Medical Records and Genomics 
ESRC Economic and Social Research Council 
FHIR Fast Health Interoperable Resources 
HASSET Humanities and Social Science Electronic Thesaurus 
HCLS IG 
 
HES 
World Wide Web Consortium Semantic Web Health Care and Life 
Sciences Interest Group 
Hospital Episode Statistics 
HIPAA The Health Insurance Portability and Accountability Act 
HITECH Health Information Technology for Economic and Clinical Health Act 
HL7 Health Level 7 
HSCIC The Health and Social Care Information Centre 
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ICD International Classification of Disease 
ICPSR 
ISO 
Inter-university Consortium for Political and Social Research 
International Organization for Standardization 
LOINC Logical Observation Identifiers Names and Codes 
LSAC 
LS DAM 
The Longitudinal Study of Australian Children 
Life Sciences Domain Analysis Model 
MCS 
MeSH 
Millennium Cohort Study 
Medical Subject Headings 
MIDUS 
NHS 
Midlife in the United States 
National Health Service 
NIH National Institutes of Health 
NLP Natural Language Processing 
OAI-PMH Open Archives Initiative Protocol for Metadata Harvesting 
OBO 
Foundry 
Open Biomedical Ontologies Foundry 
ODM Operational Data Model 
OO Object Orientation /Object oriented 
OWL Web Ontology Language 
PDF 
RDF 
Portable Document Format 
Resource Description Framework 
RDL Research data lifecycle 
REDCap Research Electronic Data Capture 
REF Research Excellence Framework 
RIM Reference Information Model 
SDMX  Statistical Data and Metadata Exchange   
SDMX HD Statistical Data and Metadata Exchange Health Domain 
SNOMED 
CT 
Systematized Nomenclature of Medicine Clinical Terms 
SPARQL Simple Protocol and RDF Query Language 
SWAN Semantic Web Applications in Neuromedicine 
SWT(s) Semantic Web technology(ies) 
TB Tuberculosis 
TMKB Translational Medicine Knowledge Base 
TMO Translational Medicine Ontology 
UAMS University of Arkansas for Medical Sciences 
UML Unified Modelling Language 
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UMLS Unified Medical Language System 
URI Uniform Resource Identifier 
W3C World Wide Web Consortium  
WHO World Health Organization 
XML eXtensible Markup Language 
XML DTD Extensible Markup Language Document Type Definition  
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Appendix  
Appendix A: Enhancing the discoverability of public health and 
epidemiological research data 
Supplementary Table 1  The 49 studies and organisations 
ID Name 
1 1958 National Child Development Study (UK) 
2 1970 British Cohort Study (UK) 
3 ALPHA Network 
4 Analysis of a sample of type 2 diabetic patients with obesity or 
overweight and at cardiovascular risk: a cross sectional study 
in Spain 
5 Australasian Association of Cancer Registries 
6 Avon Longitudinal Study of Parents and Children (UK) 
7 Birth to Twenty 
8 Born in Bradford (UK) 
9 Cancer Registries 
10 CartaGene 
11 Concord 2 
12 ELFE, Growing up in France (France) 
13 European Prospective Investigation into Cancer and Nutrition 
(EPIC) 
14 European Social Survey 
15 Generation Scotland (UK) 
16 Growing up in New Zealand 
17 ICPSR 
18 INDEPTH Network 
19 International Epidemiological Databases to Evaluate AIDS 
(leDEA) in sub-Saharan Africa 
20 IPUMS International Project 
21 Longitudinal Study of Young People in England (UK) 
22 Measure DHS, Demographic Health Surveys 
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23 MIDUS Midlife in the US 
24 Millennium Cohort Study (UK) 
25 Monitoring the efficacy and safety of three artemisinin based-
combinations therapies in Senegal: results from two years 
surveillance 
26 Norwegian Mother and Child Cohort Study (Norway) 
27 Pelotas Birth Cohort Study 
28 Population Health Metrics Research Consortium Gold 
Standard Verbal Autopsy Data 2005–2011 
29 Prevalence of schistosome antibodies with hepatosplenic 
signs and symptoms among patients from Kaoma, Western 
Province, Zambia 
30 RAND Centre for the Study of Ageing 
31 SABE - Survey on Health, Well-Being and Aging in Latin 
America and the Caribbean 
32 SABRE Southall and Brent Revisited 
33 Scottish Longitudinal Study (Scotland) 
34 Study of Environment on Aboriginal Resilience and Child 
Health 
35 The China Kadoorie Biobank 
36 The China-Anhui birth cohort study 
37 The Epidemiology - France web portal A collaborative project 
in epidemiology 
38 The International Collaboration of Incident HIV and Hepatitis C 
in Injecting Cohorts Study 
39 The Limache birth cohort study 
40 The Motorik-Modul Longitudinal Study (Germany) 
41 The National Survey of Sexual Attitudes and Lifestyles (UK) 
42 The spectrum of paediatric cardiac disease presenting to an 
outpatient clinic in Malawi 
43 TwinsUK and Healthy Aging Twin Study (UK) 
44 Udaipur health and Immunization studies 
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45 UK Biobank (UK) 
46 Understanding Society (UK) 
47 Whitehall Study (UK) 
48 WHO Study on Global AGEing and Adult Health (SAGE) 
49 Worldwide Antimalarial Resistance Network 
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Copy of the survey 
Data Discoverability Survey 
Thank you for your interest in completing this survey, which has been 
commissioned by Wellcome Trust to support the work of the Public Health 
Research Data Forum. 
 
The aim of this survey is to enhance our understanding of the current 
challenges facing everyone in making research datasets 'discoverable'. A 
great deal of emphasis is currently being placed on the promotion of data 
sharing, however this is only part of the challenge. The following questions 
seek to explore the issues in more detail but are necessarily brief. 
 
We have tried to design this survey so that it is easy to complete within one 
sitting of no more than 10 minutes although it is possible for you to save and 
return if you run out of time. 
 
Thank you again for taking the time. 
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Background information 
Please use the following sections to tell us a bit about yourself. 
 
Main employer or employment status  
 University 
 Government agency 
 Non-governmental organization 
 Charity 
 Private company 
 Self-employed 
 Student 
 Unemployed 
 Retired 
(Please select the option that applies best to you) 
Please indicate the regions of the world where you carry out your work  
 Southern Asia 
 Eastern Asia 
 Europe 
 South-Eastern Asia 
 South America 
 Eastern Africa 
 Northern America 
 Western Africa 
 Western Asia 
 Northern Africa 
 Central America 
 Middle Africa 
 Central Asia 
 Southern Africa 
 Caribbean 
 Oceania 
(Please tick all that apply) 
How would you describe your role in public health research data 
 Data provider 
 Data user 
 Archivist / Librarian 
 Funding agency 
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 Policy maker 
 Observer 
 Other 
(Please select all that apply) 
 
Other role: __________________________________ 
(Please briefly describe the role) 
 
Are you in receipt of funding from any of the following agencies 
 Agency for Healthcare Research and Quality (USA) 
 Bill and Melinda Gates Foundation 
 Canadian Institutes of Health Research 
 Centres for Disease Control and Prevention 
 Deutsche Forschungsgemeinschaft (DFG) 
 Doris Duke Charitable Foundation 
 Economic and Social Research Council (UK) 
 Health Research Council of New Zealand 
 Health Resources and Services Administration (USA) 
 Hewlett Foundation 
 INSERM 
 Medical Research Council (UK) 
 National Health and Medical Research Council 
 (Australia) 
 National Institutes of Health (USA) 
 Substance Abuse and Mental Health Services 
 Administration (USA) 
 Wellcome Trust 
 The World Bank 
 NIHR (UK) 
 Other(s) 
(Please tick all that apply) 
 
Other funders (please list one per line): 
__________________________________ 
 
Please indicate the forms of data that you commonly handle 
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 Survey 
 Healthcare records 
 Disease registries 
 Ethnographic 
 Geospatial 
 Environmental 
 Genomic/Proteomic/Metabolomic 
 Imaging 
 Physiological measurement 
 Other 
(Please tick all that apply) 
 
What other form(s) of data do you commonly work with? 
__________________________________ 
 
Please indicate which areas of the research data life-cycle are you actively 
involved in 
 Conceptualisation 
 Creation or receipt 
 Appraisal & Selection 
 Analysis 
 Metadata creation 
 Preservation action 
 Storage 
 Access, use and reuse 
 Transformation 
 Data Destruction 
 Archive management 
 Administration 
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Data Discoverability 
What are the most important things that are needed to promote data 
discoverability? 
Please indicate below how important you consider each aspect of 
discoverable data: 
 
 
 
Preferred search options 
 Keyword 
 Subject terms 
 Concepts 
 Related concepts 
(Please tick all that apply) 
 
What aspects of a research study should ideally be easily searchable? 
 Research study question 
 Research study protocol 
 Research data management plan 
 Consent form and associated information pack 
 Funding details 
 Data collection instrument designs 
 Variables 
 Code lists 
 Concepts 
 Research publications 
(Please tick all that apply) 
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Is there any other aspect of data discoverability that you feel is important? 
 __________________________________ (Please provide any other 
observation or concern) 
 
How could discoverability of public health data be improved and do you see 
any immediate priorities? 
__________________________________ 
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The following is a list of some repository services and classes of repositories 
that exist, mostly taken from Nature's website. The web-link gives examples 
of repositories for many of the categories below. Please indicate the 
repositories that you have used (data access, deposit or both) in the past or 
anticipate using in future. 
 
 
You selected "Other" in the list of repositories above. Please provide details. 
__________________________________ 
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Controlled Vocabularies and Thesauri 
Standardised taxonomies are commonly used approaches to enhance data 
discovery and facilitate comparison across datasets. 
 
Please indicate which of the following terminologies, classifications, thesauri 
or metathesauri you are familiar with 
 SNOMED CT 
 OPCS-4 
 International Classification of Disease (ICD) 
 Logical Observation Identifiers Names and Codes (LOINC) 
 Diagnostic and Statistical Manual of Mental Disorders (DSM 5) 
 Read Codes 
 Medical Subject Headings (MeSH) 
 Humanities and Social Sciences Electronic 
 Thesaurus (HASSET) 
 European Language Social Science Thesaurus (ELSST) 
 Unified Medical Language Service (UMLS) 
 Other 
(Please tick all that apply) 
 
If your answer to the previous question included "Other" please specify 
__________________________________ 
 
Which tools do you use to assist with the management of controlled 
vocabularies? For example, UMLS, Library of Congress, WHO Global Health 
Observatory indicator registry __________________________________ 
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Data documentation 
In order that researchers can reuse research data meaningfully it is important 
to ensure that data are provided with detailed descriptors, typically this has 
been in the form of a code book plus ancillary documentation that describes 
the processes associated with data collection and any processing that has 
been carried out. 
 
The following is a list of standards to assist with data documentation. Please 
indicate which of these you have experience of knowingly using. 
 
 DC 
 SDMX 
 EAD 
 METS 
 DCAT 
 CKAN 
 eGMS 
 INSPIRE 
 ADMS 
 DDI 2/3 
(Please tick all that apply) 
 
Which tools do you use to assist you with data documentation? 
__________________________________ 
 
Which are the key challenges in creating/using documenting data? 
__________________________________ 
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Data Citation and Data Publications 
Citation of data is becoming an important tool to promote and track data 
reuse. Data publication offers a mechanism to promote data citation. The 
following section explores your views and understanding of these options. 
 
It is possible to publish articles that describe research datasets 
independently of conventional research publications. Are you familiar with 
this form of data publication? 
 Yes 
 No 
 
Where did you first hear about data publications?  
 Colleague 
 Journal 
 Conference/workshop 
 Search engine 
 Other 
(Please tick all that apply) 
 
If your answer to the previous question included 'other' please specify. 
__________________________________ 
 
Please indicate which benefit(s) of data citation are most important to you  
 Easier for readers to locate data 
 Proper credit given to data contributors 
 Links between datasets and associated methodology publication provide 
context for reader 
 Links between datasets and publications describing their use can 
demonstrate impact. 
 Infrastructure can support long-term reference and reuse 
 Less danger of data plagiarism 
 Promotes professional recognition and rewards 
 Other 
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(Please tick all that apply) 
What other benefits do you see in data citation? 
__________________________________ 
 
How granular should data citations be:  
 Dataset collections 
 Single datasets (or sweep) 
 Files within datasets 
 Individual items of data 
 Other 
(Please tick all that apply) 
 
Since you selected other above, please give your suggestion here: 
__________________________________ 
 
Ideally, how should longitudinal and regularly changing datasets be handled? 
 New identifier assigned at each update 
 Publish revisions at regular intervals 
 Time series data should be published as complete 'snapshots' 
 Time series data should be published in instalments 
 All published versions of the datasets must be stored 
 Other 
(Please tick all that apply) 
 
Other mechanism suggested for handling longitudinal and changing 
datasets: __________________________________ 
Which would you say, if any, are the key challenges affecting the widespread 
adoption of data publications? __________________________________ 
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Supplementary Table 2 Use of metadata standards by role and stage of the research data lifecycle 
 
Metadata standards Role in public health Total 
Data 
provider 
Data user Archivist / 
Librarian 
Funding 
agency 
Policy maker Other 
DC 
 
Creation or receipt  0 0 3  1 0 3 
Appraisal & Selection  1 1 4  0 0 4 
Analysis  1 1 3  1 0 3 
Metadata creation  1 1 4  1 0 4 
Preservation action  2 1 4  1 0 4 
Storage  1 1 3  1 0 3 
Access, use and reuse  2 1 6  1 1 7 
Transformation  0 0 1  0 0 1 
Data Destruction  0 0 1  1 0 1 
Archive management  2 1 4  1 0 4 
Administration  1 1 1  0 0 1 
Total  2 1 6  1 1 7 
SDMX  
Conceptualisation  0 1 0  0 1 1 
Appraisal & Selection  1 2 2  0 1 3 
Analysis  1 2 1  1 1 3 
Metadata creation  1 1 2  0 0 2 
Preservation action  1 1 2  0 0 2 
  
 
2
9
2
 
Storage  1 1 2  0 0 2 
Access, use and reuse  1 2 2  0 1 3 
Transformation  0 1 0  0 1 1 
Archive management  1 2 2  0 1 3 
Administration  1 1 1  0 0 1 
Total  1 2 2  1 1 4 
EAD 
 
Appraisal & Selection  0  1    1 
Metadata creation  0  1    1 
Preservation action  1  2    2 
Storage  0  1    1 
Access, use and reuse  1  2    2 
Archive management  1  2    2 
Total  1  2    2 
METS 
 
Creation or receipt   0 2  1 0 2 
Appraisal & Selection   0 2  0 0 2 
Analysis   2 1  1 0 3 
Metadata creation   0 4  1 0 4 
Preservation action   0 4  1 0 4 
Storage   0 4  1 0 4 
Access, use and reuse   0 3  1 1 4 
Data Destruction   0 1  1 0 1 
Archive management   0 4  1 0 4 
Total   2 4  1 1 7 
DCAT  Creation or receipt    1  1 0 1 
  
 
2
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3
 
Appraisal & Selection    0  0 1 1 
Analysis    1  1 1 2 
Metadata creation    1  1 1 2 
Preservation action    1  1 0 1 
Storage    1  1 0 1 
Access, use and reuse    1  1 1 2 
Data Destruction    1  1 0 1 
Archive management    1  1 0 1 
Total    1  1 1 2 
CKAN 
 
Conceptualisation  1 1 0 1 1  1 
Creation or receipt  1 1 0 1 1  1 
Appraisal & Selection  2 1 1 1 1  2 
Analysis  1 1 0 1 1  1 
Metadata creation  1 1 0 1 1  1 
Preservation action  1 0 1 0 0  1 
Storage  2 1 1 1 1  2 
Access, use and reuse  1 1 0 1 1  1 
Archive management  1 0 1 0 0  1 
Administration  1 1 0 1 1  1 
Total  2 1 1 1 1  2 
eGMS  
Conceptualisation  1 1     1 
Creation or receipt  1 1     1 
Appraisal & Selection  1 1     1 
Analysis  1 1     1 
  
 
2
9
4
 
Preservation action  1 1     1 
Access, use and reuse  1 1     1 
Archive management  1 1     1 
Total  1 1     1 
INSPIRE 
 
Conceptualisation  2 2    0 2 
Creation or receipt  2 2    0 2 
Appraisal & Selection  1 1    1 2 
Analysis  2 4    1 5 
Metadata creation  2 2    1 3 
Preservation action  1 1    0 1 
Storage  1 1    0 1 
Access, use and reuse  2 2    1 3 
Transformation  2 2    0 2 
Data Destruction  1 1    0 1 
Archive management  1 1    0 1 
Administration  1 1    0 1 
Total  2 4    1 5 
DDI 2/3  
Conceptualisation  11 9 1 2 2 2 12 
Creation or receipt  12 9 3 2 2 2 15 
Appraisal & Selection  13 9 9 2 2 0 19 
Analysis  14 11 5 1 1 2 18 
Metadata creation  17 10 9 2 3 2 23 
Preservation action  11 6 8 1 1 2 15 
  
 
2
9
5
 
Storage  15 9 9 2 2 2 20 
Access, use and reuse  19 12 12 2 3 3 29 
Transformation  10 5 3 0 0 1 11 
Data Destruction  1 0 1 0 0 1 2 
Archive management  9 3 7 0 0 2 12 
Administration  6 5 1 1 1 1 6 
Total  19 12 12 2 3 3 29 
Percentages and totals are based on respondents. 
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Appendix B: Improving metadata quality assessment in public health 
and epidemiological research 
Supplementary Table 3 Search strategy 
Source Search terms Results 
ACM Digital 
Library 
"Epidemiology" AND "Metadata" AND "Metadata quality 
assessment" AND "Metadata quality dimensions" AND 
"Metadata quality evaluation" AND "Public health" AND 
"Public health and epidemiology" AND "Quality 
assessment" AND "Quality evaluation"   
0 
BioMed 
Central 
 "Epidemiology" AND "Metadata" AND "Metadata quality 
assessment" AND "Metadata quality dimensions" AND 
"Metadata quality evaluation" AND "Public health" AND 
"Public health and epidemiology" AND "Quality 
assessment" AND "Quality evaluation"   
0 
CINAHL Plus Epidemiology AND Metadata AND Metadata quality 
assessment AND Metadata quality dimensions AND 
Metadata quality evaluation AND Public health AND ( 
Public health and epidemiology ) AND Quality 
assessment AND Quality evaluation   
0 
The 
Cochrane 
Library 
epidemiology and metadata and metadata quality 
assessment and metadata quality dimensions and 
metadata quality evaluation and public health and public 
health and epidemiology and quality assessment and 
quality evaluation (Word variations have been 
searched)   
0 
EMBASE (Epidemiology and Metadata and Metadata quality 
assessment and Metadata quality dimensions and 
Metadata quality evaluation and Public health and (Public 
health and epidemiology) and Quality assessment and 
Quality evaluation).af.   
0 
Lecture 
Notes in 
Computer 
Science 
"Epidemiology" AND "Metadata" AND "Metadata quality 
assessment" AND "Metadata quality dimensions" AND 
"Metadata quality evaluation" AND "Public health" AND 
"Public health and epidemiology" AND "Quality 
assessment" AND "Quality evaluation" 
253 
JSTOR (((((((Epidemiology) AND (Metadata)) AND (Metadata 
quality assessment)) AND (Metadata quality 
dimensions)) AND (Metadata quality evaluation)) AND 
(Public health )) AND (Public health and epidemiology)) 
((Quality assessment) AND (Quality evaluation)) 
134 
PubMed  (((((((("epidemiology"[Subheading] OR 
"epidemiology"[All Fields] OR "epidemiology"[MeSH 
Terms]) AND Metadata[All Fields]) AND (Metadata[All 
Fields] AND quality[All Fields] AND 
("Assessment"[Journal] OR "assessment"[All Fields]))) 
AND (Metadata[All Fields] AND quality[All Fields] AND 
("Dimensions (N Y N Y)"[Journal] OR "dimensions"[All 
Fields] OR "DHS Dimens"[Journal] OR "dimensions"[All 
Fields]))) AND (Metadata[All Fields] AND quality[All 
Fields] AND ("evaluation studies"[Publication Type] OR 
0 
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"evaluation studies as topic"[MeSH Terms] OR 
"evaluation"[All Fields]))) AND ("public health"[MeSH 
Terms] OR ("public"[All Fields] AND "health"[All Fields]) 
OR "public health"[All Fields])) AND (("public 
health"[MeSH Terms] OR ("public"[All Fields] AND 
"health"[All Fields]) OR "public health"[All Fields]) AND 
("epidemiology"[Subheading] OR "epidemiology"[All 
Fields] OR "epidemiology"[MeSH Terms]))) AND 
(Quality[All Fields] AND ("Assessment"[Journal] OR 
"assessment"[All Fields]))) AND (Quality[All Fields] AND 
("evaluation studies"[Publication Type] OR "evaluation 
studies as topic"[MeSH Terms] OR "evaluation"[All 
Fields]))   
Scopus  ( ALL ( epidemiology )  AND  ALL ( metadata 
)  AND  ALL ( metadata  quality  assessment )  AND  ALL 
( metadata  quality  dimensions )  AND  ALL ( 
metadata  quality  evaluation )  AND  ALL ( public  health 
)  AND  ALL ( public  health  AND  epidemiology 
)  AND  ALL ( quality  assessment )  AND  ALL ( 
quality  evaluation ) ) 
16 
Web of 
Science 
TOPIC: (Epidemiology) AND TOPIC: (Metadata) AND 
TOPIC: (Metadata quality assessment) AND TOPIC: 
(Metadata quality dimensions) AND TOPIC: (Metadata 
quality evaluation) AND TOPIC: (Public health) AND 
TOPIC: (Public health and epidemiology) AND TOPIC: 
(Quality assessment) AND TOPIC: (Quality evaluation)  
25 
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Copy of the metadata quality survey 
Metadata Quality Survey 
 
Thank you for taking the time to complete this survey. 
 
With current drives to increase the creation and availability of metadata, and 
improve application of metadata standards, this survey aims to examine 
current issues associated with using metadata and in particular, identify ways 
through which quality may be enhanced. 
 
This survey forms a part of my work focusing on metadata quality within the 
public health and epidemiology research domains. My work is funded 
through a MRC CASE Studentship with AIMES Grid Services CIC. 
 
This survey should not take no longer than 10 minutes to complete, but the 
option to save your answers and return to the survey later is available. 
 
Once again, thank you. 
 
Christiana McMahon 
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Demographics 
Please select your current location  
 Caribbean 
 Europe 
 Eastern Asia 
 South-Eastern Asia 
 Southern Asia 
 Western Asia 
 Central Asia 
 Northern America 
 South America 
 Central America 
 Northern Africa 
 Eastern Africa 
 Southern Africa 
 Western Africa 
 Middle Africa 
 Oceania 
7.  
Please select your main employer or employment status  
 Charity 
 Government 
 Non governmental agency 
 Private company 
 Retired 
 Self-employed 
 Student 
 Unemployed 
 University 
8.  
Please select your role(s) in public health and epidemiology research  
 Archivist / librarian 
 Clinician / clinical advisor 
 Data provider 
 Data user 
 Funding agency 
 Policy maker 
 Observer 
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 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
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Metadata 
 
How often do you use metadata?  
 Never 
 Sometimes 
 Regularly 
 Frequently 
 Very frequently 
  
Please indicate which types of metadata you have used  
 Administrative 
 Descriptive 
 Microdata 
 Semantic 
 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
In which formats does the metadata you use routinely appear?  
 PDF(s) 
 Spreadsheet(s) 
 Word© document(s) 
 XML 
 RDF 
 HTML 
 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
At which points in the research data lifecycle have you handled metadata?  
 
 Conceptualisation 
 Creation or receipt 
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 Appraisal & Selection 
 Analysis 
 Preservation action 
 Access, use and reuse 
 Transformation 
 Data destruction 
 Archive management 
 Administration 
(Please select all that apply) 
 
At which levels should metadata be available?  
 
 Research study level 
 Single dataset / sweep of data 
 Variable level 
 Each time a change is made to the data 
 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
Which are the main barriers to creating and/or using metadata in biomedical 
research? __________________________________ 
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Tools and technologies 
 
How do you select a tool and/or technology?  
Funder requirement 
Suggestion from colleagues 
Standard practice 
Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
Are the data you receive documented using a clinical terminology?  
 Yes  
 No 
9.  
If yes, please indicate which of the following clinical terminologies you have 
come across  
 DSM 
 ICD 
 LOINC 
 MeSH 
 OPCS 
 Read Codes 
 SNOMED CT 
 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
Did you experience any problems when using the clinical terminology(ies)?  
 Yes 
 No 
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If yes, please briefly describe the problems you encountered 
__________________________________ 
 
 
 
Does the metadata you routinely use comply with any standards?  
 Yes 
 No 
10.  
11.  
12.  
If yes, please indicate which of the following metadata standards you have 
used  
 Dublin Core (or derived standard) 
 Data Documentation Initiative 2 (Code book) 
 Data Documentation Initiative 3 (Lifecycle) 
 ISO/IEC 11179 
 MIBBI (Minimum Information for Biological and Biomedical Investigations) 
 Observ-OM 
 OME-XML (Open Microscopy Environment XML) 
 Protocol Data Element Definitions 
 SDMX / SDMX-HD (Health Domain) 
 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
Have you ever used a metadata catalogue to help improve the discoverability 
of your research?  
 Yes  
 No 
 
Did you experience any challenges in doing so?  
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 Yes 
 No 
 
If yes, please briefly describe the challenges you experienced 
__________________________________ 
 
 
Have you ever used a metadata catalogue to identify and characterise 
research datasets?  
 Yes  
 No 
13.  
Did you experience any difficulties in accessing and/or using the metadata?  
 Yes 
 No 
 
If yes, please briefly describe the difficulties you experienced 
__________________________________ 
 
 
Have you ever used Semantic Web technologies when handling metadata 
e.g. RDF, OWL etc.  
 Yes 
 No 
 
If yes, did you experience any challenges?  
 Yes 
 No 
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If yes, please briefly describe the challenges you experienced 
__________________________________ 
 
Have you used any kind of metamodel as part of your research e.g. HL7 
RIM?  
 Yes 
 No  
If yes, please specify which one(s) 
__________________________________ 
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Metadata usability 
Please indicate which of the following you consider to be of importance to 
metadata usability 
 
 
Are there any other aspects you would consider to be of importance to 
metadata usability? __________________________________ 
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Quality Assessment 
Which of the following quality dimensions do you feel are of importance to 
good quality metadata in biomedical research? 
 
 Accessibility (extent to which the metadata can be accessed) 
 Accuracy (correctness of the metadata) 
 Appropriateness (extent to which the metadata are relevant) 
 Comprehensiveness (extent to which the metadata are complete) 
 Discoverability (how visible the metadata are - can it be easily found) 
 Extendibility (extent to which the metadata may be easily extended) 
 Interoperability (extent to which metadata can be exchanged and used 
without problems) 
 Meta-metadata (metadata about the metadata) 
 Timeliness (is the metadata current, inclusion of temporal information) 
 Versionability (extent to which a new version may be easily created) 
 Other 
(Please select all that apply) 
If other, please specify __________________________________ 
 
How often do you assess the quality of the metadata you routinely handle? 
 Never 
 Sometimes  
 Regularly 
 Frequently 
 Very frequently 
14.  
Do you use any kind of metadata assessment criteria?  
 Yes 
 No 
If yes, please select one option from the following  
 Add name of assessment criteria 
 Add link to web page detailing assessment criteria 
 Upload file containing assessment criteria 
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Name of metadata assessment criteria 
__________________________________ 
Link to web page detailing the metadata assessment criteria 
__________________________________ 
Upload file containing method of metadata assessment criteria 
 
What do you see as being the main difficulties when trying to assess 
metadata quality in biomedical research? 
__________________________________ 
 
Which are the immediate priorities when addressing metadata quality? 
__________________________________ 
 
Are you interested in participating in any small group discussions or short 
interviews regarding metadata quality? 
 Yes 
 No 
 
As this survey is anonymous, please enter your email address if you give 
consent to be contacted __________________________________ 
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Supplementary Table 4 Millennium Cohort Study 
Area of metadata 
quality 
assessment 
Headings Results  
General information Types of metadata Descriptive and administrative 
Formats of metadata 
 
PDFs from the Centre of Longitudinal Studies website 
http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=883&sitesectiontitle=The
+age+11+survey+of+the+MCS+%282012%29  
 
XML from UK Data Service metadata catalogue  
http://esds.ac.uk/DDI25/7464.xml  
Granularity of metadata Study level 
(http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=851&sitesectiontitle=Wel
come+to+the+Millennium+Cohort+Study)  
 
Single dataset/sweep of data 
(http://discover.ukdataservice.ac.uk/catalogue/?sn=7464&type=Data%20cat
alogue)  
 
Variable level 
(http://nesstar.ukdataservice.ac.uk/webview/index.jsp?v=2&mode=document
ation&submode=abstract&study=http://nesstar.ukdataservice.ac.uk:80/obj/fS
tudy/7464&top=yes)  
Missing or incomplete 
metadata 
The artefacts reviewed were: Millennium Cohort Study Fifth Sweep (MCS5) 
Technical Report, UK Data Service data catalogue record for Millennium 
Cohort Study Fifth Survey 2012 and entry in the Nesstar catalogue were all 
complete. 
   
  
 
3
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Tools and 
technologies 
Structure of metadata E.g. 
continuous prose, 
sectioned,  
The technical report was a PDF comprising of continuous prose broken 
down by numbered paragraphs.  
 
The UK Data Service record was a list consisting of headings and sub-
sections 
Nesstar catalogue had a series of collapsible headings with each sub-
section providing increasing granularity of information  
 
Presence of clinical 
terminologies  
Could not find any in the randomly selected subset of documentation 
reviewed.  
Indexing in catalogues  Metadata are indexed in Nesstar and the UK Data Service 
Restrictions on access to 
metadata 
Did not experience any restrictions 
Application of Semantic 
Web technologies 
DDI 2.5 compliant XML format publically available  
http://esds.ac.uk/DDI25/7464.xml  
Method of application and 
reason(s) for use  
Could not find this information 
   
Usability Metadata repositories  Nesstar publisher 
(http://nesstar.ukdataservice.ac.uk/webview/index.jsp?v=2&mode=document
ation&submode=abstract&study=http://nesstar.ukdataservice.ac.uk:80/obj/fS
tudy/7464&top=yes)  
 
UK Data Service  
(http://discover.ukdataservice.ac.uk/catalogue/?sn=7464&type=Data%20cat
alogue)  
Metadata standards  Data Documentation Initiative  
  
 
3
1
2
 
 
 
  
Cross-walks or other 
mappings 
Could not find cross-walks or other mappings 
   
Management and 
curation 
Creation of metadata Nesstar catalogue provides authoring entity and identification number the 
XML syntax provides two agencies and their identification numbers. The 
XML also provides the production date and to whom the copyright is 
assigned. 
Versioning  Version information was found in the XML – the date and version number. 
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Supplementary Table 5 National Survey of Midlife Development in the United States (MIDUS II): Biomarker Project, 2004-2009 
Area of metadata 
quality 
Headings Findings 
General 
information 
Names and locations of 
research artefacts reviewed  
National Survey of Midlife Development in the United States (MIDUS II): 
Biomarker Project, 2004-2009  metadata record 
http://www.icpsr.umich.edu/icpsrweb/ICPSR/series/203/studies/29282?arch
ive=ICPSR&amp;sortBy=7  
National Survey of Midlife Development in the United States (MIDUS II): 
Biomarker Project, 2004-2009 DDI Codebook www.icpsr.umich.edu/cgi-
bin/file?comp=none&study=29282&ds=1&file_id=1101115&path=ICPSR  
National Survey of Midlife Development in the United States (MIDUS II): 
Biomarker Project, 2004-2009 data file notes www.icpsr.umich.edu/cgi-
bin/file?comp=none&study=29282&ds=1&file_id=1101124&path=ICPSR  
Types of metadata Descriptive, administrative, semantic 
Formats of metadata 
 
PDF, XML 
Granularity of metadata Study 
http://www.icpsr.umich.edu/icpsrweb/content/membership/or/metadata/inde
x.html  
Sweep 
http://www.icpsr.umich.edu/icpsrweb/ICPSR/series/203/studies/29282?arch
ive=ICPSR&amp;sortBy=7  
Missing or incomplete 
metadata 
Complete  
Online data visualisation Home page states there is ‘online analysis version with question text’ but I 
could not find this. 
Provision of variable 
descriptions 
Yes - 
http://www.icpsr.umich.edu/icpsrweb/ICPSR/ssvd/studies/29282/variables  
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Links to other studies, 
sweeps or publications 
Links to publications for this sweep 
http://www.icpsr.umich.edu/icpsrweb/ICPSR/biblio/studies/29282/resources
?collection=DATA&archive=ICPSR&sortBy=1  
and study 
http://www.icpsr.umich.edu/icpsrweb/ICPSR/biblio/series/00203/resources?
sortBy=1&archive=ICPSR  
Other   
   
Tools and 
technologies 
Structure of metadata E.g. 
continuous prose, 
sectioned,  
Continuous prose, signposted with clear headings 
DDI compliant XML can be found if the page source is viewed 
http://www.icpsr.umich.edu/icpsrweb/ICPSR/ddi3/studies/29282  
Presence of clinical 
terminologies  
Could not find these 
Presence of code(s) and 
category(ies) lists 
Description of variables coding conventions 
Indexing in catalogues  Indexed in ICPSR  
Restrictions on access to 
metadata 
Did not find any 
Application of Semantic 
Web technologies 
XML  
Method of application and 
reason(s) for use  
Could not find this information 
   
Usability Metadata standards  DDI Codebook and DDI Lifecycle 
Dublin Core 
MARC21 XML 
Datacite XML 
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Cross-walks and other 
inclusive of method and 
when these were created 
Could not find cross-walks between the different versions of DDI or across 
the different standards  
Other mappings  
Provision of metadata 
model (metamodels) 
Could not find this 
   
Management and 
curation 
Date and version of 
assessment 
20150519; version 1 
Name of person assessing 
the metadata 
C McMahon 
Creation of metadata All dates provided alongside the version history 
Provision of other versions  Full version history is available inclusive of brief description of changes e.g. 
on 2013-04-13, ‘technical corrections were made to the data formats’. 
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Supplementary Table 6 Danish National Birth Cohort 
Area of metadata 
quality 
Headings Findings 
General 
information 
Names and locations of 
research artefacts reviewed  
Danish National Birth Cohort 
http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC.
aspx  
Danish National Birth Cohort (Centre of Longitudinal Studies) 
http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=342&sitesectiontitle=Da
nish+National+Birth+Cohort  
The Danish National Birth Cohort – its background, structure and aim 
http://www.ssi.dk/~/media/Indhold/DK%20-
%20dansk/Forskning/BSMB/BSMB%20artikler/danishbirthcohort.ashx  
Types of metadata Descriptive  
Formats of metadata 
 
PDF, HTML 
Granularity of metadata Study  
http://www.ssi.dk/~/media/Indhold/DK%20-
%20dansk/Forskning/BSMB/BSMB%20artikler/danishbirthcohort.ashx   
http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC/
About%20the%20DNBC/Background%20and%20Overall%20aim%20of%2
0the%20DNBC.aspx  
Missing or incomplete 
metadata 
Complete  
Online data visualisation/ 
variable tabulation tools 
Found graph showing cumulated participation across the different 
interviews 
http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC/
For%20researchers/Data%20available.aspx  
Variable description    
Links to other studies, Through the Danish Data Archive: 
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sweeps or publications Danish National Birth Cohort  I, 1997-2003 
http://samfund.dda.dk/ddakatalog/sdfiler/R17541gb.htm  
Danish National Birth Cohort  II, 1997-2003 
http://samfund.dda.dk/ddakatalog/sdfiler/R22345gb.htm 
Danish National Birth Cohort  III, 1998-2003 
http://samfund.dda.dk/ddakatalog/sdfiler/R23163gb.htm 
Danish National Birth Cohort  IV, 1999-2004 
http://samfund.dda.dk/ddakatalog/sdfiler/R23164gb.htm  
List of NCI indexed publications 
http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/40488075/?sort=date
&direction=descending  
List of DNBC theses 
http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC/
Publications/DNBC%20Theses.aspx  
Other   
   
Tools and 
technologies 
Structure of metadata E.g. 
continuous prose, 
sectioned,  
Continuous prose sign posted using headings 
Presence of clinical 
terminologies  
Could not find any 
Presence of code(s) and 
category(ies) lists 
Codebooks are available for all four interviews 
I http://www.ssi.dk/~/media/Indhold/DK%20-
%20dansk/Forskning/BSMB/BSMB%20Dokumenter/Kodeboeger/De%20fir
e%20forste%20interviews/UKInt1.ashx  
II http://www.ssi.dk/~/media/Indhold/DK%20-
%20dansk/Forskning/BSMB/BSMB%20Dokumenter/Kodeboeger/De%20fir
e%20forste%20interviews/UKInt2.ashx  
III http://www.ssi.dk/~/media/Indhold/DK%20-
%20dansk/Forskning/BSMB/BSMB%20Dokumenter/Kodeboeger/De%20fir
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e%20forste%20interviews/Int3UKJune08.ashx  
IV http://www.ssi.dk/~/media/Indhold/DK%20-
%20dansk/Forskning/BSMB/BSMB%20Dokumenter/Kodeboeger/De%20fir
e%20forste%20interviews/UKInt4.ashx  
Indexing in 
catalogues/repositories  
Centre for Longitudinal Studies 
http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=342&sitesectiontitle=Da
nish+National+Birth+Cohort  
Birthcohorts.net http://www.birthcohorts.net/bch2/?action=show&UserID=3 
The page did not load properly and the information was difficult to read 
Restrictions on access to 
metadata 
No restrictions experienced 
Application of Semantic 
Web technologies 
Description can be found here http://dda.dk/search-technical-
information?lang=en  
DDI can be found by viewing the page source e.g. data collection 
http://dda.dk/search-technical-information/cv/collectionsituation.dda.dk-
1.0.0.cv  
Method of application and 
reason(s) for use  
Could not find this information  
   
Usability  Metadata standards  Metadata at the Danish Data Archive comply with DDI 
Cross-walks inclusive of 
method and when these 
were created 
Could not find any 
Other mappings  
Provision of metadata 
model (metamodels) 
Could not find any 
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Management and 
curation 
Date and version of 
assessment 
20150520; version1 
Name of person assessing 
the metadata 
C McMahon 
Creation of metadata Dates of when websites were last update were found at the bottom of the 
screen. 
Provision of other versions  Could not find any 
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Appendix C: Improving the capture of consent for record linkage 
metadata in longitudinal studies 
Supplementary Table 7 Theme: Analysis 
Author Title 
(Hyde and 
White 2010) 
 
 
(Klassen, Lee 
et al. 2005) 
 
(Dunn, Jordan 
et al. 2004) 
 
Are organ donation communication decisions reasoned or reactive? A test of 
the utility of an augmented Theory of Planned Behavior with the 
Prototype/Willingness Model 
 
Linking Survey data with administrative health information characteristics 
associated with consent from a neonatal intensive care unit follow-up study 
 
Patterns of consent in epidemiologic research: evidence from over 25, 000 
responders 
(Knies, Burton 
et al. 2012) 
 
(Spriggs 
2010) 
 
(Lavelle-
Jones, Byrne 
et al. 1993) 
 
(Tate, 
Calderwood 
et al. 2006) 
 
(Jenkins, 
Cappellari et 
al. 2006) 
 
(Khan, 
Karuppaiah et 
al. 2012) 
 
(McGuire, 
Oliver et al. 
2011) 
 
Consenting to health record linkage: evidence from a multi-purpose 
longitudinal survey of a general population 
 
Ethical difficulties With Consent in research Involving Children: Findings from 
Key Informant Interviews 
 
Factors affecting quality of informed consent 
 
 
 
Mother’s consent to linkage of survey data with her child’s birth records in a 
multi-ethnic national cohort study 
 
 
Patterns of consent: evidence from a General Household Survey 
 
 
 
The influence of process and patient factors on the recall of consent 
information in mentally competent patients undergoing surgery for neck of 
femur fractures 
 
To share or not to share: a randomized trial of consent for data sharing in 
genome research 
(Burns, 
Magyarody et 
al. 2011) 
 
(Budin-
Ljosne, Tasse 
et al. 2011) 
 
Attitudes of the general public toward alternative consent models  
 
 
 
Bridging consent: from toll bridges to lift bridges? 
 
 
  
Appendix C: Improving the recording of consent for record linkage metadata in longitudinal studies 
321 
 
Supplementary Table 8 Theme: Comparison of models 
Author Title 
(Berry, Ryan et al. 
2012)  
 
 
(Mark and Spiro 
1990) 
A randomised controlled trial to compare opt-in and opt-out parental 
consent for childhood vaccine safety surveillance using data linkage 
 
 
Informed consent for colonoscopy a prospective study 
 
 
(Matsui, Lie et al. 
2012) 
 
(Berry, Ryan et al. 
2011) 
 
 
(Rogers, Tyson et 
al. 1998) 
 
 
(Pless, Hagel et 
al. 2011) 
 
(Pereira, Hussaini 
et al. 1995) 
 
(Zia, Heslegrave 
et al. 2011) 
 
 
(Fernando, 
Bhojwani et al. 
2007) 
 
(Ibrahim, Ong et 
al. 2004) 
 
A Randomized Controlled Trial of Short and Standard-Length Consent 
Forms for a Genetic Cohort Study: Is Longer Better? 
 
A randomised controlled trial to compare opt-in and opt-out parental 
consent for childhood vaccine safety surveillance using data linkage: 
study protocol 
 
Conventional consent with opting in versus simplified  consent with 
opting out: An exploratory trial for studies that do not increase patient 
risk 
 
Different approaches to obtaining consent for follow-up result in biased 
samples 
 
Informed consent for upper gastrointestinal endoscopy 
 
Post-trial period surveillance for randomized controlled cardiovascular 
studies: submitted protocol, consent forms and the role of the ethics 
board 
 
 
Standards in consent for cataract surgery 
 
 
 
The new consent form: is it any better? 
(Warner 2011) 
 
(Steinsbekk, Kåre 
Myskja et al. 
2013) 
 
(Gefenas, 
Dranseika et al. 
2012) 
 
(May, Craig et al. 
2007) 
   HIE Patient Consent Model Options 
 
Broad consent versus dynamic consent in biobank research: Is 
passive participation an ethical problem? 
 
 
Turning residual human biological materials into research collections: 
playing with consent 
 
 
Viewpoint: IRBs, Hospital Ethics committees, and the Need for 
“Translational Informed Consent” 
 
(Issa, Setzer et al. 
2006) 
 
Informed versus uninformed consent for prostate surgery: The value of 
electronic consents 
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Supplementary Table 9 Theme: Consent aspects of secondary uses of data 
Author Title 
(Elger, Iavindrasana 
et al. 2010) 
 
(Singleton and 
Wadsworth 2006) 
Strategies for health data exchange for secondary cross-institutional 
clinical research 
 
Consent for the use of personal medical data in research 
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Supplementary Table 10 Theme: Development of a new model/form 
Author Title 
(Gori, Greco et al. 
2012) 
A new informed consent form model for cancer patients: Preliminary results of a 
prospective study by the Italian Association of Medical Oncology (AIOM) 
 
(Davis, Pohlman 
et al. 2003) 
 
(Gold, Lebel et 
al. 1993) 
 
(Witt, Pach et al. 
2009)  
 
Improving the Process of Informed consent in the Critically Ill 
 
 
Model Consent forms for DNA Linkage Analysis and Storage 
 
 
Safety of acupuncture: Results of a prospective observational study with 229,230 
patients and introduction of a medical information and consent form 
 
(Caulfield, 
Upshur et al. 
2003) 
DNA databanks and consent: A suggested policy option involving an authorization 
model 
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Supplementary Table 11 Theme: Development of tools to assist consent process 
Author Title 
(Schmidt, Vermeulen 
et al. 2009) 
 
(Coiera and Clarke 
2004) 
Regulatory aspects of genetic research with residual human tissue: 
Effective and efficient data coding 
 
e-Consent: The design and implementation of consumer consent 
mechanisms in an electronic environment 
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Supplementary Table 12 Theme: Discussion of a single model of consent 
Author Title 
(Johnstone and 
McCartney 
2010) 
 
(Rahman, 
Clamp et al. 
2011) 
A patient survey assessing the awareness and acceptability of the 
emergency care summary and its consent model in Scotland 
 
Is consent for the hip fracture surgery older people adequate? The 
case for pre-printed consent forms  
 
(Sheehan 2011) 
 
(Henderson 
2011) 
Can broad consent be informed consent? 
 
Is Informed Consent Broken? 
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Supplementary Table 13 Theme: Establishing and/or Improving participant 
understanding 
Author Title 
(Friedlander, Loeben 
et al. 2011) 
 
 
(Arora, Rajagopalan 
et al. 2011) 
 
 
(Moseley, Wiggins et 
al. 2006) 
 
(Paris, Nogueira da 
Gama Chaves et al. 
2007) 
 
(Akkad, Jackson et 
al. 2006) 
 
(Pilegaard and Ravn 
2012)  
 
(Pesudovs, 
Luscombe et al. 
2006)  
 
(Oosthuizen, Burns 
et al. 2012) 
 
(Buckles, Powlishta 
et al. 2003) 
A novel method to enhance informed consent: a prospective and 
randomised trial of form-based versus electronic assisted informed 
consent in paediatric endoscopy 
 
Development of tool for the assessment of comprehension of informed 
consent form in healthy volunteers participating in first-in-human 
studies 
 
Effects of presentation method on the understanding of informed 
consent 
 
Improvement of the comprehension of written information given to 
healthy volunteers in biomedical research: a single-blind randomized 
controlled study 
 
Patients’ perceptions of written consent: questionnaire study  
 
 
Readability of patient information can be improved 
 
 
Recall from informed consent counselling for cataract surgery 
 
 
 
The changing face of informed surgical consent  
 
 
Understanding of informed consent by demented individuals 
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Supplementary Table 14 Theme: Other 
 
Author Title 
(Haux, Knaup et 
al. 2007) 
 
(Donnan, 
McLernon et al. 
2009) 
 
(Chulada, 
Vahdat et al. 
2008) 
 
On educating about medical data management the other side of the 
electronic health record 
 
Development of a decision support tool for primary care management of 
patients with abnormal liver function tests without clinically apparent liver 
disease: a record-linkage population cohort study and decision analysis 
(ALFIE) 
 
The Environmental Polymorphisms Registry: a DNA resource to study 
genetic susceptibility loci 
 
(Gracie, Lyon et 
al. 2010) 
 
 
(Ries, 
LeGrandeur et 
al. 2010) 
 
(Hammerschmidt 
and Keane 
1992) 
 
(Kalton 2012) 
 
(Armstrong, 
Kline-Rogers et 
al. 2005)  
 
All Our Babies cohort study: recruitment of a cohort to predict women at risk 
of preterm birth through examination of gene expression profiles and the 
environment 
 
 
Handling ethical, legal and social issues in birth cohort studies involving 
genetic research: responses from studies in six countries 
 
 
Institutional review board (IRB) review lacks Impact on the readability of 
consent forms for research 
 
Measuring health in population surveys 
 
Potential impact of the HIPAA privacy rule on data collection in a registry of 
patients with acute coronary syndrome 
(Da Rocha and 
Seoane 2008) 
 
(Terry and 
Francis 2007) 
 
(Ruan and 
Varadharajan 
2003) 
 
(Kuchinke, 
Ohmann et al. 
2014) 
Alternative consent models for biobanks: The new Spanish law on 
biomedical research  
 
Ensuring the privacy and confidentiality of electronic health records  
 
 
Supporting E-consent on Health data by Logic 
 
 
 
A standardised graphic method describing data privacy frameworks in 
primary care research using flexible zone model 
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Supplementary Figure 1 ALSPAC consent form 
ALSPAC (http://www.bristol.ac.uk/alspac/)  
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Supplementary Figure 2 Born in Bradford consent forms 
Born in Bradford (https://borninbradford.nhs.uk/)  
Father’s consent form       Mother’s consent form 
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Allergy and Infection Study     Mechanisms of the Development of Allergy 
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Supplementary Figure 3 British Household Panel Survey consent forms 
British Household Panel Survey (https://www.iser.essex.ac.uk/bhps/)  
Form B           Form C 
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Form D         Form E 
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Supplementary Figure  4 Health Survey for England consent forms 
Health Survey for England (Mindell, J., P. Biddulph, et al. (2012). “Cohort Profile: The Health Survey for England.” Int J Ep idemiol 
41(6): 1585-1593) 
NHS Central Register and Cancer Register – Adults 16+   Hospital Episode Statistics – Adults 16+ 
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Supplementary Figure  5 Life Study consent forms 
Life Study (http://www.lifestudy.ac.uk/)  
Consent form for pregnant mother at 28 weeks   Consent form for partner 28 weeks 
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Consent form for mother at 4 month visit          Consent form for partner 4 visit 
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Consent form for child at 4 month visit   Consent form for record linkage at first visit/contact (mother)  
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Consent form for record linkage at first visit/contact (father/partner)   Consent form for record linkage at 4 months 
(child)  
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Consent form for child at 4 month visit 
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Supplementary Figure  6 Millennium Cohort Study consent form 
Millennium Cohort Study 
(http://www.cls.ioe.ac.uk/page.aspx?&sitesectionid=851&sitesectiontitle=Welcome+to+the+Millennium+Cohort+Study)  
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Supplementary Figure  7 Scottish Health Surveys consent forms 
Scottish Health Survey (http://www.gov.scot/Topics/Statistics/Browse/Health/scottish-health-survey)  
Scottish Health Records – Adults 16+      Scottish Health Records – Children 0-15 
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Scottish Government Follow-up Research – Adults 16+    Scottish Government Follow-up – Research 
children 0-15 
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Supplementary Figure  8 UK Biobank consent form 
UK Biobank (https://www.ukbiobank.ac.uk/)  
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Supplementary Figure  9 Understanding Society consent form 
Understanding Society (https://www.understandingsociety.ac.uk/)  
Form A         Form B 
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Form C           Dorm D 
 
 
 
 
 
  
  
 
3
4
5
 
Supplementary Table 15: ALSPAC 
Records People Consent form Information document 
 Health records 
o Involvement in study (advising) 
 Healthcare 
provider/professional  
 GP 
o Provision of health records 
o Provision of information  
 Locations  
 Databases 
 Records  
 Organisations 
 The NHS Information 
Centre 
 NHS Central Register  
 Education records 
o School records 
 Organisation 
 Department of 
Education 
o Further education 
 Organisation 
 The Data Service 
 Department for 
Business, Innovation 
and Skills  
o Higher education  
 Organisation  
 Universities and 
Colleges Admission 
Service (UCAS) 
 Higher Education 
Statistics Agency 
 Salary and benefits 
 Person 
giving 
consent 
(cannot be 
on behalf of 
another) 
 Organisation 
o University 
 Descriptions and aims 
 Confirmatory statements 
 Signature, date and printed 
full name 
 Definitions  
 Benefits 
 How data linkage actually 
works 
 Says how consent lasts until 
it is withdrawn 
 Case studies – where record 
linkage has been used in the 
past 
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o Organisations 
 Department for Work and 
Pensions 
 HM Revenue and Customs 
o Information 
 National Insurance 
Contributions 
 Tax records 
 Pensions 
 Savings 
 Benefits 
 Work and employment  
 Police/legal records 
o Organisation 
 Ministry of Justice 
o Information  
 Convictions 
 Official cautions 
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Supplementary Table 16 British Household Panel Survey 
Records People Consent form Information document 
 Administrative health records (B) 
o Health data 
o Follow-up on health registration 
 From other sources  
o All adults 16-24 (C) 
 Education data 
 National insurance 
contributions, benefits and 
tax records, saving and 
pensions 
o All adults (D) 
 National insurance 
contributions, benefits and 
tax records, savings and 
pensions 
o All households with a child 
aged 3 to 15 years (E) 
 Education data (4-15 only) 
 Administrative health 
records (B) 
o Parent/guardian 
for child 
 From other sources 
o All adults 16-24 
(C) 
 Person 
consenting for 
themselves 
o All adults (D) 
 Parent/guardi
an for child 
o All households 
with a child 
aged 3 to 15 
years (E) 
 
 Administrative health records (B) 
o Confirmatory permission 
 From other sources 
o All adults 16-24 (C) 
 Signature, date and 
printed full name 
 Confirmatory permission 
o All adults (D) 
 Signature, date and 
printed full name 
 Confirmatory permission 
o All households with a child aged 
3 to 15 years (E) 
 Signature, date and 
printed full name 
 Confirmatory permission 
 Types of information 
 Who can use it  
 What does your 
consent cover 
 How long does it last 
 Possibility of 
including information 
relating to children 
under 16 
 Data security 
 Withdrawal of 
consent 
 Contact details 
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Supplementary Table 17 Health Survey for England 2010 
Records People Consent form Information document 
Hospital Episode Statistics 
 Adults 16+ 
o Authorisation of 
disclosure of HES 
data and linking of 
information 
NHS Central Register and 
Cancer Register 
 Adults 16+ 
o Authorisation to 
disclose personal 
information to 
National Health 
Service Central 
Register / to follow 
up health status 
NHS Central Register and Cancer Register 
 Adults 16+ 
o Demographics 
 Name 
 Date of birth  
o Confirmatory Permission for 
person giving consent  
o Withdrawal of consent 
o People 
 Interviewee and 
interviewer 
Hospital Episode Statistics 
 Adults 16+ 
o Demographics 
 Name and 
signature 
o People 
 Respondent 
and interviewer 
NHS Central Register and Cancer Register 
 Adults 16+ 
o Unique identifiers 
o Organisations 
 University 
 Funding agency 
 NHS Central Registrar 
o Description and aims 
o Statements  
o Dates 
Hospital Episode Statistics 
 Adults 16+ 
o Unique identifiers 
o Organisations 
 University 
 Funding agency 
 NHS Information 
Centre 
o Description and aims 
o Dates 
Could not find any 
accompanying 
documentation 
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Supplementary Table 18 Millennium Cohort Study 
Records People Consent form Information document 
Child of the New Century 
Age 7 Survey 
 Information from other sources 
o Teacher Survey 
 Consent to 
contact teacher 
o Health and education 
records 
 
 Teacher 
o Confirmatory permission 
 Parent/guardian 
o Parental permission to 
release of information from 
health records 
o Parental permission to 
release information 
education records 
o Confirmatory permission 
 Interviewer  
o Interviewer confirmation 
 Confirmatory 
permission 
 Child (for whom consent is being 
given) 
 Interviewer 
confirmation 
 Organisations 
 Form is divided into 
sections specifically 
for the teacher, 
parent/guardian 
and interviewer 
 Consent statements 
 Description/aims 
 Unique identifiers 
 Explains what information 
from other sources is 
 Explain might contact people 
from outside the family – 
school teachers 
 Explain about collecting 
information from routine 
records on education 
 Explain about collecting 
information from routine 
medical and other health 
related records 
 Explain about collecting 
information from routine 
records of economic 
circumstances 
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Supplementary Table 19 Scottish Health Survey 
Records People Consent form Information document 
Scottish Health Records 
 Adults 16+ 
 Consent to send 
information to allow 
health record linkage 
o Name 
o Address 
o Date of birth 
 Children 0-15 
 Consent to send 
information to allow 
health record linkage – 
on behalf of child 
o Name 
o Address 
o Date of birth 
Scottish Government Follow-up 
Research 
 Adults 16+ 
 Consent to pass 
information to the 
Scottish centre for Social 
Research 
o Name 
o Address 
o Relevant answers 
 Children 0-15 
 Consent to pass 
information to the 
Scottish centre for Social 
Research – on behalf on 
child 
o Name 
Scottish Health Records 
 Adults 16+ 
o Person giving 
consent 
 Children 0-15 
o Parent/guardian 
o Child  
Scottish Government Follow-up 
Research 
 Adults 16+ 
o Person giving 
consent 
 Children 0-15 
o Parent/guardian 
o Child  
 
 Organisations 
o Government 
o NHS 
Scotland 
 Unique 
identifiers 
 Consent 
statements 
 Confirmation of 
understanding 
 What is the survey 
 Who takes part 
 What are the questions about 
 General fact – “did you know…” 
 What can participants find out more 
 How does the Scottish government use the 
information  
 Who else uses the information  
 Contact details 
Ask all 16+ 
 NHSCanA 
o Consent for linkage with health records 
o Associated documentation 
 Pale green consent form 
 ReInterA 
o Consent for use of personal information as 
part of further studies 
o Associated documentation 
 Pale blue consent form 
Ask all aged 13-15 
 NHSCanY 
o Consent for linkage with health records – 
given by child 
o Associated documentation 
 Lemon consent form 
 ReInterY 
o Consent for use of personal information as 
part of further studies – given by child 
o Associated documentation 
 Pink consent form 
Ask all aged 0-13 
 NHSCanC/NHSCanY 
o Consent for linkage with health records – 
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o Address 
o Relevant answers 
given by respondent on behalf of 
child/children 
o Associated documentation 
 Lemon consent form 
 NHSCon 
o Coding/categories 
 1 – Consent given 
 2 – Consent not given 
o IF NHSCon = Consent given 
THEN 
 NHSSig 
o Consent for use of personal 
information as part of further studies 
– given by respondent on behalf of 
child/children 
o Associated documentation 
 Pink consent form 
 ReIntCon 
o Coding/categories 
 1 – Consent given 
 2 – Consent not given 
o IF ReIntCon = Consent given THEN 
 eIntSigritten 
consent 
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Supplementary Table 20 UK Biobank 
Records People Consent form Information document 
 Records 
o Status 
 Living 
 Incapacitated  
 Dead  
o Access to…  
 Medical  
 Other health related 
o Storage 
 Long-term 
o Use – health-related research purposes 
 Information 
 Provided information 
 Other information 
 Samples 
o Storage 
 Long-term 
o Samples given 
 Blood 
 Urine  
o Rights  
 Relinquished to UK Biobank  
 Results 
o Access to results 
 None given; although certain may be 
shared during a visit 
o Benefits 
 No financial benefit 
 Volunteer 
 Staff member 
 Participation 
o Type 
 Voluntary 
o Revocation 
(without 
reason) 
 
 Description and 
aims 
 Consent statement 
 Date and signatures 
 Unique identifier 
 Agreements  
 Contact (optional) 
o Answer further 
questions 
o Attend another 
assessment visit 
 
 Purpose of Biobank 
 Why were people chosen – used  
DOB to check age and told practices 
that there patients were being invited 
to a study 
 What does being in Biobank involve 
 What happens during a visit 
 What happens after a visit 
 What to do if you do not/want to take 
part 
 What to do if you are not sure 
 What to do before the assessment 
visit/preparation 
 Travel expenses 
 Why do you need consent 
 Do the participants need to agree to 
everything 
 Are there any risks 
 How will the information about me be 
kept confidential 
 Who will be able to use my 
information 
 Withdrawal- levels 
 What happens if something goes 
wrong – study has insurance 
 Funding/organising study 
 Contact details 
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Supplementary Table 21 Understanding Society 
Records People Consent form Information document 
Consent Form A 
 Adult Health form 
o Adding information from 
administrative health records – 
adults 16+ 
 Health data 
 Health treatment 
 Use of health services  
 Future research studies, 
inclusive of 
o Frequency 
o Causes 
o Treatment or 
outcome of 
diseases 
o Health 
conditions  
 Follow-Up Health 
Registration 
 National Health 
Service Central 
Register 
o National Health 
Service 
registration  
 Registrati
on 
 Health 
status  
Consent Form B 
 Child Health form 
o Adding information from 
administrative health records – 
children (0-15yrs) 
Consent Form A 
 Adult Health form 
o Adding information from 
administrative health records – 
adults 16+ 
o Person giving consent 
 
Consent Form B 
 Child Health form 
o Adding information from 
administrative health records – 
children (0-15yrs) 
o Parent/guardian and child/ren 
 
Consent Form C 
 Under 25 Education Form 
o Adding information from 
Administrative education 
Records – adults (16-24) 
 Person giving consent 
 
Consent Form D 
 Child Education form 
o Adding information from 
administrative education records 
– children (4-15yrs) 
o Parent/guardian and child/ren 
 
Consent Form A 
 Adult Health form 
o Adding information from 
administrative health records – 
adults 16+ 
 Organisations  
o National Health Service 
o Department of Health 
o General Registration 
Office 
o Office for National 
Statistics 
 
Consent Form B 
 Child Health form 
o Adding information from 
administrative health records – 
children (0-15yrs) 
 Organisations 
o National Health Service 
o Department of Health 
o General Registration 
Office 
o Office for National 
Statistics 
 
Consent Form C 
 Under 25 Education Form 
o Adding information from 
Administrative education Records – 
adults (16-24) 
 Organisations  
o England - Department 
for Children, Schools 
 Introduction  
 What information 
would be added 
 Who will use it 
 What does the 
permission cover 
 How long does it 
last 
 Children 
 Data security  
 Changing minds 
 Thank you 
 Contact details 
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 Health data  
 Health treatment 
 Use of health services  
 Future research studies, 
inclusive of 
o Frequency 
o Causes 
o Treatment or 
outcome of 
diseases 
o Health conditions  
 Follow-Up 
Health 
Registration 
 National 
Health 
Service 
Central 
Register 
Consent Form C 
 Under 25 Education Form 
o Adding information from 
Administrative education 
Records – adults (16-24) 
 Education data  
 Education data (records) 
 
Consent Form D 
 Child Education form 
o Adding information from 
administrative education records 
– children (4-15yrs) 
 Education data (records) 
and families 
o Wales - Department for 
Children, Education, 
Lifelong Learning, and 
Skills 
o Scotland - 
Government 
Education Directorate 
o Northern Ireland -
Department of 
Education/Education 
and Skills Authority 
Consent Form D 
 Child Education form 
o Adding information from 
administrative education records – 
children (4-15yrs) 
 Organisations  
o England - Department 
for Children, Schools 
and families 
o Wales - Department for 
Children, Education, 
Lifelong Learning, and 
Skills 
o Scotland - Government 
Education Directorate 
o Northern Ireland - 
Department of 
Education/Education 
and Skills Authority 
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Supplementary Table 22 Born in Bradford 
Records People Consent form Information document 
Mechanisms of the Development of ALLergy 
Mothers consent form 
 Blood sample 
o Take child’s blood sample, store for 
future use, may be used outside of 
the UK – can withdraw consent 
 Skin allergy test 
o Agree for child to be tested for 
allergies 
 
Born in Bradford Allergy and Infection Study 
Mother’s consent form 
 Information collected in this study will be 
linked to the Born in Bradford, can 
contact mother when child is 4 for an 
allergy test 
 Agree to a blood sample being taken – 
stored for use both in and out of UK, will 
not be told results about infection status 
 
Mother’s consent form 
 Agree to future contact 
 Agree to given biological samples – 
blood, saliva, urine (same basis as 
above) 
 Agree to blood sample from umbilical 
cord being taken post-delivery – the 
baby’s and mother’s biological samples 
will be stored. Understand that 
researchers in and out of the UK can use 
these samples and that the results of 
which will not be provided 
 
Mechanisms of the Development of ALLergy 
Mothers consent form 
 Parent/guardian and child 
 Confirm understanding that researchers 
based at BiB, with UK, in and out of Europe 
may use the samples and the results of 
which will not be given to the mother 
 Name of participant, name of person taking 
consent if different to the researcher, name 
of researcher – all have date of recruitment 
and signature 
 If withdraw, agree for the retention of the 
samples unless mother specifically requests 
they are destroyed – research team will 
make every effort to do so  
 
Born in Bradford Allergy and Infection Study 
Mother’s consent form 
 Confirmation of understanding of 
information and had opportunity to ask 
questions, participation is voluntary, free to 
withdraw at any time without giving any 
reason, without our medical care or legal 
rights being affected 
 Wish to withdraw from the study, samples 
are to be destroyed and research team to 
kame every effort that no further analysis is 
conducted on the samples 
 
Mother’s consent form  
 Confirmation of understanding, participation 
is voluntary, can withdraw without reason 
 Understand that researchers may wish to 
 Confirmation of 
understanding 
 Withdrawal of consent 
 Agree to GP knowing 
about child’s 
involvement in the 
study 
 Permission to access 
parent/guardian and 
child’s medical notes 
and data collected 
during the study, 
regulatory authorities 
or form the NHS Trust 
 
 Aim of study 
 The process 
 What will happen to 
the information 
 What will happen to 
the samples 
 Contact 
 Confidentiality 
 Advantages for taking 
part 
 Will the participants 
get to know the 
findings of the 
research  
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Father’s consent form 
 Agree to future contact 
 Agree to provide biological samples 
which may include saliva. Can withdraw 
from study but samples will be retained 
unless request to destroy all samples is 
made 
 
look at medical and educational records – 
understand that certain other countries do 
not have the same data protection laws as 
the UK but the mother has understood that 
the information cannot be linked back to her 
  Child details may be passed to the ONS 
and this will need permission from the Data 
Advisory Group 
 Name of participant, name of person taking 
consent if different from study administrator 
and name of study administrator  
 
Father’s consent form 
 Confirmation of understanding, participation 
is voluntary, can withdraw without reason 
 understand that certain other countries do 
not have the same data protection laws as 
the UK but the father has understood that 
the information cannot be linked 
 Understand that researchers in and out of 
the UK can use these samples and that the 
results of which will not be provided 
 Name of participant, name of person taking 
consent if different from study administrator 
and name of study administrator 
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Supplementary Table 23 Life Study 
Records People Consent form Information document 
Consent form for record 
linkage at 4months (child) 
 Health 
 Education  
 
Consent form for record 
linkage at first visit/contact 
(father/partner) 
 Health 
 Education  
 Mobile 
 Economic 
o Benefit claims 
o Time on 
employment 
programs 
 Work and 
employment 
 
Consent form for record 
linkage at first visit/contact 
(mother) 
 Health 
 Education  
 Mobile 
 Economic 
 
 
All Forms 
 Confirmation of understanding and 
opportunity to ask questions 
 Confirmation of understanding that 
participation is voluntary and that consent 
may be withdrawn at any time without 
reason 
 medical notes and data – consenting for 
themselves or on behalf of a child 
 Agree to GP being informed of participation 
 Agree to baby(ies) taking part 
 Give permission for regulatory authorities 
and sponsoring organisations to have 
access  
 
Forms for child:  
 Contact form for child at 4 month visit 
 Confirmation of parent/legal guardian of 
child 
 Give permission for collection, long-
term storage of child’s biological 
samples for health related research 
purposes and relinquish all right to 
these sample which I am donating to 
Life Study 
 Consent form for child at 4 month visit 
(MC) 
 Give permission for my child to be 
recorded (e.g. camera) and for these 
recording to be stored long-term and 
used for research purposes  
 Understand that none of the child’s 
results will be shared apart from a 
All forms 
 Organisations 
o Health 
 NHS 
 DH 
 Registers 
 General registration 
 ONS 
 NHS Central Register 
o Education 
 English Department 
for Children, Schools 
and Families 
 Welsh Department for 
Children, Education, 
Lifelong Learning and 
Skills 
 Scottish Government 
Education Directorate 
 Department of 
Education/Education 
and Skills Authority in 
Northern Ireland 
 
Consent form for record linkage 
at first visit/contact 
(father/partner) 
 Organisations 
o Department for Work and 
Pensions  
 HM Revenue and 
Customs 
 
Consent form for record linkage 
 What is life study going to do 
 Why have I been chosen  
 What will happen when I take 
part 
 What happens after the visits 
 What happens at the 
pregnancy visit 
 What will happen to the baby 
 Will they get any results 
 Do I have to take part 
 Travel expenses 
 Benefits to mother/child by 
taking part 
 Risks 
 Confidentiality 
 What happens if there are any 
problems 
 What to do if 
sure/unsure/undecided about 
taking part 
 Will GP know I’m taking part 
 Withdrawal 
 Who is organising/funding 
study 
 Who has reviewed the study 
 Contact details 
 Who will use the information 
 When are samples taken 
 Record linkage 
o What is it 
o How does it work 
o Why do you need the 
records 
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select number of measurement 
 
Forms for partner 
 Consent form for partner at 4month visit 
 May be contacted in the future 
 Give permission for collection, long-
term storage of biological samples for 
health related research purposes and 
relinquish all right to these sample 
which I am donating to Life Study 
 Consent form for partner at 28 week visit 
(MC) 
 May be contacted in the future 
 Give permission for collection, long-
term storage of biological samples for 
health related research purposes and 
relinquish all right to these sample 
which I am donating to Life Study 
 
Forms for mother (including pregnancy) 
 
 Consent form for mother at 4month visit 
(NC) 
 Consent form for pregnant mother at 
28week visit (MC) 
 May be contacted in the future – 
mother and child(ren) 
 Access to medical and other 
health-related records, long-term 
storage  
 Only certain results will be given to 
me 
at first visit/contact (mother) 
 Organisations  
o Education  
 Universities and 
Colleges Admissions 
Service/Higher 
Education Statistics 
Agency (HESA) – 
education records 
 Department for 
Business, Innovation 
& Skills to provide 
education records 
o Economic 
 Department for Work 
and Pensions  
 HM Revenue and 
Customs 
 Work and 
employment 
 
o Who do you link to my 
child’s records 
o Who will use the 
information 
o Which records will be 
linked 
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Elements highlighted in red indicate that an element was not found in DDI3.2 to map with. Elements highlighted in purple indicate 
the ‘Note’ element in DDI can only be used in conjunction with another maintainable object; otherwise, the consent element cannot 
be mapped. The use of the ‘Note’ element here functions very much as a work around solution. 
Supplementary Table 24 Personal records cross-walk 
Personal records 
Personal records analyses Data Documentation Initiative 3.2 (XML source) 
Health   
         Organisation   
o    National Health Service <xs:element name="Organization" type="OrganizationType"/> 
  The NHS Information Centre <xs:element name="OrganizationName" 
type="OrganizationNameType"/>   NHS Central Registrar  
o    Department of Health 
<xs:element name="Organization" type="OrganizationType"/> o    General Registration Office 
o    Office for National Statistics 
         Healthcare professional   
o    Primary care <xs:element name="Concept" type="ConceptType"/> 
  GP <xs:element name="Contributor" type="ContributorType"/> 
o    Secondary care 
<xs:element name="Concept" type="ConceptType"/> 
o    Tertiary care  
         Clinical    
o    Terminologies  <xs:element name="CodeListGroup" type="CodeListGroupType"/> 
  ICD-10 
<xs:element name="CodeList" type="CodeListType"/> 
  ICD for Oncology  
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  SNOMED-CT 
  Read Codes 
  DSM 
  OPCS  
         Treatments and management of conditions   
o    Current   
  Health treatment   
  Use of health services    
o    Previous    
  Health treatment   
  Use of health services    
o    Samples provided   
  Method <xs:element name="CodeListGroup" type="CodeListGroupType"/> 
         Invasive 
<xs:element name="CodeList" type="CodeListType"/> 
         Non-invasive  
  Type  <xs:element name="CodeListGroup" type="CodeListGroupType"/> 
         Blood 
<xs:element name="CodeList" type="CodeListType"/> 
         Urine 
         Hair  
         Saliva  
  Storage of samples    
  Rights    
  Benefits and compensation    
o    Tests and assessments   
  Rights to results    
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  Length of test   
  Location    
         Follow-up on health registration   
Education    
         Type <xs:element name="Organization" type="OrganizationType"/> 
o    School records 
<xs:element name="OrganizationName" 
type="OrganizationNameType"/> 
o    Further education 
o    Higher education  
         Provider    
o    Organisation <xs:element name="Organization" type="OrganizationType"/> 
         Department of Education 
<xs:element name="OrganizationName" 
type="OrganizationNameType"/> 
         The Data Service 
         Department for Business, Innovation and 
Skills  
         Universities and Colleges Admission Service 
(UCAS) 
         Higher Education Statistics Agency 
         Department for Children, Schools and 
families 
         Department for Children, Education, Lifelong 
Learning, and Skills 
         Government Education Directorate 
         Department of Education/Education and 
Skills Authority 
  Location  <xs:element name="LocationName" type="LocationNameType"/> 
o    Educators    
  Name <xs:element name="Contributor" type="ContributorType"/> 
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  Associated school/college/university  
<xs:element name="OrganizationName" 
type="OrganizationNameType"/> 
Criminal    
         Organisations <xs:element name="Organization" type="OrganizationType"/> 
o    Ministry of Justice 
<xs:element name="OrganizationName" 
type="OrganizationNameType"/> 
         Records    
o    Official cautions   
o    Convictions    
Work and employment   
         Organisations <xs:element name="Organization" type="OrganizationType"/> 
o    Department for Work and Pensions <xs:element name="OrganizationName" 
type="OrganizationNameType"/> o    HM Revenue and Customs 
         Records      
o    Salary   
o    National insurance contributions   
o    Tax    
o    Savings   
o    Benefits   
o    Pensions    
Mobile   
         Past   
         Current   
Future    
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Supplementary Table 25 People cross-walk 
People 
People  analyses Data Documentation Initiative 3.2 (XML source) 
·         Identifiers   
o    NHS number 
<xs:element name="Note" type="NoteType"/> 
o    Passport number 
o    other   <xs:element minOccurs="0" name="FormNumber" type="xs:string"/> 
·         Name of interviewee   
o    Forename 
<xs:element minOccurs="0" name="FullName" type="r:InternationalStringType"/> 
o    Surname 
·         Address <xs:element name="Note" type="NoteType"/> 
·         Birth details   
o    Date  <xs:element name="Date" type="DateType"/> 
o    Location  <xs:element name="LocationName" type="LocationNameType"/> 
·         Ethnicity <xs:element name="Code" type="CodeType"/> 
·         Nationality  <xs:element name="Country" substitutionGroup="CountryCode" type="CountryType"/> 
·         Disability    
·         Contact details (telephone number 
etc.) 
<xs:element name="TelephoneNumber" type="xs:string"/> 
<xs:element name="Email" type="r:EmailType"/> 
·         Next of kin  <xs:element minOccurs="0" name="FullName" type="r:InternationalStringType"/> 
·         Family   
o    Partner  
<xs:element minOccurs="0" name="FullName" type="r:InternationalStringType"/> 
o    Dependents  
·         Participant   
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o    Individual consenting for 
themselves 
<xs:element name="Note" type="NoteType"/> 
<xs:complexType name="NoteType"> 
<xs:sequence> 
<xs:element minOccurs="0" ref="TypeOfNote"/> 
<xs:element minOccurs="0" ref="NoteSubject"/> 
<xs:element maxOccurs="unbounded" ref="Relationship"/> 
<xs:element minOccurs="0" name="Responsibility" type="xs:string"/> 
<xs:element minOccurs="0" ref="Header"/> 
<xs:element minOccurs="0" ref="NoteContent"/> 
<xs:element minOccurs="0" ref="ProprietaryInfo"/> 
</xs:sequence> 
<xs:attribute ref="xml:lang" use="optional"/> 
</xs:complexType> 
o    Parent/guardian on behalf of a 
child 
·         Persons present   
o    Date <xs:element name="Date" type="DateType"/> 
o    Location <xs:element name="LocationName" type="LocationNameType"/> 
·         Interviewer   
o    Name 
<xs:element minOccurs="0" name="FullName" type="r:InternationalStringType"/> Forename  
Surname  
·         Witnesses    
o    Name 
<xs:element minOccurs="0" name="FullName" type="r:InternationalStringType"/> Forename 
Surname 
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Supplementary Table 26 Consent form cross-walk 
Consent form 
Consent form analyses Data Documentation Initiative 3.2 (XML source) 
 Description/aims   
         Method of collection <xs:element name="ModeOfCollection" type="ModeOfCollectionType"/> 
o    CAPI 
<xs:complexType name="ModeOfCollectionType"> 
<xs:complexContent> 
<xs:extension base="r:IdentifiableType"> 
<xs:sequence> 
<xs:element minOccurs="0" ref="TypeOfModeOfCollection"/> 
<xs:element minOccurs="0" ref="r:Description"/> 
</xs:sequence> 
</xs:extension> 
</xs:complexContent> 
</xs:complexType> 
o    CASI 
Undertakings   
 Declaration 
 
 
<xs:element name="Note" type="NoteType"/> 
<xs:complexType name="NoteType"> 
<xs:sequence> 
<xs:element minOccurs="0" ref="TypeOfNote"/> 
<xs:element minOccurs="0" ref="NoteSubject"/> 
<xs:element maxOccurs="unbounded" ref="Relationship"/> 
<xs:element minOccurs="0" name="Responsibility" type="xs:string"/> 
<xs:element minOccurs="0" ref="Header"/> 
<xs:element minOccurs="0" ref="NoteContent"/> 
<xs:element minOccurs="0" ref="ProprietaryInfo"/> 
</xs:sequence> 
<xs:attribute ref="xml:lang" use="optional"/> 
</xs:complexType> 
o    Rights of 
participants 
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Organisations <xs:element name="Organization" type="OrganizationType"/> 
o    Funding agencies <xs:element name="FundingInformation" type="FundingInformationType"/> 
o    Universities 
<xs:element name="Organization" type="OrganizationType"/> o    Governments 
o    Archive 
Questions/consent statements   
o    Logic <xs:element name="QuestionSequence" type="QuestionSequenceType"/> 
o    Purpose <xs:element name="QuestionIntent" type="r:StructuredStringType"/> 
o    Potential 
Reponses 
<xs:element name="ResponseText" type="DynamicTextType"/> 
<xs:element name="CodeList" type="CodeListType"/> 
<xs:element name="CodeListName" type="r:NameType"/> 
<xs:element name="CodeListReference" type="ReferenceType"/> 
o    Codes and 
categories 
<xs:element name="CodeList" type="CodeListType"/> 
<xs:element name="CodeListName" type="r:NameType"/> 
<xs:element name="CodeListReference" type="ReferenceType"/> 
Confirmatory information   
o    Confirmation of 
understanding 
<xs:element name="Note" type="NoteType"/> 
<xs:complexType name="NoteType"> 
<xs:sequence> 
<xs:element minOccurs="0" ref="TypeOfNote"/> 
<xs:element minOccurs="0" ref="NoteSubject"/> 
<xs:element maxOccurs="unbounded" ref="Relationship"/> 
<xs:element minOccurs="0" name="Responsibility" type="xs:string"/> 
<xs:element minOccurs="0" ref="Header"/> 
<xs:element minOccurs="0" ref="NoteContent"/> 
<xs:element minOccurs="0" ref="ProprietaryInfo"/> 
</xs:sequence> 
<xs:attribute ref="xml:lang" use="optional"/> 
</xs:complexType> 
o    Signature 
o    Date <xs:element name="Date" type="DateType"/> 
  
 
3
6
7
 
o    Full name <xs:element minOccurs="0" name="FullName" type="r:InternationalStringType"/> 
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Supplementary Table 27 Information document cross-walk 
Information document 
Information document analyses Data Documentation Initiative 3.2 (XML source) 
·         Study   
o    Aims 
<xs:element name="Citation" type="CitationType"/> o    Objectives 
o    Funding bodies <xs:element name="FundingInformation" type="FundingInformationType"/> 
o    Reviewers <xs:element name="Contributor" type="ContributorType"/> 
o    Contact details 
<xs:element name="TelephoneNumber" type="xs:string"/> 
<xs:element name="Email" type="r:EmailType"/> 
·         Participation   
o    Invitation process <xs:element name="EventType" type="CodeValueType"/> 
<xs:element name="LifecycleEvent" type="LifecycleEventType"/> 
o    Benefits and risks   
Immediate    
Future    
o    Consent process   
Coverage  <xs:element name="Coverage" type="CoverageType"/> 
Length of time <xs:element name="temporal" substitutionGroup="dc:coverage"/> 
Withdrawal 
<xs:element name="EventType" type="CodeValueType"/> 
<xs:element name="LifecycleEvent" type="LifecycleEventType"/> ·         Levels of withdrawal 
o    Visits <xs:element name="CodeListGroup" type="CodeListGroupType"/> 
 Prior <xs:element name="CodeList" type="CodeListType"/> 
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·         Preparation    
 During <xs:element name="CodeList" type="CodeListType"/> 
·         Biological samples   
o    Specify which ones   
o    How will these be taken   
o    Who will the samples be taken 
from   
·         Questionnaires to complete   
  Post <xs:element name="CodeList" type="CodeListType"/> 
·         Obtaining certain results    
o    Other people   
  GP 
<xs:element name="Contributor" type="ContributorType"/>  School teachers 
o    Expenses    
  travel   
·         Record linkage   
o    Definition   
o    How is it achieved   
o    Case studies/examples   
o    Data   
  Which records/registries will be linked to   
  How will the data be accessed   
·         Subsequent research   
o    Who will have access to the data   
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o    Getting to know results   
·         Confidentiality and security   
o    What safeguards are in place to protect participant 
confidentiality and data security   
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Supplementary Code 1 XML schema of combined consent elements 
<?xml version="1.0" encoding="utf-8"?> 
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema"> 
<xs:element name="consent form"> 
 <xs:complexType>  
  <xs:sequence> 
    <xs:element name="academicInstitutions" type="xs:string" minOccurs="1" 
maxOccurs="1"/> 
    <xs:element name="aim" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="archive" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="consentModel" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="fundingBodies" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="governanceFrameworks" type="xs:string" minOccurs="1" 
maxOccurs="1"/>        <xs:element name="methodOfCollection" 
type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="questions" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="regulatory" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="temporal" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="undertakings" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="version" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   </xs:sequence> 
  </xs:complexType> 
 </xs:element> 
 
 <xs:element name="participant information document"> 
  <xs:complexType> 
   <xs:sequence> 
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    <xs:element name="study" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="confidentialityAndSecurity" type="xs:string" minOccurs="1" 
maxOccurs="1"/> 
   <xs:element name="general" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="participationProcess" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="recordLinkage" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="visits" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="questionnaires" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="consentProcess" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="research" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   </xs:sequence> 
  </xs:complexType> 
 </xs:element> 
 
 <xs:element name="person"> 
  <xs:complexType> 
   <xs:sequence> 
    <xs:element name="confirmationOfUnderstanding" type="xs:string" minOccurs="1" 
maxOccurs="1"/> 
    <xs:element name="contactDetails" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="forename" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="surname" type="xs:string" minOccurs="1" maxOccurs="1"/> 
    <xs:element name="uniqueIdentifier" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   </xs:sequence> 
  </xs:complexType> 
 </xs:element> 
 
 <xs:element name="records"> 
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  <xs:complexType> 
   <xs:sequence> 
    <xs:element name="health" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="education" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="legal" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="family" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="mobile phone usage" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   <xs:element name="economic" type="xs:string" minOccurs="1" maxOccurs="1"/> 
   </xs:sequence> 
  </xs:complexType> 
 </xs:element> 
</xs:schema>  
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Supplementary Code 2 HTML report 
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-
transitional.dtd"> 
<html xmlns="http://www.w3.org/1999/xhtml"> 
<head> 
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /> 
<title>Consent form v1.0</title> 
<link href="css/ea.css" rel="stylesheet" type="text/css" /> 
<script language="JavaScript" src="js/displayToc.js" type="text/javascript"></script> 
</head> 
<body onload="initLoad(this,'toc.htm','./EARoot/EA1.htm')" onresize="resizePage()"> 
<div class="IndexTitle"> 
 Consent form v1.0 
</div> 
<div class="IndexHeader" id="IndexHeader"> 
 <img src="images/ea.gif" align="right" alt="Enterprise Architect" /> 
</div> 
<noscript> 
 <div class="NoScript"> 
  It appears that you may have Javascript disabled. 
 </div> 
</noscript> 
</body> 
</html>
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Appendix D: Grant proposal - Development a global metadata registry 
for epidemiological and public health research datasets derived from 
observational studies 
Project description: The aim of this project is to develop a novel 
registry to collate metadata for observational study research datasets. 
Currently, there is currently no known mandatory registration process for this 
kind of study so the registry would be the first of its kind. In essence, 
researchers and other stakeholders involved in observational studies would 
need to register their data by creating a metadata record. The intention is to 
build a public facing, searchable platform from which members of the 
academic community, public and study participants may in the short term 
discover and learn more about certain datasets. The longer term goal is to 
encourage stakeholders to collaborate even more as part of an enhanced 
research environment aiming to increase the repurposing and reuse of 
research data consistent with the philosophy of the RDL.  
The project will build on findings from the enhancing data 
discoverability study (Chapter 3) and directly address the recommendation 
develop a public health portal for the registering of observational studies 
worldwide (chapter Error! Reference source not found.). It will also partly 
address recommendation statements, 2: improve awareness of the 
implications associated with poor quality metadata; 4: investigate 
mechanisms to further integrate SWTs; and 6: increase identification of 
commonalities and links between studies through improved provision of 
openly available metadata and other associated research artefacts, all within 
epidemiological and public health research settings. The project will also 
serve as a proponent of improved recognition of data publications and other 
such published articles in formal academic reviews (recommendation 8, 
chapter Error! Reference source not found.) and other such settings.  
Project tasks: Initially the project will involve engaging with the wider 
scientific community to determine the requirements of the portal. This will 
help me to begin building conceptual models of what the portal will look 
which I can then circulate for comments.  
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The next stage will be to build the underlying metadata model for the 
portal. Ideally, users will not see the metadata schema and will instead be 
presented with a user interface with a list of questions they will need to 
answer. For example, Simple Dublin Core maybe used to capture basic 
descriptive metadata. The second step would be to build or reuse an 
ontology to enable users to classify their metadata. Thirdly, a more 
comprehensive metadata standard such as DDI will be incorporated to 
capture lower level metadata.  
Furthermore, as part of the user interface, advice on what constitutes 
good quality metadata will be provided as a means of supporting users. In 
doing so I will also be able to address in part recommendation statement 3: 
integrate metadata quality assessments into stakeholders’ work routines as 
supported by increased provision of training and guidance. 
The next stage is to run a pilot study to identify the strengths and 
weaknesses of the portal and determine how fit for purpose the registry is. 
Following these tests, the pilot portal will be extended to encompass all the 
envisioned functionality and made accessible globally. To encourage users 
to submit returns, this is something I will need to address with the input of the 
scientific community and the funder(s) involved. It may transpire that 
registration becomes a funder requirement and any unique identifiers 
assigned to a submission are to be included in any future publications along 
with details of where the data may be accessed / a request for access may 
be made.  
 
Deliverables: The following lists the project deliverables (non-exhaustive)  
 Report of findings from surveys conducted to engage with the wider scientific 
community and members of the public 
 Novel metadata schema 
 Ontology  
 Pilot and finalised portals 
 Provision of metadata quality assessment guidelines   
Related successful grant application: This study builds on the work 
completed during the ‘Enhancing Discoverability of Public Health and 
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Epidemiology Research Data’ study findings from which were published in 
July 2014 (Castillo, Gregory et al. 2014). A total of 14 people from six 
organisations (four academic institutions and two from industry) were 
involved in delivering this project. My role in this study as project manager 
and responsibilities are detailed in chapter 1.5.4.  
 
Related publications: 
 McMahon, C. and S. Denaxas. (2016). “A novel framework for assessing 
metadata quality in epidemiological and public health research settings”. 
AMIA Summits on Translational Science Proceedings. 2016;2016:199-208. 
 McMahon, C., T. Castillo, et al. (2015). "Improving metadata quality 
assessment in public health and epidemiology." Stud Health Technol Inform 
210: 939.  
 Castillo, T., A. Gregory, S. Moore, B. Hole, C. McMahon, S. Denaxas, V. 
Van den Eynden, H. L’Hours, L. Bell, J. Kneeshaw, M. Woollard, C. Kanjala, 
G. Knight, B. Zaba. (2014). “Enhancing Discoverability of Public Health and 
Epidemiology Research Data”. London, United Kingdom. 
 
Previous public engagement involving my project work: Posters 
were displayed at open day/evening events at UCL Institute of Child Health 
(Longitudinal studies and the Research Data Lifecycle: Application of the 
Data Documentation Initiative, 2012) and UCL Institute of Health Informatics 
(Improving metadata quality assessment in public health and epidemiology, 
2015) to disseminate my findings and encourage discussion and debate 
around my work.   
 
